Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23424.Total Lipids in VLDL,AGRP,Agouti-related protein,40516,0.268278632129279,0.00455466091310532,0.259351496739592,0.277205767518965,0
NMR metabolomics,X23424.Total Lipids in VLDL,CCL27,C-C motif chemokine 27,40359,0.211260865110159,0.00533630861541154,0.200801700223952,0.221720029996365,0
NMR metabolomics,X23424.Total Lipids in VLDL,CCN1,CCN family member 1,40280,0.380535696878448,0.00667833870399951,0.367446153018609,0.393625240738287,0
NMR metabolomics,X23424.Total Lipids in VLDL,CES1,Liver carboxylesterase 1,40352,0.276422806775358,0.00681604855801385,0.263063351601651,0.289782261949065,0
NMR metabolomics,X23424.Total Lipids in VLDL,F7,Coagulation factor VII,40376,0.114396551988056,0.00266382279255867,0.109175459314641,0.119617644661471,0
NMR metabolomics,X23424.Total Lipids in VLDL,FURIN,Furin,40411,0.122198844918789,0.00301456360314474,0.116290300256625,0.128107389580952,0
NMR metabolomics,X23424.Total Lipids in VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,37942,0.289640822239185,0.00665442194926439,0.276598155218626,0.302683489259743,0
NMR metabolomics,X23424.Total Lipids in VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,37987,0.0833761829882515,0.00196897861093131,0.0795169849108261,0.0872353810656769,0
NMR metabolomics,X23424.Total Lipids in VLDL,LDLR,Low-density lipoprotein receptor,40356,0.41915103744665,0.00363354677126368,0.412029285774973,0.426272789118327,0
NMR metabolomics,X23424.Total Lipids in VLDL,LPL,Lipoprotein lipase,40359,-0.166769448480747,0.00410563674246402,-0.174816496495977,-0.158722400465518,0
NMR metabolomics,X23424.Total Lipids in VLDL,MFGE8,Lactadherin,40332,0.210502953382826,0.00359952125827741,0.203447891716602,0.21755801504905,0
NMR metabolomics,X23424.Total Lipids in VLDL,NPY,Pro-neuropeptide Y,40489,0.346773640108159,0.00564082394621143,0.335717625173585,0.357829655042734,0
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,40332,0.155218897472003,0.00268539743679515,0.149955518495884,0.160482276448121,0
NMR metabolomics,X23424.Total Lipids in VLDL,PROC,Vitamin K-dependent protein C,40372,0.0923432724733665,0.0022561834421781,0.0879211529266974,0.0967653920200356,0
NMR metabolomics,X23424.Total Lipids in VLDL,RARRES2,Retinoic acid receptor responder protein 2,40424,0.168559301966643,0.00412171110411164,0.160480748202584,0.176637855730701,0
NMR metabolomics,X23424.Total Lipids in VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,40489,0.124686915446068,0.00294199112148997,0.118920612847948,0.130453218044189,0
NMR metabolomics,X23424.Total Lipids in VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40403,0.154213498206035,0.00376288390413825,0.146838245753924,0.161588750658146,0
NMR metabolomics,X23424.Total Lipids in VLDL,TFPI,Tissue factor pathway inhibitor,40309,0.112640466997275,0.00278687787897386,0.107178186354486,0.118102747640064,0
NMR metabolomics,X23424.Total Lipids in VLDL,GCG,Pro-glucagon,39980,0.431395786190819,0.011201918922644,0.409440025102437,0.453351547279201,1.14083632563956e-308
NMR metabolomics,X23424.Total Lipids in VLDL,GHR,Growth hormone receptor,37671,0.0975164616953803,0.002584587956475,0.0924506693006893,0.102582254090071,5.82508898264835e-296
NMR metabolomics,X23424.Total Lipids in VLDL,CCL23,C-C motif chemokine 23,40422,0.137072873963012,0.00369645835266567,0.129827815591787,0.144317932334236,8.22535095966315e-289
NMR metabolomics,X23424.Total Lipids in VLDL,PTH,Parathyroid hormone,37572,0.262655108406348,0.00707300480356379,0.248792018991363,0.276518197821334,4.18967909014352e-287
NMR metabolomics,X23424.Total Lipids in VLDL,NRP1,Neuropilin-1,40424,-0.0907853407415608,0.00254787577787693,-0.0957791772661996,-0.0857915042169221,1.2038700118121e-267
NMR metabolomics,X23424.Total Lipids in VLDL,APCS,Serum amyloid P-component,37882,0.114590495777123,0.00323749609611034,0.108245003428747,0.1209359881255,1.91662869477067e-262
NMR metabolomics,X23424.Total Lipids in VLDL,SMAD1,Mothers against decapentaplegic homolog 1,39980,0.256670196503959,0.00727516590238582,0.242410871335282,0.270929521672635,2.36567284277332e-262
NMR metabolomics,X23424.Total Lipids in VLDL,TMPRSS15,Enteropeptidase,40305,0.293349126769901,0.00833372366620271,0.277015028384144,0.309683225155658,2.04417129229076e-261
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB1,DnaJ homolog subfamily B member 1,40305,0.278322747497311,0.00795091767809667,0.262738948848241,0.29390654614638,1.18315252381945e-258
NMR metabolomics,X23424.Total Lipids in VLDL,IGSF9,Protein turtle homolog A,37990,0.250792184967897,0.00718867413744513,0.236702383658505,0.26488198627729,1.9875003116765e-255
NMR metabolomics,X23424.Total Lipids in VLDL,INHBC,Inhibin beta C chain,40332,0.133607499012951,0.00386303778038813,0.126035944963391,0.141179053062512,8.81107457908355e-253
NMR metabolomics,X23424.Total Lipids in VLDL,ADIPOQ,Adiponectin,38013,-0.208276058672675,0.00600406868413645,-0.220044033293582,-0.196508084051767,1.06798303648248e-252
NMR metabolomics,X23424.Total Lipids in VLDL,PRAP1,Proline-rich acidic protein 1,37998,0.132725028079935,0.00382790086767229,0.125222342379298,0.140227713780573,1.83181503035589e-252
NMR metabolomics,X23424.Total Lipids in VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40489,0.107921709213786,0.0031513152404346,0.101745131342534,0.114098287085038,3.8743277939428e-248
NMR metabolomics,X23424.Total Lipids in VLDL,CD4,T-cell surface glycoprotein CD4,40309,0.0946860333396151,0.00276963543454222,0.0892575478879123,0.100114518791318,3.21293919651057e-247
NMR metabolomics,X23424.Total Lipids in VLDL,SLC39A5,Zinc transporter ZIP5,40341,0.165689532604096,0.00485928902954685,0.156165326106184,0.175213739102008,5.36942576904226e-246
NMR metabolomics,X23424.Total Lipids in VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,40305,0.3210901117071,0.00951815086471438,0.30243453601226,0.33974568740194,5.4723646426609e-241
NMR metabolomics,X23424.Total Lipids in VLDL,TTR,Transthyretin,37871,0.0780470521408285,0.00231250530111175,0.0735145417506494,0.0825795625310075,9.68007637134649e-240
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G10,Group 10 secretory phospholipase A2,40228,-0.18307564647998,0.00544247445228077,-0.19374289640645,-0.17240839655351,1.23516957748447e-239
NMR metabolomics,X23424.Total Lipids in VLDL,CPM,Carboxypeptidase M,40415,0.104567668071046,0.00311369359586943,0.0984648286231421,0.11067050751895,5.62227792616656e-239
NMR metabolomics,X23424.Total Lipids in VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,40411,0.0963157838010492,0.00287915411536886,0.0906726417349263,0.101958925867172,3.35883620566993e-237
NMR metabolomics,X23424.Total Lipids in VLDL,GPR37,Prosaposin receptor GPR37,40042,0.20374828109351,0.00610085891376115,0.191790597622538,0.215705964564482,2.96343671240953e-236
NMR metabolomics,X23424.Total Lipids in VLDL,DSG2,Desmoglein-2,40332,-0.0816558358265267,0.00245019027737163,-0.0864582087701751,-0.0768534628828783,1.90668844544659e-235
NMR metabolomics,X23424.Total Lipids in VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,40305,0.204043116118763,0.00613607423857396,0.192016410611158,0.216069821626368,1.92581526108342e-234
NMR metabolomics,X23424.Total Lipids in VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,40305,0.238610011743468,0.00718998739437165,0.2245176364505,0.252702387036436,1.52709794744066e-233
NMR metabolomics,X23424.Total Lipids in VLDL,PAMR1,Inactive serine protease PAMR1,40332,0.0826270571644161,0.00254416625582753,0.0776404913029941,0.087613623025838,4.47988034953266e-224
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,40141,0.436785979821076,0.0134743074298956,0.41037633725848,0.463195622383671,3.47337367050842e-223
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL6,C-X-C motif chemokine 6,40516,0.229268158719049,0.00707917367461489,0.215392978316804,0.243143339121294,5.91965066719229e-223
NMR metabolomics,X23424.Total Lipids in VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,40311,0.0558852212925582,0.00172664838583197,0.0525009904563275,0.0592694521287888,1.3323182652439e-222
NMR metabolomics,X23424.Total Lipids in VLDL,CFP,Properdin,38013,0.0637271665780781,0.00198730709932267,0.0598320446634057,0.0676222884927505,1.51342717203942e-217
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA5,Plasma serine protease inhibitor,37835,0.0937998298075205,0.00299548690771422,0.0879286754684007,0.0996709841466404,8.64295504102439e-208
NMR metabolomics,X23424.Total Lipids in VLDL,P4HB,Protein disulfide-isomerase,40266,0.109622661445307,0.0035282340896492,0.102707322629594,0.116538000261019,8.86187208722671e-206
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN3,Contactin-3,40332,0.0989626795927625,0.00319365335625699,0.0927031190144988,0.105222240171026,9.46941421552799e-205
NMR metabolomics,X23424.Total Lipids in VLDL,SERPIND1,Heparin cofactor 2,37981,0.077225283135676,0.00249159375633745,0.0723417593732546,0.0821088068980974,7.87144741061838e-204
NMR metabolomics,X23424.Total Lipids in VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40330,0.290910110043955,0.00941383578890113,0.272458991897709,0.309361228190202,1.13297616606699e-203
NMR metabolomics,X23424.Total Lipids in VLDL,CFI,Complement factor I,38013,0.0564328927017264,0.00183121126358429,0.0528437186251012,0.0600220667783516,1.26719153827342e-201
NMR metabolomics,X23424.Total Lipids in VLDL,AGR3,Anterior gradient protein 3,39963,0.166657372515209,0.00543695314560772,0.156000944349817,0.1773138006806,2.18521136186612e-200
NMR metabolomics,X23424.Total Lipids in VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,39887,0.0514544554487682,0.00168917875004758,0.0481436650986749,0.0547652457988614,5.84076862643475e-198
NMR metabolomics,X23424.Total Lipids in VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40042,0.233344252515711,0.00768697971764561,0.218277772269126,0.248410732762296,1.0632745336026e-196
NMR metabolomics,X23424.Total Lipids in VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40471,0.144145732284929,0.00477301878899245,0.134790615458504,0.153500849111354,6.57161869661637e-195
NMR metabolomics,X23424.Total Lipids in VLDL,GUSB,Beta-glucuronidase,40419,0.161389327117412,0.00534479370631697,0.15091353145303,0.171865122781793,7.77506994806983e-195
NMR metabolomics,X23424.Total Lipids in VLDL,CFH,Complement factor H,37301,0.0637686501012962,0.00210602903776455,0.0596408331872777,0.0678964670153147,1.35385886831476e-194
NMR metabolomics,X23424.Total Lipids in VLDL,CHMP6,Charged multivesicular body protein 6,37990,0.153873973560749,0.0050875611123042,0.143902353780633,0.163845593340865,1.65541134676126e-194
NMR metabolomics,X23424.Total Lipids in VLDL,CRIP2,Cysteine-rich protein 2,40228,0.098567798020865,0.00330836195805808,0.0920834085830712,0.105052187458659,8.22127140459501e-190
NMR metabolomics,X23424.Total Lipids in VLDL,SNCA,Alpha-synuclein,37671,0.310030790823144,0.0103958042185527,0.289655014554781,0.330406567091507,3.39970096266264e-189
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA4,Kallistatin,37781,0.064986632994111,0.00218880440384593,0.060696576362573,0.069276689625649,1.21941192159243e-187
NMR metabolomics,X23424.Total Lipids in VLDL,F9,Coagulation factor IX,40372,0.0482372595033358,0.00164487432149574,0.0450133058332041,0.0514612131734674,3.69709478918891e-184
NMR metabolomics,X23424.Total Lipids in VLDL,FLI1,Friend leukemia integration 1 transcription factor,39980,0.290061991327262,0.00995543589478523,0.270549336973483,0.309574645681041,9.39153978690718e-182
NMR metabolomics,X23424.Total Lipids in VLDL,SYAP1,Synapse-associated protein 1,37671,0.150187699806676,0.00516720786468975,0.140059972391884,0.160315427221468,4.24430164043373e-180
NMR metabolomics,X23424.Total Lipids in VLDL,ASGR1,Asialoglycoprotein receptor 1,40228,0.077943075543101,0.00268926498839973,0.0726721161658376,0.0832140349203645,5.41673282948894e-180
NMR metabolomics,X23424.Total Lipids in VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,40443,0.0816971734156083,0.00282612955228715,0.0761579594931255,0.0872363873380912,3.73695138244703e-179
NMR metabolomics,X23424.Total Lipids in VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,39980,0.155086338297225,0.00537019734620916,0.144560751498655,0.165611925095795,1.11473926453454e-178
NMR metabolomics,X23424.Total Lipids in VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40228,0.195316395657883,0.00678484127789053,0.182018106753217,0.208614684562548,1.17543143522154e-177
NMR metabolomics,X23424.Total Lipids in VLDL,GSTA1,Glutathione S-transferase A1,40333,0.217935714431144,0.0075818886675608,0.203075212642725,0.232796216219563,3.55793878980068e-177
NMR metabolomics,X23424.Total Lipids in VLDL,BCHE,Cholinesterase,37748,0.0744924122843856,0.00258772043814243,0.0694204802256265,0.0795643443431448,7.83010294914736e-177
NMR metabolomics,X23424.Total Lipids in VLDL,IGSF8,Immunoglobulin superfamily member 8,40359,0.0783063931196534,0.00274058116946407,0.0729348540275038,0.083677932211803,3.75242092236003e-175
NMR metabolomics,X23424.Total Lipids in VLDL,F10,Coagulation factor X,37987,0.0675763689978777,0.00237669067843468,0.0629180552681457,0.0722346827276097,8.9928838950606e-173
NMR metabolomics,X23424.Total Lipids in VLDL,LATS1,Serine/threonine-protein kinase LATS1,37598,0.219133438162881,0.00772705607898341,0.203988408248073,0.234278468077688,9.02406990416204e-172
NMR metabolomics,X23424.Total Lipids in VLDL,GSTA3,Glutathione S-transferase A3,39980,0.194220311325002,0.00694570165912739,0.180606736073113,0.207833886576892,6.49135491236391e-168
NMR metabolomics,X23424.Total Lipids in VLDL,ERP44,Endoplasmic reticulum resident protein 44,40280,0.0655583332068656,0.00235151880854759,0.0609493563421123,0.0701673100716189,5.04241346056179e-167
NMR metabolomics,X23424.Total Lipids in VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37901,0.357330371983012,0.0127917330930575,0.33225857512062,0.382402168845405,5.66861042544511e-167
NMR metabolomics,X23424.Total Lipids in VLDL,KYNU,Kynureninase,40516,0.113944859015588,0.00409530258239668,0.105918065954091,0.121971652077086,1.95198152609613e-166
NMR metabolomics,X23424.Total Lipids in VLDL,ACY1,Aminoacylase-1,40359,0.151808532540419,0.00546200747298095,0.141102997893377,0.162514067187462,4.69193239606446e-166
NMR metabolomics,X23424.Total Lipids in VLDL,SNAPIN,SNARE-associated protein Snapin,37959,0.146299057126297,0.00525930786078858,0.135990813719152,0.156607300533443,1.19804767111841e-165
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINF1,Pigment epithelium-derived factor,37790,0.0660460557742165,0.00237542103624104,0.0613902305431841,0.0707018810052489,1.93403800807103e-165
NMR metabolomics,X23424.Total Lipids in VLDL,PLAT,Tissue-type plasminogen activator,40490,0.12486993067022,0.00450209561549076,0.116045823263858,0.133694038076582,2.01098286954497e-165
NMR metabolomics,X23424.Total Lipids in VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40042,0.138731924574487,0.00500028154028461,0.12893137275553,0.148532476393445,2.04091440393157e-165
NMR metabolomics,X23424.Total Lipids in VLDL,SMAD2,Mothers against decapentaplegic homolog 2,37900,0.173005966214514,0.00622669680041736,0.160801640485695,0.185210291943332,2.95829448569659e-165
NMR metabolomics,X23424.Total Lipids in VLDL,NCS1,Neuronal calcium sensor 1,40489,0.0725514744349414,0.00262618312082036,0.0674041555181335,0.0776987933517493,3.6687811663511e-164
NMR metabolomics,X23424.Total Lipids in VLDL,UPB1,Beta-ureidopropionase,37990,0.230697433108046,0.00838197650335308,0.214268759161474,0.247126107054618,2.61802772031551e-162
NMR metabolomics,X23424.Total Lipids in VLDL,RBP5,Retinol-binding protein 5,40305,0.139433579544128,0.00508226715122367,0.129472335927729,0.149394823160526,6.14862203621621e-162
NMR metabolomics,X23424.Total Lipids in VLDL,NUMB,Protein numb homolog,37598,0.210451168540532,0.00765769301267432,0.195442090235691,0.225460246845374,1.01447589611037e-161
NMR metabolomics,X23424.Total Lipids in VLDL,GLA,Alpha-galactosidase A,37642,0.0910596040970666,0.00332109035259244,0.0845502670059854,0.0975689411881477,5.14403515778307e-161
NMR metabolomics,X23424.Total Lipids in VLDL,GRP,Gastrin-releasing peptide,37628,0.136909310992882,0.00499576014981442,0.127117621099245,0.146701000886518,7.37892685385081e-161
NMR metabolomics,X23424.Total Lipids in VLDL,AFM,Afamin,38013,0.0467892135265175,0.00171113385934351,0.0434353911622043,0.0501430358908308,2.71947377852978e-160
NMR metabolomics,X23424.Total Lipids in VLDL,STAB2,Stabilin-2,37998,0.0698894191882235,0.00256802522016012,0.0648560897567097,0.0749227486197373,7.70708099355349e-159
NMR metabolomics,X23424.Total Lipids in VLDL,CREG1,Protein CREG1,40145,0.0899634128362811,0.00331445802386481,0.0834670751095061,0.0964597505630561,1.38354027719373e-158
NMR metabolomics,X23424.Total Lipids in VLDL,NOS3,"Nitric oxide synthase, endothelial",39961,0.135868913248764,0.00503234679734523,0.126005513525967,0.14573231297156,6.2712592775691e-157
NMR metabolomics,X23424.Total Lipids in VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,40490,0.0519398397843461,0.00192894237665175,0.0481591127261087,0.0557205668425836,3.12661716474568e-156
NMR metabolomics,X23424.Total Lipids in VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39980,0.166771107012024,0.00619442258664494,0.154630038742199,0.178912175281848,4.44653485396168e-156
NMR metabolomics,X23424.Total Lipids in VLDL,AMBP,Protein AMBP,40470,0.0495101737734114,0.00184200746666128,0.0458998391387553,0.0531205084080675,1.09382306352603e-155
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL17,C-X-C motif chemokine 17,40516,0.102194934231753,0.00380872566948374,0.0947298319195646,0.109660036543941,3.54881080679614e-155
NMR metabolomics,X23424.Total Lipids in VLDL,KLKB1,Plasma kallikrein,37721,0.0622340853444092,0.00231482332829089,0.0576970316209591,0.0667711390678594,4.50882338406543e-155
NMR metabolomics,X23424.Total Lipids in VLDL,ENO3,Beta-enolase,37628,0.140027413655537,0.00521641871500145,0.129803232974134,0.15025159433694,1.3841725069856e-154
NMR metabolomics,X23424.Total Lipids in VLDL,LAT2,Linker for activation of T-cells family member 2,40305,0.30107196829917,0.0112421775803799,0.279037300241626,0.323106636356715,1.46341683095566e-154
NMR metabolomics,X23424.Total Lipids in VLDL,FGFR2,Fibroblast growth factor receptor 2,40411,0.0525329557091157,0.00196734418907752,0.0486769610985238,0.0563889503197077,1.02942049271894e-153
NMR metabolomics,X23424.Total Lipids in VLDL,KDR,Vascular endothelial growth factor receptor 2,40411,0.0620250508882228,0.00232454953049998,0.0574689338084428,0.0665811679680027,1.71124907211329e-153
NMR metabolomics,X23424.Total Lipids in VLDL,CD300LG,CMRF35-like molecule 9,40332,-0.0925375234585727,0.00346898084701339,-0.099336725918719,-0.0857383209984265,2.11928319605111e-153
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,40497,-0.155586305086809,0.00584468052390098,-0.167041878913655,-0.144130731259963,8.11042124806257e-153
NMR metabolomics,X23424.Total Lipids in VLDL,CCL22,C-C motif chemokine 22,40204,0.125929110222739,0.00473468377520444,0.116649130023339,0.13520909042214,1.67333237669564e-152
NMR metabolomics,X23424.Total Lipids in VLDL,NAA80,N-alpha-acetyltransferase 80,37572,0.290430932315119,0.0109191134537757,0.269029469945719,0.311832394684519,7.25371953203179e-152
NMR metabolomics,X23424.Total Lipids in VLDL,PROS1,Vitamin K-dependent protein S,38013,0.0609941883091599,0.00230804188648795,0.0564704262116435,0.0655179504066763,4.12565147884253e-150
NMR metabolomics,X23424.Total Lipids in VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40160,0.111424537683717,0.00423686687616863,0.103120278606426,0.119728796761007,3.29746507884426e-149
NMR metabolomics,X23424.Total Lipids in VLDL,SOST,Sclerostin,40330,0.0935094207028254,0.00355783857381391,0.0865360570981502,0.100482784307501,4.58870386415376e-149
NMR metabolomics,X23424.Total Lipids in VLDL,IL16,Pro-interleukin-16,40516,0.0973284830881126,0.00371697472933315,0.0900432126186196,0.104613753557606,4.96274974477529e-148
NMR metabolomics,X23424.Total Lipids in VLDL,ATRN,"Attractin, Isoform 2",38013,0.039473239705443,0.00150471019817025,0.0365240077170293,0.0424224716938567,5.31718779538482e-148
NMR metabolomics,X23424.Total Lipids in VLDL,DTYMK,Thymidylate kinase,37990,0.166304359648298,0.00637266179861545,0.153813942523011,0.178794776773584,1.62648515374376e-146
NMR metabolomics,X23424.Total Lipids in VLDL,SORT1,Sortilin,40330,0.0870270064208052,0.00334423840967613,0.0804722991378399,0.0935817137037704,3.11507761870659e-146
NMR metabolomics,X23424.Total Lipids in VLDL,CDHR5,Cadherin-related family member 5,40359,0.0931380783573338,0.00358630917965238,0.0861089123652151,0.100167244349452,1.14183990956505e-145
NMR metabolomics,X23424.Total Lipids in VLDL,SNAP29,Synaptosomal-associated protein 29,40411,0.217766310394213,0.00839708690099294,0.201308020068266,0.234224600720159,2.8031389765817e-145
NMR metabolomics,X23424.Total Lipids in VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,40536,0.0933890956171574,0.00360268566593387,0.086327831711927,0.100450359522388,3.54141068426198e-145
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINF2,Alpha-2-antiplasmin,37755,0.0324402248817327,0.0012492224370961,0.0299917489050244,0.0348887008584411,4.50885166892282e-145
NMR metabolomics,X23424.Total Lipids in VLDL,SKAP1,Src kinase-associated phosphoprotein 1,40192,0.175169458446363,0.00675947390914255,0.161920889584444,0.188418027308283,4.92725270215034e-145
NMR metabolomics,X23424.Total Lipids in VLDL,EEF1D,Elongation factor 1-delta,37990,0.218387331304125,0.00843334363391099,0.201857977781659,0.23491668482659,2.36593748387419e-144
NMR metabolomics,X23424.Total Lipids in VLDL,PLTP,Phospholipid transfer protein,40461,-0.0813173541567227,0.00315174960065749,-0.0874947833740114,-0.075139924939434,7.46844978119889e-144
NMR metabolomics,X23424.Total Lipids in VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,37920,0.197623357861349,0.00766279861682285,0.182604272572377,0.212642443150322,3.34100236598668e-143
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL2,Angiopoietin-related protein 2,40377,0.094500886331012,0.00367258171949782,0.0873026261607962,0.101699146501228,4.29767623282852e-143
NMR metabolomics,X23424.Total Lipids in VLDL,CCL16,C-C motif chemokine 16,40536,0.125144343135795,0.0048738384122547,0.115591619847775,0.134697066423814,1.55827581404947e-142
NMR metabolomics,X23424.Total Lipids in VLDL,FGF21,Fibroblast growth factor 21,40453,0.276511643639338,0.0107965765437016,0.255350353613683,0.297672933664993,8.14778871771985e-142
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,40403,0.0641803039842458,0.00250609630777092,0.0592683552210148,0.0690922527474768,8.59936911864082e-142
NMR metabolomics,X23424.Total Lipids in VLDL,NOMO1,Nodal modulator 1,40332,0.0557782974839355,0.0021823186564819,0.0515009529172309,0.06005564205064,3.06502739530394e-141
NMR metabolomics,X23424.Total Lipids in VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40305,0.0976812955532924,0.00382511570900205,0.0901840687636483,0.105178522342936,5.36907899161674e-141
NMR metabolomics,X23424.Total Lipids in VLDL,IL1RN,Interleukin-1 receptor antagonist protein,40313,0.129678525349458,0.00507812594774299,0.119725398491882,0.139631652207034,5.36917899865833e-141
NMR metabolomics,X23424.Total Lipids in VLDL,AP1G2,AP-1 complex subunit gamma-like 2,37900,0.187582080903708,0.00734056788278301,0.173194567853454,0.201969593953963,1.09368906822671e-140
NMR metabolomics,X23424.Total Lipids in VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,40536,-0.0811346489692276,0.00318911235076625,-0.0873853091767295,-0.0748839887617258,5.1255719753126e-140
NMR metabolomics,X23424.Total Lipids in VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,37942,0.0863868879777369,0.00339115009743517,0.079740233786764,0.0930335421687098,7.50249052671167e-140
NMR metabolomics,X23424.Total Lipids in VLDL,ABL1,Tyrosine-protein kinase ABL1,40305,0.159041773042833,0.00626150867954722,0.146769216030921,0.171314330054746,1.5378895368761e-139
NMR metabolomics,X23424.Total Lipids in VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,40203,0.207067356071686,0.00819814059253217,0.190999000510323,0.223135711633049,5.11012570633263e-138
NMR metabolomics,X23424.Total Lipids in VLDL,DPY30,Protein dpy-30 homolog,40414,0.138289849208488,0.00548278647433373,0.127543587718794,0.149036110698182,1.11113355884622e-137
NMR metabolomics,X23424.Total Lipids in VLDL,C9,Complement component C9,37987,-0.113079900896917,0.00448807028208855,-0.121876518649811,-0.104283283144023,6.24082655235921e-137
NMR metabolomics,X23424.Total Lipids in VLDL,BPIFB1,BPI fold-containing family B member 1,40261,-0.142780959261108,0.00568198030547024,-0.153917640659829,-0.131644277862386,1.14525074970217e-136
NMR metabolomics,X23424.Total Lipids in VLDL,YES1,Tyrosine-protein kinase Yes,40305,0.262358585930842,0.0104635474111059,0.241850033005074,0.282867138856609,4.27395341563094e-136
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,40500,-0.271163375319838,0.0108173789895569,-0.29236543813937,-0.249961312500307,4.61874885930314e-136
NMR metabolomics,X23424.Total Lipids in VLDL,FAM20A,Pseudokinase FAM20A,37990,0.0653950943900415,0.00260783467884633,0.0602837384195027,0.0705064503605804,1.09757822866142e-135
NMR metabolomics,X23424.Total Lipids in VLDL,F11R,Junctional adhesion molecule A,40332,0.130443928460316,0.00521372662847943,0.120225024268496,0.140662832652136,1.56696301307363e-135
NMR metabolomics,X23424.Total Lipids in VLDL,MYH9,Myosin-9,37998,0.258675555246855,0.0103583553347865,0.238373178790673,0.278977931703037,1.31249586103194e-134
NMR metabolomics,X23424.Total Lipids in VLDL,COL4A1,Collagen alpha-1(IV) chain,40359,-0.0910485063050264,0.00365657135189749,-0.0982153861547455,-0.0838816264553073,2.74025818664361e-134
NMR metabolomics,X23424.Total Lipids in VLDL,FYB1,FYN-binding protein 1,40311,0.209033950111868,0.00843450306797847,0.19250232409863,0.225565576125106,4.57001746356179e-133
NMR metabolomics,X23424.Total Lipids in VLDL,CDHR2,Cadherin-related family member 2,40305,0.175602303239347,0.00708967594462918,0.161706538387874,0.18949806809082,6.47001609587593e-133
NMR metabolomics,X23424.Total Lipids in VLDL,MLN,Promotilin,40341,0.202737639376358,0.00818872487246887,0.186687738626319,0.218787540126397,8.22561650238285e-133
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL13,C-X-C motif chemokine 13,40471,0.144662318435151,0.00585230917049804,0.133191792460975,0.156132844409327,2.00750639918838e-132
NMR metabolomics,X23424.Total Lipids in VLDL,FCN2,Ficolin-2,40291,0.0933231299312659,0.00378526691228493,0.0859040067831875,0.100742253079344,9.94200783547782e-132
NMR metabolomics,X23424.Total Lipids in VLDL,MTSS1,Protein MTSS 1,37901,0.251424883960275,0.0102131527807588,0.231407104509988,0.271442663410562,6.30703878626946e-131
NMR metabolomics,X23424.Total Lipids in VLDL,SELPLG,P-selectin glycoprotein ligand 1,40341,0.0626875141093004,0.00255349541583335,0.0576826630942671,0.0676923651243338,1.17064966522672e-130
NMR metabolomics,X23424.Total Lipids in VLDL,HEG1,Protein HEG homolog 1,37671,0.0597708242959841,0.00243731198590685,0.0549936928036067,0.0645479557883615,6.52430121963841e-130
NMR metabolomics,X23424.Total Lipids in VLDL,YTHDF3,YTH domain-containing family protein 3,40044,0.191510987633655,0.00782279657130867,0.17617830635389,0.20684366891342,6.5678842314634e-130
NMR metabolomics,X23424.Total Lipids in VLDL,IL18R1,Interleukin-18 receptor 1,40516,0.0735504305018312,0.00300599634918774,0.0676586776574232,0.0794421833462392,7.64053624537837e-130
NMR metabolomics,X23424.Total Lipids in VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37562,0.154003579869699,0.00628274401037809,0.141689401609358,0.16631775813004,8.93523010735758e-130
NMR metabolomics,X23424.Total Lipids in VLDL,MXRA8,Matrix remodeling-associated protein 8,37671,-0.0683877983048505,0.00281464113428385,-0.0739044949280468,-0.0628711016816541,1.29368421321767e-127
NMR metabolomics,X23424.Total Lipids in VLDL,CANT1,Soluble calcium-activated nucleotidase 1,40312,0.0453699210734448,0.00187818946268144,0.0416886697265892,0.0490511724203005,1.23349124577579e-126
NMR metabolomics,X23424.Total Lipids in VLDL,MAPK9,Mitogen-activated protein kinase 9,40341,0.0956341803422048,0.00396555842592703,0.0878616858273878,0.103406674857022,3.10651815814194e-126
NMR metabolomics,X23424.Total Lipids in VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37942,0.0893831812924765,0.00371196274321574,0.0821077343157736,0.0966586282691794,1.77805973237979e-125
NMR metabolomics,X23424.Total Lipids in VLDL,TJAP1,Tight junction-associated protein 1,40411,0.183136400237391,0.00762249965879157,0.16819630090616,0.198076499568623,2.49087448406248e-125
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37628,0.187325419194424,0.00779516701460176,0.172046891845804,0.202603946543043,6.31283593540554e-125
NMR metabolomics,X23424.Total Lipids in VLDL,SARG,Specifically androgen-regulated gene protein,37931,0.240970317604898,0.0100309674844715,0.221309621335334,0.260631013874462,6.68558247954071e-125
NMR metabolomics,X23424.Total Lipids in VLDL,EHBP1,EH domain-binding protein 1,37990,0.16556151870391,0.00689374660111662,0.152049775365722,0.179073262042099,7.5631031248682e-125
NMR metabolomics,X23424.Total Lipids in VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37671,0.0471094887192108,0.00196179429615725,0.0432643718987425,0.050954605539679,9.26792191443068e-125
NMR metabolomics,X23424.Total Lipids in VLDL,DKK1,Dickkopf-related protein 1,40471,0.132102304273667,0.00551155763211401,0.121299651314724,0.142904957232611,9.28994061252918e-125
NMR metabolomics,X23424.Total Lipids in VLDL,SCLY,Selenocysteine lyase,40434,0.105483796408978,0.00440646207043174,0.0968471307509315,0.114120462067024,1.87397549081817e-124
NMR metabolomics,X23424.Total Lipids in VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37990,0.159243033638633,0.00671093444330946,0.146089602129747,0.17239646514752,5.52060434202904e-122
NMR metabolomics,X23424.Total Lipids in VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40341,0.208370248257624,0.00880188040465035,0.191118562664509,0.225621933850738,8.62726149294733e-122
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40411,0.0755480680795159,0.00319171240483328,0.0692923117660427,0.0818038243929891,9.11452567423505e-122
NMR metabolomics,X23424.Total Lipids in VLDL,CES2,Cocaine esterase,40305,0.116919606966587,0.00494751721884782,0.107222473217645,0.126616740715528,2.24945778786114e-121
NMR metabolomics,X23424.Total Lipids in VLDL,CCL17,C-C motif chemokine 17,40333,0.197247686475784,0.00836786286023935,0.180846675269714,0.213648697681853,8.76922082073977e-121
NMR metabolomics,X23424.Total Lipids in VLDL,ADH1B,All-trans-retinol dehydrogenase,37671,0.161162466581186,0.00682797109859332,0.147779643227944,0.174545289934429,1.09925487072791e-120
NMR metabolomics,X23424.Total Lipids in VLDL,CPB2,Carboxypeptidase B2,37981,0.0486806274105739,0.00206484617533619,0.044633528906915,0.0527277259142328,1.80020390705516e-120
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37990,0.0632272259107536,0.0026841331809209,0.0579663248761486,0.0684881269453585,2.82250374657761e-120
NMR metabolomics,X23424.Total Lipids in VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37901,0.0651089245759966,0.00276674291791194,0.0596861084568892,0.070531740695104,4.95034839991768e-120
NMR metabolomics,X23424.Total Lipids in VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,40411,0.0526659487919307,0.0022422568876255,0.0482711252921847,0.0570607722916767,5.8273653327887e-120
NMR metabolomics,X23424.Total Lipids in VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37628,0.124294954056407,0.00528834750019476,0.113929792956025,0.134660115156788,1.07052321270492e-119
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,37628,0.156912805348008,0.00668683362955986,0.14380661143407,0.170018999261945,2.50332457486749e-119
NMR metabolomics,X23424.Total Lipids in VLDL,SHBG,Sex hormone-binding globulin,37987,-0.116864638853874,0.00498580197878794,-0.126636810732298,-0.107092466975449,3.93400804080673e-119
NMR metabolomics,X23424.Total Lipids in VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37922,0.180979320048775,0.00774946079527572,0.165790376890034,0.196168263207515,2.78091645398149e-118
NMR metabolomics,X23424.Total Lipids in VLDL,SORD,Sorbitol dehydrogenase,40417,0.144094098237237,0.00618502240519795,0.131971454323049,0.156216742151425,4.37387859449422e-118
NMR metabolomics,X23424.Total Lipids in VLDL,TXLNA,Alpha-taxilin,40228,0.191898565966105,0.00824574715387141,0.175736901544517,0.208060230387693,8.07498258253517e-118
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40516,0.0555823516231775,0.00239680510503852,0.0508846136173021,0.060280089629053,4.7500546450155e-117
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJA2,DnaJ homolog subfamily A member 2,40471,0.175944603997132,0.00759260313274623,0.16106310185695,0.190826106137315,7.04878771408877e-117
NMR metabolomics,X23424.Total Lipids in VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,37900,0.109531862682358,0.00472768948859975,0.100265591284702,0.118798134080013,1.7948221544895e-116
NMR metabolomics,X23424.Total Lipids in VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39980,0.13170163454721,0.00570063183901838,0.120528396142734,0.142874872951686,3.89339936293049e-116
NMR metabolomics,X23424.Total Lipids in VLDL,EPHA1,Ephrin type-A receptor 1,40400,0.0728103200434363,0.00315713324886607,0.0666223388756588,0.0789983012112137,8.64458968354975e-116
NMR metabolomics,X23424.Total Lipids in VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40228,0.115801840400547,0.00502377782717386,0.105955235859286,0.125648444941808,1.16864809275344e-115
NMR metabolomics,X23424.Total Lipids in VLDL,KHK,Ketohexokinase,37628,0.137182435747456,0.00596183746004093,0.125497234325775,0.148867637169136,6.69816937420353e-115
NMR metabolomics,X23424.Total Lipids in VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40305,0.206429623222849,0.0089893652781839,0.188810467277609,0.224048779168089,7.96721301594757e-115
NMR metabolomics,X23424.Total Lipids in VLDL,FN1,Fibronectin,38013,0.0557192471301814,0.00242491988519389,0.0509664041552014,0.0604720901051614,1.18775228663208e-114
NMR metabolomics,X23424.Total Lipids in VLDL,CTBS,Di-N-acetylchitobiase,37819,0.0575954882288876,0.00250637842635277,0.0526829865132362,0.062507989944539,1.22552677635194e-114
NMR metabolomics,X23424.Total Lipids in VLDL,BTD,Biotinidase,38013,0.0439048712248049,0.00191108571569373,0.0401591432220452,0.0476505992275646,1.29735946433582e-114
NMR metabolomics,X23424.Total Lipids in VLDL,TARBP2,RISC-loading complex subunit TARBP2,39961,0.167232942017219,0.00730069044179555,0.152923588751299,0.181542295283138,3.12594819678356e-114
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40305,0.0962605286412971,0.00420560281884655,0.0880175471163578,0.104503510166236,4.23273840096075e-114
NMR metabolomics,X23424.Total Lipids in VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,37671,0.176137219138272,0.00768356258608693,0.161077436469541,0.191197001807002,4.43712090142666e-114
NMR metabolomics,X23424.Total Lipids in VLDL,CD63,CD63 antigen,40203,0.109903688874322,0.00482740220213672,0.100441980558134,0.11936539719051,6.47738933331077e-113
NMR metabolomics,X23424.Total Lipids in VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37901,0.0568711779250371,0.00249492962558473,0.0519811158588911,0.0617612399911832,7.03289065702148e-113
NMR metabolomics,X23424.Total Lipids in VLDL,NUCB2,Nucleobindin-2,40447,0.0781871661341659,0.00343854289507487,0.0714476220598191,0.0849267102085126,1.13346633166954e-112
NMR metabolomics,X23424.Total Lipids in VLDL,DAB2,Disabled homolog 2,40489,0.231343238190896,0.0102048674297233,0.211341698028638,0.251344778353153,5.08323588472027e-112
NMR metabolomics,X23424.Total Lipids in VLDL,GGT1,Glutathione hydrolase 1 proenzyme,40303,0.101654621906359,0.00448450613976405,0.0928649898724216,0.110444253940297,5.55587036771457e-112
NMR metabolomics,X23424.Total Lipids in VLDL,CEP20,Centrosomal protein 20,39980,0.154135861864701,0.00681382554094131,0.140780763804456,0.167490959924946,1.69219492398797e-111
NMR metabolomics,X23424.Total Lipids in VLDL,AXIN1,Axin-1,40341,0.196687130324232,0.00869761529903888,0.179639804338116,0.213734456310348,1.80482526278776e-111
NMR metabolomics,X23424.Total Lipids in VLDL,BECN1,Beclin-1,37628,0.127805400270099,0.005644782490445,0.116741626588827,0.138869173951371,2.23444128093767e-111
NMR metabolomics,X23424.Total Lipids in VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37714,0.23378902055124,0.010329987030107,0.21354224597223,0.25403579513025,2.65209299590935e-111
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC1B,C-type lectin domain family 1 member B,40471,0.201275102052947,0.00891566781193772,0.183800393141549,0.218749810964345,4.06532044157098e-111
NMR metabolomics,X23424.Total Lipids in VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37959,0.200187946228723,0.00886675280636652,0.182809110728245,0.217566781729201,8.03267223841265e-111
NMR metabolomics,X23424.Total Lipids in VLDL,TIMP4,Metalloproteinase inhibitor 4,40332,-0.0847208277692929,0.00376481482395738,-0.0920998648242494,-0.0773417907143365,2.03862943039899e-110
NMR metabolomics,X23424.Total Lipids in VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40305,0.0638979334366967,0.00284791749664262,0.0583160151432772,0.0694798517301162,8.77578351249616e-110
NMR metabolomics,X23424.Total Lipids in VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,37942,0.222929306827896,0.00993609438399127,0.203454561835273,0.242404051820519,1.73326471280014e-109
NMR metabolomics,X23424.Total Lipids in VLDL,NPPC,C-type natriuretic peptide,40341,0.0893929593159835,0.0039922118781547,0.0815682240348003,0.0972176945971667,2.31138363050464e-109
NMR metabolomics,X23424.Total Lipids in VLDL,AP3S2,AP-3 complex subunit sigma-2,37942,0.096778202734094,0.00431671939624275,0.0883174327174583,0.10523897275073,2.50092940396981e-109
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA3F,Semaphorin-3F,40359,0.0535493500436659,0.00239498346947192,0.0488551824435009,0.0582435176438308,4.70232391681901e-109
NMR metabolomics,X23424.Total Lipids in VLDL,NHLRC3,NHL repeat-containing protein 3,37370,0.0662139369704866,0.00295752956225035,0.0604171790284759,0.0720106949124973,5.9733942604031e-109
NMR metabolomics,X23424.Total Lipids in VLDL,ARF6,ADP-ribosylation factor 6,37901,0.217533139665099,0.00972966489990061,0.198462996461293,0.236603282868904,9.62096583454794e-109
NMR metabolomics,X23424.Total Lipids in VLDL,ELN,Elastin,37990,0.0726208855246142,0.00325672573910167,0.0662377030759749,0.0790040679732535,3.33622277925396e-108
NMR metabolomics,X23424.Total Lipids in VLDL,HBEGF,Proheparin-binding EGF-like growth factor,40434,0.148950065372403,0.00670764630839839,0.135803078607942,0.162097052136864,1.26776285235795e-107
NMR metabolomics,X23424.Total Lipids in VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,40341,0.217849957726816,0.00981578240259237,0.198611024217735,0.237088891235897,1.6840258794321e-107
NMR metabolomics,X23424.Total Lipids in VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,39980,0.137575901895619,0.00620203304620468,0.125419917125058,0.14973188666618,2.34811367408333e-107
NMR metabolomics,X23424.Total Lipids in VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,39980,0.143634923578218,0.0064815901723999,0.130931006840314,0.156338840316122,3.76646706903416e-107
NMR metabolomics,X23424.Total Lipids in VLDL,OTUD7B,OTU domain-containing protein 7B,37959,0.129810261357226,0.0058541460025298,0.118336135192267,0.141284387522184,4.91329713111766e-107
NMR metabolomics,X23424.Total Lipids in VLDL,HJV,Hemojuvelin,37959,0.0946399294671358,0.00427048986067857,0.0862697693402058,0.103010089594066,6.45006851373364e-107
NMR metabolomics,X23424.Total Lipids in VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37860,0.222113261884677,0.010032904809382,0.202448768458288,0.241777755311066,1.08685148850655e-106
NMR metabolomics,X23424.Total Lipids in VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,40109,0.0424588979770669,0.00192129720326155,0.0386931554586742,0.0462246404954595,1.36649460481025e-106
NMR metabolomics,X23424.Total Lipids in VLDL,DCTN1,Dynactin subunit 1,40489,0.134481317900644,0.00609235435896796,0.122540303357066,0.146422332444221,2.15654377836724e-106
NMR metabolomics,X23424.Total Lipids in VLDL,SELP,P-selectin,40403,0.117725113608701,0.00533679244719149,0.107265000412206,0.128185226805197,3.00937276220666e-106
NMR metabolomics,X23424.Total Lipids in VLDL,CES3,Carboxylesterase 3,40305,0.140203444180714,0.00635591998420471,0.127745841011672,0.152661047349755,3.1054744969949e-106
NMR metabolomics,X23424.Total Lipids in VLDL,ATG16L1,Autophagy-related protein 16-1,37901,0.173017235382794,0.0078410282108284,0.157648820089571,0.188385650676018,5.08889027841665e-106
NMR metabolomics,X23424.Total Lipids in VLDL,CKB,Creatine kinase B-type,37998,-0.123891329144008,0.0056152103583288,-0.134897141446332,-0.112885516841683,5.16448205252995e-106
NMR metabolomics,X23424.Total Lipids in VLDL,KAZN,Kazrin,37901,0.211948438230564,0.00961686801790237,0.193099376915476,0.230797499545653,8.93467431547857e-106
NMR metabolomics,X23424.Total Lipids in VLDL,MTSS2,Protein MTSS 2,37900,0.200215270089061,0.00911201519716289,0.182355720302622,0.2180748198755,3.68627122944125e-105
NMR metabolomics,X23424.Total Lipids in VLDL,PLXNA4,Plexin-A4,40341,0.167726087709647,0.00764692407075099,0.152738116530975,0.182714058888319,4.45699637374683e-105
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL5,C-X-C motif chemokine 5,40309,0.233214416011881,0.010632527859939,0.2123746614064,0.254054170617361,4.46448379775053e-105
NMR metabolomics,X23424.Total Lipids in VLDL,EZR,Ezrin,40471,0.0481028655967086,0.00219324528483976,0.0438041048384227,0.0524016263549946,4.47444238528137e-105
NMR metabolomics,X23424.Total Lipids in VLDL,PLIN1,Perilipin-1,39961,0.0718268488343409,0.0032867345382067,0.0653848491394558,0.0782688485292261,2.67926003066451e-104
NMR metabolomics,X23424.Total Lipids in VLDL,VEGFC,Vascular endothelial growth factor C,40411,0.113003883194107,0.00517471280014068,0.102861446105831,0.123146320282383,3.39524185682769e-104
NMR metabolomics,X23424.Total Lipids in VLDL,CD6,T-cell differentiation antigen CD6,40502,0.107403689896764,0.00492423726587984,0.0977521848556393,0.117055194937888,5.84299805488061e-104
NMR metabolomics,X23424.Total Lipids in VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40403,-0.0757942177427335,0.00347831117034467,-0.0826117076366091,-0.0689767278488579,9.26043241835543e-104
NMR metabolomics,X23424.Total Lipids in VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37663,0.0917087498516819,0.00421549392906593,0.0834463817507126,0.0999711179526511,3.94674195532816e-103
NMR metabolomics,X23424.Total Lipids in VLDL,SMAD5,Mothers against decapentaplegic homolog 5,40305,0.0415900697933962,0.0019148865201635,0.0378368922138757,0.0453432473729166,4.26788223874581e-103
NMR metabolomics,X23424.Total Lipids in VLDL,MVK,Mevalonate kinase,40044,0.154154307951247,0.00710336267407125,0.140231717110067,0.168076898792426,6.57007239738624e-103
NMR metabolomics,X23424.Total Lipids in VLDL,CTSD,Cathepsin D,39243,0.0801956898565768,0.00370101585323572,0.0729416987842348,0.0874496809289188,1.58626463556672e-102
NMR metabolomics,X23424.Total Lipids in VLDL,PDLIM7,PDZ and LIM domain protein 7,40422,0.250630577127307,0.0115789338381518,0.22793586680453,0.273325287450085,1.98272305344358e-102
NMR metabolomics,X23424.Total Lipids in VLDL,AGRN,Agrin,40422,0.0665140349543691,0.00307528501387826,0.0604864763271677,0.0725415935815705,2.8256560830698e-102
NMR metabolomics,X23424.Total Lipids in VLDL,CD2AP,CD2-associated protein,40359,0.128082457957525,0.00592590838508689,0.116467677522754,0.139697238392295,3.8926852958373e-102
NMR metabolomics,X23424.Total Lipids in VLDL,THOP1,Thimet oligopeptidase,40288,0.0598817233394552,0.00277598825269768,0.0544407863641677,0.0653226603147426,9.68614870467294e-102
NMR metabolomics,X23424.Total Lipids in VLDL,TPD52L2,Tumor protein D54,37671,0.215962422802306,0.0100059277266714,0.19635080445803,0.235574041146582,1.4421600251547e-101
NMR metabolomics,X23424.Total Lipids in VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37959,0.168239683031703,0.007796298243131,0.152958938475166,0.183520427588239,1.44218818322331e-101
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,40341,0.207047985057415,0.00960746600992765,0.188217351677957,0.225878618436873,1.47566627465458e-101
NMR metabolomics,X23424.Total Lipids in VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37671,0.0971218232141093,0.00450194439512561,0.0882980121996631,0.105945634228555,1.78247620724632e-101
NMR metabolomics,X23424.Total Lipids in VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,37628,0.149574700757837,0.00694014015699257,0.135972026050132,0.163177375465543,2.80981698873673e-101
NMR metabolomics,X23424.Total Lipids in VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,39980,0.0989462061983075,0.0045979299407568,0.0899342635144241,0.107958148882191,3.05001756492359e-101
NMR metabolomics,X23424.Total Lipids in VLDL,RAB11FIP3,Rab11 family-interacting protein 3,37990,0.21352891493049,0.00992880902563792,0.194068449240239,0.23298938062074,6.62075448687879e-101
NMR metabolomics,X23424.Total Lipids in VLDL,PAXX,Protein PAXX,37671,0.0903227180364137,0.00420223100405132,0.0820863452684731,0.0985590908043543,9.31465947029496e-101
NMR metabolomics,X23424.Total Lipids in VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,37990,0.129943200879446,0.0060530111959021,0.118079298935478,0.141807102823414,1.4748706021613e-100
NMR metabolomics,X23424.Total Lipids in VLDL,AAMDC,Mth938 domain-containing protein,37628,0.106806018428851,0.00497809523609579,0.097048951766103,0.116563085091599,2.11337653007388e-100
NMR metabolomics,X23424.Total Lipids in VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40536,0.0567765715321726,0.00265184542824976,0.051578954492803,0.0619741885715421,2.68446089257278e-100
NMR metabolomics,X23424.Total Lipids in VLDL,PHACTR2,Phosphatase and actin regulator 2,37959,0.2264009337681,0.0105734668539286,0.2056769387344,0.2471249288018,4.69936661552428e-100
NMR metabolomics,X23424.Total Lipids in VLDL,PON3,Serum paraoxonase/lactonase 3,40422,-0.0542605485844964,0.00253990884163272,-0.0592387699140966,-0.0492823272548963,7.31442847434627e-100
NMR metabolomics,X23424.Total Lipids in VLDL,ERBIN,Erbin,40305,0.202662212679621,0.00949535741641689,0.184051312143444,0.221273113215798,1.13239666452415e-99
NMR metabolomics,X23424.Total Lipids in VLDL,TNIP1,TNFAIP3-interacting protein 1,37942,0.175557600082041,0.00822075613014165,0.159444918066963,0.191670282097119,1.53147143321513e-99
NMR metabolomics,X23424.Total Lipids in VLDL,TCTN3,Tectonic-3,37990,0.0578335078168822,0.00270834327008651,0.0525251550075126,0.0631418606262517,1.56161239715848e-99
NMR metabolomics,X23424.Total Lipids in VLDL,S100A4,Protein S100-A4,40411,0.114076692496073,0.0053534738454436,0.103583883759004,0.124569501233142,2.26561800567509e-99
NMR metabolomics,X23424.Total Lipids in VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,40341,0.0745727072910057,0.00350021800958681,0.0677122799922155,0.0814331345897958,2.48295898024237e-99
NMR metabolomics,X23424.Total Lipids in VLDL,MINK1,Misshapen-like kinase 1,37942,0.183259422223245,0.00859122084574384,0.166420629365587,0.200098215080902,2.5371415261012e-99
NMR metabolomics,X23424.Total Lipids in VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,37628,0.203471922310847,0.00953792437953002,0.184777590526968,0.222166254094726,2.66201486357083e-99
NMR metabolomics,X23424.Total Lipids in VLDL,RTN4R,Reticulon-4 receptor,40489,0.0668066679050493,0.00314189758929074,0.0606485486300394,0.0729647871800591,5.76513327339211e-99
NMR metabolomics,X23424.Total Lipids in VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,40044,0.135939209236729,0.00639956844897867,0.123396055076731,0.148482363396727,9.76849513963594e-99
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R9B,Neurabin-2,40516,0.184780199283734,0.00870305024277353,0.167722220807898,0.20183817775957,1.10128977605684e-98
NMR metabolomics,X23424.Total Lipids in VLDL,CEP85,Centrosomal protein of 85 kDa,39980,0.123700994915109,0.00584155312097218,0.112251550798003,0.135150439032214,3.86002377624006e-98
NMR metabolomics,X23424.Total Lipids in VLDL,FABP5,Fatty acid-binding protein 5,40432,0.135359018281052,0.00641369115373459,0.122788183619732,0.147929852942372,1.53729143098164e-97
NMR metabolomics,X23424.Total Lipids in VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40277,0.20376950344124,0.00966573126238841,0.184824670166959,0.222714336715522,2.54342392121117e-97
NMR metabolomics,X23424.Total Lipids in VLDL,MME,Neprilysin,40305,0.159009552018017,0.00754322270774852,0.14422483551083,0.173794268525204,2.62812448240175e-97
NMR metabolomics,X23424.Total Lipids in VLDL,CRHBP,Corticotropin-releasing factor-binding protein,40357,0.0548045313848236,0.00260212833629739,0.0497043598456807,0.0599047029239664,3.79509896410011e-97
NMR metabolomics,X23424.Total Lipids in VLDL,FETUB,Fetuin-B,40372,0.0659680562774082,0.0031325054662366,0.0598283455635844,0.0721077669912319,3.96142282626443e-97
NMR metabolomics,X23424.Total Lipids in VLDL,BCR,Breakpoint cluster region protein,40341,0.17776181772278,0.00844283378506848,0.161213863504046,0.194309771941514,4.36505487353204e-97
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4B,Eukaryotic translation initiation factor 4B,40228,0.115739214009787,0.00549755524368071,0.104964005732173,0.126514422287401,4.63758316464637e-97
NMR metabolomics,X23424.Total Lipids in VLDL,NPL,N-acetylneuraminate lyase,37990,0.0841762722542999,0.00400321450515185,0.0763299718242023,0.0920225726843975,1.28751264377981e-96
NMR metabolomics,X23424.Total Lipids in VLDL,STC1,Stanniocalcin-1,40471,0.0805615535892502,0.00384197515395029,0.0730312822875076,0.0880918248909928,2.48103621635413e-96
NMR metabolomics,X23424.Total Lipids in VLDL,DOK2,Docking protein 2,40359,0.234548885204728,0.0111931104701093,0.212610388683313,0.256487381726142,3.37404379660408e-96
NMR metabolomics,X23424.Total Lipids in VLDL,TGFB1,Transforming growth factor beta-1 proprotein,40502,0.0736444181405505,0.00351571789715999,0.066753611062117,0.0805352252189841,3.83638641619579e-96
NMR metabolomics,X23424.Total Lipids in VLDL,CLUL1,Clusterin-like protein 1,40338,-0.0884221087545095,0.00422221875176192,-0.0966976575079629,-0.0801465600010562,4.38697093402253e-96
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINH1,Serpin H1,37714,0.250542937929781,0.0119484856499072,0.227123906055963,0.273961969803599,4.56344942274852e-96
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40516,0.194116382935239,0.00927477480523075,0.175937824316987,0.212294941553491,5.49288990477924e-96
NMR metabolomics,X23424.Total Lipids in VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,40332,0.0444881856093921,0.0021282738775794,0.0403167688093365,0.0486596024094477,9.67159412417787e-96
NMR metabolomics,X23424.Total Lipids in VLDL,NCK2,Cytoplasmic protein NCK2,40422,0.201886163313874,0.00968925535897467,0.182895222810284,0.220877103817465,3.74747236618004e-95
NMR metabolomics,X23424.Total Lipids in VLDL,IDUA,Alpha-L-iduronidase,40489,0.0873611944143657,0.00419762543762755,0.0791338485566157,0.0955885402721157,6.03509974961252e-95
NMR metabolomics,X23424.Total Lipids in VLDL,SLA2,Src-like-adapter 2,37959,0.199036437946792,0.0095720126884909,0.180275293077349,0.217797582816234,1.48813225977218e-94
NMR metabolomics,X23424.Total Lipids in VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37562,0.142983922714364,0.00688998685894212,0.129479548470837,0.156488296957891,3.77373435096831e-94
NMR metabolomics,X23424.Total Lipids in VLDL,SUGP1,SURP and G-patch domain-containing protein 1,37901,0.0762363829871784,0.00367827750014109,0.0690269590869018,0.0834458068874549,5.88417663876623e-94
NMR metabolomics,X23424.Total Lipids in VLDL,CMIP,C-Maf-inducing protein,37900,0.157855310730811,0.00762494791764219,0.142910412812232,0.17280020864939,9.46883900324593e-94
NMR metabolomics,X23424.Total Lipids in VLDL,USO1,General vesicular transport factor p115,40305,0.173473741961134,0.00840936533902262,0.156991385896649,0.189956098025618,2.54492491725613e-93
NMR metabolomics,X23424.Total Lipids in VLDL,IKBKG,NF-kappa-B essential modulator,40341,0.175844615085702,0.0085329042707892,0.159120122714955,0.192569107456449,3.84464663973293e-93
NMR metabolomics,X23424.Total Lipids in VLDL,SNAP23,Synaptosomal-associated protein 23,40359,0.1662100554554,0.00806735754257759,0.150398034671948,0.182022076238852,4.24159428109896e-93
NMR metabolomics,X23424.Total Lipids in VLDL,CD99L2,CD99 antigen-like protein 2,40332,0.0454701696280891,0.00220784812048297,0.0411427873119425,0.0497975519442357,5.00497285322862e-93
NMR metabolomics,X23424.Total Lipids in VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37628,0.0497253098781194,0.0024111959372452,0.0449993658411188,0.05445125391512,5.02389740863993e-93
NMR metabolomics,X23424.Total Lipids in VLDL,THPO,Thrombopoietin,40042,0.0728983090777821,0.00354390128803131,0.0659522625532408,0.0798443556023235,8.65351935697768e-93
NMR metabolomics,X23424.Total Lipids in VLDL,CCL5,C-C motif chemokine 5,40403,0.190944700064798,0.00929181051481739,0.172732751455756,0.20915664867384,1.22102795802832e-92
NMR metabolomics,X23424.Total Lipids in VLDL,PPY,Pancreatic prohormone,40337,0.192371765455029,0.00936531253179819,0.174015752892704,0.210727778017353,1.47635090831408e-92
NMR metabolomics,X23424.Total Lipids in VLDL,CCN2,CCN family member 2,40358,0.109670738206037,0.00534350921456228,0.0991974601454954,0.12014401626658,2.05926265678874e-92
NMR metabolomics,X23424.Total Lipids in VLDL,SRPK2,SRSF protein kinase 2,40341,0.157481250086185,0.00767449030013845,0.142439249097914,0.172523251074457,2.23810846880124e-92
NMR metabolomics,X23424.Total Lipids in VLDL,STAT5B,Signal transducer and activator of transcription 5B,40305,0.261877166158623,0.012779173149674,0.236829986785262,0.286924345531985,3.91314537264643e-92
NMR metabolomics,X23424.Total Lipids in VLDL,HGF,Hepatocyte growth factor,40516,0.0651477116647582,0.00317938383532767,0.058916119347516,0.0713793039820004,3.91734785769223e-92
NMR metabolomics,X23424.Total Lipids in VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39886,0.10443720009593,0.00509561186162624,0.0944498008471427,0.114424599344718,3.96366062045123e-92
NMR metabolomics,X23424.Total Lipids in VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,37901,0.173162428002347,0.00844396552430314,0.156612255574713,0.189712600429981,4.71834284799226e-92
NMR metabolomics,X23424.Total Lipids in VLDL,BID,BH3-interacting domain death agonist,40341,0.127089153472726,0.00621705550553577,0.114903724681876,0.139274582263576,1.06681898643162e-91
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40411,0.180802849387104,0.00884790823507458,0.163460949246358,0.19814474952785,1.22439540602986e-91
NMR metabolomics,X23424.Total Lipids in VLDL,COL18A1,Collagen alpha-1(XVIII) chain,40391,0.0438091963250741,0.00215040991316596,0.0395943928952688,0.0480239997548794,4.23091767966085e-91
NMR metabolomics,X23424.Total Lipids in VLDL,NT5E,5'-nucleotidase,40411,0.109429911907276,0.00537362429240574,0.0988976082941604,0.119962215520391,4.96653498931716e-91
NMR metabolomics,X23424.Total Lipids in VLDL,PLSCR3,Phospholipid scramblase 3,37919,0.113379252203133,0.00556152051104051,0.102478672001494,0.124279832404773,5.19242399002163e-91
NMR metabolomics,X23424.Total Lipids in VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39980,0.155599449892766,0.00764615737325248,0.140612981441191,0.170585918344341,7.08834837142576e-91
NMR metabolomics,X23424.Total Lipids in VLDL,FABP4,"Fatty acid-binding protein, adipocyte",40536,0.0925015300261336,0.00455516461409382,0.0835734073825097,0.101429652669758,1.52004066711294e-90
NMR metabolomics,X23424.Total Lipids in VLDL,DCXR,L-xylulose reductase,40411,0.0984704544717919,0.00485303474271774,0.0889585063760652,0.107982402567519,2.14999522971968e-90
NMR metabolomics,X23424.Total Lipids in VLDL,CTSO,Cathepsin O,40516,0.056630521726648,0.00279355510089999,0.051155153728884,0.062105889724412,3.0592369036797e-90
NMR metabolomics,X23424.Total Lipids in VLDL,BACH1,Transcription regulator protein BACH1,40341,0.136541048781425,0.0067410523749522,0.123328586126519,0.149753511436332,4.37907448854457e-90
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37901,0.204630791092779,0.0101134869900044,0.184808356592371,0.224453225593188,1.06911222337751e-89
NMR metabolomics,X23424.Total Lipids in VLDL,HCLS1,Hematopoietic lineage cell-specific protein,40516,0.10488557300085,0.00519403141921159,0.0947052714191953,0.115065874582505,1.4412322366161e-89
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS8,Prostasin,40293,0.0756000930910945,0.00374946446953886,0.0682511427307984,0.0829490434513907,2.72885194851836e-89
NMR metabolomics,X23424.Total Lipids in VLDL,NFX1,Transcriptional repressor NF-X1,37562,0.127422965974751,0.00631423968191951,0.115047056198189,0.139798875751313,3.28597165458514e-89
NMR metabolomics,X23424.Total Lipids in VLDL,CRELD2,Protein disulfide isomerase CRELD2,40396,0.0968175375335699,0.00480696421210331,0.0873958876778474,0.106239187389292,4.12506683974232e-89
NMR metabolomics,X23424.Total Lipids in VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,40305,0.159389332611937,0.00792037988145412,0.143865388044287,0.174913277179587,5.86450957630265e-89
NMR metabolomics,X23424.Total Lipids in VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,39961,0.093877994056672,0.00466885728688777,0.084727033774372,0.103028954338972,8.60520822536751e-89
NMR metabolomics,X23424.Total Lipids in VLDL,CIRBP,Cold-inducible RNA-binding protein,37901,0.17818712258189,0.00885500551661508,0.160831311769324,0.195542933394456,9.39506557783156e-89
NMR metabolomics,X23424.Total Lipids in VLDL,FOXO1,Forkhead box protein O1,40341,0.157849310552891,0.00785605648732054,0.142451439837742,0.173247181268039,1.07803184065731e-88
NMR metabolomics,X23424.Total Lipids in VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40273,0.0504342944308776,0.00251004808656497,0.0455146001812103,0.055353988680545,1.08389780097939e-88
NMR metabolomics,X23424.Total Lipids in VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,37900,0.213391214986473,0.0106158069091546,0.19258423344453,0.234198196528416,1.43096492455449e-88
NMR metabolomics,X23424.Total Lipids in VLDL,MASP1,Mannan-binding lectin serine protease 1,40192,0.0443951887298249,0.00221111895189953,0.0400613955841018,0.0487289818755479,1.46827028552924e-88
NMR metabolomics,X23424.Total Lipids in VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40228,0.176470179505616,0.00879668466975135,0.159228677552903,0.193711681458328,2.04451192613889e-88
NMR metabolomics,X23424.Total Lipids in VLDL,MAMDC4,Apical endosomal glycoprotein,37900,0.101899131325259,0.00507593232384861,0.0919503039705157,0.111847958680002,2.3935754583359e-88
NMR metabolomics,X23424.Total Lipids in VLDL,PCBP2,Poly(rC)-binding protein 2,37959,0.133893009825377,0.00667049369354527,0.120818842186028,0.146967177464725,2.48302618777734e-88
NMR metabolomics,X23424.Total Lipids in VLDL,LEFTY2,Left-right determination factor 2,40453,0.0966742650797708,0.004826286656933,0.0872147432321821,0.106133786927359,3.56914362690687e-88
NMR metabolomics,X23424.Total Lipids in VLDL,ACE2,Angiotensin-converting enzyme 2,40042,0.0909694653921439,0.00454100083779508,0.0820691037500656,0.0998698270342223,3.65088403311921e-88
NMR metabolomics,X23424.Total Lipids in VLDL,PDCD5,Programmed cell death protein 5,40471,0.108293715669154,0.0054187639205016,0.097672938384971,0.118914492953337,8.72643243926138e-88
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL10,C-X-C motif chemokine 10,40422,0.125211315058258,0.0062692496077586,0.112923585827051,0.137499044289465,1.12569780672479e-87
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS9,Galectin-9,40350,0.059622077669413,0.00298716829245255,0.053767227816206,0.06547692752262,1.46412828255029e-87
NMR metabolomics,X23424.Total Lipids in VLDL,LBR,Delta(14)-sterol reductase LBR,40471,0.121251324736127,0.00609296328775087,0.109309116692136,0.133193532780119,4.55675801014924e-87
NMR metabolomics,X23424.Total Lipids in VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,40341,0.206498089440577,0.0103798774905846,0.186153529559032,0.226842649322123,5.23664346804038e-87
NMR metabolomics,X23424.Total Lipids in VLDL,OGFR,Opioid growth factor receptor,40305,0.0610161916361999,0.0030690913326421,0.0550007726242214,0.0670316106481785,6.8082334559922e-87
NMR metabolomics,X23424.Total Lipids in VLDL,PLXNB3,Plexin-B3,40310,0.086058424371023,0.00433485156809147,0.0775621152975637,0.0945547334444823,1.17645859692069e-86
NMR metabolomics,X23424.Total Lipids in VLDL,LEP,Leptin,40359,0.117803212912485,0.00593403818714902,0.106172498065673,0.129433927759297,1.18074344874863e-86
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB6,DnaJ homolog subfamily B member 6,37557,0.156148439824485,0.00785623855072103,0.140750212265072,0.171546667383898,1.24074934456177e-86
NMR metabolomics,X23424.Total Lipids in VLDL,TANK,TRAF family member-associated NF-kappa-B activator,40044,0.12853429098891,0.00647489535854559,0.115843496086161,0.141225085891659,1.2615412816154e-86
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFC,Platelet-derived growth factor C,39980,0.0547697451524573,0.00275988950189009,0.0493603617287528,0.0601791285761619,1.43909448832282e-86
NMR metabolomics,X23424.Total Lipids in VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37990,0.119207184323122,0.00600275667800379,0.107441781234235,0.130972587412009,1.57206527783987e-86
NMR metabolomics,X23424.Total Lipids in VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40305,0.080772190618813,0.00407305261262091,0.072789007498076,0.0887553737395499,1.7977557901252e-86
NMR metabolomics,X23424.Total Lipids in VLDL,FUOM,Fucose mutarotase,37671,0.115048868289378,0.00579978090787814,0.103681297709936,0.126416438868819,2.57044968518843e-86
NMR metabolomics,X23424.Total Lipids in VLDL,YOD1,Ubiquitin thioesterase OTU1,37562,0.117214125669774,0.00591615827953349,0.105618455441888,0.12880979589766,4.19955308779636e-86
NMR metabolomics,X23424.Total Lipids in VLDL,LSP1,Lymphocyte-specific protein 1,40341,0.0733894239215506,0.00371269805430263,0.0661125357351174,0.0806663121079837,6.14571668717235e-86
NMR metabolomics,X23424.Total Lipids in VLDL,CCL13,C-C motif chemokine 13,40483,0.12797542901208,0.00647644905651715,0.115281588861306,0.140669269162853,6.89492521502389e-86
NMR metabolomics,X23424.Total Lipids in VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,40283,0.0591509855838744,0.00299328668713314,0.0532841436770934,0.0650178274906553,6.95094305994292e-86
NMR metabolomics,X23424.Total Lipids in VLDL,STK11,Serine/threonine-protein kinase STK11,40042,0.133878648481029,0.00677587353022995,0.120597936361778,0.14715936060028,7.64895132423283e-86
NMR metabolomics,X23424.Total Lipids in VLDL,FKBPL,FK506-binding protein-like,37901,0.108321406574731,0.00548174724142806,0.0975771819815323,0.11906563116793,1.06846348120994e-85
NMR metabolomics,X23424.Total Lipids in VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37990,0.141334444815817,0.00716576449664615,0.127289546402391,0.155379343229244,2.13057052205956e-85
NMR metabolomics,X23424.Total Lipids in VLDL,ITGA5,Integrin alpha-5,40332,0.0455702524766117,0.00231430636302733,0.0410342120050781,0.0501062929481452,2.69328882469852e-85
NMR metabolomics,X23424.Total Lipids in VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37942,0.126075534629956,0.00641255667679241,0.113506923543443,0.138644145716469,7.18484659272837e-85
NMR metabolomics,X23424.Total Lipids in VLDL,HEXIM1,Protein HEXIM1,40341,0.149009719719374,0.00759054485879465,0.134132251796136,0.163887187642611,8.48635065513013e-85
NMR metabolomics,X23424.Total Lipids in VLDL,CMC1,COX assembly mitochondrial protein homolog,37990,0.164449949304975,0.0083730049937489,0.148038859517227,0.180861039092723,1.04862733769698e-84
NMR metabolomics,X23424.Total Lipids in VLDL,GLB1,Beta-galactosidase,40228,0.0744463475192682,0.00379470971719155,0.0670087164735728,0.0818839785649636,1.09681487110505e-84
NMR metabolomics,X23424.Total Lipids in VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,40044,0.101513598846144,0.0051773313129796,0.0913660294727044,0.111661168219584,1.39522596509151e-84
NMR metabolomics,X23424.Total Lipids in VLDL,PON2,Serum paraoxonase/arylesterase 2,40042,0.0626192377472951,0.00319480103119526,0.0563574277261523,0.0688810477684378,1.59513563448342e-84
NMR metabolomics,X23424.Total Lipids in VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40042,0.175157601277453,0.00896532233008268,0.157585569510491,0.192729633044415,5.34251968638483e-84
NMR metabolomics,X23424.Total Lipids in VLDL,LAT,Linker for activation of T-cells family member 1,40516,0.137043995112956,0.00702032561057397,0.123284156916231,0.150803833309681,6.81046919279206e-84
NMR metabolomics,X23424.Total Lipids in VLDL,GIGYF2,GRB10-interacting GYF protein 2,37959,0.137735208043852,0.00704861103112467,0.123919930422848,0.151550485664856,7.0879143498786e-84
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL7,Angiopoietin-related protein 7,40489,0.0671196838710844,0.00344228288334793,0.0603728094197225,0.0738665583224464,1.04943826454937e-83
NMR metabolomics,X23424.Total Lipids in VLDL,C1S,Complement C1s subcomponent,38013,0.0376615046425723,0.00192974055223825,0.0338792131601853,0.0414437961249593,1.11640337410909e-83
NMR metabolomics,X23424.Total Lipids in VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40192,0.202483620885904,0.0103854603676059,0.182128118565397,0.222839123206412,1.13118152063718e-83
NMR metabolomics,X23424.Total Lipids in VLDL,PYY,Peptide YY,37562,0.172421782418582,0.00884585435141594,0.155083907889807,0.189759656947357,1.94549306474204e-83
NMR metabolomics,X23424.Total Lipids in VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,37671,0.129076389545717,0.00662493796832547,0.116091511127799,0.142061267963635,2.23271898479072e-83
NMR metabolomics,X23424.Total Lipids in VLDL,CEP43,Centrosomal protein 43,39934,0.124751289941849,0.00641149029040238,0.112184768972661,0.137317810911038,2.48713451681206e-83
NMR metabolomics,X23424.Total Lipids in VLDL,DAG1,Dystroglycan,40422,0.0854869977576447,0.00439776061774535,0.0768673869468639,0.0941066085684256,3.3149497589729e-83
NMR metabolomics,X23424.Total Lipids in VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37901,0.18565298969655,0.0095435533926529,0.16694762504695,0.204358354346149,3.78466963080165e-83
NMR metabolomics,X23424.Total Lipids in VLDL,EGLN1,Egl nine homolog 1,40341,0.0957857333267554,0.00493305594123453,0.0861169436819357,0.105454522971575,5.05940066788837e-83
NMR metabolomics,X23424.Total Lipids in VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37959,0.139042145136216,0.007153825465894,0.125020647223064,0.153063643049369,5.18467334132975e-83
NMR metabolomics,X23424.Total Lipids in VLDL,GH1,Somatotropin,40330,-0.315442935543689,0.0162745476116976,-0.347341048862616,-0.283544822224762,9.76467021009261e-83
NMR metabolomics,X23424.Total Lipids in VLDL,VAMP8,Vesicle-associated membrane protein 8,37598,0.159832325482153,0.00825747588520932,0.143647672747143,0.176016978217163,2.52309747084206e-82
NMR metabolomics,X23424.Total Lipids in VLDL,AP3B1,AP-3 complex subunit beta-1,37901,0.137248429785705,0.00710338760263008,0.12332579008455,0.15117106948686,4.56603000976046e-82
NMR metabolomics,X23424.Total Lipids in VLDL,SIAE,Sialate O-acetylesterase,40374,0.0839918672152001,0.00435435420078424,0.0754573329816629,0.0925264014487372,5.69688568048535e-82
NMR metabolomics,X23424.Total Lipids in VLDL,TOP2B,DNA topoisomerase 2-beta,37598,0.142049435430594,0.0073596894363375,0.127624444135372,0.156474426725815,7.12189950056299e-82
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL3,Angiopoietin-related protein 3,40355,0.0649719508403671,0.00337286574267018,0.0583611339847336,0.0715827676960007,9.33908976611934e-82
NMR metabolomics,X23424.Total Lipids in VLDL,RABEP1,Rab GTPase-binding effector protein 1,37671,0.141431661930097,0.00734387100445829,0.127037674761358,0.155825649098835,1.56278745255982e-81
NMR metabolomics,X23424.Total Lipids in VLDL,RGCC,Regulator of cell cycle RGCC,37959,0.134143089714638,0.00696756102634748,0.120486670102997,0.147799509326279,1.65601024874387e-81
NMR metabolomics,X23424.Total Lipids in VLDL,NIT2,Omega-amidase NIT2,37936,0.135368084524972,0.00703159619728963,0.121586155978284,0.14915001307166,1.69820823907741e-81
NMR metabolomics,X23424.Total Lipids in VLDL,CD36,Platelet glycoprotein 4,37598,0.0795331891138286,0.00413231760703397,0.071433846604042,0.0876325316236152,1.97903600196727e-81
NMR metabolomics,X23424.Total Lipids in VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40422,0.185143016096734,0.00964359730806609,0.166241565372924,0.204044466820543,3.12672010756657e-81
NMR metabolomics,X23424.Total Lipids in VLDL,DNMBP,Dynamin-binding protein,40228,0.10990279163981,0.00573197620962311,0.0986681182689483,0.121137465010671,5.12344856034863e-81
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFB,Platelet-derived growth factor subunit B,40422,0.152586914088786,0.00796453180933806,0.136976431742483,0.168197396435088,6.66177477550496e-81
NMR metabolomics,X23424.Total Lipids in VLDL,METAP2,Methionine aminopeptidase 2,40453,0.10488573835924,0.00547482801911154,0.0941550754417811,0.115616401276698,6.69646164927182e-81
NMR metabolomics,X23424.Total Lipids in VLDL,AKT1S1,Proline-rich AKT1 substrate 1,39961,0.120416421467695,0.00628496446622161,0.108097891113901,0.132734951821489,6.93170011539733e-81
NMR metabolomics,X23424.Total Lipids in VLDL,SEC31A,Protein transport protein Sec31A,37628,0.13653208503917,0.00712159278141913,0.122573763187589,0.150490406890752,8.03070680339184e-81
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,37942,0.16219209297718,0.0084703119016768,0.145590281649894,0.178793904304467,1.17108593888889e-80
NMR metabolomics,X23424.Total Lipids in VLDL,CCL7,C-C motif chemokine 7,40341,0.108146564526605,0.00565717829847939,0.0970584950615853,0.119234633991625,1.46916294093478e-80
NMR metabolomics,X23424.Total Lipids in VLDL,GHRL,Appetite-regulating hormone,40359,0.140161920186931,0.00733471852409742,0.1257858718797,0.154537968494162,1.68113321008048e-80
NMR metabolomics,X23424.Total Lipids in VLDL,PAK4,Serine/threonine-protein kinase PAK 4,39961,0.108733704638436,0.0056903379681057,0.0975806422209489,0.119886767055923,1.80176703045387e-80
NMR metabolomics,X23424.Total Lipids in VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40305,0.135180970032487,0.00707648282888815,0.121311063687866,0.149050876377108,1.91317285153894e-80
NMR metabolomics,X23424.Total Lipids in VLDL,AHSG,Alpha-2-HS-glycoprotein,37987,0.0481439086110174,0.00251858970730529,0.043207472784699,0.0530803444373358,2.14691277463595e-80
NMR metabolomics,X23424.Total Lipids in VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37900,0.128623721919698,0.00672981691023439,0.115433280775638,0.141814163063757,2.30203180076446e-80
NMR metabolomics,X23424.Total Lipids in VLDL,ASAH2,Neutral ceramidase,40228,0.0933133606150106,0.00488936149681422,0.0837302120812547,0.102896509148766,2.69969922654821e-80
NMR metabolomics,X23424.Total Lipids in VLDL,KRT18,"Keratin, type I cytoskeletal 18",40305,0.136617598671722,0.00715970624533327,0.122584574430868,0.150650622912575,2.85516977593275e-80
NMR metabolomics,X23424.Total Lipids in VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,39980,0.113834512512763,0.00596668030259491,0.102139819119677,0.125529205905849,3.1566324447503e-80
NMR metabolomics,X23424.Total Lipids in VLDL,MYDGF,Myeloid-derived growth factor,37990,0.178033082704954,0.00934641315408364,0.15971411292295,0.196352052486958,7.49769151290131e-80
NMR metabolomics,X23424.Total Lipids in VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37714,0.188096239416144,0.0098888646496202,0.168714064702889,0.2074784141294,1.30689060854778e-79
NMR metabolomics,X23424.Total Lipids in VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37901,0.157766564790373,0.00832071990735449,0.141457953771958,0.174075175808787,3.86975342996438e-79
NMR metabolomics,X23424.Total Lipids in VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,37714,0.0930344408906163,0.00490755942592027,0.0834156244158126,0.10265325736542,4.25198462909445e-79
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP45,Rho GTPase-activating protein 45,37671,0.14506162083179,0.00765743352665855,0.130053051119539,0.16007019054404,5.49827235804856e-79
NMR metabolomics,X23424.Total Lipids in VLDL,RTBDN,Retbindin,40305,0.0514947962786432,0.00272276783405987,0.0461581713238858,0.0568314212334005,6.62127704770809e-79
NMR metabolomics,X23424.Total Lipids in VLDL,EREG,Proepiregulin,40192,0.141272921207859,0.00747115690438649,0.126629453675262,0.155916388740457,7.17327144496385e-79
NMR metabolomics,X23424.Total Lipids in VLDL,SH2D1A,SH2 domain-containing protein 1A,40341,0.0963569376366875,0.00509852757871024,0.0863638235824155,0.10635005169096,8.4967751414843e-79
NMR metabolomics,X23424.Total Lipids in VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40305,0.0776799324346784,0.00411292372429605,0.0696186019350582,0.0857412629342987,1.06957930984358e-78
NMR metabolomics,X23424.Total Lipids in VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,37942,0.109673296607258,0.00580369364779075,0.0982980570575884,0.121048536156928,1.24389555083215e-78
NMR metabolomics,X23424.Total Lipids in VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,40419,0.0559228980852074,0.00296256617563339,0.050116268380966,0.0617295277894489,1.27605379677703e-78
NMR metabolomics,X23424.Total Lipids in VLDL,HYOU1,Hypoxia up-regulated protein 1,40536,0.0379894184758095,0.0020130802188435,0.0340437812468763,0.0419350557047428,1.38576356355644e-78
NMR metabolomics,X23424.Total Lipids in VLDL,TBCC,Tubulin-specific chaperone C,40228,0.142629930901529,0.00756190355884693,0.127808599926189,0.157451261876869,1.71992825039864e-78
NMR metabolomics,X23424.Total Lipids in VLDL,MITD1,MIT domain-containing protein 1,40228,0.169496180667421,0.00899299495475674,0.151869910556098,0.187122450778745,2.23078515905727e-78
NMR metabolomics,X23424.Total Lipids in VLDL,SYTL4,Synaptotagmin-like protein 4,37990,0.128443989364649,0.0068189699887724,0.115078808186655,0.141809170542643,3.79021140600008e-78
NMR metabolomics,X23424.Total Lipids in VLDL,VNN1,Pantetheinase,37987,0.126681231598448,0.00674014620108511,0.113470545044321,0.139891918152575,8.09587365545801e-78
NMR metabolomics,X23424.Total Lipids in VLDL,ARSB,Arylsulfatase B,40305,0.0958995297798132,0.0051088774181467,0.0858861300402457,0.105912929519381,9.05145521698796e-78
NMR metabolomics,X23424.Total Lipids in VLDL,VEGFA,Vascular endothelial growth factor A,40456,0.102555649944269,0.00546483373810624,0.0918445758175808,0.113266724070957,9.69027884681604e-78
NMR metabolomics,X23424.Total Lipids in VLDL,STAMBP,STAM-binding protein,40192,0.11293868676829,0.00602058857800157,0.101138333155406,0.124739040381173,1.15313479958561e-77
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINE1,Plasminogen activator inhibitor 1,40536,0.117746225866747,0.00627866829062907,0.105440036017114,0.13005241571638,1.22168078595077e-77
NMR metabolomics,X23424.Total Lipids in VLDL,SKAP2,Src kinase-associated phosphoprotein 2,40422,0.182071022144727,0.00970857077501841,0.163042223425691,0.201099820863763,1.23221049976776e-77
NMR metabolomics,X23424.Total Lipids in VLDL,HMOX2,Heme oxygenase 2,39961,0.0796210461490031,0.00424598546693013,0.0712989146338201,0.0879431776641862,1.34140789167656e-77
NMR metabolomics,X23424.Total Lipids in VLDL,CDH2,Cadherin-2,40359,0.0614592085748564,0.00327946665504207,0.055031453930974,0.0678869632187389,1.57762226872583e-77
NMR metabolomics,X23424.Total Lipids in VLDL,CDC27,Cell division cycle protein 27 homolog,39980,0.106027582822096,0.0056638019039699,0.0949265310903151,0.117128634553877,2.4031640800571e-77
NMR metabolomics,X23424.Total Lipids in VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,37628,0.0545495607742067,0.00291433321636792,0.0488374676701256,0.0602616538782879,3.54932148906226e-77
NMR metabolomics,X23424.Total Lipids in VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,40042,0.160247300992667,0.00857018237289747,0.143449743541788,0.177044858443546,3.56938211802975e-77
NMR metabolomics,X23424.Total Lipids in VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,37901,0.0925577758483075,0.00494756243713765,0.0828605534715177,0.102254998225097,4.06501731798798e-77
NMR metabolomics,X23424.Total Lipids in VLDL,COMMD1,COMM domain-containing protein 1,37628,0.107159008606685,0.00573405882432607,0.0959202533110058,0.118397763902364,6.08692947445241e-77
NMR metabolomics,X23424.Total Lipids in VLDL,GIT1,ARF GTPase-activating protein GIT1,37598,0.170237601762535,0.00910959704970048,0.152382791545122,0.188092411979948,6.16753839340565e-77
NMR metabolomics,X23424.Total Lipids in VLDL,PSIP1,PC4 and SFRS1-interacting protein,40341,0.107612638744362,0.00576898822883946,0.0963054218158362,0.118919855672887,7.79637909401182e-77
NMR metabolomics,X23424.Total Lipids in VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40341,0.174262405601544,0.00935089355964373,0.155934654224643,0.192590156978446,1.07845882787127e-76
NMR metabolomics,X23424.Total Lipids in VLDL,QDPR,Dihydropteridine reductase,40290,0.0759243693116222,0.00407546770646648,0.0679364526069479,0.0839122860162965,1.21739373173996e-76
NMR metabolomics,X23424.Total Lipids in VLDL,SNCG,Gamma-synuclein,40228,0.11609894148979,0.00623214149432349,0.103883944160916,0.128313938818664,1.2386671335028e-76
NMR metabolomics,X23424.Total Lipids in VLDL,ISM1,Isthmin-1,40341,0.0675825394986981,0.00362966331507338,0.0604683994011542,0.0746966795962419,1.45558785428076e-76
NMR metabolomics,X23424.Total Lipids in VLDL,F13B,Coagulation factor XIII B chain,37934,0.0447016019538175,0.0024045704073358,0.0399886439554394,0.0494145599521957,3.44336816453356e-76
NMR metabolomics,X23424.Total Lipids in VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,40305,0.200199621346459,0.0107856115859307,0.179059822638035,0.221339420054883,4.19458453191672e-76
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37959,0.113473032111504,0.00611476517702168,0.101488092364542,0.125457971858467,6.25080100492357e-76
NMR metabolomics,X23424.Total Lipids in VLDL,GFRA1,GDNF family receptor alpha-1,40453,0.0480090467286553,0.00259229855016418,0.0429281415703335,0.0530899518869771,8.83549753449971e-76
NMR metabolomics,X23424.Total Lipids in VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,40357,0.086549793836721,0.00468142898902886,0.0773741930182245,0.0957253946552176,1.59666037883033e-75
NMR metabolomics,X23424.Total Lipids in VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40359,-0.168807516006376,0.00913427806326559,-0.186710701010376,-0.150904331002375,1.82036239802389e-75
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40359,0.0479392013655268,0.00259408743706401,0.0428547899888814,0.0530236127421723,1.83640899263672e-75
NMR metabolomics,X23424.Total Lipids in VLDL,MUC13,Mucin-13,39961,0.0863660447208418,0.00467454927479549,0.0772039281422426,0.0955281612994409,2.081676924125e-75
NMR metabolomics,X23424.Total Lipids in VLDL,AZI2,5-azacytidine-induced protein 2,37959,0.0947709581423753,0.00513145419821914,0.0847133079138658,0.104828608370885,3.10838841669819e-75
NMR metabolomics,X23424.Total Lipids in VLDL,IST1,IST1 homolog,37812,0.172219826113009,0.00932685057942593,0.153939198977334,0.190500453248684,3.39981977850009e-75
NMR metabolomics,X23424.Total Lipids in VLDL,CNST,Consortin,40359,0.185041958491936,0.0100326292011941,0.165378005257595,0.204705911726276,3.53740246168742e-75
NMR metabolomics,X23424.Total Lipids in VLDL,WASHC3,WASH complex subunit 3,37942,0.128800054914515,0.00698492674617488,0.115109598492013,0.142490511337018,5.25320906388671e-75
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL3,C-X-C motif chemokine 3,40350,0.159479611751323,0.00866122342858223,0.142503613831302,0.176455609671344,6.20019521964079e-75
NMR metabolomics,X23424.Total Lipids in VLDL,MTDH,Protein LYRIC,37598,0.157203717538133,0.00852950395089742,0.140485889794374,0.173921545281892,6.540263126522e-75
NMR metabolomics,X23424.Total Lipids in VLDL,ORM1,Alpha-1-acid glycoprotein 1,37950,0.0340195368433819,0.00184865705597104,0.0303961690136787,0.0376429046730852,1.02978133405615e-74
NMR metabolomics,X23424.Total Lipids in VLDL,SNX15,Sorting nexin-15,37671,0.0928342269617362,0.00504939796581519,0.0829374069487384,0.102731046974734,1.46282769464566e-74
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS1,Galectin-1,40359,0.0574521466305095,0.00313204082080095,0.0513133466217397,0.0635909466392794,2.17932707770653e-74
NMR metabolomics,X23424.Total Lipids in VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40411,0.123815179791632,0.00677303245138741,0.110540036186912,0.137090323396351,6.69952889554535e-74
NMR metabolomics,X23424.Total Lipids in VLDL,DTNB,Dystrobrevin beta,37878,0.0711609280378815,0.00389150265010353,0.0635335828436786,0.0787882732320844,8.36121331573614e-74
NMR metabolomics,X23424.Total Lipids in VLDL,FAM13A,Protein FAM13A,37901,0.114582478967857,0.00627540079372673,0.102282693412152,0.126882264523561,1.35630113005417e-73
NMR metabolomics,X23424.Total Lipids in VLDL,GOLM2,Protein GOLM2,40471,0.0380774605592396,0.00208943668527311,0.0339821646561043,0.0421727564623749,1.84416659238805e-73
NMR metabolomics,X23424.Total Lipids in VLDL,TBC1D23,TBC1 domain family member 23,40305,0.151986050625532,0.00834227276013035,0.135635196015677,0.168336905235388,2.05311238733508e-73
NMR metabolomics,X23424.Total Lipids in VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,39980,0.107470031967017,0.00590153343223514,0.095903026439836,0.119037037494198,2.46600822667521e-73
NMR metabolomics,X23424.Total Lipids in VLDL,SDC4,Syndecan-4,40359,0.0766804136134797,0.004211818633386,0.0684252490920431,0.0849355781349162,2.56542101866038e-73
NMR metabolomics,X23424.Total Lipids in VLDL,CRKL,Crk-like protein,40374,0.180322028850078,0.00990864182108326,0.160901090880755,0.199742966819401,2.93161448247155e-73
NMR metabolomics,X23424.Total Lipids in VLDL,SH2B3,SH2B adapter protein 3,39980,0.165376962548715,0.00909202246672522,0.147556598513934,0.183197326583496,3.60778546598396e-73
NMR metabolomics,X23424.Total Lipids in VLDL,FGF19,Fibroblast growth factor 19,40422,0.129666947867217,0.00713211796265867,0.115687996660406,0.143645899074028,4.00607762629366e-73
NMR metabolomics,X23424.Total Lipids in VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,37942,0.0540124312876113,0.00296841826858984,0.0481943314811752,0.0598305310940474,4.17032081887645e-73
NMR metabolomics,X23424.Total Lipids in VLDL,DLK1,Protein delta homolog 1,40536,0.0896186335374006,0.0049334447897499,0.0799490817494908,0.0992881853253104,5.1916145078596e-73
NMR metabolomics,X23424.Total Lipids in VLDL,LYN,Tyrosine-protein kinase Lyn,40305,0.141808790404782,0.00781039583950194,0.126500414559358,0.157117166250206,6.25771760764937e-73
NMR metabolomics,X23424.Total Lipids in VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37959,0.182264070394163,0.010038053757424,0.162589485029612,0.201938655758714,8.23633521133898e-73
NMR metabolomics,X23424.Total Lipids in VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37959,0.133992245033389,0.00738350143084435,0.119520582228934,0.148463907837843,9.80189398029014e-73
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM5,Tripartite motif-containing protein 5,40341,0.143674031172317,0.00792576381709774,0.128139534090805,0.159208528253828,1.04444215358654e-72
NMR metabolomics,X23424.Total Lipids in VLDL,GAS6,Growth arrest-specific protein 6,40429,-0.043383224512598,0.00239331178335774,-0.0480741156079792,-0.0386923334172169,1.04621467152495e-72
NMR metabolomics,X23424.Total Lipids in VLDL,STAT2,Signal transducer and activator of transcription 2,37598,0.129940800786783,0.00716501573463664,0.115897369946896,0.143984231626671,1.28134874129997e-72
NMR metabolomics,X23424.Total Lipids in VLDL,BAG4,BAG family molecular chaperone regulator 4,37598,0.0822630255262233,0.00453770234928697,0.0733691289216208,0.0911569221308257,1.44228725221531e-72
NMR metabolomics,X23424.Total Lipids in VLDL,DDHD2,Phospholipase DDHD2,37959,0.111579164108758,0.0061673423853985,0.0994911730333766,0.123667155184139,2.62805535478889e-72
NMR metabolomics,X23424.Total Lipids in VLDL,RILPL2,RILP-like protein 2,37990,0.163943984226737,0.00906924432311281,0.146168265353436,0.181719703100038,3.41376225295149e-72
NMR metabolomics,X23424.Total Lipids in VLDL,HAO1,Hydroxyacid oxidase 1,40489,0.219203835055049,0.0121437857774154,0.195402014931315,0.243005655178783,4.02755938357342e-72
NMR metabolomics,X23424.Total Lipids in VLDL,TAX1BP1,Tax1-binding protein 1,37942,0.107910546048015,0.00597737462357931,0.0961948917857993,0.11962620031023,5.23225605932496e-72
NMR metabolomics,X23424.Total Lipids in VLDL,GORASP2,Golgi reassembly-stacking protein 2,37901,0.0787507202281408,0.00436712232784519,0.0701911604655642,0.0873102799907174,7.56489800674513e-72
NMR metabolomics,X23424.Total Lipids in VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37628,0.117782707755643,0.00653227557927777,0.104979447620259,0.130585967891027,8.11798265279279e-72
NMR metabolomics,X23424.Total Lipids in VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40333,0.102550966932159,0.00569661911650963,0.0913855934638004,0.113716340400518,9.68580438424653e-72
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,40341,0.134172686145418,0.0074604345469087,0.119550234433477,0.148795137857359,1.31909942841442e-71
NMR metabolomics,X23424.Total Lipids in VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",37642,0.143268097080516,0.00797005839156376,0.127646782633051,0.158889411527981,2.13932000648055e-71
NMR metabolomics,X23424.Total Lipids in VLDL,BRAP,BRCA1-associated protein,37778,0.183246540053647,0.0102014492352673,0.163251699552523,0.203241380554771,2.63662873649344e-71
NMR metabolomics,X23424.Total Lipids in VLDL,MPHOSPH8,M-phase phosphoprotein 8,40042,0.124867308667722,0.00695859571974307,0.111228461057026,0.138506156278419,2.76847840513946e-71
NMR metabolomics,X23424.Total Lipids in VLDL,A1BG,Alpha-1B-glycoprotein,38013,0.0293201727050759,0.00163289642492945,0.0261196957122141,0.0325206496979376,2.87862693067788e-71
NMR metabolomics,X23424.Total Lipids in VLDL,PDLIM5,PDZ and LIM domain protein 5,37959,0.197730503936917,0.0110323359044318,0.176107125564231,0.219353882309603,5.19044166704914e-71
NMR metabolomics,X23424.Total Lipids in VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37901,0.0851053466367515,0.0047486268088589,0.0757980380913881,0.094412655182115,5.29865306988066e-71
NMR metabolomics,X23424.Total Lipids in VLDL,TIA1,Nucleolysin TIA-1 isoform p40,39836,0.200852679608793,0.0112187272789025,0.178863974142144,0.222841385075442,5.82366298339238e-71
NMR metabolomics,X23424.Total Lipids in VLDL,CNPY4,Protein canopy homolog 4,40305,0.124590767614497,0.00696203239058559,0.110945184128949,0.138236351100044,6.34191106027563e-71
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40516,0.0484806123174691,0.00271015472434335,0.0431687090577562,0.0537925155771821,7.05557435275624e-71
NMR metabolomics,X23424.Total Lipids in VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,39961,0.0445618758366789,0.00249140899068767,0.0396787142149311,0.0494450374584267,7.76733981868326e-71
NMR metabolomics,X23424.Total Lipids in VLDL,HS1BP3,HCLS1-binding protein 3,37628,0.149150747675973,0.00833859609305247,0.13280709933359,0.165494396018356,1.02282975967603e-70
NMR metabolomics,X23424.Total Lipids in VLDL,IGSF3,Immunoglobulin superfamily member 3,40305,0.0574040995771768,0.00321604453072061,0.0511006522969645,0.0637075468573892,1.43489156494949e-70
NMR metabolomics,X23424.Total Lipids in VLDL,NAGK,N-acetyl-D-glucosamine kinase,37608,0.0943180941426924,0.00527929241604184,0.0839706810072504,0.104665507278134,1.48477028460179e-70
NMR metabolomics,X23424.Total Lipids in VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37671,0.0973773499172141,0.00546136705857378,0.0866730704824095,0.108081629352019,2.73489510324563e-70
NMR metabolomics,X23424.Total Lipids in VLDL,OPHN1,Oligophrenin-1,37942,0.177419379622847,0.00996391765517078,0.157890101018712,0.196948658226982,4.00783578797877e-70
NMR metabolomics,X23424.Total Lipids in VLDL,DBNL,Drebrin-like protein,40422,0.152853789662133,0.00859224344431701,0.136012992511271,0.169694586812994,4.02782086532309e-70
NMR metabolomics,X23424.Total Lipids in VLDL,PLG,Plasminogen,37705,0.0372023016769172,0.00209029644406539,0.0331053206465491,0.0412992827072854,4.80741106659491e-70
NMR metabolomics,X23424.Total Lipids in VLDL,KLK10,Kallikrein-10,40354,0.0650628618880859,0.00366042226861717,0.0578884342415962,0.0722372895345755,5.27562390997065e-70
NMR metabolomics,X23424.Total Lipids in VLDL,CRELD1,Protein disulfide isomerase CRELD1,37671,0.0623646856602179,0.00350822464769469,0.0554885653507363,0.0692408059696995,6.95397541254381e-70
NMR metabolomics,X23424.Total Lipids in VLDL,OGA,Protein O-GlcNAcase,37901,0.116282307273639,0.00654565039760056,0.103452832494342,0.129111782052936,8.28840152747178e-70
NMR metabolomics,X23424.Total Lipids in VLDL,VWA1,von Willebrand factor A domain-containing protein 1,40453,0.0693729077388504,0.00391055369313519,0.0617082225003054,0.0770375929773954,9.59210628940271e-70
NMR metabolomics,X23424.Total Lipids in VLDL,GPC5,Glypican-5,40228,0.0926042043746062,0.00522085172631544,0.0823713349910279,0.102837073758184,1.02468637707826e-69
NMR metabolomics,X23424.Total Lipids in VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37901,0.243879706561714,0.0137447419523407,0.216940012335126,0.270819400788301,1.20136615854652e-69
NMR metabolomics,X23424.Total Lipids in VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40359,0.138360672883535,0.0078187614566321,0.123035900428536,0.153685445338534,2.08158495772512e-69
NMR metabolomics,X23424.Total Lipids in VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,40350,0.0814098107744824,0.00460084837596878,0.0723921479575836,0.0904274735913812,2.13706522552772e-69
NMR metabolomics,X23424.Total Lipids in VLDL,TWF2,Twinfilin-2,37998,0.136798291935452,0.007730559066319,0.121646396165466,0.151950187705437,2.71672156542057e-69
NMR metabolomics,X23424.Total Lipids in VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,37598,0.148140900827808,0.00838462855641952,0.131707028857226,0.16457477279839,4.62679866425037e-69
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40305,0.0455294351144769,0.00257968684245711,0.040473248903261,0.0505856213256929,4.71849926953348e-69
NMR metabolomics,X23424.Total Lipids in VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40044,0.0720853139689267,0.00408790268887676,0.0640730246987283,0.0800976032391252,6.32023309638232e-69
NMR metabolomics,X23424.Total Lipids in VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,37901,0.0950501393763016,0.00538662498359355,0.0844923544084583,0.105607924344145,6.56565639377762e-69
NMR metabolomics,X23424.Total Lipids in VLDL,SELE,E-selectin,40536,0.0820151522924452,0.00465400676134624,0.0728932990402066,0.0911370055446838,7.34365578091242e-69
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE4,Ribonuclease 4,37575,0.044935795647852,0.00254987176277749,0.0399380469928081,0.0499335443028959,1.01739296936434e-68
NMR metabolomics,X23424.Total Lipids in VLDL,CASC3,Protein CASC3,37572,0.0673637412005749,0.00382350356104921,0.0598696742209184,0.0748578081802313,1.09888826697908e-68
NMR metabolomics,X23424.Total Lipids in VLDL,NSFL1C,NSFL1 cofactor p47,40471,0.109318040150214,0.00621199192992851,0.0971425359675542,0.121493544332874,1.13109114617675e-68
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT5,ADP-sugar pyrophosphatase,40332,0.085533131963799,0.00486160364454929,0.0760043888204824,0.0950618751071157,1.23427720511247e-68
NMR metabolomics,X23424.Total Lipids in VLDL,F2,Prothrombin,38013,0.0241529152072256,0.00137259758442953,0.0214626239417437,0.0268432064727074,1.51127860800406e-68
NMR metabolomics,X23424.Total Lipids in VLDL,TIMP3,Metalloproteinase inhibitor 3,40422,0.215929743132353,0.0122846473567659,0.191851834313092,0.240007651951615,1.62580097244011e-68
NMR metabolomics,X23424.Total Lipids in VLDL,SPART,Spartin,37671,0.126488816264661,0.00719683164511079,0.112383026240243,0.140594606289078,2.26479563776677e-68
NMR metabolomics,X23424.Total Lipids in VLDL,SUSD1,Sushi domain-containing protein 1,40042,0.0805596734762045,0.00458797181495568,0.0715672487188914,0.0895520982335176,2.3124152031252e-68
NMR metabolomics,X23424.Total Lipids in VLDL,DGKA,Diacylglycerol kinase alpha,37598,0.088967484429446,0.00507062243124984,0.0790290644641963,0.0989059043946957,3.82990885056931e-68
NMR metabolomics,X23424.Total Lipids in VLDL,GTPBP2,GTP-binding protein 2,37572,0.130719747146035,0.0074514625729484,0.116114880503056,0.145324613789014,4.03582012532119e-68
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R2,Protein phosphatase inhibitor 2,40359,0.129352552343278,0.00738467298712749,0.114878593288508,0.143826511398048,4.67676300523099e-68
NMR metabolomics,X23424.Total Lipids in VLDL,PGF,Placenta growth factor,40516,0.042841951464237,0.00244677008245568,0.0380462821026239,0.0476376208258502,5.18086113851608e-68
NMR metabolomics,X23424.Total Lipids in VLDL,APPL2,DCC-interacting protein 13-beta,37671,0.182448307993929,0.0104095429852074,0.162045603742923,0.202851012244936,5.22663210783757e-68
NMR metabolomics,X23424.Total Lipids in VLDL,TXNDC5,Thioredoxin domain-containing protein 5,40471,0.109347721228846,0.00624552376958105,0.0971064946404671,0.121588947817225,5.33064439951837e-68
NMR metabolomics,X23424.Total Lipids in VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39980,0.0725908805928181,0.00414649898628187,0.0644637425797056,0.0807180186059305,5.73732276011638e-68
NMR metabolomics,X23424.Total Lipids in VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,37562,0.101411318058723,0.0057903899087868,0.0900621538375009,0.112760482279945,6.66315401589062e-68
NMR metabolomics,X23424.Total Lipids in VLDL,CHMP1A,Charged multivesicular body protein 1a,40228,0.129555792486067,0.0074064545316277,0.115039141604077,0.144072443368057,7.16600049738521e-68
NMR metabolomics,X23424.Total Lipids in VLDL,COCH,Cochlin,37990,0.0761488572639485,0.00435076000755466,0.0676213676491414,0.0846763468787556,7.65481438280182e-68
NMR metabolomics,X23424.Total Lipids in VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,37563,0.0805751263824405,0.00460390806822761,0.0715514665687144,0.0895987861961666,8.22335541559848e-68
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37900,0.13454544451995,0.00769167422366601,0.119469763041565,0.149621125998335,9.20401953900906e-68
NMR metabolomics,X23424.Total Lipids in VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40341,0.117197843654582,0.00671544782641633,0.104035565914806,0.130360121394358,1.41849062228668e-67
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS8,Galectin-8,40471,0.0981089499780512,0.00562931676192406,0.08707548912468,0.109142410831422,2.10848643959183e-67
NMR metabolomics,X23424.Total Lipids in VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",40042,0.148717417135217,0.00854928007725666,0.131960828183794,0.16547400608664,3.85218896859015e-67
NMR metabolomics,X23424.Total Lipids in VLDL,CCL11,Eotaxin,40516,0.0609799888218768,0.00350714992097341,0.0541059749767689,0.0678540026669847,4.23246600117618e-67
NMR metabolomics,X23424.Total Lipids in VLDL,CST3,Cystatin-C,40372,0.0452884668139059,0.00261410971286469,0.0401648117766911,0.0504121218511207,1.25176072206439e-66
NMR metabolomics,X23424.Total Lipids in VLDL,CDNF,Cerebral dopamine neurotrophic factor,40305,0.0523015531912212,0.00301901219981435,0.0463842892795851,0.0582188171028573,1.27126082721341e-66
NMR metabolomics,X23424.Total Lipids in VLDL,PSME1,Proteasome activator complex subunit 1,40216,0.060839148187139,0.00351474371869455,0.0539502504984977,0.0677280458757804,1.63689257952985e-66
NMR metabolomics,X23424.Total Lipids in VLDL,RAB27B,Ras-related protein Rab-27B,37990,0.132547932593464,0.00765324970235218,0.117547563176853,0.147548302010074,1.75269230431368e-66
NMR metabolomics,X23424.Total Lipids in VLDL,FLT4,Vascular endothelial growth factor receptor 3,40411,0.0536207259535078,0.00309957277597953,0.0475455633125879,0.0596958885944277,1.91808453641724e-66
NMR metabolomics,X23424.Total Lipids in VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40280,0.122001263922315,0.00705420493527154,0.108175022249183,0.135827505595447,2.09691512930421e-66
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA11,Annexin A11,40312,0.108519373327949,0.00627621046334725,0.0962180008197887,0.12082074583611,2.2476091368611e-66
NMR metabolomics,X23424.Total Lipids in VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40228,0.125596069992532,0.00727150379888614,0.111343922546715,0.139848217438349,3.0874198255045e-66
NMR metabolomics,X23424.Total Lipids in VLDL,TALDO1,Transaldolase,37966,0.0719028113874749,0.00416672056365187,0.0637360390827172,0.0800695836922325,5.09555329393056e-66
NMR metabolomics,X23424.Total Lipids in VLDL,AMN,Protein amnionless,40044,0.0765666819097687,0.00444070795135545,0.067862894325112,0.0852704694944253,5.25724464942249e-66
NMR metabolomics,X23424.Total Lipids in VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40396,0.140010320830242,0.00812865004263297,0.124078166746682,0.155942474913803,6.88462165531332e-66
NMR metabolomics,X23424.Total Lipids in VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,37959,0.109849848373767,0.00637314569052567,0.0973584828203367,0.122341213927197,7.16589216202782e-66
NMR metabolomics,X23424.Total Lipids in VLDL,DOK1,Docking protein 1,37942,0.219121888136069,0.0127184849050586,0.194193657722154,0.244050118549984,8.18580948657951e-66
NMR metabolomics,X23424.Total Lipids in VLDL,RWDD1,RWD domain-containing protein 1,40471,0.103344897455023,0.00600405879074067,0.0915769422251708,0.115112852684874,8.35637535504414e-66
NMR metabolomics,X23424.Total Lipids in VLDL,ICA1,Islet cell autoantigen 1,40044,0.127170154663482,0.00739003125098776,0.112685693411546,0.141654615915418,9.30453799503873e-66
NMR metabolomics,X23424.Total Lipids in VLDL,TDRKH,Tudor and KH domain-containing protein,39961,0.136371728758545,0.00792922646331917,0.120830444890439,0.15191301262665,1.10512359110814e-65
NMR metabolomics,X23424.Total Lipids in VLDL,C3,Complement C3,37360,0.0753332111823186,0.00439149368959599,0.0667258835507105,0.0839405388139268,3.07760794803331e-65
NMR metabolomics,X23424.Total Lipids in VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37391,0.0560915845123253,0.00327089809933839,0.0496806242376221,0.0625025447870286,3.37232892694631e-65
NMR metabolomics,X23424.Total Lipids in VLDL,CRADD,Death domain-containing protein CRADD,40192,0.122282300609118,0.00714301860372638,0.108281984145815,0.136282617072422,4.14924206365785e-65
NMR metabolomics,X23424.Total Lipids in VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39853,0.14128395087015,0.00825737261456375,0.125099500545605,0.157468401194695,4.98153552947265e-65
NMR metabolomics,X23424.Total Lipids in VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40305,0.14236087194305,0.00833856426384113,0.126017285985921,0.158704457900179,9.00145271711428e-65
NMR metabolomics,X23424.Total Lipids in VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,40340,0.0901118907381028,0.00528046809133553,0.0797621732790852,0.10046160819712,1.01743160532646e-64
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA4D,Semaphorin-4D,40471,0.0473994846442884,0.00278217183784001,0.041946427842122,0.0528525414464548,1.61864198113802e-64
NMR metabolomics,X23424.Total Lipids in VLDL,RBM17,Splicing factor 45,37959,0.121371446018257,0.0071218429133324,0.107412633908126,0.135330258128389,1.8835169982305e-64
NMR metabolomics,X23424.Total Lipids in VLDL,TRAF2,TNF receptor-associated factor 2,40341,0.11294955576117,0.00663639718597998,0.0999422172766492,0.125956894245691,2.18151713442065e-64
NMR metabolomics,X23424.Total Lipids in VLDL,IL1RL2,Interleukin-1 receptor-like 2,40044,0.0642974018889593,0.00377768651092224,0.0568931363275518,0.0717016674503669,2.2136581767409e-64
NMR metabolomics,X23424.Total Lipids in VLDL,UBXN1,UBX domain-containing protein 1,37671,0.109820367333918,0.00644929887649478,0.0971797415359884,0.122460993131848,2.45594705407875e-64
NMR metabolomics,X23424.Total Lipids in VLDL,CSNK2A1,Casein kinase II subunit alpha,37959,-0.0719878586178218,0.00422843842431718,-0.0802755979294834,-0.0637001193061601,2.52212891236348e-64
NMR metabolomics,X23424.Total Lipids in VLDL,PXN,Paxillin,39961,0.0819926762568119,0.00482545033334469,0.0725347936034563,0.0914505589101675,3.5994301140039e-64
NMR metabolomics,X23424.Total Lipids in VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37628,0.0733090809872257,0.00431186339885138,0.064857828725477,0.0817603332489744,3.84625445166622e-64
NMR metabolomics,X23424.Total Lipids in VLDL,MAX,Protein max,39961,0.165405331634805,0.00974149926942986,0.146311993066723,0.184498670202888,4.41914545286209e-64
NMR metabolomics,X23424.Total Lipids in VLDL,GMPR2,GMP reductase 2,37671,0.107466005122815,0.00632913289284275,0.0950609046528435,0.119871105592787,5.53691989978474e-64
NMR metabolomics,X23424.Total Lipids in VLDL,SH3GLB2,Endophilin-B2,37942,0.106100329110324,0.00625066703723126,0.0938490217173505,0.118351636503297,5.86818819987166e-64
NMR metabolomics,X23424.Total Lipids in VLDL,ST13,Hsc70-interacting protein,37671,0.0902675991240423,0.00531855134697916,0.0798432384839631,0.100691959764121,6.25998938416804e-64
NMR metabolomics,X23424.Total Lipids in VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",40422,0.174600722782747,0.010298810486472,0.154415054229262,0.194786391336233,6.56809985885567e-64
NMR metabolomics,X23424.Total Lipids in VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39980,0.123765699200591,0.00730491217830624,0.109448071331111,0.138083327070072,8.13958690885175e-64
NMR metabolomics,X23424.Total Lipids in VLDL,IFNLR1,Interferon lambda receptor 1,40341,0.0589984879837508,0.0034890809048079,0.0521598894103273,0.0658370865571743,1.37820009108555e-63
NMR metabolomics,X23424.Total Lipids in VLDL,PARP1,Poly [ADP-ribose] polymerase 1,40341,0.0853097648605056,0.00504721061423811,0.0754172320565989,0.0952022976644123,1.55144295602175e-63
NMR metabolomics,X23424.Total Lipids in VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40332,0.0720792503566388,0.00426805569395894,0.0637138611964793,0.0804446395167983,1.96948200858188e-63
NMR metabolomics,X23424.Total Lipids in VLDL,KIFBP,KIF-binding protein,40305,0.129397583338214,0.00767866839084453,0.114347393292159,0.144447773384269,3.62225089095666e-63
NMR metabolomics,X23424.Total Lipids in VLDL,MOCS2,Molybdopterin synthase catalytic subunit,37671,0.105790657368813,0.00627859919270622,0.0934846029511092,0.118096711786518,4.81389063458927e-63
NMR metabolomics,X23424.Total Lipids in VLDL,MAVS,Mitochondrial antiviral-signaling protein,39980,0.145541782581899,0.0086492995899685,0.128589155385561,0.162494409778237,5.58956176928057e-63
NMR metabolomics,X23424.Total Lipids in VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40414,0.0912602659638871,0.00543221332919753,0.0806131278386599,0.101907404089114,8.47273199978408e-63
NMR metabolomics,X23424.Total Lipids in VLDL,NUB1,NEDD8 ultimate buster 1,40341,0.130420829657041,0.00778488809022267,0.115162449000204,0.145679210313877,1.84658908233582e-62
NMR metabolomics,X23424.Total Lipids in VLDL,PRKG1,cGMP-dependent protein kinase 1,37671,0.195866373274038,0.0116879219792365,0.172958046194734,0.218774700353341,2.17661459106332e-62
NMR metabolomics,X23424.Total Lipids in VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39980,0.132055124129963,0.00788706370206444,0.116596479273917,0.14751376898601,2.23407144565115e-62
NMR metabolomics,X23424.Total Lipids in VLDL,GMPR,GMP reductase 1,40516,0.0795622257085764,0.00475916013505948,0.0702342718438598,0.088890179573293,3.26731806535501e-62
NMR metabolomics,X23424.Total Lipids in VLDL,CD22,B-cell receptor CD22,40516,0.0638716067056898,0.00382200691258156,0.05638047315703,0.0713627402543497,3.61699697873355e-62
NMR metabolomics,X23424.Total Lipids in VLDL,SRP14,Signal recognition particle 14 kDa protein,40305,0.0924001557087431,0.00553200487480834,0.0815574261541187,0.103242885263367,4.24157529307336e-62
NMR metabolomics,X23424.Total Lipids in VLDL,CTSZ,Cathepsin Z,40345,0.0483615422133444,0.00289643991493342,0.0426845199800749,0.0540385644466139,4.66348900908586e-62
NMR metabolomics,X23424.Total Lipids in VLDL,GOLGA3,Golgin subfamily A member 3,37959,0.122211283793876,0.00731522741332495,0.107873438063759,0.136549129523993,4.92998798760215e-62
NMR metabolomics,X23424.Total Lipids in VLDL,MMP10,Stromelysin-2,40341,-0.0932582053669827,0.00558830490659671,-0.104211282983912,-0.0823051277500531,5.3911413201185e-62
NMR metabolomics,X23424.Total Lipids in VLDL,MAP2,Microtubule-associated protein 2,37942,0.0714926539314274,0.0042812119670149,0.0631014784760782,0.0798838293867766,5.56421436438346e-62
NMR metabolomics,X23424.Total Lipids in VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37671,0.0983192495700982,0.00590184654665158,0.0867516303386611,0.109886868801535,1.10522491668726e-61
NMR metabolomics,X23424.Total Lipids in VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37900,0.07401300289287,0.00445468608495487,0.0652818181663584,0.0827441876193815,2.23122153590309e-61
NMR metabolomics,X23424.Total Lipids in VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,37863,0.0673395492595178,0.00405352715808474,0.0593946360296717,0.0752844624893639,2.31637763352261e-61
NMR metabolomics,X23424.Total Lipids in VLDL,TP53,Cellular tumor antigen p53,39980,0.0666349296904195,0.00401915698844178,0.0587573819930736,0.0745124773877654,3.30052592002238e-61
NMR metabolomics,X23424.Total Lipids in VLDL,SPRY2,Protein sprouty homolog 2,40044,0.142289298308252,0.00858938758828813,0.125454098635207,0.159124497981297,4.10329335840324e-61
NMR metabolomics,X23424.Total Lipids in VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37671,0.129864680578116,0.00784496051083543,0.114488557976878,0.145240803179353,6.15320736692326e-61
NMR metabolomics,X23424.Total Lipids in VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,40341,0.16126390955409,0.00975130656459885,0.142151348687476,0.180376470420704,6.34346791199841e-61
NMR metabolomics,X23424.Total Lipids in VLDL,YJU2,Splicing factor YJU2,37900,0.0494891844001961,0.0029904138272475,0.043627973298791,0.0553503955016012,6.47867943563786e-61
NMR metabolomics,X23424.Total Lipids in VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,40305,0.086519585343173,0.0052347180447269,0.0762595379755083,0.0967796327108377,7.44325131443312e-61
NMR metabolomics,X23424.Total Lipids in VLDL,CETN3,Centrin-3,37901,0.118297377178399,0.00716871644153491,0.10424669295299,0.132348061403807,1.39948406481964e-60
NMR metabolomics,X23424.Total Lipids in VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37942,0.148891100154979,0.00902703343009185,0.131198114631999,0.166584085677959,1.58643416220606e-60
NMR metabolomics,X23424.Total Lipids in VLDL,NUDC,Nuclear migration protein nudC,40516,0.0971915654289109,0.0058979492109301,0.0856315849754879,0.108751545882334,1.63254898278757e-60
NMR metabolomics,X23424.Total Lipids in VLDL,CD5,T-cell surface glycoprotein CD5,40470,0.0513569573544071,0.00311848111987896,0.0452447343594443,0.0574691803493698,1.93625553497203e-60
NMR metabolomics,X23424.Total Lipids in VLDL,OTUD6B,Deubiquitinase OTUD6B,37901,0.0905006538122637,0.00549826196640374,0.0797240603581124,0.101277247266415,2.76623201705478e-60
NMR metabolomics,X23424.Total Lipids in VLDL,STIP1,Stress-induced-phosphoprotein 1,40307,0.100399876606846,0.00610829414429415,0.0884276200840299,0.112372133129663,3.28984496356675e-60
NMR metabolomics,X23424.Total Lipids in VLDL,CD69,Early activation antigen CD69,40288,0.13475734818259,0.00820048404015868,0.118684399463879,0.150830296901301,3.50342117939692e-60
NMR metabolomics,X23424.Total Lipids in VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",40332,0.118710878798545,0.00722455048455077,0.104550759848825,0.132870997748264,3.56447810141054e-60
NMR metabolomics,X23424.Total Lipids in VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39980,0.131219456365537,0.00798848365243566,0.115562028406763,0.146876884324311,3.9989543294973e-60
NMR metabolomics,X23424.Total Lipids in VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,39980,0.117017580725754,0.00714122786210784,0.103020774116023,0.131014387335485,7.6256616438304e-60
NMR metabolomics,X23424.Total Lipids in VLDL,ELOA,Elongin-A,40305,0.0779520317175738,0.00475769758280912,0.0686269444552679,0.0872771189798797,7.66861362774721e-60
NMR metabolomics,X23424.Total Lipids in VLDL,DLG4,Disks large homolog 4,37942,0.107313021580158,0.00654798090970165,0.0944789789971426,0.120147064163173,8.69939350535921e-60
NMR metabolomics,X23424.Total Lipids in VLDL,NIT1,Deaminated glutathione amidase,37628,0.0759369376527068,0.00463491951090431,0.0668524954113343,0.0850213798940792,9.73847491024619e-60
NMR metabolomics,X23424.Total Lipids in VLDL,ESM1,Endothelial cell-specific molecule 1,40357,-0.0517134880908622,0.00315935021193849,-0.0579058145062616,-0.0455211616754627,9.89715408422282e-60
NMR metabolomics,X23424.Total Lipids in VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37714,0.0754705385534771,0.00460806240131893,0.066438736246892,0.0845023408600622,1.05872495504983e-59
NMR metabolomics,X23424.Total Lipids in VLDL,ATOX1,Copper transport protein ATOX1,40411,0.109414061355369,0.00669058969589972,0.0963005055514053,0.122527617159332,1.25563819432907e-59
NMR metabolomics,X23424.Total Lipids in VLDL,KRT5,"Keratin, type II cytoskeletal 5",39961,0.0745192422806055,0.00456129482876205,0.0655791044162319,0.0834593801449791,1.68160062817501e-59
NMR metabolomics,X23424.Total Lipids in VLDL,GP1BB,Platelet glycoprotein Ib beta chain,37562,0.103419573302473,0.00632655154020959,0.0910195322836619,0.115819614321283,1.77141381266775e-59
NMR metabolomics,X23424.Total Lipids in VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,37598,0.0877864767223441,0.00537963695799442,0.077242388284675,0.0983305651600131,2.79540613494263e-59
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINC1,Antithrombin-III,37981,0.0224351701872325,0.00137535642985534,0.019739471584716,0.025130868789749,2.9664860687699e-59
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40379,0.045172839893367,0.00277372070943737,0.0397363473028698,0.0506093324838643,3.7285654510997e-59
NMR metabolomics,X23424.Total Lipids in VLDL,GRAP2,GRB2-related adapter protein 2,40359,0.192487596897911,0.0118308673901452,0.169299096813227,0.215676096982596,4.83320312978569e-59
NMR metabolomics,X23424.Total Lipids in VLDL,GYS1,"Glycogen [starch] synthase, muscle",40042,0.141131053184948,0.00868098953587899,0.124116313694625,0.158145792675271,6.03540859818692e-59
NMR metabolomics,X23424.Total Lipids in VLDL,PF4,Platelet factor 4,37934,0.147489538554468,0.0090868379644985,0.129679336144051,0.165299740964885,1.09307569921801e-58
NMR metabolomics,X23424.Total Lipids in VLDL,MCAM,Cell surface glycoprotein MUC18,40403,-0.0513707092160587,0.00317192891916629,-0.0575876898976246,-0.0451537285344927,1.59137901714863e-58
NMR metabolomics,X23424.Total Lipids in VLDL,HSPA1A,Heat shock 70 kDa protein 1A,40400,0.10757268745566,0.00664856742331924,0.0945414953059541,0.120603879605366,2.04209194222462e-58
NMR metabolomics,X23424.Total Lipids in VLDL,CACYBP,Calcyclin-binding protein,37642,0.155039295344755,0.00957682086996439,0.136268726439624,0.173809864249885,2.20043372766772e-58
NMR metabolomics,X23424.Total Lipids in VLDL,BPIFB2,BPI fold-containing family B member 2,37951,0.102741834661753,0.0063477753480472,0.0903001949795808,0.115183474343926,2.26059295630036e-58
NMR metabolomics,X23424.Total Lipids in VLDL,TMED8,Protein TMED8,37901,0.155149485519725,0.00959150736058709,0.136350131092974,0.173948839946475,2.65370832190231e-58
NMR metabolomics,X23424.Total Lipids in VLDL,RRAS,Ras-related protein R-Ras,37572,0.196928512148779,0.0121884675581248,0.173039115734854,0.220817908562703,3.6905735840116e-58
NMR metabolomics,X23424.Total Lipids in VLDL,PALM2,Paralemmin-2,37942,0.0556972286772754,0.00345403425799072,0.0489273215316136,0.0624671358229372,5.89721232807753e-58
NMR metabolomics,X23424.Total Lipids in VLDL,LPP,Lipoma-preferred partner,37562,0.101171603345031,0.00627944780001541,0.0888638856570007,0.113479321033061,7.59794561767463e-58
NMR metabolomics,X23424.Total Lipids in VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,37572,0.102654909402865,0.00637267387072635,0.0901644686162414,0.115145350189489,7.95240859637788e-58
NMR metabolomics,X23424.Total Lipids in VLDL,APOC1,Apolipoprotein C-I,37981,0.0545115246235498,0.00338460889479575,0.0478776911897502,0.0611453580573495,8.01558480121109e-58
NMR metabolomics,X23424.Total Lipids in VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,40470,0.0918629911280415,0.0057086071558144,0.0806741211026453,0.103051861153438,8.23971656273209e-58
NMR metabolomics,X23424.Total Lipids in VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40379,0.0400220280685991,0.00248717178669737,0.0351471713666723,0.044896884770526,8.37242845803049e-58
NMR metabolomics,X23424.Total Lipids in VLDL,PKD2,Polycystin-2,37562,0.0897696641873087,0.00557404728422568,0.0788445315102264,0.100694796864391,8.4375687654618e-58
NMR metabolomics,X23424.Total Lipids in VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40341,0.144618334886349,0.00899039384252324,0.126997162955003,0.162239506817694,9.16094257865325e-58
NMR metabolomics,X23424.Total Lipids in VLDL,DFFA,DNA fragmentation factor subunit alpha,40516,0.10187999463518,0.00633487470542143,0.0894636402125539,0.114296349057806,9.57162286184045e-58
NMR metabolomics,X23424.Total Lipids in VLDL,GASK1A,Golgi-associated kinase 1A,37562,0.0652706547111177,0.00405592310507135,0.0573210454251779,0.0732202639970575,1.02467125029115e-57
NMR metabolomics,X23424.Total Lipids in VLDL,YWHAQ,14-3-3 protein theta,37671,0.110673315900117,0.00689392584471249,0.0971612212444803,0.124185410555753,1.87788381782868e-57
NMR metabolomics,X23424.Total Lipids in VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,40044,0.0898467991648489,0.00561598988722731,0.0788394589858833,0.100854139343814,3.73629726748103e-57
NMR metabolomics,X23424.Total Lipids in VLDL,GZMA,Granzyme A,40516,0.0525422490190479,0.00328501112136636,0.0461036272211699,0.058980870816926,3.8515588608658e-57
NMR metabolomics,X23424.Total Lipids in VLDL,MPI,Mannose-6-phosphate isomerase,40305,0.128105627661656,0.00801041800148297,0.112405208378749,0.143806046944563,4.03925081944313e-57
NMR metabolomics,X23424.Total Lipids in VLDL,MEP1A,Meprin A subunit alpha,37901,0.102363289958643,0.00639654063441988,0.0898260703151802,0.114900509602106,4.10237556676134e-57
NMR metabolomics,X23424.Total Lipids in VLDL,IL1R2,Interleukin-1 receptor type 2,40330,0.0291021557073878,0.00182168857117361,0.0255316461078875,0.0326726653068881,5.27498781132678e-57
NMR metabolomics,X23424.Total Lipids in VLDL,SPARC,SPARC,40411,0.1054890179969,0.00660600631908429,0.0925412456114948,0.118436790382305,5.83524859060833e-57
NMR metabolomics,X23424.Total Lipids in VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37900,0.0576431044527091,0.0036080763956454,0.0505712747172441,0.064714934188174,6.25593283204972e-57
NMR metabolomics,X23424.Total Lipids in VLDL,TBCB,Tubulin-folding cofactor B,40228,0.150541477179781,0.00944190627024291,0.132035340890105,0.169047613469457,8.71161558907188e-57
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37959,0.11935582549027,0.00748392115187562,0.104687340032594,0.134024310947946,9.64124194018089e-57
NMR metabolomics,X23424.Total Lipids in VLDL,VASP,Vasodilator-stimulated phosphoprotein,37987,0.107426194784553,0.00674214267371061,0.0942115951440803,0.120640794425026,1.21277053832882e-56
NMR metabolomics,X23424.Total Lipids in VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37959,0.0704598227709781,0.00442592082331146,0.0617850179572876,0.0791346275846686,1.50800680167912e-56
NMR metabolomics,X23424.Total Lipids in VLDL,GPI,Glucose-6-phosphate isomerase,37987,0.0695450841511729,0.0043760999059187,0.0609679283355722,0.0781222399667735,2.32551365939384e-56
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM40,E3 ubiquitin ligase TRIM40,37572,0.106857050720854,0.00672446780227416,0.0936770938283968,0.120037007613311,2.45964009219928e-56
NMR metabolomics,X23424.Total Lipids in VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40489,0.0934952784538786,0.00588924960301058,0.0819523492319779,0.105038207675779,2.51162778374993e-56
NMR metabolomics,X23424.Total Lipids in VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,37959,0.126863401242881,0.00798621844788175,0.111210413085032,0.142516389400729,2.59030146464288e-56
NMR metabolomics,X23424.Total Lipids in VLDL,IGBP1,Immunoglobulin-binding protein 1,37959,0.0908273988965368,0.0057232812233781,0.0796097676987157,0.102045030094358,3.30018579381024e-56
NMR metabolomics,X23424.Total Lipids in VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39976,0.115196698666553,0.00726804834803614,0.100951323904402,0.129442073428704,3.8891378724459e-56
NMR metabolomics,X23424.Total Lipids in VLDL,FAM172A,Cotranscriptional regulator FAM172A,37628,0.0915944932461441,0.00577677131913188,0.0802720214606457,0.102916965031643,4.23849198781876e-56
NMR metabolomics,X23424.Total Lipids in VLDL,FUS,RNA-binding protein FUS,39960,0.0582440029593451,0.00368126314950887,0.0510287271863078,0.0654592787323825,6.03320765906378e-56
NMR metabolomics,X23424.Total Lipids in VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39980,0.0779676100757643,0.00493209568044536,0.0683007025420913,0.0876345176094372,7.44437115869383e-56
NMR metabolomics,X23424.Total Lipids in VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39980,0.14576110221828,0.00922520543045007,0.127679699574598,0.163842504861962,8.42200163878875e-56
NMR metabolomics,X23424.Total Lipids in VLDL,BAG6,Large proline-rich protein BAG6,40042,0.0529505702075413,0.00335224327571056,0.0463801733871486,0.059520967027934,9.03410271808654e-56
NMR metabolomics,X23424.Total Lipids in VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",40411,0.0904351797304486,0.00573030742632288,0.0792037771748557,0.101666582286041,1.09283586993007e-55
NMR metabolomics,X23424.Total Lipids in VLDL,FIS1,Mitochondrial fission 1 protein,40354,0.113534239440619,0.00720530376146343,0.099411844068151,0.127656634813088,1.61591790103814e-55
NMR metabolomics,X23424.Total Lipids in VLDL,PPBP,Platelet basic protein,37934,0.123653926460849,0.00784246767289993,0.108282689821965,0.139025163099733,1.63740297483356e-55
NMR metabolomics,X23424.Total Lipids in VLDL,ERP29,Endoplasmic reticulum resident protein 29,37671,0.174597745070922,0.0110727662511224,0.152895123218722,0.196300366923122,1.64892441361481e-55
NMR metabolomics,X23424.Total Lipids in VLDL,ESYT2,Extended synaptotagmin-2,37942,0.120151937590143,0.00762432090073596,0.105208268624701,0.135095606555586,1.85830989205249e-55
NMR metabolomics,X23424.Total Lipids in VLDL,MGLL,Monoglyceride lipase,40396,0.126468582176156,0.00804890807027452,0.110692722358418,0.142244441993894,3.22197250381289e-55
NMR metabolomics,X23424.Total Lipids in VLDL,EGF,Pro-epidermal growth factor,40324,0.150613552754746,0.00958678103774443,0.131823461920767,0.169403643588725,3.33631316530561e-55
NMR metabolomics,X23424.Total Lipids in VLDL,STX4,Syntaxin-4,40305,0.0873758820280934,0.00557565145704861,0.0764476051722782,0.0983041588839087,6.17114971011763e-55
NMR metabolomics,X23424.Total Lipids in VLDL,NEXN,Nexilin,37987,0.100099853519191,0.00638515445263403,0.0875849507920283,0.112614756246354,6.60506316739935e-55
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS2,Trypsin-2,40403,0.0733405520536805,0.00468181617236222,0.0641641923558505,0.0825169117515104,6.73268185793421e-55
NMR metabolomics,X23424.Total Lipids in VLDL,C2,Complement C2,40372,0.0350394508433432,0.0022370912289189,0.0306547520346622,0.0394241496520243,6.96011598997254e-55
NMR metabolomics,X23424.Total Lipids in VLDL,MMP7,Matrilysin,40015,0.0705720594529633,0.00450688613732294,0.0617385626238104,0.0794055562821163,7.59232290959753e-55
NMR metabolomics,X23424.Total Lipids in VLDL,LACTB2,Endoribonuclease LACTB2,40359,0.0964502468392075,0.0061624168560383,0.0843719098013724,0.108528583877043,8.33370249307592e-55
NMR metabolomics,X23424.Total Lipids in VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40044,0.0799061487747756,0.00510567102318165,0.0698990335693396,0.0899132639802116,8.61072157174228e-55
NMR metabolomics,X23424.Total Lipids in VLDL,CD226,CD226 antigen,37598,0.0612727461962766,0.00392160291670901,0.053586404479527,0.0689590879130263,1.53487453122112e-54
NMR metabolomics,X23424.Total Lipids in VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37990,0.0902290844599114,0.00577822479951139,0.0789037638528691,0.101554405066954,1.70841751933939e-54
NMR metabolomics,X23424.Total Lipids in VLDL,ALDH1A1,Retinal dehydrogenase 1,40332,0.0769263452265373,0.00493118277834017,0.0672612269809905,0.086591463472084,1.8465845569046e-54
NMR metabolomics,X23424.Total Lipids in VLDL,VAV3,Guanine nucleotide exchange factor VAV3,37541,0.145486187032798,0.00932054240158404,0.127217923925694,0.163754450139903,1.94942385017104e-54
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH9,Protocadherin-9,37901,0.0492817751706789,0.00316283769808283,0.0430826132824365,0.0554809370589212,2.89672681238181e-54
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4G,C-type lectin domain family 4 member G,40341,0.0478428204583237,0.00307487138430022,0.0418160725450953,0.0538695683715521,3.45463339202865e-54
NMR metabolomics,X23424.Total Lipids in VLDL,CD244,Natural killer cell receptor 2B4,40516,0.0386734653848148,0.00248650244700846,0.0337999205886783,0.0435470101809514,3.74746486931595e-54
NMR metabolomics,X23424.Total Lipids in VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37628,0.112848878415306,0.00725126110443711,0.098636406650609,0.127061350180002,3.95644022026253e-54
NMR metabolomics,X23424.Total Lipids in VLDL,OXT,Oxytocin-neurophysin 1,40471,0.191864500390072,0.0123465883204106,0.167665187282067,0.216063813498077,4.62231217862828e-54
NMR metabolomics,X23424.Total Lipids in VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40305,0.0559085210343482,0.00360150365332224,0.0488495738738366,0.0629674681948598,5.98627867061921e-54
NMR metabolomics,X23424.Total Lipids in VLDL,STX8,Syntaxin-8,40341,0.0707887110569662,0.00456140028014507,0.0618483665078819,0.0797290556060506,6.4098078833012e-54
NMR metabolomics,X23424.Total Lipids in VLDL,STK24,Serine/threonine-protein kinase 24,39961,0.0895190317302458,0.0057694139836024,0.0782109803223851,0.100827083138107,6.85486543033034e-54
NMR metabolomics,X23424.Total Lipids in VLDL,RFC4,Replication factor C subunit 4,37900,0.0298126246657506,0.00192110063045934,0.0260472674300503,0.0335779819014509,7.61298039035094e-54
NMR metabolomics,X23424.Total Lipids in VLDL,AP2B1,AP-2 complex subunit beta,37572,0.0710213134840008,0.0045762689949056,0.0620518262539859,0.0799908007140158,7.70288171141047e-54
NMR metabolomics,X23424.Total Lipids in VLDL,GLOD4,Glyoxalase domain-containing protein 4,40328,0.0526130393498924,0.00339314610823795,0.045962472977746,0.0592636057220387,7.87807311011846e-54
NMR metabolomics,X23424.Total Lipids in VLDL,CASP7,Caspase-7,37942,0.12141709401605,0.00782906833185678,0.106072120085611,0.136762067946489,8.84464612798953e-54
NMR metabolomics,X23424.Total Lipids in VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,40338,0.136048393160775,0.00878421612348424,0.118831329558745,0.153265456762804,1.0352618304551e-53
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,37900,0.12554590001118,0.00810641445047364,0.109657327688251,0.141434472334108,1.2283880646321e-53
NMR metabolomics,X23424.Total Lipids in VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37671,0.15035538652866,0.00970891252613634,0.131325917977433,0.169384855079887,1.26838026829533e-53
NMR metabolomics,X23424.Total Lipids in VLDL,OCLN,Occludin,37959,0.0631221137074192,0.00407779810458736,0.055129629422428,0.0711145979924105,1.37683121556984e-53
NMR metabolomics,X23424.Total Lipids in VLDL,PENK,Proenkephalin-A,37671,0.0446069880449414,0.00288499609133377,0.0389523957059273,0.0502615803839556,1.84659782837739e-53
NMR metabolomics,X23424.Total Lipids in VLDL,PDIA4,Protein disulfide-isomerase A4,37998,0.0874360213556463,0.00565636509762363,0.076349545764304,0.0985224969469887,1.90505952339185e-53
NMR metabolomics,X23424.Total Lipids in VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,40359,0.0508106722951182,0.00329766985751899,0.044347239374381,0.0572741052158554,3.49942838400647e-53
NMR metabolomics,X23424.Total Lipids in VLDL,CCL3,C-C motif chemokine 3,40341,0.0885001744793611,0.00574662240481131,0.0772367945659309,0.0997635543927912,3.93740654616549e-53
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB14,DnaJ homolog subfamily B member 14,37901,0.0926145136891047,0.0060101549361195,0.0808346100143105,0.104394417363899,4.00591992615048e-53
NMR metabolomics,X23424.Total Lipids in VLDL,ATXN2L,Ataxin-2-like protein,37959,0.0695011466440281,0.00451358753923367,0.0606545150671301,0.0783477782209261,4.74762243549581e-53
NMR metabolomics,X23424.Total Lipids in VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,37900,0.0829894539803687,0.00539001615476955,0.0724250223170203,0.093553885643717,4.86571326948883e-53
NMR metabolomics,X23424.Total Lipids in VLDL,CD207,C-type lectin domain family 4 member K,40029,0.0551766235843652,0.00359122329644762,0.0481378259233279,0.0622154212454025,6.93845265706117e-53
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40228,0.0825555928513737,0.00537681556788877,0.0720170343383117,0.0930941513644357,8.02457010394458e-53
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFA,Platelet-derived growth factor subunit A,40536,0.102988106186093,0.00670816508191582,0.0898401026255383,0.116136109746648,8.05472677355737e-53
NMR metabolomics,X23424.Total Lipids in VLDL,MESD,LRP chaperone MESD,40332,0.173049321368316,0.0112995442355642,0.15090221466661,0.195196428070021,1.44805257301613e-52
NMR metabolomics,X23424.Total Lipids in VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,40422,0.0547694208289162,0.0035767480606102,0.0477589946301202,0.0617798470277122,1.48738073340163e-52
NMR metabolomics,X23424.Total Lipids in VLDL,CDCP1,CUB domain-containing protein 1,40228,0.0694345457122385,0.00453793466880841,0.060540193761374,0.078328897663103,1.79490956684897e-52
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINE2,Glia-derived nexin,37990,0.0919569765934297,0.00600688772992816,0.0801834766427705,0.103730476544089,1.84183118056501e-52
NMR metabolomics,X23424.Total Lipids in VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37714,0.0951220135262352,0.00621758432844296,0.082935548242487,0.107308478809983,2.17785567084652e-52
NMR metabolomics,X23424.Total Lipids in VLDL,EHD3,EH domain-containing protein 3,37628,0.167271732528964,0.0109581451288891,0.145793768076341,0.188749696981587,3.67556558993241e-52
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB6,Serpin B6,40433,0.0849798695954807,0.00558030896579626,0.0740424640225201,0.0959172751684414,5.29992174730695e-52
NMR metabolomics,X23424.Total Lipids in VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40341,0.143056220944013,0.00939491167667431,0.124642194057732,0.161470247830295,5.45015237502814e-52
NMR metabolomics,X23424.Total Lipids in VLDL,F2R,Proteinase-activated receptor 1,40396,0.0816636092942202,0.00536371595799866,0.0711507260165429,0.0921764925718976,5.58361635112725e-52
NMR metabolomics,X23424.Total Lipids in VLDL,CTF1,Cardiotrophin-1,40042,0.120206324917365,0.00789608429584437,0.10472999969751,0.13568265013722,5.83409223860175e-52
NMR metabolomics,X23424.Total Lipids in VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37608,0.114639510090281,0.00752848156031605,0.0998836862320611,0.1293953339485,6.43888140019155e-52
NMR metabolomics,X23424.Total Lipids in VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,40359,0.0964363210445362,0.00634159971353217,0.0840067856060131,0.108865856483059,7.36479316020529e-52
NMR metabolomics,X23424.Total Lipids in VLDL,BIN2,Bridging integrator 2,40332,0.12880501184912,0.00847383888254118,0.112196287639339,0.145413736058901,8.14848440386732e-52
NMR metabolomics,X23424.Total Lipids in VLDL,DIABLO,"Diablo homolog, mitochondrial",40314,0.155301974710347,0.0102243261875282,0.135262295382791,0.175341654037902,9.60285679079378e-52
NMR metabolomics,X23424.Total Lipids in VLDL,HSPB1,Heat shock protein beta-1,40116,0.0961864183928372,0.00633245526334858,0.083774806076674,0.108598030709,9.70749855651589e-52
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,37959,0.131904278830521,0.00868188289590085,0.114887788354555,0.148920769306487,1.05137143318377e-51
NMR metabolomics,X23424.Total Lipids in VLDL,IMPACT,Protein IMPACT,37942,0.0807840143034671,0.00532160415120718,0.0703536701671011,0.0912143584398332,1.27277061156796e-51
NMR metabolomics,X23424.Total Lipids in VLDL,THTPA,Thiamine-triphosphatase,37884,0.125701477680812,0.00828478910075023,0.109463291043342,0.141939664318283,1.4371347513346e-51
NMR metabolomics,X23424.Total Lipids in VLDL,APOM,Apolipoprotein M,40372,0.0377922530303872,0.00249680454304755,0.032898516126014,0.0426859899347604,2.12805970942003e-51
NMR metabolomics,X23424.Total Lipids in VLDL,IL18,Interleukin-18,40292,0.0669395641376716,0.00442329967449029,0.0582698967756706,0.0756092314996725,2.23000243825953e-51
NMR metabolomics,X23424.Total Lipids in VLDL,FOXJ3,Forkhead box protein J3,37598,0.061755280002972,0.00409048894918004,0.0537379216625791,0.0697726383433649,4.51969943518748e-51
NMR metabolomics,X23424.Total Lipids in VLDL,LRRC59,Leucine-rich repeat-containing protein 59,37990,0.0663763386095639,0.00439769103137298,0.0577568641880729,0.074995813031055,4.6524352564999e-51
NMR metabolomics,X23424.Total Lipids in VLDL,UROD,Uroporphyrinogen decarboxylase,37671,0.0993309579148552,0.00658228906984457,0.0864296713379598,0.112232244491751,4.96343039304846e-51
NMR metabolomics,X23424.Total Lipids in VLDL,CIAPIN1,Anamorsin,40411,0.089836420498204,0.00596000815465309,0.078154804515084,0.101518036481324,5.45282495151201e-51
NMR metabolomics,X23424.Total Lipids in VLDL,JAM3,Junctional adhesion molecule C,37671,0.0714550312826438,0.00473727154800547,0.0621699790485531,0.0807400835167345,5.51360744017807e-51
NMR metabolomics,X23424.Total Lipids in VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37990,0.126660188717878,0.00840253574602856,0.110191218655662,0.143129158780094,6.21248462342935e-51
NMR metabolomics,X23424.Total Lipids in VLDL,PPP3R1,Calcineurin subunit B type 1,40228,0.0581726429649804,0.00386233022205171,0.050602475729759,0.0657428102002017,6.54973994992276e-51
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40341,0.0855086144922353,0.00567787677570209,0.0743799760118593,0.0966372529726114,6.66726332960252e-51
NMR metabolomics,X23424.Total Lipids in VLDL,DNM3,Dynamin-3,37959,0.0772866655725016,0.00513048385521339,0.0672309172162833,0.0873424139287198,7.20767961719456e-51
NMR metabolomics,X23424.Total Lipids in VLDL,JPT2,Jupiter microtubule associated homolog 2,37901,0.123499703611735,0.00820230240356526,0.107423190900747,0.139576216322723,8.09042431413174e-51
NMR metabolomics,X23424.Total Lipids in VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,37714,0.103101964458255,0.00685376765688654,0.0896685798507578,0.116535349065753,1.00357600360885e-50
NMR metabolomics,X23424.Total Lipids in VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37959,0.0669713188973583,0.00445595100450693,0.0582376549285247,0.0757049828661919,1.20491255858994e-50
NMR metabolomics,X23424.Total Lipids in VLDL,PMVK,Phosphomevalonate kinase,39951,0.155400271591153,0.0103510362645547,0.135112240512626,0.175688302669681,1.36834525866061e-50
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40397,0.154330089784905,0.0102811327974243,0.134179069501953,0.174481110067857,1.37833597481225e-50
NMR metabolomics,X23424.Total Lipids in VLDL,SUGT1,Protein SGT1 homolog,39980,0.114135411113785,0.00760606783543455,0.0992275181563329,0.129043304071236,1.5200914499474e-50
NMR metabolomics,X23424.Total Lipids in VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40305,0.076350543867986,0.00509085337065894,0.0663724712614944,0.0863286164744775,1.68992969955177e-50
NMR metabolomics,X23424.Total Lipids in VLDL,MSR1,Macrophage scavenger receptor types I and II,40471,0.0626449255804807,0.0041785578792252,0.0544549521371993,0.0708348990237621,1.82141036825152e-50
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB1,Leukocyte elastase inhibitor,40287,0.12456581181369,0.00830953819184214,0.10827911695768,0.140852506669701,1.87367480920183e-50
NMR metabolomics,X23424.Total Lipids in VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39961,0.157232533696843,0.0104952159839809,0.136661910368241,0.177803157025446,2.18848648094464e-50
NMR metabolomics,X23424.Total Lipids in VLDL,NACC1,Nucleus accumbens-associated protein 1,37900,0.0770378376117689,0.00514342220342403,0.0669567300930578,0.08711894513048,2.60335731671208e-50
NMR metabolomics,X23424.Total Lipids in VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,39961,0.1054252124266,0.00704269438422448,0.0916215314335199,0.11922889341968,2.61117113140871e-50
NMR metabolomics,X23424.Total Lipids in VLDL,SULT2A1,Bile salt sulfotransferase,40341,0.0744577385453776,0.00497549091977642,0.0647057763426159,0.0842097007481394,2.73994513188349e-50
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4E,Eukaryotic translation initiation factor 4E,37598,0.127853104736745,0.0085397106342487,0.111115271893617,0.144590937579872,2.92041287585493e-50
NMR metabolomics,X23424.Total Lipids in VLDL,IL7,Interleukin-7,40341,0.0900382229128131,0.00601914631002867,0.0782406961451569,0.101835749680469,3.0065651288631e-50
NMR metabolomics,X23424.Total Lipids in VLDL,ATXN3,Ataxin-3,37942,0.0872383754494162,0.00583222293868387,0.0758072184895958,0.0986695324092366,3.48601478520002e-50
NMR metabolomics,X23424.Total Lipids in VLDL,GP5,Platelet glycoprotein V,37671,0.0502436981970052,0.00335969231563413,0.0436587012583623,0.0568286951356481,3.72105730734193e-50
NMR metabolomics,X23424.Total Lipids in VLDL,MIF,Macrophage migration inhibitory factor,40307,0.0961989820537297,0.0064387511894121,0.083579029722482,0.108818934384977,3.93196624757363e-50
NMR metabolomics,X23424.Total Lipids in VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39939,0.08070289898668,0.00540228016923403,0.0701144298549813,0.0912913681183787,4.12278528102745e-50
NMR metabolomics,X23424.Total Lipids in VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37628,0.136538598053541,0.00913438435023163,0.118635204727087,0.154441991379995,4.14435300422378e-50
NMR metabolomics,X23424.Total Lipids in VLDL,CPB1,Carboxypeptidase B,40536,0.0785735877173201,0.00526063595866387,0.0682627412383389,0.0888844341963013,4.15574092273711e-50
NMR metabolomics,X23424.Total Lipids in VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39980,0.0808333732140045,0.00541260001447755,0.0702246771856285,0.0914420692423805,4.38927434167585e-50
NMR metabolomics,X23424.Total Lipids in VLDL,DYNLT1,Dynein light chain Tctex-type 1,37572,0.113215345206593,0.00758504782873947,0.0983486514622634,0.128082038950922,5.72577110569954e-50
NMR metabolomics,X23424.Total Lipids in VLDL,VSNL1,Visinin-like protein 1,37942,0.0523186663570919,0.0035059923408925,0.0454469213689426,0.0591904113452412,5.87495474664027e-50
NMR metabolomics,X23424.Total Lipids in VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,37628,0.102449287186801,0.00687230686039703,0.0889795657404225,0.115919008633179,7.49764641146373e-50
NMR metabolomics,X23424.Total Lipids in VLDL,TP53I3,Quinone oxidoreductase PIG3,37419,0.0747570540507758,0.00502061795622745,0.06491664285657,0.0845974652449816,9.85145286781605e-50
NMR metabolomics,X23424.Total Lipids in VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40305,0.131309758253429,0.00882563696779532,0.11401150979655,0.148608006710308,9.88419287299055e-50
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40228,0.0626089758071182,0.00420922681617393,0.0543588912474173,0.0708590603668191,1.05230144598842e-49
NMR metabolomics,X23424.Total Lipids in VLDL,CERT,Ceramide transfer protein,39961,0.0855108625218704,0.00575035065796445,0.0742401752322601,0.0967815498114807,1.12561782463559e-49
NMR metabolomics,X23424.Total Lipids in VLDL,F12,Coagulation factor XII,38013,0.0580638882826166,0.00390841433966699,0.0504033961768693,0.0657243803883639,1.55611204909826e-49
NMR metabolomics,X23424.Total Lipids in VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40341,0.127292264320842,0.00858484679028738,0.110465964611878,0.144118564029805,2.07963272578816e-49
NMR metabolomics,X23424.Total Lipids in VLDL,SMAD3,Mothers against decapentaplegic homolog 3,37900,0.0703823280185256,0.00474608585540949,0.061079999741923,0.0796846562951282,2.31505052630583e-49
NMR metabolomics,X23424.Total Lipids in VLDL,TMSB10,Thymosin beta-10,40332,0.105012486699429,0.00709230450748562,0.091111569864757,0.118913403534101,2.83234763490196e-49
NMR metabolomics,X23424.Total Lipids in VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,37628,0.12929851685924,0.00872932711886872,0.112189035706257,0.146407998012223,3.0503170009981e-49
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM24,Transcription intermediary factor 1-alpha,37687,0.0891288079529826,0.00601790108431291,0.0773337218277293,0.100923894078236,3.09891761945619e-49
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL16,C-X-C motif chemokine 16,40517,0.0328444308927217,0.00221925539911959,0.0284946903104473,0.0371941714749961,3.1019607635861e-49
NMR metabolomics,X23424.Total Lipids in VLDL,BCL2L1,Bcl-2-like protein 1,37942,0.138212417516433,0.00933655149886425,0.119912776578659,0.156512058454207,3.3875945439163e-49
NMR metabolomics,X23424.Total Lipids in VLDL,STXBP1,Syntaxin-binding protein 1,37959,0.107027538021457,0.0072384858106764,0.0928401058325315,0.121214970210383,4.36872180858565e-49
NMR metabolomics,X23424.Total Lipids in VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,40332,0.0806514156379754,0.00546528590434801,0.0699394552654533,0.0913633760104975,5.84865320778307e-49
NMR metabolomics,X23424.Total Lipids in VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,37671,0.120649544745897,0.00817097841481731,0.104634427052855,0.136664662438939,5.98753056643386e-49
NMR metabolomics,X23424.Total Lipids in VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37990,0.10268044285002,0.00695586652270198,0.0890469444655242,0.116313941234516,6.20827358931887e-49
NMR metabolomics,X23424.Total Lipids in VLDL,KLK13,Kallikrein-13,40032,0.0598219965159952,0.00405503850096759,0.0518741210540987,0.0677698719778917,6.33823304454187e-49
NMR metabolomics,X23424.Total Lipids in VLDL,CASP2,Caspase-2,40341,0.0931581417347419,0.00631519364487845,0.0807803621907801,0.105535921278704,6.34541915144657e-49
NMR metabolomics,X23424.Total Lipids in VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40305,0.04453646127037,0.00301955199463273,0.0386181393608899,0.0504547831798502,6.55133581947796e-49
NMR metabolomics,X23424.Total Lipids in VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,37900,0.130214525653869,0.00883324911953231,0.112901357379585,0.147527693928152,8.39518128573451e-49
NMR metabolomics,X23424.Total Lipids in VLDL,CPA1,Carboxypeptidase A1,40536,0.0787000250490569,0.00534373325493319,0.0682263078693879,0.089173742228726,8.91615107985657e-49
NMR metabolomics,X23424.Total Lipids in VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,37716,0.0582559776117465,0.00395391758449603,0.0505062991461342,0.0660056560773587,9.50135239444744e-49
NMR metabolomics,X23424.Total Lipids in VLDL,RAB33A,Ras-related protein Rab-33A,37562,0.0920226345329736,0.00624942111722957,0.0797737691432036,0.104271499922744,1.09037671524567e-48
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37959,0.13614638622198,0.00926713481264066,0.117982801989204,0.154309970454756,1.73354334365363e-48
NMR metabolomics,X23424.Total Lipids in VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40471,0.0785456260814331,0.00535454185756713,0.0680507240406015,0.0890405281222647,2.09897518287281e-48
NMR metabolomics,X23424.Total Lipids in VLDL,FMNL1,Formin-like protein 1,39961,0.0821373429175286,0.00560257308075259,0.0711562996792535,0.0931183861558036,2.4253725869141e-48
NMR metabolomics,X23424.Total Lipids in VLDL,TBC1D5,TBC1 domain family member 5,40341,0.107318727599176,0.00732263751248099,0.0929663580747134,0.121671097123639,2.55872231456023e-48
NMR metabolomics,X23424.Total Lipids in VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,40471,0.0645415040348109,0.00441021422102611,0.0558974841615997,0.0731855239080221,3.46049664113495e-48
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40228,0.129817245654711,0.00887324632540999,0.112425682856907,0.147208808452514,3.72715784745637e-48
NMR metabolomics,X23424.Total Lipids in VLDL,CETN2,Centrin-2,39961,0.0918623903622904,0.00628089593707658,0.0795518343256204,0.104172946398961,4.02819157614343e-48
NMR metabolomics,X23424.Total Lipids in VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37900,0.147688565601082,0.0101063517343889,0.12788011620168,0.167497015000484,5.37734196360237e-48
NMR metabolomics,X23424.Total Lipids in VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37990,0.133952902110248,0.00916733081141874,0.115984933719867,0.151920870500628,5.46109878489369e-48
NMR metabolomics,X23424.Total Lipids in VLDL,MICALL2,MICAL-like protein 2,37572,0.0936590892066854,0.00640936196140028,0.0810967397623408,0.10622143865103,5.53760617674172e-48
NMR metabolomics,X23424.Total Lipids in VLDL,LAP3,Cytosol aminopeptidase,40044,0.0670693241692584,0.00459324576825837,0.058066562463472,0.0760720858750448,5.67668243794705e-48
NMR metabolomics,X23424.Total Lipids in VLDL,CASP10,Caspase-10,39961,0.0979582640425066,0.00670946009829778,0.084807722249843,0.11110880583517,5.8410905056566e-48
NMR metabolomics,X23424.Total Lipids in VLDL,ADD1,Alpha-adducin,37671,0.0959420571292479,0.0065702650990134,0.0830643375351816,0.108819776723314,6.3932130511537e-48
NMR metabolomics,X23424.Total Lipids in VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37628,0.139897804014521,0.00959082568956585,0.121099785662971,0.15869582236607,8.05673527708385e-48
NMR metabolomics,X23424.Total Lipids in VLDL,SLMAP,Sarcolemmal membrane-associated protein,37901,0.113634661673793,0.00779117871194228,0.0983639513983863,0.1289053719492,8.10243518998173e-48
NMR metabolomics,X23424.Total Lipids in VLDL,TMEM106A,Transmembrane protein 106A,37900,0.0956740068262101,0.00655989004428209,0.0828166223394172,0.108531391313003,8.14328698115504e-48
NMR metabolomics,X23424.Total Lipids in VLDL,PARK7,Parkinson disease protein 7,40332,0.0728786110081947,0.00500256102752048,0.0630735913942545,0.0826836306221348,9.0900030633387e-48
NMR metabolomics,X23424.Total Lipids in VLDL,CASP3,Caspase-3,40536,0.11976906279127,0.00822247881548807,0.103653004312914,0.135885121269627,9.30113624647942e-48
NMR metabolomics,X23424.Total Lipids in VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,39980,0.0787604411702343,0.00540765103114081,0.0681614451491983,0.0893594371912703,9.7329003607038e-48
NMR metabolomics,X23424.Total Lipids in VLDL,GMFG,Glia maturation factor gamma,37990,0.0978335091108216,0.00671484207486286,0.0846724186440904,0.110994599577553,1.00473802333816e-47
NMR metabolomics,X23424.Total Lipids in VLDL,F11,Coagulation factor XI,37810,0.0412552154895057,0.00283403572674233,0.0357005054650908,0.0468099255139207,1.21959083298952e-47
NMR metabolomics,X23424.Total Lipids in VLDL,SCARF1,Scavenger receptor class F member 1,40536,0.0575419655521798,0.00395582507023209,0.0497885484145249,0.0652953826898347,1.23992251413789e-47
NMR metabolomics,X23424.Total Lipids in VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40396,0.104081711508925,0.00715582378171925,0.0900562968967552,0.118107126121095,1.26739852330873e-47
NMR metabolomics,X23424.Total Lipids in VLDL,COMT,Catechol O-methyltransferase,39877,0.11550573713746,0.00794602450922746,0.0999315290993738,0.131079945175545,1.47164071027514e-47
NMR metabolomics,X23424.Total Lipids in VLDL,DCTD,Deoxycytidylate deaminase,37671,0.128521804088748,0.00884173815983436,0.111191997295473,0.145851610882024,1.67010629379023e-47
NMR metabolomics,X23424.Total Lipids in VLDL,DBI,Acyl-CoA-binding protein,40270,0.106924613749459,0.00737261623100962,0.0924742859366798,0.121374941562237,2.33657903216684e-47
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB9,Serpin B9,40228,0.0454757171578918,0.00313900676193688,0.0393232639044955,0.0516281704112881,2.93113506186581e-47
NMR metabolomics,X23424.Total Lipids in VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37671,0.0828636286426629,0.00571973040358433,0.0716529570516376,0.0940743002336882,3.3487304766588e-47
NMR metabolomics,X23424.Total Lipids in VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,40182,0.0403922721918903,0.00279046738424542,0.0349229561187693,0.0458615882650113,3.49952714349104e-47
NMR metabolomics,X23424.Total Lipids in VLDL,REEP4,Receptor expression-enhancing protein 4,37959,0.0842243009087405,0.00581737385778437,0.0728222481474831,0.0956263536699979,3.757777439483e-47
NMR metabolomics,X23424.Total Lipids in VLDL,CCL8,C-C motif chemokine 8,40470,0.0816535123928289,0.00564427577963219,0.0705907318647498,0.092716292920908,3.9038947961379e-47
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT16,U8 snoRNA-decapping enzyme,37880,0.118619650731173,0.00819472067996432,0.102557998198443,0.134681303263903,3.93750628087114e-47
NMR metabolomics,X23424.Total Lipids in VLDL,CD274,Programmed cell death 1 ligand 1,40228,0.0469558043171542,0.003250786018565,0.0405842637207668,0.0533273449135416,5.41955989298998e-47
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP25,Rho GTPase-activating protein 25,39980,0.0801728896365821,0.00555038142962037,0.0692941420345261,0.091051637238638,5.46918733543666e-47
NMR metabolomics,X23424.Total Lipids in VLDL,MCEMP1,Mast cell-expressed membrane protein 1,37598,0.125128742204542,0.00865758738455178,0.10815987093082,0.142097613478263,5.49266695510091e-47
NMR metabolomics,X23424.Total Lipids in VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37990,0.0541192752807957,0.00375228905630987,0.0467647887304283,0.061473761831163,8.24210791895245e-47
NMR metabolomics,X23424.Total Lipids in VLDL,TADA3,Transcriptional adapter 3,37900,0.0524954347784829,0.00364468167865956,0.0453518586883101,0.0596390108686556,1.09744828488513e-46
NMR metabolomics,X23424.Total Lipids in VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40341,0.108971613650182,0.00757038375992213,0.0941336614807351,0.12380956581963,1.10226338185712e-46
NMR metabolomics,X23424.Total Lipids in VLDL,RP2,Protein XRP2,40305,0.055583032541219,0.00386171094706982,0.0480140790849622,0.0631519859974759,1.1213214741698e-46
NMR metabolomics,X23424.Total Lipids in VLDL,TXNDC9,Thioredoxin domain-containing protein 9,37942,0.0715818465121824,0.00497523684237653,0.0618303823011244,0.0813333107232404,1.36857905283387e-46
NMR metabolomics,X23424.Total Lipids in VLDL,MYO9B,Unconventional myosin-IXb,40044,0.089165299402166,0.00620076806226174,0.077011794000133,0.101318804804199,1.37780822504775e-46
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6AP2,Renin receptor,39980,0.0560107112988533,0.00389953574564506,0.048367621237389,0.0636538013603176,1.74266308190525e-46
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPT1,Angiopoietin-1,40263,0.113575727642658,0.00792541518452524,0.0980419138809884,0.129109541404327,2.74795659973087e-46
NMR metabolomics,X23424.Total Lipids in VLDL,RILP,Rab-interacting lysosomal protein,40434,0.0807060764742484,0.00563292004615611,0.0696655531837824,0.0917465997647144,2.84735307840048e-46
NMR metabolomics,X23424.Total Lipids in VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40422,0.158816739274919,0.0110970496181077,0.137066522023428,0.18056695652641,3.57350459803451e-46
NMR metabolomics,X23424.Total Lipids in VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,37671,0.0488545895675572,0.00341158907439748,0.0421678749817382,0.0555413041533763,3.62418896589887e-46
NMR metabolomics,X23424.Total Lipids in VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37225,0.144595883535334,0.0101003998935696,0.124799099743937,0.16439266732673,3.9605555075294e-46
NMR metabolomics,X23424.Total Lipids in VLDL,SCGB3A2,Secretoglobin family 3A member 2,40396,-0.113318634819155,0.00792453774386927,-0.128850728797139,-0.0977865408411715,4.23568434511421e-46
NMR metabolomics,X23424.Total Lipids in VLDL,NRGN,Neurogranin,37987,0.121278272255715,0.00848032833778304,0.10465682871366,0.13789971579777,4.66087572547121e-46
NMR metabolomics,X23424.Total Lipids in VLDL,CEP170,Centrosomal protein of 170 kDa,37628,0.10325049679651,0.00724026939095988,0.089059568790229,0.117441424802792,8.43969703473731e-46
NMR metabolomics,X23424.Total Lipids in VLDL,SUOX,"Sulfite oxidase, mitochondrial",37959,0.0823118129875179,0.00577696589345624,0.0709889598363436,0.0936346661386921,9.8515878618839e-46
NMR metabolomics,X23424.Total Lipids in VLDL,HPSE,Heparanase,37848,0.123971902062927,0.00870251398726303,0.106914974647891,0.141028829477962,1.03054426382346e-45
NMR metabolomics,X23424.Total Lipids in VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,40411,0.117029958333225,0.00822166676921867,0.100915491465557,0.133144425200894,1.06808509666094e-45
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB2,DnaJ homolog subfamily B member 2,37671,0.0726673722797724,0.00510419778774855,0.0626631446157853,0.0826715999437596,1.17759738264921e-45
NMR metabolomics,X23424.Total Lipids in VLDL,GGCT,Gamma-glutamylcyclotransferase,37978,0.0644817777393986,0.0045296646103997,0.0556036351030152,0.0733599203757821,1.17935367810614e-45
NMR metabolomics,X23424.Total Lipids in VLDL,DXO,Decapping and exoribonuclease protein,37942,0.0610457036223363,0.00429055154268564,0.0526362225986724,0.0694551846460001,1.31349743653691e-45
NMR metabolomics,X23424.Total Lipids in VLDL,SMTN,Smoothelin,37905,0.128139125912132,0.0090177616384717,0.110464313100728,0.145813938723537,1.7029798473872e-45
NMR metabolomics,X23424.Total Lipids in VLDL,APP,Amyloid-beta precursor protein,40309,0.088932694948767,0.00626232474503223,0.0766585384485038,0.10120685144903,1.71094951216429e-45
NMR metabolomics,X23424.Total Lipids in VLDL,GP6,Platelet glycoprotein VI,40311,0.116787784772628,0.00822597460449119,0.100664874547825,0.132910694997431,1.80456478062343e-45
NMR metabolomics,X23424.Total Lipids in VLDL,FST,Follistatin,40396,0.0688737762055296,0.00485715947951666,0.0593537436256769,0.0783938087853822,2.30403476232748e-45
NMR metabolomics,X23424.Total Lipids in VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37990,0.117567513072825,0.00829521761373905,0.101308886549897,0.133826139595754,2.83922289011292e-45
NMR metabolomics,X23424.Total Lipids in VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37598,0.105825134162308,0.00747054833915646,0.0911828594175611,0.120467408907054,3.21446016840173e-45
NMR metabolomics,X23424.Total Lipids in VLDL,SCARB2,Lysosome membrane protein 2,40011,0.0408892763062264,0.00288872508745952,0.0352273751348057,0.046551177477647,3.32853070252138e-45
NMR metabolomics,X23424.Total Lipids in VLDL,CRYBB1,Beta-crystallin B1,37990,0.0859433333866841,0.00607111330176015,0.0740439513152342,0.097842715458134,3.59465089574586e-45
NMR metabolomics,X23424.Total Lipids in VLDL,SPON2,Spondin-2,40267,-0.0455783036764107,0.00322927939351347,-0.0519076912876971,-0.0392489160651244,5.83066071495977e-45
NMR metabolomics,X23424.Total Lipids in VLDL,RASSF2,Ras association domain-containing protein 2,39980,0.0724493851588055,0.00514304900774195,0.0623690091036313,0.0825297612139797,8.63262726180654e-45
NMR metabolomics,X23424.Total Lipids in VLDL,TSC22D1,TSC22 domain family protein 1,37959,0.0881528902300773,0.0063032652819693,0.0757984902774175,0.100507290182737,3.89392957030696e-44
NMR metabolomics,X23424.Total Lipids in VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37575,0.0468043546567216,0.00334706001892175,0.0402441170196349,0.0533645922938082,4.06106385153079e-44
NMR metabolomics,X23424.Total Lipids in VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,40471,0.0861426961428606,0.00616718267786797,0.0740550180942394,0.0982303741914818,4.43751252221293e-44
NMR metabolomics,X23424.Total Lipids in VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,37572,0.0800742851267459,0.00573257864904822,0.0688384309746114,0.0913101392788804,5.02928793210765e-44
NMR metabolomics,X23424.Total Lipids in VLDL,MENT,Protein MENT,37671,-0.0283080871887644,0.00203151398398104,-0.0322898545973673,-0.0243263197801616,7.98090110692587e-44
NMR metabolomics,X23424.Total Lipids in VLDL,RBKS,Ribokinase,39991,0.0646500413844071,0.00465044362215271,0.0555351718849878,0.0737649108838264,1.12619994093042e-43
NMR metabolomics,X23424.Total Lipids in VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",37928,0.0529813359868328,0.0038129188178346,0.045508015103877,0.0604546568697886,1.35298301372721e-43
NMR metabolomics,X23424.Total Lipids in VLDL,AKT2,RAC-beta serine/threonine-protein kinase,37959,0.163362730600235,0.0117620854095943,0.14030904319743,0.18641641800304,1.47307729758628e-43
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA3,Annexin A3,40442,0.0908245421837871,0.00654498055782515,0.0779963802904498,0.103652704077124,1.56192165415837e-43
NMR metabolomics,X23424.Total Lipids in VLDL,CTSS,Cathepsin S,37057,0.0320833690251956,0.00231142600658453,0.0275529740522899,0.0366137639981013,1.74065305085655e-43
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL11,C-X-C motif chemokine 11,40471,0.103013155913454,0.00743481966303415,0.0884409093739071,0.117585402453001,2.09726363755796e-43
NMR metabolomics,X23424.Total Lipids in VLDL,TBCA,Tubulin-specific chaperone A,37671,0.113156547500242,0.00816231593418792,0.0971584082692339,0.129154686731251,2.12687997962422e-43
NMR metabolomics,X23424.Total Lipids in VLDL,FADD,FAS-associated death domain protein,40359,0.0987661622942304,0.00713902897601382,0.0847736655012433,0.112758659087217,2.80390448350129e-43
NMR metabolomics,X23424.Total Lipids in VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40471,-0.0585157631478487,0.00423294152284169,-0.0668123285326184,-0.0502191977630789,3.2382946263885e-43
NMR metabolomics,X23424.Total Lipids in VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,37562,0.0869042341528647,0.00629179184662276,0.0745723221334841,0.0992361461722453,4.3024017454412e-43
NMR metabolomics,X23424.Total Lipids in VLDL,CCL18,C-C motif chemokine 18,40172,0.0906377849063851,0.00656994738656873,0.0777606880287104,0.10351488178406,4.81151990735902e-43
NMR metabolomics,X23424.Total Lipids in VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39980,0.0875199470487724,0.00634942078459517,0.0750750823109659,0.099964811786579,5.70255332878391e-43
NMR metabolomics,X23424.Total Lipids in VLDL,CDC26,Anaphase-promoting complex subunit CDC26,37879,0.0907713685693985,0.00660175384531043,0.07783193103259,0.103710806106207,9.97274915927084e-43
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40377,0.0290107506376394,0.00211232024874727,0.0248706029500947,0.033150898325184,1.11115308416598e-42
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,40042,0.141614057484801,0.0103378669090177,0.121351838343126,0.161876276626476,1.82372941076334e-42
NMR metabolomics,X23424.Total Lipids in VLDL,SDHB,Succinate dehydrogenase,37901,0.0913596143021564,0.00666833082343952,0.0782896858882149,0.104429542716098,1.94206785805565e-42
NMR metabolomics,X23424.Total Lipids in VLDL,PTX3,Pentraxin-related protein PTX3,40341,-0.0629564428616621,0.00459861444746941,-0.0719697271787022,-0.0539431585446221,2.01945181030689e-42
NMR metabolomics,X23424.Total Lipids in VLDL,CDC37,Hsp90 co-chaperone Cdc37,40411,0.107142222627051,0.00782645324100154,0.0918023742746883,0.122482070979414,2.02978251188742e-42
NMR metabolomics,X23424.Total Lipids in VLDL,CTRB1,Chymotrypsinogen B,40332,0.0680370649399224,0.00498033999526181,0.0582755985492093,0.0777985313306356,3.00300501743226e-42
NMR metabolomics,X23424.Total Lipids in VLDL,CCT5,T-complex protein 1 subunit epsilon,39980,0.0580673887546854,0.00425337477959925,0.0497307741866709,0.0664040033227,3.43772694264452e-42
NMR metabolomics,X23424.Total Lipids in VLDL,GIPC3,PDZ domain-containing protein GIPC3,37901,0.125112508109623,0.00916610415544916,0.107146943964943,0.143078072254304,3.8802313327242e-42
NMR metabolomics,X23424.Total Lipids in VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37901,0.0829756651976282,0.00609024944950476,0.0710387762765989,0.0949125541186575,5.4504614988384e-42
NMR metabolomics,X23424.Total Lipids in VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,39897,0.0729217310256071,0.00535955309256163,0.0624170069641863,0.083426455087028,6.43962555593164e-42
NMR metabolomics,X23424.Total Lipids in VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37990,0.0943402989299262,0.00693927571756352,0.0807393185235017,0.107941279336351,8.05248108726383e-42
NMR metabolomics,X23424.Total Lipids in VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37900,0.0447425109857413,0.00329273679988743,0.0382887468579619,0.0511962751135207,8.87182111103976e-42
NMR metabolomics,X23424.Total Lipids in VLDL,SLAMF6,SLAM family member 6,39980,0.0483136431483684,0.00355759472417497,0.0413407574889855,0.0552865288077513,9.06172256407843e-42
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G4A,Cytosolic phospholipase A2,40422,0.110407536235185,0.00813956416124775,0.0944539904791396,0.126361081991231,1.10939413475167e-41
NMR metabolomics,X23424.Total Lipids in VLDL,CALCA,Calcitonin,40192,0.0698668357917746,0.00515099179221408,0.0597708918790351,0.0799627797045142,1.12617505857967e-41
NMR metabolomics,X23424.Total Lipids in VLDL,SEPTIN9,Septin-9,40305,0.0357149069429241,0.002634051730481,0.0305521655511813,0.0408776483346669,1.19750961253427e-41
NMR metabolomics,X23424.Total Lipids in VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37942,0.0491484015678797,0.0036259351353921,0.0420415687025112,0.0562552344332482,1.39108698945927e-41
NMR metabolomics,X23424.Total Lipids in VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40182,0.051888102233084,0.00383670078682573,0.0443681686909056,0.0594080357752625,1.92018414424137e-41
NMR metabolomics,X23424.Total Lipids in VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,37746,0.0706032564456703,0.00521779338058674,0.0603763814197203,0.0808301314716203,1.92319991640603e-41
NMR metabolomics,X23424.Total Lipids in VLDL,CTSL,Cathepsin L1,40359,0.0306558204859898,0.00226767300297183,0.026211181400165,0.0351004595718145,2.05595168320445e-41
NMR metabolomics,X23424.Total Lipids in VLDL,CD72,B-cell differentiation antigen CD72,37671,0.0536818912007938,0.00397083002352431,0.0458990643546861,0.0614647180469014,2.27279153047383e-41
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS3,Galectin-3,40374,0.0373931355866964,0.00276770710561498,0.0319684296596911,0.0428178415137018,2.29160575175444e-41
NMR metabolomics,X23424.Total Lipids in VLDL,BDNF,Brain-derived neurotrophic factor,37998,0.104716548335534,0.00775431332452084,0.0895180942194732,0.119915002451595,2.72853412117345e-41
NMR metabolomics,X23424.Total Lipids in VLDL,CALB2,Calretinin,39961,0.0397414231585381,0.00294902110840552,0.0339613417860632,0.0455215045310129,3.6839781431674e-41
NMR metabolomics,X23424.Total Lipids in VLDL,CD74,HLA class II histocompatibility antigen gamma chain,40471,0.0438089397032594,0.00325283444677707,0.0374333841875763,0.0501844952189424,4.04361612641162e-41
NMR metabolomics,X23424.Total Lipids in VLDL,CCL4,C-C motif chemokine 4,40376,0.0851893139089338,0.00632815439762641,0.072786131289586,0.0975924965282815,4.39372058104316e-41
NMR metabolomics,X23424.Total Lipids in VLDL,LARP1,La-related protein 1,37900,0.0800977578642179,0.00595070589040579,0.0684343743190225,0.0917611414094132,4.94236521221955e-41
NMR metabolomics,X23424.Total Lipids in VLDL,INPP1,Inositol polyphosphate 1-phosphatase,40305,0.0676647999923515,0.00503466845768872,0.0577968498152816,0.0775327501694214,5.9242783385081e-41
NMR metabolomics,X23424.Total Lipids in VLDL,SNAP25,Synaptosomal-associated protein 25,37541,0.0589757502983414,0.00438893995167026,0.0503734279930677,0.0675780726036151,6.81618576536068e-41
NMR metabolomics,X23424.Total Lipids in VLDL,GGACT,Gamma-glutamylaminecyclotransferase,37990,0.0890645550822057,0.00664181208097187,0.0760466034035009,0.102082506760911,9.65500273198012e-41
NMR metabolomics,X23424.Total Lipids in VLDL,GDF2,Growth/differentiation factor 2,40359,0.0447973950209276,0.00334321444850186,0.0382446947018639,0.0513500953399912,1.01216624551067e-40
NMR metabolomics,X23424.Total Lipids in VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40341,0.076634853866612,0.00572273911513848,0.0654182852009406,0.0878514225322834,1.12975000441516e-40
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37628,0.0568519671057605,0.00424331348214993,0.0485350726807467,0.0651688615307744,1.14600443677196e-40
NMR metabolomics,X23424.Total Lipids in VLDL,AIF1,Allograft inflammatory factor 1,39980,0.0661092845307528,0.00493769456290832,0.0564314031874525,0.0757871658740531,1.18322669179169e-40
NMR metabolomics,X23424.Total Lipids in VLDL,C1RL,Complement C1r subcomponent-like protein,37993,0.0243244183350068,0.00181817631182479,0.0207607927638303,0.0278880439061834,1.46162679995586e-40
NMR metabolomics,X23424.Total Lipids in VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40341,0.153268528845473,0.0114647520447181,0.130797614837825,0.17573944285312,1.52633865732705e-40
NMR metabolomics,X23424.Total Lipids in VLDL,TPP1,Tripeptidyl-peptidase 1,40255,0.055856321920299,0.00418115563395155,0.047661256877754,0.0640513869628441,1.73898037867627e-40
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",40516,0.0866283244084437,0.00648725258834431,0.0739133093352888,0.0993433394815985,1.85411025923784e-40
NMR metabolomics,X23424.Total Lipids in VLDL,NPDC1,Neural proliferation differentiation and control protein 1,40359,0.0386580907020137,0.00290070454690814,0.0329727097900738,0.0443434716139537,2.64750521166798e-40
NMR metabolomics,X23424.Total Lipids in VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,40490,0.0399108037820311,0.00299752851634033,0.0340356478900041,0.0457859596740582,3.11457130544683e-40
NMR metabolomics,X23424.Total Lipids in VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37671,0.0516453270069899,0.00387984885385805,0.0440408232534281,0.0592498307605516,3.61452887214787e-40
NMR metabolomics,X23424.Total Lipids in VLDL,GIP,Gastric inhibitory polypeptide,37628,0.0645222061171697,0.00484757572843852,0.0550209576894302,0.0740234545449092,3.66814300549037e-40
NMR metabolomics,X23424.Total Lipids in VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37628,0.0590812495913718,0.00443952179449018,0.0503797868741711,0.0677827123085726,3.7752634001881e-40
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,37671,0.0455106211763743,0.00342303324573229,0.038801476014739,0.0522197663380096,4.45060915356068e-40
NMR metabolomics,X23424.Total Lipids in VLDL,ATG4A,Cysteine protease ATG4A,39980,0.073984808328519,0.0055716917428725,0.0630642925124889,0.0849053241445491,5.08542377376781e-40
NMR metabolomics,X23424.Total Lipids in VLDL,PNMA1,Paraneoplastic antigen Ma1,37628,0.0696561129525797,0.00524460694165271,0.0593766833469403,0.079935542558219,5.35846622068086e-40
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS3BP,Galectin-3-binding protein,38013,0.0368414643601742,0.00277612789268678,0.0314002536905081,0.0422826750298402,6.06525572027918e-40
NMR metabolomics,X23424.Total Lipids in VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37901,0.128261514779506,0.00966744968701186,0.109313313392963,0.147209716166049,6.37747165199241e-40
NMR metabolomics,X23424.Total Lipids in VLDL,CEBPB,CCAAT/enhancer-binding protein beta,40042,0.0469088865129487,0.00353909257975033,0.039972265056638,0.0538455079692593,6.98434515892057e-40
NMR metabolomics,X23424.Total Lipids in VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,37900,0.0511103748550644,0.00385535048052622,0.0435538879132331,0.0586668617968958,7.30963450037204e-40
NMR metabolomics,X23424.Total Lipids in VLDL,BGLAP,Osteocalcin,37998,0.113306065731467,0.00856072090342976,0.0965270527607449,0.13008507870219,9.64837701438953e-40
NMR metabolomics,X23424.Total Lipids in VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39980,0.081223254751037,0.00613933565118541,0.0691901568747136,0.0932563526273604,9.66523650824958e-40
NMR metabolomics,X23424.Total Lipids in VLDL,ITGA2,Integrin alpha-2,37671,0.0419709032613943,0.00317455411090369,0.035748777204023,0.0481930293187655,1.18410045056453e-39
NMR metabolomics,X23424.Total Lipids in VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,40044,0.0819174981397611,0.00619965844418291,0.0697661675891626,0.0940688286903596,1.20218249713915e-39
NMR metabolomics,X23424.Total Lipids in VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,37562,0.0862803157487779,0.00652932301047339,0.0734828426482501,0.0990777888493058,1.30003560115063e-39
NMR metabolomics,X23424.Total Lipids in VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37671,0.0356266259075168,0.00269716892438973,0.0303401748157129,0.0409130769993207,1.38852922235066e-39
NMR metabolomics,X23424.Total Lipids in VLDL,ANG,Angiogenin,40309,0.042556115227089,0.00322383715213892,0.0362373944088967,0.0488748360452813,1.41030044658779e-39
NMR metabolomics,X23424.Total Lipids in VLDL,CCL2,C-C motif chemokine 2,40203,0.0653526401227879,0.00495380867542084,0.055643175118963,0.0750621051266127,1.57255076170339e-39
NMR metabolomics,X23424.Total Lipids in VLDL,BLMH,Bleomycin hydrolase,40536,0.0397748890806128,0.00302165265747652,0.0338524498719588,0.0456973282892668,2.28071658523024e-39
NMR metabolomics,X23424.Total Lipids in VLDL,ABHD14B,Protein ABHD14B,40171,0.0721111802257278,0.0054797921712567,0.0613707875700647,0.082851572881391,2.42360063820702e-39
NMR metabolomics,X23424.Total Lipids in VLDL,MZT1,Mitotic-spindle organizing protein 1,39980,0.0649277188022761,0.00493647842748526,0.055252221084405,0.0746032165201472,2.66588070873861e-39
NMR metabolomics,X23424.Total Lipids in VLDL,IL17RB,Interleukin-17 receptor B,40126,-0.0657330477020085,0.00500333828122771,-0.0755395907332148,-0.0559265046708021,3.22071556080805e-39
NMR metabolomics,X23424.Total Lipids in VLDL,DDT,D-dopachrome decarboxylase,37998,0.0503910506157031,0.00383817591111562,0.0428682258299165,0.0579138754014897,3.89788303420539e-39
NMR metabolomics,X23424.Total Lipids in VLDL,CCL26,C-C motif chemokine 26,40341,0.109114436620859,0.00831656951667586,0.0928139603681744,0.125414912873544,4.03320825972928e-39
NMR metabolomics,X23424.Total Lipids in VLDL,IL10RB,Interleukin-10 receptor subunit beta,40422,0.0349496526889107,0.00266410953680483,0.0297279979967733,0.0401713073810482,4.09931239334721e-39
NMR metabolomics,X23424.Total Lipids in VLDL,IFT20,Intraflagellar transport protein 20 homolog,37572,0.0530967098446966,0.00404619358496978,0.0451661704181559,0.0610272492712374,4.30547176943581e-39
NMR metabolomics,X23424.Total Lipids in VLDL,DBN1,Drebrin,37598,0.0636710273826095,0.00485658566639604,0.0541521194764732,0.0731899352887457,5.05346712687817e-39
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH7,Protocadherin-7,37901,0.0428257261448274,0.00327118219812943,0.0364142090364937,0.0492372432531611,6.3421174540219e-39
NMR metabolomics,X23424.Total Lipids in VLDL,FNDC1,Fibronectin type III domain-containing protein 1,37942,0.0562481315452019,0.00430229607435187,0.0478156312394723,0.0646806318509316,7.98337958743535e-39
NMR metabolomics,X23424.Total Lipids in VLDL,CA13,Carbonic anhydrase 13,40173,0.126648780756748,0.00969453262598731,0.107647496809813,0.145650064703683,8.4265952487986e-39
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJC9,DnaJ homolog subfamily C member 9,37901,0.0942096035484246,0.00721563369290187,0.0800669615103369,0.108352245586512,1.00562290325113e-38
NMR metabolomics,X23424.Total Lipids in VLDL,LONP1,"Lon protease homolog, mitochondrial",37628,0.106167771028842,0.00813162504034231,0.0902297859497709,0.122105756107913,1.01900098753409e-38
NMR metabolomics,X23424.Total Lipids in VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37628,0.0645844153865584,0.00495037780154035,0.0548816748955394,0.0742871558775775,1.15693172385609e-38
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40228,0.0670562212573501,0.00514504227099768,0.0569719384061947,0.0771405041085056,1.25442533649464e-38
NMR metabolomics,X23424.Total Lipids in VLDL,ITGA6,Integrin alpha-6,40341,0.0647537308174772,0.00497512655534949,0.0550024827689922,0.0745049788659622,1.57235074180411e-38
NMR metabolomics,X23424.Total Lipids in VLDL,MFAP5,Microfibrillar-associated protein 5,40536,0.0499171313437992,0.00383659729152641,0.0423974006524074,0.057436862035191,1.66220450460334e-38
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,37990,0.0364738357656345,0.00280286196613106,0.0309802263120176,0.0419674452192514,1.75427692390292e-38
NMR metabolomics,X23424.Total Lipids in VLDL,FOXO3,Forkhead box protein O3,39980,0.118066839396234,0.0090774045216768,0.100275126533747,0.13585855225872,1.78109891532885e-38
NMR metabolomics,X23424.Total Lipids in VLDL,BLNK,B-cell linker protein,37598,0.0467164426772837,0.00359936922253302,0.0396616790011189,0.0537712063534484,2.76391233707713e-38
NMR metabolomics,X23424.Total Lipids in VLDL,SFRP1,Secreted frizzled-related protein 1,40178,0.0529582156872141,0.00408299901807353,0.04495553761179,0.0609608937626383,2.82935405387469e-38
NMR metabolomics,X23424.Total Lipids in VLDL,ITPA,Inosine triphosphate pyrophosphatase,37562,0.0827553102573898,0.00637841083153383,0.0702536250275835,0.0952569954871961,2.94387436325983e-38
NMR metabolomics,X23424.Total Lipids in VLDL,FAM3B,Protein FAM3B,40305,0.043813669302697,0.00337978271047876,0.0371892951901587,0.0504380434152354,3.08429900437295e-38
NMR metabolomics,X23424.Total Lipids in VLDL,CEMIP2,Cell surface hyaluronidase,37598,0.0411191810930906,0.0031719000397299,0.03490225701522,0.0473361051709612,3.37405101569199e-38
NMR metabolomics,X23424.Total Lipids in VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,40422,-0.0249334604820204,0.00192868744548223,-0.0287136878751656,-0.0211532330888753,4.87479710936339e-38
NMR metabolomics,X23424.Total Lipids in VLDL,HSPB6,Heat shock protein beta-6,40489,0.0441509835312904,0.00341597231147068,0.0374556778008079,0.0508462892617729,5.04558408584154e-38
NMR metabolomics,X23424.Total Lipids in VLDL,SCRN1,Secernin-1,40341,0.0680374286730856,0.0052645328768667,0.0577189442344269,0.0783559131117443,5.14025716398759e-38
NMR metabolomics,X23424.Total Lipids in VLDL,RAB2B,Ras-related protein Rab-2B,37900,0.0743891889087473,0.00575897151734418,0.0631016047347527,0.0856767730827419,6.06019254483108e-38
NMR metabolomics,X23424.Total Lipids in VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,40312,0.107343012897591,0.00831416980171233,0.0910472400862347,0.123638785708947,6.07126505676159e-38
NMR metabolomics,X23424.Total Lipids in VLDL,TTF2,Transcription termination factor 2,37572,0.0589086284288819,0.00456546115790163,0.0499603245593947,0.0678569322983691,7.34505727927366e-38
NMR metabolomics,X23424.Total Lipids in VLDL,CFB,Complement factor B,37770,0.0396496431175338,0.00307629903911067,0.0336200970008769,0.0456791892341908,8.75979510723231e-38
NMR metabolomics,X23424.Total Lipids in VLDL,GGH,Gamma-glutamyl hydrolase,40077,0.0412775177706139,0.00320625708770904,0.0349932538787042,0.0475617816625236,9.80003479186499e-38
NMR metabolomics,X23424.Total Lipids in VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37594,0.0466480126280255,0.00362564912819012,0.0395417403367728,0.0537542849192781,1.17827557634913e-37
NMR metabolomics,X23424.Total Lipids in VLDL,C1R,Complement C1r subcomponent,38013,0.0239715657127719,0.00186747548143008,0.0203113137691689,0.0276318176563748,1.69586501772283e-37
NMR metabolomics,X23424.Total Lipids in VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37598,0.0588390401997857,0.00458685331684326,0.0498488076987729,0.0678292727007985,1.92217632525329e-37
NMR metabolomics,X23424.Total Lipids in VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",37901,0.104970305029291,0.00818695357052671,0.0889238760310588,0.121016734027524,2.05374821542923e-37
NMR metabolomics,X23424.Total Lipids in VLDL,ARSA,Arylsulfatase A,40332,0.0534376120558515,0.00417210352389173,0.0452602891490237,0.0616149349626793,2.25518126782573e-37
NMR metabolomics,X23424.Total Lipids in VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,39980,0.0596505615916071,0.00465821966177548,0.0505204510545271,0.068780672128687,2.3618260827381e-37
NMR metabolomics,X23424.Total Lipids in VLDL,TREML2,Trem-like transcript 2 protein,40332,0.0401894482963154,0.00313897231475177,0.034037062559402,0.0463418340332289,2.40169393619567e-37
NMR metabolomics,X23424.Total Lipids in VLDL,TST,Thiosulfate sulfurtransferase,39923,0.0909347122172307,0.00710245530304697,0.0770138998232586,0.104855524611203,2.43173641060486e-37
NMR metabolomics,X23424.Total Lipids in VLDL,SCRG1,Scrapie-responsive protein 1,37990,0.0329620333729386,0.00257595833995206,0.0279131550266326,0.0380109117192446,2.83680152512448e-37
NMR metabolomics,X23424.Total Lipids in VLDL,AGXT,Serine--pyruvate aminotransferase,40359,0.0919269534454511,0.00719219200031906,0.0778302571248257,0.106023649766076,3.17159865405361e-37
NMR metabolomics,X23424.Total Lipids in VLDL,HNMT,Histamine N-methyltransferase,40147,0.0553728156130405,0.00434585987823151,0.0468549302517067,0.0638907009743742,5.30137769031598e-37
NMR metabolomics,X23424.Total Lipids in VLDL,KLRD1,Natural killer cells antigen CD94,40516,0.0543910051953177,0.00426948118797697,0.0460228220668828,0.0627591883237525,5.38699621748612e-37
NMR metabolomics,X23424.Total Lipids in VLDL,PSAP,Prosaposin,37901,0.0339501538296445,0.00266979609264273,0.0287173534880647,0.0391829541712242,7.81331735899899e-37
NMR metabolomics,X23424.Total Lipids in VLDL,RAB10,Ras-related protein Rab-10,37990,0.0639785732044205,0.00503469439359489,0.0541105721929745,0.0738465742158664,8.7097964688876e-37
NMR metabolomics,X23424.Total Lipids in VLDL,C19orf12,Protein C19orf12,39961,0.0738908158122005,0.00582000400399244,0.0624836079643753,0.0852980236600257,9.48057937836649e-37
NMR metabolomics,X23424.Total Lipids in VLDL,AMOT,Angiomotin,37671,0.0497117933632113,0.00391408066842534,0.0420401952530976,0.0573833914733249,9.59884614113556e-37
NMR metabolomics,X23424.Total Lipids in VLDL,CD164,Sialomucin core protein 24,40332,0.0314998312835796,0.00248509960183051,0.0266290360639918,0.0363706265031674,1.21684652943854e-36
NMR metabolomics,X23424.Total Lipids in VLDL,FRMD4B,FERM domain-containing protein 4B,37562,0.0838812115482503,0.00661645420733911,0.0709129613018656,0.096849461794635,1.28962455207334e-36
NMR metabolomics,X23424.Total Lipids in VLDL,CD83,CD83 antigen,40341,0.0398966385681372,0.00314884404109093,0.033724904247599,0.0460683728886754,1.29961461463944e-36
NMR metabolomics,X23424.Total Lipids in VLDL,AK2,"Adenylate kinase 2, mitochondrial",37942,0.125407007610549,0.00989607106402683,0.106010708325057,0.144803306896042,1.35917000377791e-36
NMR metabolomics,X23424.Total Lipids in VLDL,BMPER,BMP-binding endothelial regulator protein,37671,0.026706082971845,0.00210829471653118,0.0225738253274439,0.0308383406162461,1.46641597146868e-36
NMR metabolomics,X23424.Total Lipids in VLDL,IMMT,MICOS complex subunit MIC60,37900,0.0527631908403445,0.00417016987400081,0.0445896578873029,0.0609367237933861,1.74823167274485e-36
NMR metabolomics,X23424.Total Lipids in VLDL,MIA,Melanoma-derived growth regulatory protein,40411,0.0437574558881659,0.00346360288786065,0.036968794227959,0.0505461175483727,2.06133844736037e-36
NMR metabolomics,X23424.Total Lipids in VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",40305,0.0708450184103629,0.00561506417492077,0.0598394926275181,0.0818505441932076,2.54517219832467e-36
NMR metabolomics,X23424.Total Lipids in VLDL,ACRBP,Acrosin-binding protein,37900,0.0448373136532315,0.00355279792385664,0.0378738297224724,0.0518007975839905,2.62158739319098e-36
NMR metabolomics,X23424.Total Lipids in VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,40291,0.0509324880691366,0.00403976290095456,0.0430145527832657,0.0588504233550076,2.85679749327289e-36
NMR metabolomics,X23424.Total Lipids in VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37598,0.0671168790283203,0.00532155183452982,0.0566866374326419,0.0775471206239987,2.93000487442542e-36
NMR metabolomics,X23424.Total Lipids in VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38013,0.0319036095212936,0.0025311056017515,0.0269426425418606,0.0368645765007265,3.17847353754432e-36
NMR metabolomics,X23424.Total Lipids in VLDL,WDR46,WD repeat-containing protein 46,37900,0.0420913823603172,0.00333933509327931,0.0355462855774897,0.0486364791431446,3.18667493961577e-36
NMR metabolomics,X23424.Total Lipids in VLDL,CPXM1,Probable carboxypeptidase X1,40411,0.0810747448077836,0.00643545116451791,0.0684612605253285,0.0936882290902387,3.21501789809713e-36
NMR metabolomics,X23424.Total Lipids in VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,37959,0.0463232467883126,0.00368632243021975,0.0390980548250819,0.0535484387515433,5.14730318667784e-36
NMR metabolomics,X23424.Total Lipids in VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40341,0.140119899339294,0.0111686082908675,0.118229427089194,0.162010371589395,6.1988887840465e-36
NMR metabolomics,X23424.Total Lipids in VLDL,CCL24,C-C motif chemokine 24,40396,0.0973119177400439,0.00775829228742171,0.0821056648566973,0.11251817062339,6.42015800841271e-36
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G15,Phospholipase A2 group XV,40411,0.0301942256571391,0.00240921912185965,0.0254721561782942,0.0349162951359841,7.28739791022501e-36
NMR metabolomics,X23424.Total Lipids in VLDL,FAM3C,Protein FAM3C,40330,0.0348104286347405,0.00277846243084639,0.0293646422702815,0.0402562149991994,7.68711478224894e-36
NMR metabolomics,X23424.Total Lipids in VLDL,MARCO,Macrophage receptor MARCO,40359,0.0311519190992092,0.00248798279841353,0.0262754728143187,0.0360283653840997,8.45779012645622e-36
NMR metabolomics,X23424.Total Lipids in VLDL,CD40LG,CD40 ligand,40516,0.0896945101547982,0.00716531618096317,0.0756504904401104,0.103738529869486,8.75629137015824e-36
NMR metabolomics,X23424.Total Lipids in VLDL,NFAT5,Nuclear factor of activated T-cells 5,37598,0.103001097900358,0.00822644202710245,0.0868772715272371,0.119124924273479,9.19637215502047e-36
NMR metabolomics,X23424.Total Lipids in VLDL,NBN,Nibrin,40044,0.0596449913096193,0.00477102393281473,0.0502937844013024,0.0689961982179361,1.08622529095454e-35
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL1,Growth-regulated alpha protein,40329,0.113796614187547,0.00910429325107823,0.0959521994154334,0.13164102895966,1.10972020973163e-35
NMR metabolomics,X23424.Total Lipids in VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,37562,0.0793771072927038,0.00634826767996476,0.0669345026399729,0.0918197119454347,1.13760365304622e-35
NMR metabolomics,X23424.Total Lipids in VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39961,0.0749070521390587,0.00599495178359599,0.0631569466432106,0.0866571576349068,1.18005864322229e-35
NMR metabolomics,X23424.Total Lipids in VLDL,BAG3,BAG family molecular chaperone regulator 3,40203,0.046391795896018,0.00371719398145874,0.0391060956923589,0.0536774960996772,1.4083029688079e-35
NMR metabolomics,X23424.Total Lipids in VLDL,APOL1,Apolipoprotein L1,37987,0.076206635239217,0.00610553881502642,0.0642397791617652,0.0881734913166688,1.4770632771928e-35
NMR metabolomics,X23424.Total Lipids in VLDL,RNASEH2A,Ribonuclease H2 subunit A,37959,0.0579013883355563,0.00464267025160985,0.048801754642401,0.0670010220287116,1.67356089846587e-35
NMR metabolomics,X23424.Total Lipids in VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37901,0.0900414315002929,0.00722301917315455,0.07588431392091,0.104198549079676,1.79898486946811e-35
NMR metabolomics,X23424.Total Lipids in VLDL,FCN1,Ficolin-1,37967,0.0659410258424209,0.00529304317289356,0.0555666612235496,0.0763153904612923,1.97840637755383e-35
NMR metabolomics,X23424.Total Lipids in VLDL,ITGAL,Integrin alpha-L,37598,0.0510189854699493,0.00409682206115425,0.0429892142300869,0.0590487567098116,2.12460629076018e-35
NMR metabolomics,X23424.Total Lipids in VLDL,BTC,Probetacellulin,39980,0.0878278394230662,0.0070593811941458,0.0739914522825404,0.101664226563592,2.29914300584356e-35
NMR metabolomics,X23424.Total Lipids in VLDL,ACYP1,Acylphosphatase-1,37622,0.0772283327773163,0.00620682542283885,0.0650629549485522,0.0893937106060805,2.42724089028812e-35
NMR metabolomics,X23424.Total Lipids in VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,40385,0.139324921310165,0.011207178188953,0.117358852059817,0.161290990560513,2.56241171960053e-35
NMR metabolomics,X23424.Total Lipids in VLDL,APOD,Apolipoprotein D,37345,-0.0519979919266794,0.00418193215302755,-0.0601945789466134,-0.0438014049067454,2.723468171657e-35
NMR metabolomics,X23424.Total Lipids in VLDL,APOA2,Apolipoprotein A-II,37987,-0.0554691510626508,0.00446367225525008,-0.0642179486829409,-0.0467203534423606,2.91134533900766e-35
NMR metabolomics,X23424.Total Lipids in VLDL,SLC27A4,Long-chain fatty acid transport protein 4,39961,0.077376544757199,0.0062298412419971,0.0651660559228847,0.0895870335915133,2.98311290998156e-35
NMR metabolomics,X23424.Total Lipids in VLDL,MDK,Midkine,40352,0.0588833020156962,0.00474777104949916,0.0495776707586779,0.0681889332727146,3.69231261374471e-35
NMR metabolomics,X23424.Total Lipids in VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,37598,0.061877184888254,0.00498817658792857,0.052100358775914,0.071654011000594,3.8715800569588e-35
NMR metabolomics,X23424.Total Lipids in VLDL,CD84,SLAM family member 5,40341,0.0356984294562149,0.00288454141618573,0.0300447282804909,0.0413521306319389,5.12515215272364e-35
NMR metabolomics,X23424.Total Lipids in VLDL,RGS10,Regulator of G-protein signaling 10,37959,0.0695974082906175,0.00562234459938733,0.0585776128758183,0.0806172037054166,5.2747713285231e-35
NMR metabolomics,X23424.Total Lipids in VLDL,TIMP1,Metalloproteinase inhibitor 1,40167,0.0325774901049544,0.00263463650664004,0.02741360255194,0.0377413776579689,5.87142516338491e-35
NMR metabolomics,X23424.Total Lipids in VLDL,PKN3,Serine/threonine-protein kinase N3,37714,0.0895344688351341,0.00724532408862463,0.0753336336214298,0.103735304048838,6.89911995230603e-35
NMR metabolomics,X23424.Total Lipids in VLDL,FGF2,Fibroblast growth factor 2,40341,0.0765761990798154,0.00620062254319546,0.0644229788951523,0.0887294192644785,7.06213412902513e-35
NMR metabolomics,X23424.Total Lipids in VLDL,SCARA5,Scavenger receptor class A member 5,40471,0.0338986102011783,0.00274529902390199,0.0285178241143304,0.0392793962880262,7.20645013884685e-35
NMR metabolomics,X23424.Total Lipids in VLDL,PARD3,Partitioning defective 3 homolog,37714,0.086021603278778,0.00696992139752256,0.0723605573396338,0.0996826492179222,8.36919607557302e-35
NMR metabolomics,X23424.Total Lipids in VLDL,CORO1A,Coronin-1A,39990,0.103966347155259,0.00843232015063828,0.0874389996600081,0.12049369465051,9.13499209863836e-35
NMR metabolomics,X23424.Total Lipids in VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37942,0.0878996943556037,0.00715982694560141,0.0738664335422249,0.101932955168982,1.84316886987506e-34
NMR metabolomics,X23424.Total Lipids in VLDL,NPC2,NPC intracellular cholesterol transporter 2,37815,0.0357231438633186,0.00291069631449036,0.0300181790869175,0.0414281086397197,1.93689119878603e-34
NMR metabolomics,X23424.Total Lipids in VLDL,ZNRD2,Protein ZNRD2,37901,0.0782443012874957,0.00638502243521641,0.0657296573144716,0.0907589452605199,2.42722603804653e-34
NMR metabolomics,X23424.Total Lipids in VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37901,0.0523662899930484,0.00427365957086052,0.0439899172341618,0.060742662751935,2.4595240716722e-34
NMR metabolomics,X23424.Total Lipids in VLDL,ASAH1,Acid ceramidase,37882,0.0530940558658383,0.00433307451043532,0.0446012298253851,0.0615868819062915,2.46279058213043e-34
NMR metabolomics,X23424.Total Lipids in VLDL,NID1,Nidogen-1,40355,0.0452996964545173,0.00370238419189831,0.0380430234383966,0.052556369470638,2.87192103171616e-34
NMR metabolomics,X23424.Total Lipids in VLDL,CSTB,Cystatin-B,40097,0.0479827243259315,0.00392267515595689,0.040294281020256,0.055671167631607,3.00122552219776e-34
NMR metabolomics,X23424.Total Lipids in VLDL,EGFL7,Epidermal growth factor-like protein 7,39980,0.0462447640014274,0.00378168623343662,0.0388326589838916,0.0536568690189631,3.1418354628022e-34
NMR metabolomics,X23424.Total Lipids in VLDL,ARAF,Serine/threonine-protein kinase A-Raf,37714,0.0770958038541855,0.00630912601972512,0.0647299168555243,0.0894616908528467,3.72234750052667e-34
NMR metabolomics,X23424.Total Lipids in VLDL,GET3,ATPase GET3,37990,0.0643905216952397,0.00527340000204751,0.0540546576912266,0.0747263856992529,4.13210219153396e-34
NMR metabolomics,X23424.Total Lipids in VLDL,TPK1,Thiamin pyrophosphokinase 1,37990,0.0310384769984029,0.00254417293053708,0.0260518980545502,0.0360250559422556,4.70061790352395e-34
NMR metabolomics,X23424.Total Lipids in VLDL,IL12A_IL12B,Interleukin-12,40305,0.089385724551751,0.00734165819642705,0.074996074486754,0.103775374616748,5.97778204206437e-34
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,40063,0.0484037438919763,0.0039772446848965,0.0406083443095791,0.0561991434743734,6.38382941386448e-34
NMR metabolomics,X23424.Total Lipids in VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40042,0.100069670859929,0.00822710948681236,0.083944536265777,0.116194805454081,6.93312122345155e-34
NMR metabolomics,X23424.Total Lipids in VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40305,0.027269366342102,0.00224239226259705,0.0228742775074117,0.0316644551767922,7.11100181642675e-34
NMR metabolomics,X23424.Total Lipids in VLDL,SCG2,Secretogranin-2,40392,0.0366623353151515,0.00302281869309385,0.0307376106766876,0.0425870599536155,1.04978006880399e-33
NMR metabolomics,X23424.Total Lipids in VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,39980,0.0871944177015187,0.00719493278847854,0.0730923494361007,0.101296485966937,1.19053879990167e-33
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40359,0.0726133483802962,0.00599575973790133,0.0608616592940096,0.0843650374665828,1.30184520961724e-33
NMR metabolomics,X23424.Total Lipids in VLDL,ARFIP1,Arfaptin-1,37959,0.0780806604331992,0.00644749300282277,0.0654435741476666,0.0907177467187318,1.39163236044421e-33
NMR metabolomics,X23424.Total Lipids in VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37959,0.103212351569785,0.00852317536280779,0.0865069278586817,0.119917775280888,1.40213137611984e-33
NMR metabolomics,X23424.Total Lipids in VLDL,C4BPB,C4b-binding protein beta chain,40411,0.0467075644251186,0.00386484661450252,0.0391324650606937,0.0542826637895436,1.77015860589117e-33
NMR metabolomics,X23424.Total Lipids in VLDL,SNX9,Sorting nexin-9,40359,0.0775772143713498,0.00643162017278512,0.064971238832691,0.0901831899100086,2.34862289046189e-33
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4A,C-type lectin domain family 4 member A,40341,-0.0388615051445536,0.00322306439891941,-0.0451787113664356,-0.0325442989226716,2.4811335757575e-33
NMR metabolomics,X23424.Total Lipids in VLDL,FGL1,Fibrinogen-like protein 1,37987,-0.0710887235718772,0.00589369452305853,-0.0826403648370719,-0.0595370823066825,2.49026125531074e-33
NMR metabolomics,X23424.Total Lipids in VLDL,SERPING1,Plasma protease C1 inhibitor,37981,0.0210405024854424,0.00174623025083238,0.017617891193811,0.0244631137770739,2.90197973811704e-33
NMR metabolomics,X23424.Total Lipids in VLDL,SPINT2,Kunitz-type protease inhibitor 2,40422,0.0471246224589614,0.00392783076222287,0.0394260741650046,0.0548231707529182,5.070387852703e-33
NMR metabolomics,X23424.Total Lipids in VLDL,EFNA4,Ephrin-A4,40203,0.0330352918597357,0.00276106586976489,0.0276236027549965,0.0384469809644748,7.55058932591373e-33
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM1,Intercellular adhesion molecule 1,40291,0.0319315903449532,0.00267143137476759,0.0266955848504087,0.0371675958394977,8.66614859751775e-33
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJC21,DnaJ homolog subfamily C member 21,37942,0.042082542021495,0.00353184354879469,0.0351601286658574,0.0490049553771326,1.43709082917854e-32
NMR metabolomics,X23424.Total Lipids in VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40341,0.0918358082033396,0.00771595884585493,0.0767125288654639,0.106959087541215,1.58734241062098e-32
NMR metabolomics,X23424.Total Lipids in VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37562,0.0456717355920098,0.00383548479963276,0.0381541853847296,0.05318928579929,1.58784307466849e-32
NMR metabolomics,X23424.Total Lipids in VLDL,RAD23B,UV excision repair protein RAD23 homolog B,39980,0.0531403304315409,0.00446535476511169,0.044388235091922,0.0618924257711598,1.62734126303931e-32
NMR metabolomics,X23424.Total Lipids in VLDL,PECAM1,Platelet endothelial cell adhesion molecule,40332,0.0333764168533998,0.0028047489660723,0.027879108879898,0.0388737248269015,1.62762139097043e-32
NMR metabolomics,X23424.Total Lipids in VLDL,KLF4,Krueppel-like factor 4,37541,0.04361720455539,0.00367358478524328,0.0364169783763131,0.0508174307344668,2.39039847271483e-32
NMR metabolomics,X23424.Total Lipids in VLDL,TSNAX,Translin-associated protein X,37562,0.0440241641265866,0.00371029401030547,0.0367519878663879,0.0512963403867853,2.6194114104446e-32
NMR metabolomics,X23424.Total Lipids in VLDL,FAP,Prolyl endopeptidase FAP,40536,0.0300187262272417,0.0025334326838917,0.025053198166814,0.0349842542876695,2.96492379091753e-32
NMR metabolomics,X23424.Total Lipids in VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,39980,0.039942727828668,0.00337119887293957,0.0333351780377064,0.0465502776196296,3.02641501960018e-32
NMR metabolomics,X23424.Total Lipids in VLDL,CCDC134,Coiled-coil domain-containing protein 134,37900,0.0546638333468631,0.0046136121604456,0.0456211535123897,0.0637065131813365,3.17304142220997e-32
NMR metabolomics,X23424.Total Lipids in VLDL,SWAP70,Switch-associated protein 70,37901,0.0390852846221045,0.00330230537511618,0.0326127660868768,0.0455578031573323,3.68271220233851e-32
NMR metabolomics,X23424.Total Lipids in VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,37990,0.0660013421057798,0.00559893390709867,0.0550274316478664,0.0769752525636932,6.43155484656983e-32
NMR metabolomics,X23424.Total Lipids in VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37337,0.054654907332283,0.00463937044506737,0.0455617412599509,0.063748073404615,7.15382770595794e-32
NMR metabolomics,X23424.Total Lipids in VLDL,ING1,Inhibitor of growth protein 1,39925,0.0492780346621376,0.00418514593087992,0.041075148637613,0.0574809206866623,7.22496712228802e-32
NMR metabolomics,X23424.Total Lipids in VLDL,BAP18,Chromatin complexes subunit BAP18,37942,0.0715982578257569,0.00608314093716648,0.0596753015889106,0.0835212140626032,7.97864536998211e-32
NMR metabolomics,X23424.Total Lipids in VLDL,PPM1F,Protein phosphatase 1F,37990,0.0577827212940174,0.00491273398190104,0.0481537626894913,0.0674116798985434,8.76519050365609e-32
NMR metabolomics,X23424.Total Lipids in VLDL,BOLA2_BOLA2B,BolA-like protein 2,37628,0.0618876950789859,0.00526453173664605,0.0515692128751597,0.0722061772828122,9.52141768785795e-32
NMR metabolomics,X23424.Total Lipids in VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',37942,0.0436168345091348,0.00371061638344844,0.0363440263975758,0.0508896426206937,9.55126727375629e-32
NMR metabolomics,X23424.Total Lipids in VLDL,PDZD2,PDZ domain-containing protein 2,37562,0.0678518555951816,0.00577542233255718,0.0565320278233695,0.0791716833669937,1.03797633627625e-31
NMR metabolomics,X23424.Total Lipids in VLDL,OPLAH,5-oxoprolinase,37628,0.075079114019822,0.0063949501972801,0.062545011633153,0.087613216406491,1.13786628737641e-31
NMR metabolomics,X23424.Total Lipids in VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37671,0.0978098784175382,0.00834973964306999,0.081444388717121,0.114175368117955,1.54474490860913e-31
NMR metabolomics,X23424.Total Lipids in VLDL,IMPA1,Inositol monophosphatase 1,40228,0.0668494475528218,0.00571270258530704,0.05565255048562,0.0780463446200236,1.6820065187654e-31
NMR metabolomics,X23424.Total Lipids in VLDL,ESAM,Endothelial cell-selective adhesion molecule,40536,0.0342994593292153,0.00293153902062605,0.0285536428487882,0.0400452758096423,1.70680461270298e-31
NMR metabolomics,X23424.Total Lipids in VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37865,0.0342523262988522,0.00293678353051375,0.0284962305790453,0.0400084220186592,2.78165940924022e-31
NMR metabolomics,X23424.Total Lipids in VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40305,0.076037264597975,0.00652305563408313,0.0632520755551721,0.088822453640778,2.84549175081995e-31
NMR metabolomics,X23424.Total Lipids in VLDL,CCN4,CCN family member 4,40489,0.0447116337215249,0.00383635985965212,0.0371923683966067,0.052230899046443,2.90248713177386e-31
NMR metabolomics,X23424.Total Lipids in VLDL,AFP,Alpha-fetoprotein,40182,0.0758841125980349,0.00652118012676257,0.0631025995495802,0.0886656256464895,3.60450318010091e-31
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA4,Annexin A4,40279,0.078185042889448,0.00672107827308576,0.0650117294741999,0.091358356304696,3.75825432519275e-31
NMR metabolomics,X23424.Total Lipids in VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40192,0.0807282704204556,0.00695053447138544,0.0671052228565402,0.0943513179843711,4.64594465142856e-31
NMR metabolomics,X23424.Total Lipids in VLDL,EPPK1,Epiplakin,37628,0.0801643537729855,0.00691045317433059,0.0666198655512975,0.0937088419946734,5.79589099941337e-31
NMR metabolomics,X23424.Total Lipids in VLDL,GBP1,Guanylate-binding protein 1,37931,0.0700911523060202,0.00604649094631995,0.0582400300512331,0.0819422745608073,6.3387800763217e-31
NMR metabolomics,X23424.Total Lipids in VLDL,UMOD,Uromodulin,40502,-0.0586171826534157,0.00507802011098648,-0.0685701020709492,-0.0486642632358822,1.05483986747789e-30
NMR metabolomics,X23424.Total Lipids in VLDL,VWC2,Brorin,40167,0.0420898305946333,0.00364675311798414,0.0349421944833844,0.0492374667058822,1.08069478626133e-30
NMR metabolomics,X23424.Total Lipids in VLDL,DKK4,Dickkopf-related protein 4,40203,0.0493307367206535,0.00427583697097713,0.0409500962575383,0.0577113771837687,1.139236422291e-30
NMR metabolomics,X23424.Total Lipids in VLDL,MRI1,Methylthioribose-1-phosphate isomerase,37572,0.0747043700957051,0.00647287811392043,0.062017528992421,0.0873912111989891,1.15071412067726e-30
NMR metabolomics,X23424.Total Lipids in VLDL,DMD,Dystrophin,37628,0.0563442193885854,0.00488667492019451,0.0467663365450042,0.0659221022321666,1.30349529512788e-30
NMR metabolomics,X23424.Total Lipids in VLDL,PQBP1,Polyglutamine-binding protein 1,39980,0.0595463162742012,0.0051725324263693,0.0494081527185174,0.069684479829885,1.52656384127282e-30
NMR metabolomics,X23424.Total Lipids in VLDL,DYNLT3,Dynein light chain Tctex-type 3,37900,0.0470734833177364,0.00408844490218814,0.0390601313094476,0.0550868353260251,1.56302998962115e-30
NMR metabolomics,X23424.Total Lipids in VLDL,PTGDS,Prostaglandin-H2 D-isomerase,40234,0.0318480229060258,0.00276914133686801,0.0264205058857645,0.0372755399262871,1.72399576840955e-30
NMR metabolomics,X23424.Total Lipids in VLDL,CBLN4,Cerebellin-4,40489,0.0339593165518482,0.00295326469127072,0.0281709177569576,0.0397477153467388,1.75909848255062e-30
NMR metabolomics,X23424.Total Lipids in VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39980,0.066380810028468,0.00577410192007594,0.0550635702651192,0.0776980497918169,1.82889255935048e-30
NMR metabolomics,X23424.Total Lipids in VLDL,ASGR2,Asialoglycoprotein receptor 2,37987,0.0279083299015102,0.00242800685516593,0.023149436465385,0.0326672233376354,1.9498528266282e-30
NMR metabolomics,X23424.Total Lipids in VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37598,0.0484464466463167,0.00421826259842766,0.0401786519533985,0.0567142413392349,2.19270159412057e-30
NMR metabolomics,X23424.Total Lipids in VLDL,WAS,Wiskott-Aldrich syndrome protein,40044,0.0733684725671896,0.00639790653542558,0.0608285757577555,0.0859083693766238,2.53972182448347e-30
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40324,0.0261741199920526,0.00228371806343071,0.0216980325877284,0.0306502073963768,2.71914915969404e-30
NMR metabolomics,X23424.Total Lipids in VLDL,PALM,Paralemmin-1,37824,0.0314908317747789,0.00275279242518713,0.0260953586214121,0.0368863049281457,3.66181907633996e-30
NMR metabolomics,X23424.Total Lipids in VLDL,HPCAL1,Hippocalcin-like protein 1,40516,0.0785155562769484,0.00687088974997815,0.0650486123669912,0.0919825001869056,3.9944102557488e-30
NMR metabolomics,X23424.Total Lipids in VLDL,FXN,"Frataxin, mitochondrial",40489,0.0791135172293878,0.00693216780842074,0.0655264683248831,0.0927005661338924,4.72913545308357e-30
NMR metabolomics,X23424.Total Lipids in VLDL,CTSE,Cathepsin E,37671,0.0552096525668856,0.00484269345510181,0.0457179733948861,0.0647013317388852,5.73098951495351e-30
NMR metabolomics,X23424.Total Lipids in VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,37621,0.0306685203949128,0.00269385882681805,0.0253885570943494,0.0359484836954762,6.88269234518675e-30
NMR metabolomics,X23424.Total Lipids in VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,37628,0.0475556959026239,0.00419002030832032,0.0393432560983161,0.0557681357069317,1.02180783784131e-29
NMR metabolomics,X23424.Total Lipids in VLDL,LGMN,Legumain,40422,0.037715411129758,0.00332566626073553,0.0311971052587164,0.0442337170007996,1.07129361497617e-29
NMR metabolomics,X23424.Total Lipids in VLDL,DNM1,Dynamin-1,37901,0.120860648925956,0.010655396844497,0.0999760711107422,0.141745226741171,1.10007730418995e-29
NMR metabolomics,X23424.Total Lipids in VLDL,SOD1,Superoxide dismutase [Cu-Zn],39978,0.052079460780539,0.0045955441000704,0.043072194344401,0.061086727216677,1.18314584920124e-29
NMR metabolomics,X23424.Total Lipids in VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37562,0.0298213021434244,0.0026334573004824,0.0246597258344789,0.0349828784523699,1.36939213204823e-29
NMR metabolomics,X23424.Total Lipids in VLDL,GNAS,Neuroendocrine secretory protein 55,37959,0.0959198004205738,0.00847693195860587,0.0793050137817063,0.112534587059441,1.49561565982458e-29
NMR metabolomics,X23424.Total Lipids in VLDL,SH3BP1,SH3 domain-binding protein 1,37901,0.049574407859576,0.00438986714412949,0.0409702682570822,0.0581785474620698,1.92985083202929e-29
NMR metabolomics,X23424.Total Lipids in VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40384,-0.0322715472068428,0.00286636599904993,-0.0378896245649806,-0.0266534698487049,2.70718789129426e-29
NMR metabolomics,X23424.Total Lipids in VLDL,GSR,"Glutathione reductase, mitochondrial",37944,0.0233710468405918,0.00208006442487866,0.0192941205678296,0.0274479731133539,3.66776267414134e-29
NMR metabolomics,X23424.Total Lipids in VLDL,ENO2,Gamma-enolase,40471,0.06923367382607,0.00616449510485891,0.0571512634205466,0.0813160842315935,3.68966514220948e-29
NMR metabolomics,X23424.Total Lipids in VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,40332,0.0287860958636056,0.00256308100138871,0.0237624571008837,0.0338097346263274,3.69712281100184e-29
NMR metabolomics,X23424.Total Lipids in VLDL,GRK5,G protein-coupled receptor kinase 5,40042,0.0553905555697005,0.00493441149463322,0.0457191090402194,0.0650620020991816,3.95945960254414e-29
NMR metabolomics,X23424.Total Lipids in VLDL,PTGES2,Prostaglandin E synthase 2,37484,0.057705409828379,0.00514069036315595,0.0476296567165933,0.0677811629401646,4.16956304748298e-29
NMR metabolomics,X23424.Total Lipids in VLDL,CD46,Membrane cofactor protein,40250,0.0300987475850256,0.00268673920333675,0.0248327387464856,0.0353647564235657,5.08745901723227e-29
NMR metabolomics,X23424.Total Lipids in VLDL,POMC,Pro-opiomelanocortin,37628,0.0716573966181699,0.00641053253291782,0.059092752853651,0.0842220403826888,7.04128477228367e-29
NMR metabolomics,X23424.Total Lipids in VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37671,0.0706147630435748,0.00633191058871077,0.0582042182897017,0.0830253077974479,9.38583126431018e-29
NMR metabolomics,X23424.Total Lipids in VLDL,DCTN6,Dynactin subunit 6,39961,0.0739515039559877,0.00663723655895989,0.0609425203004263,0.086960487611549,1.00798964780792e-28
NMR metabolomics,X23424.Total Lipids in VLDL,XCL1,Lymphotactin,40489,0.0588922601245796,0.00528613033258273,0.0485314446727175,0.0692530755764418,1.01104601592039e-28
NMR metabolomics,X23424.Total Lipids in VLDL,CCS,Copper chaperone for superoxide dismutase,40228,0.0503701421016862,0.00452955450225669,0.0414922152772631,0.0592480689261093,1.27631635097371e-28
NMR metabolomics,X23424.Total Lipids in VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40450,0.0316642889632495,0.00284787171806524,0.0260824603958416,0.0372461175306574,1.29701439594768e-28
NMR metabolomics,X23424.Total Lipids in VLDL,CCDC80,Coiled-coil domain-containing protein 80,40359,0.0366147736393211,0.00329416586198628,0.030158208549828,0.0430713387288142,1.35098974402873e-28
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40044,0.0436253988469749,0.0039288030297011,0.0359249449087608,0.0513258527851891,1.53481933502433e-28
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS27,Serine protease 27,40314,0.0421231428783446,0.00379406589149289,0.0346867737310185,0.0495595120256707,1.55612690622125e-28
NMR metabolomics,X23424.Total Lipids in VLDL,ERMAP,Erythroid membrane-associated protein,37598,0.0468231687402209,0.0042221758341404,0.0385477041053057,0.0550986333751361,1.8795537877036e-28
NMR metabolomics,X23424.Total Lipids in VLDL,POSTN,Periostin,37998,-0.0394749543250631,0.00356067017991691,-0.0464538678777002,-0.0324960407724259,1.93589693138927e-28
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX6,Peroxiredoxin-6,40489,-0.0620513701166673,0.005608546028541,-0.0730441203326077,-0.051058619900727,2.38253218197068e-28
NMR metabolomics,X23424.Total Lipids in VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,39980,0.0562224606226952,0.00508334694475189,0.0462591006109815,0.0661858206344089,2.49826591048005e-28
NMR metabolomics,X23424.Total Lipids in VLDL,ABCA2,ATP-binding cassette sub-family A member 2,37562,0.0384663564369404,0.00348310630181769,0.0316394680853777,0.0452932447885031,3.13190118407183e-28
NMR metabolomics,X23424.Total Lipids in VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,40215,0.097496150674585,0.00884012464411408,0.0801695063721214,0.114822794977049,3.51786030955325e-28
NMR metabolomics,X23424.Total Lipids in VLDL,CD1C,T-cell surface glycoprotein CD1c,40411,0.0247148330482159,0.00224461045730953,0.0203153965518892,0.0291142695445426,4.28124698923354e-28
NMR metabolomics,X23424.Total Lipids in VLDL,UNC79,Protein unc-79 homolog,37482,0.0585080004647225,0.00531982747078916,0.0480811386219758,0.0689348623074693,5.1822734424739e-28
NMR metabolomics,X23424.Total Lipids in VLDL,ENAH,Protein enabled homolog,40044,0.0487253894567805,0.00443832131929463,0.040026279670963,0.057424499242598,6.14806876719474e-28
NMR metabolomics,X23424.Total Lipids in VLDL,PSMG3,Proteasome assembly chaperone 3,40341,0.0527124580123561,0.00480447451913373,0.043295687954854,0.0621292280698582,6.59599875357988e-28
NMR metabolomics,X23424.Total Lipids in VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37998,0.0639809866651242,0.00583528805997224,0.0525438220675786,0.0754181512626697,7.41327243380568e-28
NMR metabolomics,X23424.Total Lipids in VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40516,0.0382913451115856,0.00349870860879795,0.0314338762383416,0.0451488139848296,8.85753620887412e-28
NMR metabolomics,X23424.Total Lipids in VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37598,0.0445222162113756,0.0040672014028389,0.0365505014618113,0.0524939309609398,9.08644590573156e-28
NMR metabolomics,X23424.Total Lipids in VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40332,0.0247370552783963,0.00226300853815275,0.0203015585436169,0.0291725520131757,1.02805924314711e-27
NMR metabolomics,X23424.Total Lipids in VLDL,CPA2,Carboxypeptidase A2,40398,0.065631007991604,0.00601047170769437,0.053850483444523,0.0774115325386849,1.16603827791479e-27
NMR metabolomics,X23424.Total Lipids in VLDL,CCL25,C-C motif chemokine 25,40516,0.0500159504815659,0.00458111934389713,0.0410369565675275,0.0589949443956043,1.18463622475515e-27
NMR metabolomics,X23424.Total Lipids in VLDL,APLP1,Amyloid-like protein 1,40359,-0.0532378347114007,0.00487752690867246,-0.0627977874523987,-0.0436778819704027,1.22573978264432e-27
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40044,0.0737111348635919,0.00675429809320349,0.0604727106009131,0.0869495591262708,1.25445097318865e-27
NMR metabolomics,X23424.Total Lipids in VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,37990,0.0332054076232221,0.00304219659503391,0.0272427022969557,0.0391681129494886,1.27453120994343e-27
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA9,Serpin A9,40228,0.0736559769551227,0.00676127587459186,0.0604038762409227,0.0869080776693227,1.54640951965951e-27
NMR metabolomics,X23424.Total Lipids in VLDL,DPT,Dermatopontin,40536,0.0270353911227118,0.0024820727107101,0.02217052860972,0.0319002536357036,1.56574823020651e-27
NMR metabolomics,X23424.Total Lipids in VLDL,TREML1,Trem-like transcript 1 protein,37987,0.0539822104185905,0.00495552360452929,0.0442693841537131,0.0636950366834679,1.61297938530392e-27
NMR metabolomics,X23424.Total Lipids in VLDL,TNF,Tumor necrosis factor,40014,0.0406138566552872,0.00373352423023832,0.0332961491640201,0.0479315641465543,1.83938611767098e-27
NMR metabolomics,X23424.Total Lipids in VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",40228,0.059760155587394,0.0054992041344423,0.0489817154838871,0.0705385956909009,2.06916551671706e-27
NMR metabolomics,X23424.Total Lipids in VLDL,IGF1R,Insulin-like growth factor 1 receptor,40305,0.0223633712300362,0.00205997546060436,0.0183258193272517,0.0264009231328208,2.32747664636646e-27
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40516,0.0387594253982655,0.00357599220031509,0.0317504806856479,0.0457683701108831,2.80172894860694e-27
NMR metabolomics,X23424.Total Lipids in VLDL,DCTN2,Dynactin subunit 2,40305,0.0954539956355921,0.00881618196288572,0.0781742789883361,0.112733712282848,3.18828465170813e-27
NMR metabolomics,X23424.Total Lipids in VLDL,AMOTL2,Angiomotin-like protein 2,37855,0.0489432416940282,0.00452324519914501,0.040077681103704,0.0578088022843524,3.56945255982126e-27
NMR metabolomics,X23424.Total Lipids in VLDL,NID2,Nidogen-2,40332,0.0748255142421418,0.00691891630326446,0.0612644382877435,0.0883865901965401,3.64945456466083e-27
NMR metabolomics,X23424.Total Lipids in VLDL,NGRN,Neugrin,37942,0.0223571997224024,0.00207021332914431,0.0182995815972795,0.0264148178475252,4.46734724224189e-27
NMR metabolomics,X23424.Total Lipids in VLDL,BOLA1,BolA-like protein 1,37541,0.0553886226338141,0.0051551560536098,0.0452845167687389,0.0654927284988893,8.15320842913267e-27
NMR metabolomics,X23424.Total Lipids in VLDL,IL12B,Interleukin-12 subunit beta,40516,0.0545400226636598,0.00508766632416378,0.0445681966682988,0.0645118486590208,1.00922636022725e-26
NMR metabolomics,X23424.Total Lipids in VLDL,FGR,Tyrosine-protein kinase Fgr,39961,0.0555688933074436,0.00518615778738509,0.0454040240441688,0.0657337625707184,1.07506147452394e-26
NMR metabolomics,X23424.Total Lipids in VLDL,BPIFA2,BPI fold-containing family A member 2,37150,-0.111807334649368,0.0104391260592973,-0.132268021725591,-0.0913466475731455,1.1820134304569e-26
NMR metabolomics,X23424.Total Lipids in VLDL,KIF22,Kinesin-like protein KIF22,37562,0.123055111843772,0.011508954191192,0.100497561629036,0.145612662058509,1.42582650292264e-26
NMR metabolomics,X23424.Total Lipids in VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,40471,0.0484429185110838,0.00453441883686834,0.0395554575908219,0.0573303794313458,1.49590024385719e-26
NMR metabolomics,X23424.Total Lipids in VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,37598,0.0408421399875435,0.0038217524116818,0.0333515052606471,0.0483327747144398,1.50889698790573e-26
NMR metabolomics,X23424.Total Lipids in VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,37942,0.0302576730851115,0.00283373315702496,0.0247035560973426,0.0358117900728805,1.65215598382491e-26
NMR metabolomics,X23424.Total Lipids in VLDL,SF3B4,Splicing factor 3B subunit 4,40305,0.0733681232426471,0.00687879766756444,0.0598856798142208,0.0868505666710734,1.8083619134774e-26
NMR metabolomics,X23424.Total Lipids in VLDL,TGFA,Protransforming growth factor alpha,40341,0.0479182489942057,0.00449380770845748,0.039110385885629,0.0567261121027823,1.85965283478381e-26
NMR metabolomics,X23424.Total Lipids in VLDL,STX16,Syntaxin-16,39980,0.0591087111028895,0.00554351741774361,0.048243416964112,0.069974005241667,1.87854758851909e-26
NMR metabolomics,X23424.Total Lipids in VLDL,GLO1,Lactoylglutathione lyase,40042,0.0592091080651669,0.00555405715873541,0.0483231560340455,0.0700950600962883,1.92072371236669e-26
NMR metabolomics,X23424.Total Lipids in VLDL,TLR3,Toll-like receptor 3,40516,0.0608076615516551,0.00571047424187803,0.0496151320375741,0.072000191065736,2.17137335352578e-26
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL1,Fc receptor-like protein 1,40359,0.0449610855245235,0.00422272098259454,0.0366845523986382,0.0532376186504088,2.19956544193872e-26
NMR metabolomics,X23424.Total Lipids in VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,40536,-0.0315242943045662,0.00296140205968587,-0.0373286423415505,-0.0257199462675819,2.25064955355327e-26
NMR metabolomics,X23424.Total Lipids in VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37959,0.0584695025167116,0.00549259471261362,0.0477040168799889,0.0692349881534343,2.33630530046714e-26
NMR metabolomics,X23424.Total Lipids in VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37942,0.0860555170029887,0.00810485423121282,0.0701700027098116,0.101941031296166,3.12682322740678e-26
NMR metabolomics,X23424.Total Lipids in VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,40502,0.0506295641340268,0.0047705039912514,0.0412793763111741,0.0599797519568795,3.16605574157987e-26
NMR metabolomics,X23424.Total Lipids in VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37901,0.116118909974182,0.0109392402442759,0.0946779990954014,0.137559820852963,3.22618635579682e-26
NMR metabolomics,X23424.Total Lipids in VLDL,CASP8,Caspase-8,40434,0.0615214743727712,0.00580453698929585,0.0501445818737513,0.072898366871791,3.68405355556761e-26
NMR metabolomics,X23424.Total Lipids in VLDL,MATN2,Matrilin-2,40379,0.0294685960869546,0.00278180044252479,0.024016267219606,0.0349209249543032,3.9084612668894e-26
NMR metabolomics,X23424.Total Lipids in VLDL,STK4,Serine/threonine-protein kinase 4,40359,0.0853420482004952,0.00805886287647884,0.0695466769625967,0.101137419438394,4.05804008088122e-26
NMR metabolomics,X23424.Total Lipids in VLDL,HPGDS,Hematopoietic prostaglandin D synthase,39980,0.0372099523587535,0.00352712893499612,0.0302967796461611,0.0441231250713459,6.24062914837859e-26
NMR metabolomics,X23424.Total Lipids in VLDL,NPPB,Natriuretic peptides B,40042,-0.126908654045186,0.0120474384152354,-0.150521633339047,-0.103295674751324,7.34963116734325e-26
NMR metabolomics,X23424.Total Lipids in VLDL,EFCAB2,Dynein regulatory complex protein 8,37714,0.0342854689942726,0.00326901211083453,0.0278782052570369,0.0406927327315083,1.23535832032942e-25
NMR metabolomics,X23424.Total Lipids in VLDL,S100P,Protein S100-P,40042,0.0527006717844492,0.00502902503437581,0.0428437827170726,0.0625575608518258,1.30815575216788e-25
NMR metabolomics,X23424.Total Lipids in VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40192,0.0935944595751261,0.0089416379768795,0.0760688491404423,0.11112007000981,1.48158881474495e-25
NMR metabolomics,X23424.Total Lipids in VLDL,NADK,NAD kinase,40359,0.0525355268333649,0.00502052191362741,0.0426953038826552,0.0623757497840747,1.52753489222645e-25
NMR metabolomics,X23424.Total Lipids in VLDL,FEN1,Flap endonuclease 1,39980,0.0608193502499927,0.00581491830903482,0.0494221103642845,0.072216590135701,1.61660051240242e-25
NMR metabolomics,X23424.Total Lipids in VLDL,MMP1,Interstitial collagenase,39757,0.0911278313337668,0.00871957231501938,0.0740374695963289,0.108218193071205,1.76733193049391e-25
NMR metabolomics,X23424.Total Lipids in VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37628,0.0896856911718354,0.00858817111223983,0.0728528757918453,0.106518506551825,1.98386011874831e-25
NMR metabolomics,X23424.Total Lipids in VLDL,DSCAM,Down syndrome cell adhesion molecule,37959,0.0345639365318116,0.00331130268794065,0.0280737832634479,0.0410540898001753,2.07353695133655e-25
NMR metabolomics,X23424.Total Lipids in VLDL,LAMA4,Laminin subunit alpha-4,40422,0.0320856990541376,0.00307518174780525,0.0260583428284393,0.0381130552798359,2.09851452986166e-25
NMR metabolomics,X23424.Total Lipids in VLDL,STXBP3,Syntaxin-binding protein 3,39980,0.0432629909334316,0.0041467031657175,0.0351354527286253,0.0513905291382379,2.12414798119578e-25
NMR metabolomics,X23424.Total Lipids in VLDL,NAA10,N-alpha-acetyltransferase 10,37562,0.0501571044199208,0.00483317038930315,0.0406840904568866,0.0596301183829549,3.91965990348146e-25
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6V1F,V-type proton ATPase subunit F,39925,0.0643609580649524,0.00620405127608845,0.0522010175638191,0.0765208985660858,3.93539889318728e-25
NMR metabolomics,X23424.Total Lipids in VLDL,ERI1,3'-5' exoribonuclease 1,37714,0.0328006057652744,0.00316185516454552,0.0266033696427652,0.0389978418877837,4.06846665765126e-25
NMR metabolomics,X23424.Total Lipids in VLDL,ADM,Pro-adrenomedullin,40489,0.02616075682523,0.00252667487080377,0.0212084740784546,0.0311130395720054,4.82184765755557e-25
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC3B,Tetranectin,37681,0.0205203825374814,0.00198127464959457,0.0166370842242761,0.0244036808506868,4.84017683919414e-25
NMR metabolomics,X23424.Total Lipids in VLDL,DENR,Density-regulated protein,37598,0.0560275700370055,0.00541997140219754,0.0454044260886983,0.0666507139853126,5.9574020773421e-25
NMR metabolomics,X23424.Total Lipids in VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,37901,0.110043959784105,0.0106494910451957,0.0891709573355211,0.130916962232688,6.17764112616521e-25
NMR metabolomics,X23424.Total Lipids in VLDL,THBD,Thrombomodulin,40359,0.0268569063756277,0.0026031343928117,0.0217547629657167,0.0319590497855386,7.0620705765338e-25
NMR metabolomics,X23424.Total Lipids in VLDL,TPMT,Thiopurine S-methyltransferase,39980,0.0716451416210667,0.00694444617868377,0.0580340271108465,0.0852562561312869,7.11103867592439e-25
NMR metabolomics,X23424.Total Lipids in VLDL,PMM2,Phosphomannomutase 2,37562,0.0587336682185686,0.00569323834642601,0.0475749210595736,0.0698924153775635,7.39514865185776e-25
NMR metabolomics,X23424.Total Lipids in VLDL,SPOCK1,Testican-1,40228,0.0242696627589221,0.00236220596689555,0.0196397390638068,0.0288995864540374,1.102271326609e-24
NMR metabolomics,X23424.Total Lipids in VLDL,MAGED1,Melanoma-associated antigen D1,39980,0.0468661452196244,0.00456204661301084,0.0379245338581231,0.0558077565811256,1.11799947006354e-24
NMR metabolomics,X23424.Total Lipids in VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40228,-0.112555962355292,0.0109686716583499,-0.134054558805658,-0.0910573659049263,1.25450241259565e-24
NMR metabolomics,X23424.Total Lipids in VLDL,TREH,Trehalase,37998,0.0717614307979241,0.00700041155718354,0.0580406241458443,0.0854822374500038,1.43959003535112e-24
NMR metabolomics,X23424.Total Lipids in VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,37628,-0.0612671011093764,0.00597840108446939,-0.0729847672349365,-0.0495494349838164,1.49251637594378e-24
NMR metabolomics,X23424.Total Lipids in VLDL,CPQ,Carboxypeptidase Q,37986,0.0351708326729132,0.00343713755300796,0.0284340430690176,0.0419076222768088,1.73961533587299e-24
NMR metabolomics,X23424.Total Lipids in VLDL,CD302,CD302 antigen,40305,0.0288217385611073,0.0028224084506321,0.0232898179978683,0.0343536591243462,2.09047542492787e-24
NMR metabolomics,X23424.Total Lipids in VLDL,CA4,Carbonic anhydrase 4,40536,-0.0223473020707307,0.00219068028751667,-0.0266410354342634,-0.018053568707198,2.32604714460667e-24
NMR metabolomics,X23424.Total Lipids in VLDL,NFASC,Neurofascin,40516,0.0260334705805851,0.00255369955527388,0.0210282194522483,0.0310387217089219,2.49065837168265e-24
NMR metabolomics,X23424.Total Lipids in VLDL,GLRX,Glutaredoxin-1,40260,0.05413730281134,0.00531224045592994,0.0437253115177173,0.0645492941049627,2.58491920957712e-24
NMR metabolomics,X23424.Total Lipids in VLDL,ENTR1,Endosome-associated-trafficking regulator 1,37628,0.0545999504757314,0.00536005556225712,0.0440942415737074,0.0651056593777554,2.8038686629164e-24
NMR metabolomics,X23424.Total Lipids in VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40400,0.0497143662210573,0.00488727686622782,0.0401353035632507,0.0592934288788638,3.12877888345841e-24
NMR metabolomics,X23424.Total Lipids in VLDL,ASS1,Argininosuccinate synthase,37562,0.0768343275287275,0.00756148464206089,0.0620138176302882,0.0916548374271669,3.62765958181743e-24
NMR metabolomics,X23424.Total Lipids in VLDL,NECTIN2,Nectin-2,40330,0.0275186167573416,0.00271091218053783,0.0222052288834874,0.0328320046311957,3.88422529943921e-24
NMR metabolomics,X23424.Total Lipids in VLDL,PTN,Pleiotrophin,40042,0.0477810912668193,0.00471132445693924,0.0385468953312184,0.0570152872024203,4.28315044075475e-24
NMR metabolomics,X23424.Total Lipids in VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37959,0.0651315284133753,0.0064239288330307,0.0525406279006352,0.0777224289261155,4.52749070371873e-24
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40379,0.0314511588559428,0.00310390457684339,0.0253675058853298,0.0375348118265558,4.67572551095612e-24
NMR metabolomics,X23424.Total Lipids in VLDL,STX6,Syntaxin-6,39980,0.0654910010700912,0.00646359841198117,0.0528223481826082,0.0781596539575743,4.7193299974065e-24
NMR metabolomics,X23424.Total Lipids in VLDL,FGF23,Fibroblast growth factor 23,40469,0.0585533570852202,0.00578598415788785,0.04721282813576,0.0698938860346804,5.32599096121968e-24
NMR metabolomics,X23424.Total Lipids in VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37628,-0.0345996795182166,0.00341824416170492,-0.0412994380751583,-0.027899920961275,5.39748567384242e-24
NMR metabolomics,X23424.Total Lipids in VLDL,DPP4,Dipeptidyl peptidase 4,40068,0.0283331479742421,0.00280467050161544,0.0228359937910759,0.0338303021574084,6.40234928537971e-24
NMR metabolomics,X23424.Total Lipids in VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,37959,0.0493559542753609,0.00489022934382289,0.0397711047614681,0.0589408037892538,7.22600469014351e-24
NMR metabolomics,X23424.Total Lipids in VLDL,RPE,Ribulose-phosphate 3-epimerase,37714,0.0663461094933755,0.00657564090197992,0.0534578533254949,0.0792343656612561,7.48201789860862e-24
NMR metabolomics,X23424.Total Lipids in VLDL,BMP6,Bone morphogenetic protein 6,40024,0.0400187326361032,0.00397151621825838,0.0322345608483167,0.0478029044238896,8.30760872576344e-24
NMR metabolomics,X23424.Total Lipids in VLDL,BRK1,Protein BRICK1,39961,0.0417933964620803,0.0041490143953277,0.033661328247238,0.0499254646769226,8.59923132421013e-24
NMR metabolomics,X23424.Total Lipids in VLDL,MMP12,Macrophage metalloelastase,40346,0.0488737550251683,0.00485904067454371,0.0393500353030626,0.0583974747472739,9.94266229242382e-24
NMR metabolomics,X23424.Total Lipids in VLDL,IL6R,Interleukin-6 receptor subunit alpha,40273,0.0317175341586103,0.0031574887257189,0.0255288562562013,0.0379062120610194,1.13596162638326e-23
NMR metabolomics,X23424.Total Lipids in VLDL,COLEC12,Collectin-12,40357,0.0240096197948279,0.00239639596092723,0.0193126837114106,0.0287065558782453,1.47636946049641e-23
NMR metabolomics,X23424.Total Lipids in VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37572,0.0507274612181216,0.00506229253983684,0.0408053678400414,0.0606495545962018,1.50310171895347e-23
NMR metabolomics,X23424.Total Lipids in VLDL,ADA,Adenosine deaminase,40516,0.0319035410000608,0.0031899551908055,0.025651228826082,0.0381558531740396,1.76269137682723e-23
NMR metabolomics,X23424.Total Lipids in VLDL,LAMB1,Laminin subunit beta-1,37628,0.0277497648665375,0.00277647655330662,0.0223078708220565,0.0331916589110185,1.95033062652454e-23
NMR metabolomics,X23424.Total Lipids in VLDL,PNLIP,Pancreatic triacylglycerol lipase,37987,0.0566867121712814,0.00567302071031092,0.045567591579072,0.0678058327634908,1.98498161487337e-23
NMR metabolomics,X23424.Total Lipids in VLDL,LEPR,Leptin receptor,40359,-0.0287094399986329,0.00287669657759994,-0.0343477652907288,-0.023071114706537,2.18457901347983e-23
NMR metabolomics,X23424.Total Lipids in VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,40453,0.0619574382560857,0.00621076086949981,0.049784346951866,0.0741305295603053,2.27589592093046e-23
NMR metabolomics,X23424.Total Lipids in VLDL,LIPF,Gastric triacylglycerol lipase,37628,0.0560761192634708,0.00562199745190431,0.0450570042577383,0.0670952342692032,2.38689198186331e-23
NMR metabolomics,X23424.Total Lipids in VLDL,CCL20,C-C motif chemokine 20,40516,0.0828866274082254,0.00832018647838122,0.0665790619105982,0.0991941929058526,2.60889391821136e-23
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTSL2,ADAMTS-like protein 2,37998,0.0289644225720377,0.002907580131661,0.0232655655139821,0.0346632796300932,2.69637359865973e-23
NMR metabolomics,X23424.Total Lipids in VLDL,HDGF,Hepatoma-derived growth factor,40471,0.08864132317773,0.00896312189009035,0.0710736042731529,0.106209042082307,5.3775315671005e-23
NMR metabolomics,X23424.Total Lipids in VLDL,TXN,Thioredoxin,37819,0.0414359381548691,0.00419052757049207,0.0332225041167046,0.0496493721930336,5.62734543686747e-23
NMR metabolomics,X23424.Total Lipids in VLDL,STX7,Syntaxin-7,37598,0.0468591874235122,0.0047390337421454,0.0375706812889072,0.0561476935581172,5.64895019879344e-23
NMR metabolomics,X23424.Total Lipids in VLDL,EPCAM,Epithelial cell adhesion molecule,40358,-0.0924749533220332,0.00936175718057715,-0.110823997395964,-0.074125909248102,6.04060929194659e-23
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB8,Serpin B8,40516,0.050404419182607,0.00511588854171843,0.0403772776408389,0.0604315607243752,7.75876963865002e-23
NMR metabolomics,X23424.Total Lipids in VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37714,0.0808883536385017,0.00820803606766868,0.0648006029458711,0.0969761043311323,7.82971316912095e-23
NMR metabolomics,X23424.Total Lipids in VLDL,BGN,Biglycan,39956,-0.11237969344245,0.0114118213081627,-0.134746863206449,-0.0900125236784511,8.18518018063201e-23
NMR metabolomics,X23424.Total Lipids in VLDL,C7,Complement component C7,37678,-0.029177910168545,0.00296403216507318,-0.0349874132120885,-0.0233684071250016,8.71385894031103e-23
NMR metabolomics,X23424.Total Lipids in VLDL,SPAG1,Sperm-associated antigen 1,37959,0.0530717160896866,0.00541561960402522,0.0424571016657972,0.063686330513576,1.34238295418109e-22
NMR metabolomics,X23424.Total Lipids in VLDL,C7orf50,Uncharacterized protein C7orf50,37942,0.0202210431392589,0.00206477028728521,0.0161740933761798,0.0242679929023379,1.42965277501241e-22
NMR metabolomics,X23424.Total Lipids in VLDL,CR1,Complement receptor type 1,37959,0.0333454596743465,0.0034084064185407,0.0266649830940067,0.0400259362546863,1.57778327226476e-22
NMR metabolomics,X23424.Total Lipids in VLDL,MSTN,Growth/differentiation factor 8,40042,0.0468998375751503,0.00480011104523656,0.0374916199264866,0.0563080552238139,1.74721668392514e-22
NMR metabolomics,X23424.Total Lipids in VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,37910,0.0376920223977894,0.00386164015328095,0.0301232076973587,0.04526083709822,1.97172830846736e-22
NMR metabolomics,X23424.Total Lipids in VLDL,LTA,Lymphotoxin-alpha,40341,0.0368489724265886,0.00377859260003375,0.0294429309305224,0.0442550139226547,2.08956622340203e-22
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40228,0.0318136981975487,0.00326392080469531,0.0254164134203458,0.0382109829747515,2.19572868365402e-22
NMR metabolomics,X23424.Total Lipids in VLDL,PVR,Poliovirus receptor,40471,0.0336036930642219,0.0034485493997208,0.0268445362407691,0.0403628498876747,2.25139455794793e-22
NMR metabolomics,X23424.Total Lipids in VLDL,APRT,Adenine phosphoribosyltransferase,40216,0.0443377177592451,0.00455108469035456,0.0354175917661501,0.05325784375234,2.30269940995454e-22
NMR metabolomics,X23424.Total Lipids in VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40341,0.0342226462210329,0.00351336028826721,0.0273364600560292,0.0411088323860367,2.33441329244866e-22
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA2,Annexin A2,37441,0.0654904829029826,0.00672983876232935,0.0522999989288171,0.0786809668771481,2.64094565754624e-22
NMR metabolomics,X23424.Total Lipids in VLDL,ALCAM,CD166 antigen,40536,0.017678499052816,0.00181948900081122,0.0141123006112261,0.021244697494406,2.96149581278085e-22
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,37671,0.0346852373938265,0.00357796934446549,0.0276724174786742,0.0416980573089789,3.78498004855042e-22
NMR metabolomics,X23424.Total Lipids in VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37942,0.0436154258871069,0.00450169041766275,0.0347921126684879,0.0524387391057259,3.97689718933654e-22
NMR metabolomics,X23424.Total Lipids in VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,40522,0.0501612431334205,0.00518277675644704,0.0400030006907843,0.0603194855760567,4.27784845983355e-22
NMR metabolomics,X23424.Total Lipids in VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40432,0.0253662978869069,0.00262202885603137,0.0202271213290854,0.0305054744447284,4.4573297668511e-22
NMR metabolomics,X23424.Total Lipids in VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39980,0.0396814937384673,0.00411124952967255,0.0316234446603091,0.0477395428166255,5.560735569288e-22
NMR metabolomics,X23424.Total Lipids in VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,37790,0.0508647582879469,0.00527683531969683,0.0405221610613411,0.0612073555145527,6.43440518302635e-22
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS7_LGALS7B,Galectin-7,40270,0.0363411836886087,0.00377290488973918,0.0289462901047199,0.0437360772724975,6.71769553253939e-22
NMR metabolomics,X23424.Total Lipids in VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,37990,0.0227625297812524,0.00236577304905401,0.0181256146051066,0.0273994449573983,7.61297569754906e-22
NMR metabolomics,X23424.Total Lipids in VLDL,DDX58,Antiviral innate immune response receptor RIG-I,39980,0.0515693063625337,0.00537134305333724,0.0410414739779927,0.0620971387470747,9.11545997309335e-22
NMR metabolomics,X23424.Total Lipids in VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,37998,0.0449431474697563,0.00468790183200913,0.0357548598790184,0.0541314350604942,1.06214876332429e-21
NMR metabolomics,X23424.Total Lipids in VLDL,PZP,Pregnancy zone protein,38013,0.0587106601232406,0.00613183023052956,0.0466922728714026,0.0707290473750785,1.19547623861733e-21
NMR metabolomics,X23424.Total Lipids in VLDL,FRZB,Secreted frizzled-related protein 3,40176,0.0239362015919665,0.00250274860951438,0.0190308143173183,0.0288415888666147,1.29760599547126e-21
NMR metabolomics,X23424.Total Lipids in VLDL,IFNAR1,Interferon alpha/beta receptor 1,37901,0.0237596090632936,0.00248571039751736,0.0188876166841596,0.0286316014424276,1.39932499667811e-21
NMR metabolomics,X23424.Total Lipids in VLDL,XRCC4,DNA repair protein XRCC4,39961,0.033418062513585,0.00349853903700119,0.0265609260010627,0.0402751990261074,1.45828062613509e-21
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,40489,0.0483834874485916,0.00506967269573556,0.0384469289649499,0.0583200459322332,1.57203852330086e-21
NMR metabolomics,X23424.Total Lipids in VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37564,0.0256680673626884,0.00268898101309291,0.0203976645770263,0.0309384701483505,1.58889613762837e-21
NMR metabolomics,X23424.Total Lipids in VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",37628,0.0581194453297324,0.00610113136962081,0.0461612278452757,0.0700776628141892,1.91599598485519e-21
NMR metabolomics,X23424.Total Lipids in VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40228,0.0262844321328044,0.00276605670530242,0.0208629609904116,0.0317059032751971,2.33739449374216e-21
NMR metabolomics,X23424.Total Lipids in VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37900,0.0489533755435636,0.00515042480552339,0.0388585429247378,0.0590482081623895,2.34057212001063e-21
NMR metabolomics,X23424.Total Lipids in VLDL,KITLG,Kit ligand,40359,-0.0324403114969639,0.00341560747542105,-0.0391349021487891,-0.0257457208451386,2.44490714095986e-21
NMR metabolomics,X23424.Total Lipids in VLDL,PIGR,Polymeric immunoglobulin receptor,40154,0.0313552817212192,0.00330252220446251,0.0248823382004727,0.0378282252419657,2.5280348054985e-21
NMR metabolomics,X23424.Total Lipids in VLDL,NEK7,Serine/threonine-protein kinase Nek7,37714,0.0676037504497412,0.00713909286105459,0.0536111284420742,0.0815963724574082,3.28035478545852e-21
NMR metabolomics,X23424.Total Lipids in VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40332,0.0336446753928047,0.00355654801466532,0.0266738412840607,0.0406155095015488,3.5038766337388e-21
NMR metabolomics,X23424.Total Lipids in VLDL,AK1,Adenylate kinase isoenzyme 1,40359,0.0567491278216258,0.00599910036592994,0.0449908911044031,0.0685073645388484,3.51372833723987e-21
NMR metabolomics,X23424.Total Lipids in VLDL,SV2A,Synaptic vesicle glycoprotein 2A,37572,0.054887300030514,0.00581249882031813,0.0434948023426904,0.0662797977183375,4.22739170971363e-21
NMR metabolomics,X23424.Total Lipids in VLDL,PTGR1,Prostaglandin reductase 1,37990,0.0704173777564518,0.00747449816767678,0.0557673613478053,0.0850673941650982,5.18044206143271e-21
NMR metabolomics,X23424.Total Lipids in VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37990,0.0270628539270281,0.00287393833300135,0.0214299347943455,0.0326957730597108,5.39928892450912e-21
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL1,Angiopoietin-related protein 1,40136,0.0260858784748373,0.00277480172869585,0.0206472670865934,0.0315244898630812,6.13623078221175e-21
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40228,0.0282357764873678,0.00300496341227085,0.0223460481993169,0.0341255047754186,6.40466313677647e-21
NMR metabolomics,X23424.Total Lipids in VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37990,0.0478661662851842,0.00509428633790692,0.0378813650628867,0.0578509675074818,6.55912061462544e-21
NMR metabolomics,X23424.Total Lipids in VLDL,TCOF1,Treacle protein,37990,0.0267110843722049,0.00284502692326382,0.0211348316026078,0.032287337141802,7.03054987087295e-21
NMR metabolomics,X23424.Total Lipids in VLDL,SMS,Spermine synthase,37541,0.056486777232378,0.00601801722189003,0.0446914634774736,0.0682820909872825,7.2285024980649e-21
NMR metabolomics,X23424.Total Lipids in VLDL,TPR,Nucleoprotein TPR,37562,0.04141117001921,0.00442398730960252,0.032740154892389,0.0500821851460309,9.20314754699105e-21
NMR metabolomics,X23424.Total Lipids in VLDL,C5,Complement C5,38013,0.0134582093352733,0.00143871612680634,0.0106383257267329,0.0162780929438137,9.71478058393726e-21
NMR metabolomics,X23424.Total Lipids in VLDL,CLTA,Clathrin light chain A,40042,0.0416072501189602,0.00444974568814251,0.0328857485702009,0.0503287516677195,9.88607287852683e-21
NMR metabolomics,X23424.Total Lipids in VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37598,0.0617287954862011,0.00660379266395662,0.0487853618648461,0.0746722291075561,1.04065812067246e-20
NMR metabolomics,X23424.Total Lipids in VLDL,SLIT2,Slit homolog 2 protein,39961,0.046012329028565,0.00492719828352692,0.0363550203928522,0.0556696376642777,1.10775696869772e-20
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP1,Rho GTPase-activating protein 1,39980,0.040180897168725,0.00430707788587849,0.0317390245124031,0.0486227698250468,1.2097224825047e-20
NMR metabolomics,X23424.Total Lipids in VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,40291,0.0302211561817461,0.00324113639135311,0.023868528854694,0.0365737835087982,1.26226542692176e-20
NMR metabolomics,X23424.Total Lipids in VLDL,CNDP1,Beta-Ala-His dipeptidase,40403,0.0399380217835456,0.00428674883463269,0.0315359940676655,0.0483400494994256,1.35463102486834e-20
NMR metabolomics,X23424.Total Lipids in VLDL,CLSTN3,Calsyntenin-3,37942,0.0268030248991135,0.00287690870640828,0.0211642838345533,0.0324417659636738,1.38479137673058e-20
NMR metabolomics,X23424.Total Lipids in VLDL,MMP3,Stromelysin-1,40332,-0.0422458079200946,0.00453814361330626,-0.0511405694021748,-0.0333510464380143,1.4549808678812e-20
NMR metabolomics,X23424.Total Lipids in VLDL,ROBO2,Roundabout homolog 2,40471,0.0203493243835284,0.00218636436805717,0.0160640502221364,0.0246345985449205,1.47637411519283e-20
NMR metabolomics,X23424.Total Lipids in VLDL,MTUS1,Microtubule-associated tumor suppressor 1,37714,0.0484902379742792,0.00521459802645413,0.0382696258424291,0.0587108501061293,1.63752376816012e-20
NMR metabolomics,X23424.Total Lipids in VLDL,ELOB,Elongin-B,37562,0.0351687469596251,0.0037831140134181,0.0277538434933257,0.0425836504259246,1.68210007672346e-20
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40228,0.0327150245518876,0.00352136460122629,0.0258131499334841,0.0396168991702912,1.73301903744947e-20
NMR metabolomics,X23424.Total Lipids in VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37562,0.0587557599675577,0.00632620940783831,0.0463563895281947,0.0711551304069208,1.82222096928464e-20
NMR metabolomics,X23424.Total Lipids in VLDL,PER3,Period circadian protein homolog 3,37598,0.103255469120781,0.0111216031555395,0.0814571269359241,0.125053811305639,1.88103667164554e-20
NMR metabolomics,X23424.Total Lipids in VLDL,CFHR5,Complement factor H-related protein 5,37785,0.0364734555509344,0.00393344706865443,0.0287638992963717,0.0441830118054971,2.09130780989869e-20
NMR metabolomics,X23424.Total Lipids in VLDL,STAM,Signal transducing adapter molecule 1,37900,0.0327172685941033,0.00353395068932477,0.0257907252430267,0.0396438119451799,2.39424920020353e-20
NMR metabolomics,X23424.Total Lipids in VLDL,PDIA3,Protein disulfide-isomerase A3,37671,0.0222593545636499,0.00240448130999908,0.0175465711960517,0.0269721379312481,2.41211876230877e-20
NMR metabolomics,X23424.Total Lipids in VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40228,0.0607608783972748,0.00656816783688702,0.0478872694369762,0.0736344873575733,2.50781877244568e-20
NMR metabolomics,X23424.Total Lipids in VLDL,HRG,Histidine-rich glycoprotein,37934,0.0273759575922345,0.00296483502966233,0.0215648809340963,0.0331870342503727,3.00352006290814e-20
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,37998,0.0194113698977738,0.00210741994434076,0.0152808268068659,0.0235419129886817,3.70071242660836e-20
NMR metabolomics,X23424.Total Lipids in VLDL,VCAM1,Vascular cell adhesion protein 1,40372,-0.0233443070826014,0.00253637304521843,-0.0283155982512295,-0.0183730159139733,3.87537638693909e-20
NMR metabolomics,X23424.Total Lipids in VLDL,BRDT,Bromodomain testis-specific protein,37562,0.0323037626926321,0.00350893429402378,0.0254262514763455,0.0391812739089187,3.88684782180255e-20
NMR metabolomics,X23424.Total Lipids in VLDL,CCL19,C-C motif chemokine 19,40471,0.113151294709088,0.0122975939382104,0.0890480105901962,0.137254578827981,3.97149955170079e-20
NMR metabolomics,X23424.Total Lipids in VLDL,PRG2,Bone marrow proteoglycan,37998,-0.0452096782020658,0.00491579655988986,-0.0548446394594499,-0.0355747169446817,4.21827227676466e-20
NMR metabolomics,X23424.Total Lipids in VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,40516,0.028403406779598,0.0030921817966611,0.0223427304581422,0.0344640831010537,4.58392874372487e-20
NMR metabolomics,X23424.Total Lipids in VLDL,CRYGD,Gamma-crystallin D,37942,0.0829191688145544,0.00902898326420078,0.0652223616167209,0.100615976012388,4.76583469671276e-20
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL8,Interleukin-8,40209,0.0582486678626092,0.00636765520078625,0.0457680636690681,0.0707292720561502,6.52073762856403e-20
NMR metabolomics,X23424.Total Lipids in VLDL,SCRIB,Protein scribble homolog,37628,0.0800829317671808,0.00875883604395408,0.0629156131210309,0.0972502504133308,6.94701534530725e-20
NMR metabolomics,X23424.Total Lipids in VLDL,CAPG,Macrophage-capping protein,40185,0.0497548611235915,0.00544829821315936,0.0390761966257991,0.0604335256213838,7.51438924030586e-20
NMR metabolomics,X23424.Total Lipids in VLDL,GRSF1,G-rich sequence factor 1,37402,0.0679108840118121,0.00743693079394312,0.0533344996556836,0.0824872683679406,7.74112477167741e-20
NMR metabolomics,X23424.Total Lipids in VLDL,KLK7,Kallikrein-7,37352,0.0333106117917972,0.00365041542835306,0.0261557975522252,0.0404654260313692,8.21501779882667e-20
NMR metabolomics,X23424.Total Lipids in VLDL,ECI2,Enoyl-CoA delta isomerase 2,37562,0.0539651536487906,0.00591497508609911,0.0423718024800364,0.0655585048175448,8.32415712421155e-20
NMR metabolomics,X23424.Total Lipids in VLDL,MEP1B,Meprin A subunit beta,40359,0.101235646911634,0.0111121837409553,0.079455766779362,0.123015527043907,9.17267490666041e-20
NMR metabolomics,X23424.Total Lipids in VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,39961,0.0450722800150646,0.00494990430799312,0.0353704675713981,0.0547740924587311,9.59843590007176e-20
NMR metabolomics,X23424.Total Lipids in VLDL,MOG,Myelin-oligodendrocyte glycoprotein,40489,0.0276365867226292,0.00304800823768068,0.0216624905767751,0.0336106828684834,1.36108355108555e-19
NMR metabolomics,X23424.Total Lipids in VLDL,SFRP4,Secreted frizzled-related protein 4,37671,0.0356819111075674,0.00393666552700637,0.0279660466746349,0.0433977755404999,1.43248043356803e-19
NMR metabolomics,X23424.Total Lipids in VLDL,BST2,Bone marrow stromal antigen 2,40471,0.0455458299394955,0.00502715516815456,0.0356926058099126,0.0553990540690784,1.45283226124425e-19
NMR metabolomics,X23424.Total Lipids in VLDL,HLA_E,,40341,0.0245119675546042,0.00270582486168911,0.0192085508256936,0.0298153842835149,1.46739914108245e-19
NMR metabolomics,X23424.Total Lipids in VLDL,CHCHD6,MICOS complex subunit MIC25,37900,0.0247368085133702,0.00273006306972847,0.0193858848967024,0.030087732130038,1.47029438802781e-19
NMR metabolomics,X23424.Total Lipids in VLDL,EDF1,Endothelial differentiation-related factor 1,37959,0.0592978789321898,0.00654945281217624,0.0464609514203243,0.0721348064440552,1.56659422362162e-19
NMR metabolomics,X23424.Total Lipids in VLDL,CCL14,C-C motif chemokine 14,40309,0.033116600067144,0.00365941384097945,0.0259441489388242,0.0402890511954637,1.59701534554101e-19
NMR metabolomics,X23424.Total Lipids in VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37959,0.0568270499616914,0.00628061258478591,0.044517049295511,0.0691370506278718,1.65239121119231e-19
NMR metabolomics,X23424.Total Lipids in VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,37959,0.0337572208175512,0.0037357029655287,0.0264352430051149,0.0410791986299874,1.83681457952266e-19
NMR metabolomics,X23424.Total Lipids in VLDL,PRL,Prolactin,40471,-0.0650339484652146,0.0072043342177484,-0.0791544435320015,-0.0509134533984278,1.96028745846624e-19
NMR metabolomics,X23424.Total Lipids in VLDL,AHCY,Adenosylhomocysteinase,40359,0.0574219932939026,0.00636249146714342,0.0449515100183015,0.0698924765695037,1.99734323572213e-19
NMR metabolomics,X23424.Total Lipids in VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",40359,0.0612811048543006,0.00679697113812975,0.0479590414235663,0.074603168285035,2.17015970045369e-19
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39980,0.0405056360419226,0.00449639710241699,0.0316926977211853,0.0493185743626599,2.32851081274555e-19
NMR metabolomics,X23424.Total Lipids in VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40403,0.03488797228459,0.00387942697243314,0.027284295418621,0.0424916491505589,2.66942745874508e-19
NMR metabolomics,X23424.Total Lipids in VLDL,RANBP1,Ran-specific GTPase-activating protein,37628,0.0448785264703097,0.00500153517334866,0.0350755175305464,0.0546815354100731,3.27285918099853e-19
NMR metabolomics,X23424.Total Lipids in VLDL,HMOX1,Heme oxygenase 1,40184,-0.0394911102068754,0.00440513493550372,-0.0481251746804627,-0.0308570457332882,3.4522875784408e-19
NMR metabolomics,X23424.Total Lipids in VLDL,KLB,Beta-klotho,39961,-0.0619398229576217,0.00691190764201411,-0.0754871619359693,-0.048392483979274,3.56744315281173e-19
NMR metabolomics,X23424.Total Lipids in VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37628,0.0422780438299356,0.0047276491996313,0.0330118513986582,0.0515442362612129,4.29776975757514e-19
NMR metabolomics,X23424.Total Lipids in VLDL,CIT,Citron Rho-interacting kinase,37572,0.0377633129829138,0.00424471505364953,0.0294436714777608,0.0460829544880669,6.50777884611671e-19
NMR metabolomics,X23424.Total Lipids in VLDL,LY75,Lymphocyte antigen 75,40341,0.032381728086946,0.00365438123291871,0.0252191408704254,0.0395443153034667,8.75091882002254e-19
NMR metabolomics,X23424.Total Lipids in VLDL,FABP6,Gastrotropin,40017,0.046464926472897,0.00524698649046373,0.0361808329515881,0.0567490199942059,9.21207929224429e-19
NMR metabolomics,X23424.Total Lipids in VLDL,CSNK1D,Casein kinase I isoform delta,37598,0.05304771521222,0.00600459712568313,0.041278704845881,0.0648167255785589,1.13160164887423e-18
NMR metabolomics,X23424.Total Lipids in VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37628,0.0345144274651865,0.00390890010831038,0.0268529832528982,0.0421758716774749,1.18076271392975e-18
NMR metabolomics,X23424.Total Lipids in VLDL,IL32,Interleukin-32,40341,-0.0353099515634895,0.00400961006978283,-0.0431687873002639,-0.0274511158267152,1.42444147619394e-18
NMR metabolomics,X23424.Total Lipids in VLDL,RPL14,60S ribosomal protein L14,37628,0.0342910087856436,0.00389372953034203,0.0266592989061732,0.041922718665114,1.44790393425219e-18
NMR metabolomics,X23424.Total Lipids in VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37901,0.0844886188809227,0.00959441697423137,0.0656835616114292,0.103293676150416,1.45357482389415e-18
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,37942,0.0295223239427447,0.00335910390057416,0.0229384802976194,0.0361061675878701,1.69323592795035e-18
NMR metabolomics,X23424.Total Lipids in VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,38013,-0.0211467756020017,0.00240648307300146,-0.0258634824250846,-0.0164300687789189,1.71228130777514e-18
NMR metabolomics,X23424.Total Lipids in VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40359,0.0402508442615974,0.00458315243278652,0.0312678654933358,0.049233823029859,1.76155892853413e-18
NMR metabolomics,X23424.Total Lipids in VLDL,CBLIF,Cobalamin binding intrinsic factor,40330,0.0600947518035279,0.00685431174883908,0.0466603007758034,0.0735292028312525,2.01020325898535e-18
NMR metabolomics,X23424.Total Lipids in VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37959,0.0391535154159699,0.00446608006766047,0.0303999984833554,0.0479070323485844,2.05431110444132e-18
NMR metabolomics,X23424.Total Lipids in VLDL,RGMB,RGM domain family member B,40471,0.0213576489517177,0.00243804131429361,0.0165790879757023,0.0261362099277332,2.1417485005997e-18
NMR metabolomics,X23424.Total Lipids in VLDL,CASP9,Caspase-9,37598,0.051532646345996,0.00588598233729722,0.0399961209648934,0.0630691717270985,2.28494072433115e-18
NMR metabolomics,X23424.Total Lipids in VLDL,LRRC25,Leucine-rich repeat-containing protein 25,40305,0.0318955194673575,0.00364755012601,0.0247463212203779,0.0390447177143372,2.46445379204934e-18
NMR metabolomics,X23424.Total Lipids in VLDL,NTRK3,NT-3 growth factor receptor,40471,-0.0178332687177129,0.00204928869552368,-0.0218498745609393,-0.0138166628744865,3.56801445003273e-18
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39925,0.0389928866784253,0.0044826875733202,0.0302068190347177,0.0477789543221329,3.69510726590678e-18
NMR metabolomics,X23424.Total Lipids in VLDL,CDA,Cytidine deaminase,37970,0.0375391283220616,0.00431663470900007,0.0290785242924214,0.0459997323517017,3.81750698512115e-18
NMR metabolomics,X23424.Total Lipids in VLDL,IFNGR2,Interferon gamma receptor 2,40228,0.0420556879565805,0.00484931608571834,0.0325510284285726,0.0515603474845885,4.63348340952411e-18
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL2,Fc receptor-like protein 2,40442,0.0396153536413294,0.00457030696093914,0.0306575519978887,0.0485731552847701,4.81405713162998e-18
NMR metabolomics,X23424.Total Lipids in VLDL,HEPH,Hephaestin,37990,0.0204046703633044,0.00236004374330203,0.0157789846264324,0.0250303561001764,5.93322278166126e-18
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINI2,Serpin I2,37901,0.0454407706314546,0.00526813703494678,0.0351152220429589,0.0557663192199503,7.08431043897039e-18
NMR metabolomics,X23424.Total Lipids in VLDL,COL2A1,Collagen alpha-1(II) chain,37628,0.0667663795194218,0.00774869216076112,0.05157894288433,0.0819538161545136,7.6846477380809e-18
NMR metabolomics,X23424.Total Lipids in VLDL,COL6A3,Collagen alpha-3(VI) chain,40536,0.0277177668317814,0.00321978466325531,0.021406988891801,0.0340285447717618,8.07275905712609e-18
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40536,0.0184694125276373,0.00214847042626502,0.0142584104921578,0.0226804145631167,8.96145143038055e-18
NMR metabolomics,X23424.Total Lipids in VLDL,EGFR,Epidermal growth factor receptor,40536,0.0132066816321973,0.00153645112252132,0.0101952374320555,0.0162181258323391,9.036720097351e-18
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTSL4,ADAMTS-like protein 4,37628,0.0190050849093598,0.0022134103919818,0.0146668005410755,0.0233433692776442,9.97792595851247e-18
NMR metabolomics,X23424.Total Lipids in VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,37879,0.0336554775181066,0.00392233955287271,0.0259676919944761,0.0413432630417371,1.04775268658221e-17
NMR metabolomics,X23424.Total Lipids in VLDL,NCAM2,Neural cell adhesion molecule 2,40332,-0.0217228882518655,0.00253675117777688,-0.0266949205603082,-0.0167508559434228,1.19643874394821e-17
NMR metabolomics,X23424.Total Lipids in VLDL,CDH5,Cadherin-5,40536,-0.0243765995443799,0.002851358157076,-0.0299652615322488,-0.0187879375565109,1.35039829726738e-17
NMR metabolomics,X23424.Total Lipids in VLDL,WFDC1,WAP four-disulfide core domain protein 1,37653,0.0438682168649302,0.00513526581236459,0.0338030958726956,0.0539333378571647,1.45579792499652e-17
NMR metabolomics,X23424.Total Lipids in VLDL,GRN,Progranulin,40262,0.0194599560855427,0.00227948103546768,0.014992173256026,0.0239277389150593,1.50110263766148e-17
NMR metabolomics,X23424.Total Lipids in VLDL,FSHB,Follitropin subunit beta,37628,0.0560923826143643,0.00658238816388148,0.0431909018131566,0.068993863415572,1.74357556870028e-17
NMR metabolomics,X23424.Total Lipids in VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,37598,0.0313896400072524,0.00369218641969651,0.0241529546246473,0.0386263253898576,2.06943741074681e-17
NMR metabolomics,X23424.Total Lipids in VLDL,INSR,Insulin receptor,37598,0.0135349680510047,0.0015927151497632,0.0104132463574688,0.0166566897445406,2.13413334026889e-17
NMR metabolomics,X23424.Total Lipids in VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40042,0.045688725443213,0.00538746107353923,0.0351293017390761,0.0562481491473499,2.43974931292465e-17
NMR metabolomics,X23424.Total Lipids in VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40305,-0.0158221592224414,0.00186841431372849,-0.0194842512773492,-0.0121600671675335,2.70741112364667e-17
NMR metabolomics,X23424.Total Lipids in VLDL,RNASET2,Ribonuclease T2,40465,0.0209401840834317,0.00247832785831681,0.0160826614811307,0.0257977066857326,3.17899879537795e-17
NMR metabolomics,X23424.Total Lipids in VLDL,NCF2,Neutrophil cytosol factor 2,40324,0.0659577052539693,0.00780672572527367,0.0506565228324329,0.0812588876755057,3.19457893405312e-17
NMR metabolomics,X23424.Total Lipids in VLDL,CRYM,Ketimine reductase mu-crystallin,37541,0.0611209710887669,0.00726095816994857,0.0468894930756677,0.0753524491018661,4.23379594617723e-17
NMR metabolomics,X23424.Total Lipids in VLDL,CD28,T-cell-specific surface glycoprotein CD28,39980,0.0284440984501444,0.00338162123220772,0.0218161208350172,0.0350720760652715,4.40112596332431e-17
NMR metabolomics,X23424.Total Lipids in VLDL,SLITRK6,SLIT and NTRK-like protein 6,40042,-0.026974114808033,0.00320850821278506,-0.0332627909050917,-0.0206854387109743,4.56402126196001e-17
NMR metabolomics,X23424.Total Lipids in VLDL,SNX5,Sorting nexin-5,37628,0.0237232779856326,0.00282396522376012,0.0181883061470628,0.0292582498242024,4.8895235552763e-17
NMR metabolomics,X23424.Total Lipids in VLDL,CGA,Glycoprotein hormones alpha chain,40332,0.0706556937187429,0.0084186129128398,0.0541552124095768,0.0871561750279089,5.1429747283656e-17
NMR metabolomics,X23424.Total Lipids in VLDL,TF,Serotransferrin,38013,0.0172163170672413,0.00205293210465163,0.0131925701421241,0.0212400639923585,5.51245955124697e-17
NMR metabolomics,X23424.Total Lipids in VLDL,COL15A1,Collagen alpha-1(XV) chain,37998,0.0204376757499454,0.00244211196770417,0.0156511362932452,0.0252242152066456,6.38383716479726e-17
NMR metabolomics,X23424.Total Lipids in VLDL,DAPK2,Death-associated protein kinase 2,37598,0.0413022273072977,0.0049364949651414,0.0316266971756206,0.0509777574389749,6.51858326830048e-17
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE6,Ribonuclease K6,37917,0.0232133153986504,0.00277694673810773,0.0177704997919592,0.0286561310053415,6.92380997611291e-17
NMR metabolomics,X23424.Total Lipids in VLDL,CTSF,Cathepsin F,40411,0.031392717153861,0.00375791004615741,0.0240272134633925,0.0387582208443295,7.1498374745648e-17
NMR metabolomics,X23424.Total Lipids in VLDL,PVALB,Parvalbumin alpha,40417,0.0886369724405538,0.0106157677291028,0.0678300676915123,0.109443877189595,7.40808527002593e-17
NMR metabolomics,X23424.Total Lipids in VLDL,PPL,Periplakin,37598,0.0259737481764622,0.00311147010922271,0.0198752667623856,0.0320722295905387,7.64880675554375e-17
NMR metabolomics,X23424.Total Lipids in VLDL,SMARCA2,Probable global transcription activator SNF2L2,39961,0.0574150752927857,0.00688072780514998,0.0439288487946917,0.0709013017908796,7.75934713252878e-17
NMR metabolomics,X23424.Total Lipids in VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40332,0.0380354716303702,0.00456576763549608,0.0290865670647979,0.0469843761959425,8.6956452338436e-17
NMR metabolomics,X23424.Total Lipids in VLDL,ROBO1,Roundabout homolog 1,40379,0.0188089604886037,0.00226040938630687,0.0143785580914422,0.0232393628857652,9.41906407227271e-17
NMR metabolomics,X23424.Total Lipids in VLDL,SPRR3,Small proline-rich protein 3,37942,0.0557888489263403,0.00670418169075998,0.0426486528124507,0.0689290450402299,9.51417924315125e-17
NMR metabolomics,X23424.Total Lipids in VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40403,0.0332518576033956,0.00399762779787158,0.0254165071195673,0.0410872080872239,9.67003039701957e-17
NMR metabolomics,X23424.Total Lipids in VLDL,C1QA,Complement C1q subcomponent subunit A,40442,-0.0177527396530032,0.0021351477765251,-0.0219376292949924,-0.013567850011014,9.94590611425178e-17
NMR metabolomics,X23424.Total Lipids in VLDL,CBS,Cystathionine beta-synthase,37628,0.0397051555252149,0.00478291463748108,0.030330642835752,0.0490796682146778,1.12797388867633e-16
NMR metabolomics,X23424.Total Lipids in VLDL,BSG,Basigin,40502,0.0157256173584533,0.00189640118920396,0.0120086710276136,0.0194425636892931,1.19750560405165e-16
NMR metabolomics,X23424.Total Lipids in VLDL,FGA,Fibrinogen alpha chain,37698,0.0239609340396941,0.00289806469081922,0.0182807272456885,0.0296411408336998,1.4923492594774e-16
NMR metabolomics,X23424.Total Lipids in VLDL,PPME1,Protein phosphatase methylesterase 1,40305,0.0475797434012647,0.00575642444197385,0.0362971514949959,0.0588623353075334,1.50020673578945e-16
NMR metabolomics,X23424.Total Lipids in VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,37628,0.023550446767954,0.00285448053006659,0.0179556649290235,0.0291452286068846,1.72842035644867e-16
NMR metabolomics,X23424.Total Lipids in VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,40305,0.0430477589590501,0.00523114461158699,0.0327947155203395,0.0533008023977606,2.03111984695494e-16
NMR metabolomics,X23424.Total Lipids in VLDL,BAX,Apoptosis regulator BAX,39934,0.0690246633648726,0.00839276031099949,0.0525748531553136,0.0854744735744316,2.11782895976578e-16
NMR metabolomics,X23424.Total Lipids in VLDL,IL17D,Interleukin-17D,40044,0.0264433174806182,0.00322129412959862,0.0201295809866049,0.0327570539746315,2.40524913724278e-16
NMR metabolomics,X23424.Total Lipids in VLDL,CST5,Cystatin-D,40070,0.0425536414956225,0.00518596782026025,0.0323891445679124,0.0527181384233326,2.47320840830877e-16
NMR metabolomics,X23424.Total Lipids in VLDL,PDCD1,Programmed cell death protein 1,40455,0.0336774584748357,0.00411295575176292,0.0256160652013804,0.0417388517482911,2.85128835082064e-16
NMR metabolomics,X23424.Total Lipids in VLDL,MANSC1,MANSC domain-containing protein 1,40411,-0.0210505399169426,0.00257579984782097,-0.0260991076186717,-0.0160019722152135,3.24728304257583e-16
NMR metabolomics,X23424.Total Lipids in VLDL,VGF,Neurosecretory protein VGF,37959,0.0234676461832041,0.00287166267781243,0.0178391873346918,0.0290961050317165,3.29740014554252e-16
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40359,0.025919691216169,0.003179771663824,0.0196873387550739,0.032152043677264,3.86206645494686e-16
NMR metabolomics,X23424.Total Lipids in VLDL,LBP,Lipopolysaccharide-binding protein,40403,-0.0445517851260201,0.00546646560867087,-0.055266057719015,-0.0338375125330252,3.90657206908746e-16
NMR metabolomics,X23424.Total Lipids in VLDL,DPP7,Dipeptidyl peptidase 2,40251,0.0443716801734546,0.00544608817260566,0.0336973473551475,0.0550460129917617,3.99302841919423e-16
NMR metabolomics,X23424.Total Lipids in VLDL,PAEP,Glycodelin,40228,-0.100276792491729,0.0123654972595058,-0.12451316712036,-0.0760404178630978,5.4580091673932e-16
NMR metabolomics,X23424.Total Lipids in VLDL,REG4,Regenerating islet-derived protein 4,40379,0.0370100436504,0.00456715439403203,0.0280584210380973,0.0459616662627028,5.72349510748483e-16
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40305,0.043430485079632,0.00536474908337233,0.0329155768762222,0.0539453932830417,6.1125213990358e-16
NMR metabolomics,X23424.Total Lipids in VLDL,RARRES1,Retinoic acid receptor responder protein 1,39980,0.0266746615613979,0.00329610796480613,0.0202142899503779,0.0331350331724179,6.26087677768797e-16
NMR metabolomics,X23424.Total Lipids in VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,39961,0.063673140278132,0.00787344418334321,0.0482411896787794,0.0791050908774847,6.56008734414199e-16
NMR metabolomics,X23424.Total Lipids in VLDL,COL24A1,Collagen alpha-1(XXIV) chain,37901,0.0418732043735162,0.00518041891687098,0.031719583296449,0.0520268254505833,6.85716169446242e-16
NMR metabolomics,X23424.Total Lipids in VLDL,CSDE1,Cold shock domain-containing protein E1,37562,0.0891253048164307,0.0110393524024216,0.0674881741076843,0.110762435525177,7.42885608362646e-16
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37598,0.0270653620582307,0.00335261122097113,0.0204942440651273,0.0336364800513341,7.45737974457466e-16
NMR metabolomics,X23424.Total Lipids in VLDL,SNX2,Sorting nexin-2,37900,0.0593013481966468,0.00734739763627207,0.0449004488295536,0.0737022475637401,7.55676511695606e-16
NMR metabolomics,X23424.Total Lipids in VLDL,C2orf69,UPF0565 protein C2orf69,37572,0.045810928539816,0.00568321284814705,0.0346718313574478,0.0569500257221842,8.23634555321701e-16
NMR metabolomics,X23424.Total Lipids in VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40310,0.0475943600947226,0.00592431691546606,0.0359826989404092,0.0592060212490361,1.01156989370608e-15
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40332,0.0271896388769833,0.00338444622219422,0.0205561242814826,0.0338231534724839,1.01168643939132e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CXADR,Coxsackievirus and adenovirus receptor,40341,0.0400110144055564,0.00498588797337415,0.030238673977743,0.0497833548333697,1.08701120531301e-15
NMR metabolomics,X23424.Total Lipids in VLDL,MNDA,Myeloid cell nuclear differentiation antigen,40333,0.0730891945570922,0.0091086001870632,0.0552363381904483,0.090942050923736,1.09284944139142e-15
NMR metabolomics,X23424.Total Lipids in VLDL,RAB6A,Ras-related protein Rab-6A,40341,0.0359493037363559,0.00448712163053586,0.0271545453405056,0.0447440621322062,1.2096802358551e-15
NMR metabolomics,X23424.Total Lipids in VLDL,SLITRK2,SLIT and NTRK-like protein 2,40489,0.0284986387569383,0.00356107029120171,0.021518940986183,0.0354783365276937,1.29855766109927e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CLGN,Calmegin,37572,0.0335210319640464,0.00418898439820535,0.0253106225435639,0.0417314413845289,1.32449295845942e-15
NMR metabolomics,X23424.Total Lipids in VLDL,COPB2,Coatomer subunit beta',37562,0.0326086264113231,0.00407616171240247,0.0246193494550142,0.0405979033676319,1.34997015826761e-15
NMR metabolomics,X23424.Total Lipids in VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37714,0.0278433535023296,0.0034819997267528,0.0210186340378941,0.034668072966765,1.38705897634889e-15
NMR metabolomics,X23424.Total Lipids in VLDL,DKK3,Dickkopf-related protein 3,40536,-0.0220899860112505,0.00276532069042588,-0.0275100145644853,-0.0166699574580158,1.46110088272221e-15
NMR metabolomics,X23424.Total Lipids in VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,40203,0.0181752507095108,0.00227539004198268,0.0137154862272247,0.0226350151917968,1.46863452893912e-15
NMR metabolomics,X23424.Total Lipids in VLDL,AMIGO2,Amphoterin-induced protein 2,40305,0.0168828725882095,0.00211849107500798,0.0127306300811939,0.0210351150952252,1.70376589096006e-15
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB6,Integrin beta-6,40044,0.0225630767098571,0.00283727840313018,0.017002011039722,0.0281241423799923,1.95459214269067e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,40359,0.0313409048695696,0.00394958839822889,0.023599711609041,0.0390820981300982,2.24011373715777e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37901,0.0592588700111725,0.00747254296110042,0.0446126858074156,0.0739050542149293,2.35948572844134e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CD300E,CMRF35-like molecule 2,40436,0.0297285440854966,0.0037537205896499,0.0223712517297828,0.0370858364412104,2.53535932657658e-15
NMR metabolomics,X23424.Total Lipids in VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,40357,0.0283368672184179,0.00358907065430739,0.0213022887359754,0.0353714457008604,3.08354249762678e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CD300A,CMRF35-like molecule 8,37671,0.0219675400700818,0.00278673255742418,0.0165055442575304,0.0274295358826332,3.44819815286831e-15
NMR metabolomics,X23424.Total Lipids in VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37901,0.0312061921053993,0.00396616944959473,0.0234324999841936,0.038979884226605,3.87473174785654e-15
NMR metabolomics,X23424.Total Lipids in VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39925,0.0348256339520488,0.00442745994750852,0.0261478124549321,0.0435034554491655,3.90770807997647e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CFHR4,Complement factor H-related protein 4,37973,0.0543259158132595,0.00691263070051437,0.0407771596402513,0.0678746719862676,4.16577113496577e-15
NMR metabolomics,X23424.Total Lipids in VLDL,GDNF,Glial cell line-derived neurotrophic factor,39961,0.0282879004376629,0.0036007078244443,0.0212305131017521,0.0353452877735738,4.21783051301696e-15
NMR metabolomics,X23424.Total Lipids in VLDL,ECE1,Endothelin-converting enzyme 1,39961,0.0260437577618956,0.00331641540977547,0.0195435835587357,0.0325439319650555,4.32719077869306e-15
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL4,Angiopoietin-related protein 4,40396,-0.0335866947196211,0.00428408307257327,-0.0419834975418647,-0.0251898918973775,4.79342203119266e-15
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,40291,0.0213500363832807,0.00272425760396648,0.0160104914795064,0.026689581287055,4.90570924203342e-15
NMR metabolomics,X23424.Total Lipids in VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,39961,0.0474754756486147,0.00606228162450636,0.0355934036645822,0.0593575476326472,5.14003667990737e-15
NMR metabolomics,X23424.Total Lipids in VLDL,SCT,Secretin,37572,0.0339030701287381,0.00433285005108062,0.0254106840286201,0.0423954562288561,5.47871725860877e-15
NMR metabolomics,X23424.Total Lipids in VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40044,0.0425775483043276,0.00545011324341197,0.0318953263472401,0.0532597702614151,5.97482460505475e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CD80,T-lymphocyte activation antigen CD80,37990,0.0249517316475445,0.00320681211551085,0.0186663799011432,0.0312370833939457,7.72375677123564e-15
NMR metabolomics,X23424.Total Lipids in VLDL,IGHMBP2,DNA-binding protein SMUBP-2,37562,0.0407660943057141,0.0052461733756933,0.0304835944893553,0.051048594122073,8.38904135064772e-15
NMR metabolomics,X23424.Total Lipids in VLDL,ULBP2,UL16-binding protein 2,40228,0.027108993276005,0.00350513698655501,0.0202389247823572,0.0339790617696529,1.10425127334256e-14
NMR metabolomics,X23424.Total Lipids in VLDL,TSHB,Thyrotropin subunit beta,40359,0.0606902232403991,0.00787894642905696,0.0452474882394474,0.0761329582413507,1.40891816421111e-14
NMR metabolomics,X23424.Total Lipids in VLDL,CD276,CD276 antigen,40357,-0.0260316961771495,0.00337974276123109,-0.0326559919891624,-0.0194074003651365,1.41513296593066e-14
NMR metabolomics,X23424.Total Lipids in VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37598,0.0324444746834276,0.00421741274116959,0.0241783457107351,0.04071060365612,1.53959136999842e-14
NMR metabolomics,X23424.Total Lipids in VLDL,VAMP5,Vesicle-associated membrane protein 5,40042,0.0404824875304622,0.00526503858672347,0.0301630119004842,0.0508019631604402,1.57202668639527e-14
NMR metabolomics,X23424.Total Lipids in VLDL,DHPS,Deoxyhypusine synthase,37900,0.0297945459849545,0.00388037634405993,0.0221890083505971,0.037400083619312,1.72366835097123e-14
NMR metabolomics,X23424.Total Lipids in VLDL,GPR15L,Protein GPR15L,37901,0.0435984644776075,0.00568076871531909,0.032464157795582,0.0547327711596329,1.7713705969666e-14
NMR metabolomics,X23424.Total Lipids in VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37572,0.0394364767307923,0.00514171302257029,0.0293587192065546,0.0495142342550301,1.8422179788665e-14
NMR metabolomics,X23424.Total Lipids in VLDL,DGKZ,Diacylglycerol kinase zeta,40044,0.0252181805856244,0.0032957556135305,0.0187584995831046,0.0316778615881442,2.09883924211215e-14
NMR metabolomics,X23424.Total Lipids in VLDL,CCL15,C-C motif chemokine 15,40536,0.0319615841945443,0.00417745107386915,0.0237737800897608,0.0401493882993278,2.10721061989135e-14
NMR metabolomics,X23424.Total Lipids in VLDL,SPTLC1,Serine palmitoyltransferase 1,37942,0.0258345043077738,0.00338333195139892,0.0192031736830319,0.0324658349325156,2.39453055542019e-14
NMR metabolomics,X23424.Total Lipids in VLDL,LACRT,Extracellular glycoprotein lacritin,37863,0.0382101596925911,0.00501880044002288,0.0283733108301462,0.0480470085550359,2.8478090473409e-14
NMR metabolomics,X23424.Total Lipids in VLDL,CLU,Clusterin,38013,0.0237128782923286,0.00311740826710061,0.0176027580888114,0.0298229984958458,2.99895179903788e-14
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40489,0.0222555394942397,0.00293169877977597,0.0165094098858788,0.0280016691026006,3.33974793980784e-14
NMR metabolomics,X23424.Total Lipids in VLDL,TAFA5,Chemokine-like protein TAFA-5,40305,0.0255258548752011,0.00337192994148861,0.0189168721898835,0.0321348375605188,3.93407479100245e-14
NMR metabolomics,X23424.Total Lipids in VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37598,0.0433114198660913,0.005721260844597,0.0320977486106811,0.0545250911215014,3.97275465416814e-14
NMR metabolomics,X23424.Total Lipids in VLDL,TGFBR2,TGF-beta receptor type-2,40411,0.0224459549576748,0.00296574317881238,0.0166330983272025,0.028258811588147,3.9841151502147e-14
NMR metabolomics,X23424.Total Lipids in VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,37835,0.0418229730170274,0.00552893694777993,0.0309862565993788,0.0526596894346761,4.1510866632818e-14
NMR metabolomics,X23424.Total Lipids in VLDL,MCTS1,Malignant T-cell-amplified sequence 1,37901,0.0185345231805929,0.0024528498263454,0.0137269375209559,0.0233421088402299,4.41382533688867e-14
NMR metabolomics,X23424.Total Lipids in VLDL,WFDC2,WAP four-disulfide core domain protein 2,39535,0.0270155995847073,0.00358066542547717,0.0199974953507721,0.0340337038186426,4.78606575706565e-14
NMR metabolomics,X23424.Total Lipids in VLDL,CTSC,Dipeptidyl peptidase 1,40349,0.0301415372916428,0.00399914627276814,0.0223032105970172,0.0379798639862683,5.06803556871725e-14
NMR metabolomics,X23424.Total Lipids in VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,37900,0.0466152080701139,0.00619169173305499,0.0344794922733262,0.0587509238669017,5.45187602903955e-14
NMR metabolomics,X23424.Total Lipids in VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,40042,0.0287881867169599,0.00382995776968943,0.0212814694883686,0.0362949039455512,5.92795207653569e-14
NMR metabolomics,X23424.Total Lipids in VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",37998,0.0284957117161204,0.0037930043881454,0.0210614231153554,0.0359300003168854,6.15433268544131e-14
NMR metabolomics,X23424.Total Lipids in VLDL,S100A12,Protein S100-A12,40139,0.0539939727449006,0.00718904407495428,0.0399034463579902,0.068084499131811,6.20255127421702e-14
NMR metabolomics,X23424.Total Lipids in VLDL,NFIC,Nuclear factor 1 C-type,37959,0.0308210199028265,0.00411223011841664,0.0227610488707299,0.0388809909349231,7.04383260555722e-14
NMR metabolomics,X23424.Total Lipids in VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39980,0.0564551687253105,0.00754155551287714,0.0416737199200713,0.0712366175305497,7.48803133223855e-14
NMR metabolomics,X23424.Total Lipids in VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40305,0.0385065373416329,0.00516169600663546,0.0283896131686274,0.0486234615146384,9.09629048908881e-14
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA7,Thyroxine-binding globulin,38013,0.0131124616275799,0.00176159369088765,0.00965973799344009,0.0165651852617197,1.03937859372108e-13
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS22,Brain-specific serine protease 4,37598,0.0248025628788288,0.00333591724497848,0.018264165078671,0.0313409606789866,1.11033049657653e-13
NMR metabolomics,X23424.Total Lipids in VLDL,FOLR2,Folate receptor beta,40471,-0.0205615107557062,0.00276851389268293,-0.0259877979853648,-0.0151352235260477,1.16753589810403e-13
NMR metabolomics,X23424.Total Lipids in VLDL,NPHS1,Nephrin,37598,0.0243189703801492,0.00327394764749013,0.0179020329910686,0.0307359077692299,1.17023857086166e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CD93,Complement component C1q receptor,39725,-0.0219112155514183,0.00296515718640638,-0.0277229236367748,-0.0160995074660618,1.54936708736563e-13
NMR metabolomics,X23424.Total Lipids in VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,40044,0.0267544931530732,0.00362453936667643,0.0196503959943874,0.033858590311759,1.64427590670635e-13
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE3,Eosinophil cationic protein,40288,0.0753306751476861,0.0102093289021207,0.0553203904995296,0.0953409597958426,1.67878562280142e-13
NMR metabolomics,X23424.Total Lipids in VLDL,MPO,Myeloperoxidase,40332,0.0324188450546396,0.00439494763265001,0.0238047476946456,0.0410329424146336,1.70670935533885e-13
NMR metabolomics,X23424.Total Lipids in VLDL,S100A11,Protein S100-A11,40207,0.0310042006435159,0.0042249340527165,0.0227233299001915,0.0392850713868402,2.26723889511295e-13
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB103A_DEFB103B,Beta-defensin 103,37539,0.028533080740421,0.00388799586783586,0.0209126088394627,0.0361535526413793,2.28289059186896e-13
NMR metabolomics,X23424.Total Lipids in VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,40536,0.0106960057830557,0.00145798637696677,0.00783835248420086,0.0135536590819106,2.30308017641662e-13
NMR metabolomics,X23424.Total Lipids in VLDL,PLXNB2,Plexin-B2,40472,0.0160569172348482,0.00219025112722326,0.0117640250254906,0.0203498094442057,2.39196022336656e-13
NMR metabolomics,X23424.Total Lipids in VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,38484,-0.0215521457728733,0.00294310235934076,-0.0273206263971812,-0.0157836651485654,2.55810165480648e-13
NMR metabolomics,X23424.Total Lipids in VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40341,0.030992756563789,0.00424398789478581,0.0226745402900088,0.0393109728375692,2.95322534588347e-13
NMR metabolomics,X23424.Total Lipids in VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,37628,0.0346638513747671,0.00474670551849762,0.0253603085585117,0.0439673941910224,2.98201857508295e-13
NMR metabolomics,X23424.Total Lipids in VLDL,GIMAP8,GTPase IMAP family member 8,37482,0.0356374310605796,0.00488383715296279,0.0260651102407725,0.0452097518803867,3.11254010086132e-13
NMR metabolomics,X23424.Total Lipids in VLDL,S100A13,Protein S100-A13,37598,0.0239455523700401,0.00328833099481323,0.0175004236202062,0.030390681119874,3.47675308680594e-13
NMR metabolomics,X23424.Total Lipids in VLDL,GAST,Gastrin,37942,0.0891818304782663,0.0122630042570939,0.0651463421343622,0.11321731882217,3.72537062797172e-13
NMR metabolomics,X23424.Total Lipids in VLDL,APOA1,Apolipoprotein A-I,38013,-0.0188607085295812,0.00259782027050249,-0.0239524362597661,-0.0137689807993963,4.07545278481532e-13
NMR metabolomics,X23424.Total Lipids in VLDL,C8B,Complement component C8 beta chain,38013,0.0208523266376303,0.00287775182657999,0.0152119330575335,0.0264927202177271,4.5228816649657e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CCN5,CCN family member 5,40332,0.0266798686741707,0.00368869151459965,0.0194500333055554,0.0339097040427861,4.94429508951051e-13
NMR metabolomics,X23424.Total Lipids in VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37628,0.0531233989662574,0.00734450145666186,0.0387281761112002,0.0675186218213147,4.98223834841231e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CFHR2,Complement factor H-related protein 2,37911,0.0388937323992892,0.00538602855867563,0.0283371164242849,0.0494503483742934,5.42867940861957e-13
NMR metabolomics,X23424.Total Lipids in VLDL,SRPX,Sushi repeat-containing protein SRPX,37990,-0.022231083872516,0.0030816861071843,-0.0282711886425973,-0.0161909791024348,5.72467922203273e-13
NMR metabolomics,X23424.Total Lipids in VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,37562,0.0310855365179871,0.00431056301838365,0.0226368330019552,0.0395342400340191,5.83831754680266e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CD300LF,CMRF35-like molecule 1,40489,0.0411517758436964,0.0057093069587236,0.0299615342045981,0.0523420174827947,5.93786957482089e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CD101,Immunoglobulin superfamily member 2,37901,0.0288335152642469,0.00400779571922556,0.0209782356545648,0.036688794873929,6.60771487953048e-13
NMR metabolomics,X23424.Total Lipids in VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,40422,0.0174439578459158,0.00242775536206976,0.012685557336259,0.0222023583555725,7.00634293936205e-13
NMR metabolomics,X23424.Total Lipids in VLDL,SFTPD,Pulmonary surfactant-associated protein D,40359,0.0448068835631593,0.00624179204249019,0.0325729711598786,0.0570407959664401,7.35799325588851e-13
NMR metabolomics,X23424.Total Lipids in VLDL,YAP1,Transcriptional coactivator YAP1,37942,0.0179994136725694,0.00251018591149091,0.0130794492860472,0.0229193780590916,7.85861795458998e-13
NMR metabolomics,X23424.Total Lipids in VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,40044,0.0255794398124102,0.00357808928223585,0.0185663848192279,0.0325924948055924,9.13500567622731e-13
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINI1,Neuroserpin,37642,0.0214605648136172,0.0030080858454793,0.0155647165564778,0.0273564130707566,1.02364685507871e-12
NMR metabolomics,X23424.Total Lipids in VLDL,RBP2,Retinol-binding protein 2,40305,-0.0509641772798908,0.00715438156590328,-0.0649867651490612,-0.0369415894107204,1.09751777239107e-12
NMR metabolomics,X23424.Total Lipids in VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37628,0.0460028599324995,0.00646520652070315,0.0333310551519213,0.0586746647130777,1.17315217302055e-12
NMR metabolomics,X23424.Total Lipids in VLDL,GC,Vitamin D-binding protein,38013,0.0173970207240849,0.00244849501778799,0.0125979704892204,0.0221960709589493,1.26155433800083e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,37998,-0.0220663840235399,0.00311068420550437,-0.0281633250663284,-0.0159694429807513,1.37016587363185e-12
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL3,Fc receptor-like protein 3,40044,0.0363604269387854,0.00514947365284459,0.02626745857921,0.0464533952983608,1.72289749383397e-12
NMR metabolomics,X23424.Total Lipids in VLDL,APOBR,Apolipoprotein B receptor,37628,-0.0280471402854763,0.00399795145200578,-0.0358831251314077,-0.020211155439545,2.40530297571234e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC5A,C-type lectin domain family 5 member A,40314,-0.0186192889732576,0.00265585237150567,-0.0238247596214087,-0.0134138183251065,2.46752895733026e-12
NMR metabolomics,X23424.Total Lipids in VLDL,ENSA,Alpha-endosulfine,37900,0.0348948993408939,0.00497693243667804,0.0251401117650049,0.0446496869167829,2.47335770273063e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CYTL1,Cytokine-like protein 1,37998,0.0151945939932037,0.00216837253500931,0.0109445838245855,0.019444604161822,2.54313570806644e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CABP2,Calcium-binding protein 2,37572,0.0431931226650211,0.00616950162222512,0.0311008994854599,0.0552853458445823,2.66372293196853e-12
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40470,0.0193593703272534,0.0027664481439522,0.013937131965107,0.0247816086893997,2.70094725822813e-12
NMR metabolomics,X23424.Total Lipids in VLDL,LCP1,Plastin-2,37998,0.0309864545193932,0.00444042260127275,0.0222832262208986,0.0396896828178878,3.12735378852946e-12
NMR metabolomics,X23424.Total Lipids in VLDL,ZBP1,Z-DNA-binding protein 1,37598,0.0263808115249838,0.00380007974244974,0.0189326552297823,0.0338289678201853,4.04239418810396e-12
NMR metabolomics,X23424.Total Lipids in VLDL,MYOM3,Myomesin-3,37671,-0.058976291495021,0.00849623382581253,-0.0756289097936135,-0.0423236731964284,4.06167428383709e-12
NMR metabolomics,X23424.Total Lipids in VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,37900,0.0268179927164732,0.00386487423384377,0.0192428392181395,0.034393146214807,4.13243530745331e-12
NMR metabolomics,X23424.Total Lipids in VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,40411,-0.0158679000560433,0.00228856121044448,-0.0203534800285145,-0.0113823200835722,4.26082260728811e-12
NMR metabolomics,X23424.Total Lipids in VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39980,0.0333453515590049,0.00481144856197971,0.0239149123775247,0.0427757907404852,4.36109066274842e-12
NMR metabolomics,X23424.Total Lipids in VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,37572,0.0474120191772148,0.00684637415066753,0.0339931258419065,0.0608309125125232,4.5586925274117e-12
NMR metabolomics,X23424.Total Lipids in VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37900,0.0240906804387349,0.00348341212937738,0.0172631926651552,0.0309181682123146,4.86150205689296e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CD300C,CMRF35-like molecule 6,40471,0.0221453000426411,0.00320545432038513,0.0158626095746862,0.0284279905105959,5.07777213027978e-12
NMR metabolomics,X23424.Total Lipids in VLDL,LYZL2,Lysozyme-like protein 2,37482,0.0233203867972646,0.00338623181414696,0.0166833724415366,0.0299574011529927,5.96685124056885e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CA2,Carbonic anhydrase 2,40291,0.0456943940737591,0.00664433834805419,0.0326714909115729,0.0587172972359453,6.33263799957146e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CD59,CD59 glycoprotein,39665,0.0145731931077357,0.00212196850663691,0.0104141348347274,0.0187322513807441,6.77398541665727e-12
NMR metabolomics,X23424.Total Lipids in VLDL,AGER,Advanced glycosylation end product-specific receptor,40311,0.0261070890661077,0.00380784983728651,0.0186437033850261,0.0335704747471893,7.33645800764583e-12
NMR metabolomics,X23424.Total Lipids in VLDL,TFPI2,Tissue factor pathway inhibitor 2,40357,0.0256583335779665,0.00374347126261443,0.0183211299032422,0.0329955372526908,7.43708919350614e-12
NMR metabolomics,X23424.Total Lipids in VLDL,FES,Tyrosine-protein kinase Fes/Fps,39980,0.0306107421961401,0.00447043626160059,0.021848687123403,0.0393727972688773,7.80395425002497e-12
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,40359,-0.0182791660499285,0.00267671790784148,-0.0235255331492977,-0.0130327989505592,8.86366864581361e-12
NMR metabolomics,X23424.Total Lipids in VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37482,-0.0194498836692708,0.00285304573664293,-0.0250418533130909,-0.0138579140254507,9.68974450367456e-12
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37714,0.0475118564372453,0.006992102850749,0.0338073348497773,0.0612163780247134,1.12879979395761e-11
NMR metabolomics,X23424.Total Lipids in VLDL,PKD1,Polycystin-1,37990,0.0165629863929293,0.00243959226015369,0.011781385563028,0.0213445872228305,1.17420582445149e-11
NMR metabolomics,X23424.Total Lipids in VLDL,KLK6,Kallikrein-6,40387,0.0193721534508511,0.00286205127992423,0.0137625329421996,0.0249817739595026,1.34546808143485e-11
NMR metabolomics,X23424.Total Lipids in VLDL,KLRK1,NKG2-D type II integral membrane protein,37942,0.0294048097583528,0.00434681720405982,0.0208850480383955,0.03792457147831,1.39115833121536e-11
NMR metabolomics,X23424.Total Lipids in VLDL,CTSH,Pro-cathepsin H,40013,0.0460134704295691,0.00680583442238772,0.0326740349616892,0.059352905897449,1.42029262697045e-11
NMR metabolomics,X23424.Total Lipids in VLDL,GSTT2B,Glutathione S-transferase theta-2B,37942,0.152020677421333,0.0225035629576726,0.107913694024295,0.196127660818371,1.48276837036654e-11
NMR metabolomics,X23424.Total Lipids in VLDL,SCGB3A1,Secretoglobin family 3A member 1,37671,-0.0159292246795289,0.00235856215909632,-0.0205520065113577,-0.0113064428477001,1.50058815872775e-11
NMR metabolomics,X23424.Total Lipids in VLDL,PODXL,Podocalyxin,40305,0.00963355994453254,0.00142916267210201,0.00683240110721259,0.0124347187818525,1.63060124318578e-11
NMR metabolomics,X23424.Total Lipids in VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37628,0.018157903367628,0.00269460099263793,0.0128764854220577,0.0234393213131984,1.66541667199855e-11
NMR metabolomics,X23424.Total Lipids in VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37990,0.0212147754825502,0.00314853024410501,0.0150436562041043,0.027385894760996,1.67082116430982e-11
NMR metabolomics,X23424.Total Lipids in VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,39925,0.027750853715818,0.00412090393723566,0.0196738819988361,0.0358278254327999,1.7067871832206e-11
NMR metabolomics,X23424.Total Lipids in VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,37900,0.0363770021489527,0.00541236657801034,0.0257687636560525,0.046985240641853,1.87639635251175e-11
NMR metabolomics,X23424.Total Lipids in VLDL,HSPA2,Heat shock-related 70 kDa protein 2,37900,0.0210224021026632,0.0031330895684307,0.014881546548539,0.0271632576567873,2.02694411409414e-11
NMR metabolomics,X23424.Total Lipids in VLDL,XG,Glycoprotein Xg,40458,0.0188064185280815,0.00281426159742593,0.0132904657971267,0.0243223712590363,2.42584317158672e-11
NMR metabolomics,X23424.Total Lipids in VLDL,PSME2,Proteasome activator complex subunit 2,40152,0.0232907311584518,0.00348530903534677,0.0164595254491722,0.0301219368677315,2.42732567267109e-11
NMR metabolomics,X23424.Total Lipids in VLDL,RHOC,Rho-related GTP-binding protein RhoC,40152,0.0729415355862785,0.0109178143197191,0.051542619519629,0.0943404516529281,2.4535524534222e-11
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,40305,0.0132581602224502,0.00198801320158897,0.00936165434733579,0.0171546660975645,2.65975315259379e-11
NMR metabolomics,X23424.Total Lipids in VLDL,INSL5,Insulin-like peptide INSL5,37901,0.0590308978996929,0.00885318210723985,0.0416786609695028,0.076383134829883,2.69876027355703e-11
NMR metabolomics,X23424.Total Lipids in VLDL,CD14,Monocyte differentiation antigen CD14,40048,0.0260183796226916,0.00390713357553961,0.018360397814634,0.0336763614307493,2.8452398852379e-11
NMR metabolomics,X23424.Total Lipids in VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37482,0.0418450859551379,0.00628795022620382,0.0295207035117785,0.0541694683984974,2.95023280096894e-11
NMR metabolomics,X23424.Total Lipids in VLDL,LMNB2,Lamin-B2,37942,0.0171508989974378,0.0025780628154726,0.0120978958791115,0.0222039021157641,2.99004206566882e-11
NMR metabolomics,X23424.Total Lipids in VLDL,AFAP1,Actin filament-associated protein 1,37671,0.0529719409283881,0.00798526467431311,0.0373208221667344,0.0686230596900418,3.40092553939688e-11
NMR metabolomics,X23424.Total Lipids in VLDL,NTRK2,BDNF/NT-3 growth factors receptor,40359,0.0160718464945868,0.00242312501782231,0.0113225214596551,0.0208211715295185,3.40240741540635e-11
NMR metabolomics,X23424.Total Lipids in VLDL,DSG4,Desmoglein-4,40250,0.0316950543581837,0.00478586006465564,0.0223147686314587,0.0410753400849088,3.64211487566426e-11
NMR metabolomics,X23424.Total Lipids in VLDL,RSPO3,R-spondin-3,40489,0.0177912651921022,0.00268769806402693,0.0125233769866094,0.023059153397595,3.7180362480584e-11
NMR metabolomics,X23424.Total Lipids in VLDL,MDM1,Nuclear protein MDM1,37572,0.0194995280080328,0.0029513522068652,0.0137148776825771,0.0252841783334886,4.07376663512451e-11
NMR metabolomics,X23424.Total Lipids in VLDL,BCL2,Apoptosis regulator Bcl-2,37901,0.0335918513877345,0.00509724598357271,0.023601249259932,0.043582453515537,4.5561229856965e-11
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA12,Serpin A12,39903,0.0707130771861848,0.0107466077371751,0.0496497260213217,0.0917764283510479,4.85460246721624e-11
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB8,DnaJ homolog subfamily B member 8,40042,0.036205781963384,0.00552405772094039,0.0253786288303408,0.0470329350964271,5.76963108030043e-11
NMR metabolomics,X23424.Total Lipids in VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,37628,-0.0161123254846683,0.00245971856706459,-0.0209333738761149,-0.0112912770932217,5.94844787626009e-11
NMR metabolomics,X23424.Total Lipids in VLDL,MST1,Hepatocyte growth factor-like protein,37787,0.0379745974731403,0.00580318421583145,0.0266003564101107,0.04934883853617,6.21865987794923e-11
NMR metabolomics,X23424.Total Lipids in VLDL,IL6,Interleukin-6,40305,0.044808193118974,0.00686068687935213,0.0313612468354438,0.0582551394025041,6.72512406179473e-11
NMR metabolomics,X23424.Total Lipids in VLDL,MSLN,Mesothelin,40271,0.0331899157011565,0.00509491648553684,0.0232038793895043,0.0431759520128087,7.52236369287529e-11
NMR metabolomics,X23424.Total Lipids in VLDL,NAGA,Alpha-N-acetylgalactosaminidase,37567,0.0365699106904113,0.00561635197350864,0.0255618608223344,0.0475779605584883,7.72033913784961e-11
NMR metabolomics,X23424.Total Lipids in VLDL,APOF,Apolipoprotein F,37987,-0.0147682820851681,0.00227468275197635,-0.0192266602790417,-0.0103099038912944,8.7392986760698e-11
NMR metabolomics,X23424.Total Lipids in VLDL,RABEPK,Rab9 effector protein with kelch motifs,39980,0.0366849261174376,0.0056570858737926,0.0255970378048041,0.0477728144300711,9.15488253428431e-11
NMR metabolomics,X23424.Total Lipids in VLDL,EFNA1,Ephrin-A1,40303,0.0166169804222498,0.00256748462228172,0.0115847105625776,0.021649250281922,9.94965790971868e-11
NMR metabolomics,X23424.Total Lipids in VLDL,IL1B,Interleukin-1 beta,39946,0.0343005909709238,0.0053022306002395,0.0239082189944544,0.0446929629473932,1.01553110678694e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CHRDL1,Chordin-like protein 1,40396,0.0185013738837303,0.00286745356820605,0.0128811648900464,0.0241215828774142,1.13418338028677e-10
NMR metabolomics,X23424.Total Lipids in VLDL,FABP2,"Fatty acid-binding protein, intestinal",40359,-0.0468539762180329,0.00726639462394354,-0.0610961096809623,-0.0326118427551036,1.16574252032495e-10
NMR metabolomics,X23424.Total Lipids in VLDL,HGFAC,Hepatocyte growth factor activator,37849,0.0175550928888917,0.00272966550022608,0.0122049485084485,0.0229052372693348,1.30876640738645e-10
NMR metabolomics,X23424.Total Lipids in VLDL,THBS4,Thrombospondin-4,40355,0.0272542091948452,0.00423841858183206,0.0189469087744544,0.0355615096152361,1.31002821073615e-10
NMR metabolomics,X23424.Total Lipids in VLDL,TSPAN1,Tetraspanin-1,40042,0.0184397164853456,0.00287131205980079,0.0128119448481361,0.0240674881225551,1.38341046661535e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CX3CL1,Fractalkine,40228,-0.0206108903327868,0.00321624718839958,-0.02691473482205,-0.0143070458435236,1.51258645779379e-10
NMR metabolomics,X23424.Total Lipids in VLDL,GBP4,Guanylate-binding protein 4,39961,0.0296869881731711,0.00464047808884309,0.0205916511190386,0.0387823252273035,1.62575979499193e-10
NMR metabolomics,X23424.Total Lipids in VLDL,GAS2,Growth arrest-specific protein 2,37714,0.0322881400589815,0.00504768190483542,0.0223946835255041,0.0421815965924589,1.64178972676625e-10
NMR metabolomics,X23424.Total Lipids in VLDL,AGT,Angiotensinogen,37987,0.0145750446854347,0.00228343858992288,0.0100995050491858,0.0190505843216836,1.79387750456075e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CKAP4,Cytoskeleton-associated protein 4,40457,0.0156871897306961,0.00245859006221126,0.010868353208762,0.0205060262526301,1.81285002449144e-10
NMR metabolomics,X23424.Total Lipids in VLDL,ACAN,Aggrecan core protein,40224,0.0170153358816867,0.00266795070950234,0.0117861524910621,0.0222445192723113,1.84795014716964e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37628,0.0205349436011459,0.00322399609879325,0.0142159112475111,0.0268539759547807,1.96065311854164e-10
NMR metabolomics,X23424.Total Lipids in VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37598,0.0258776799628763,0.00406805784312001,0.0179042865903611,0.0338510733353915,2.06832630132346e-10
NMR metabolomics,X23424.Total Lipids in VLDL,IL18BP,Interleukin-18-binding protein,40403,0.0182055352297593,0.00286513020179625,0.0125898800342386,0.0238211904252799,2.15232598912679e-10
NMR metabolomics,X23424.Total Lipids in VLDL,IL5RA,Interleukin-5 receptor subunit alpha,40341,-0.0329149963159946,0.00518494498677289,-0.0430774884900695,-0.0227525041419198,2.23777871776374e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37562,0.0214229133207116,0.00337532806410203,0.0148072703150716,0.0280385563263516,2.26912442809708e-10
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40442,0.0166280877570108,0.00262064026768428,0.0114916328323496,0.021764542681672,2.28337493172148e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SUSD2,Sushi domain-containing protein 2,40332,-0.0170670886211137,0.00269335931379659,-0.0223460728761551,-0.0117881043660724,2.41018238973237e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4D,C-type lectin domain family 4 member D,40341,0.0363620288696598,0.00575433364050761,0.0250835349342649,0.0476405228050547,2.70153586177648e-10
NMR metabolomics,X23424.Total Lipids in VLDL,GM2A,Ganglioside GM2 activator,37714,0.0229267497382038,0.00362807655783763,0.0158157196848421,0.0300377797915656,2.71230542114333e-10
NMR metabolomics,X23424.Total Lipids in VLDL,PDIA5,Protein disulfide-isomerase A5,37482,0.0366137107832089,0.00579837260399768,0.0252489004793734,0.0479785210870443,2.79871838802147e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CHI3L1,Chitinase-3-like protein 1,40054,0.0439741939161799,0.00699081317465882,0.0302722000938486,0.0576761877385112,3.25331373389552e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CFC1,Cryptic protein,39980,0.0272949305801712,0.00434255442954227,0.0187835238982684,0.0358063372620741,3.35620725054872e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CD248,Endosialin,37998,-0.0237286529025972,0.00377874804391136,-0.0311349990686634,-0.0163223067365309,3.50032835222388e-10
NMR metabolomics,X23424.Total Lipids in VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40359,0.034375948179388,0.00547942748201266,0.0236362703146432,0.0451156260441328,3.61826510374168e-10
NMR metabolomics,X23424.Total Lipids in VLDL,HSBP1,Heat shock factor-binding protein 1,37628,0.0565345282264585,0.00901067189442224,0.0388736113133909,0.0741954451395261,3.62495672421201e-10
NMR metabolomics,X23424.Total Lipids in VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40396,0.0522157068994893,0.0083333496852728,0.0358823415163546,0.068549072282624,3.80260737410184e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40489,0.0199225707766979,0.00317979676895032,0.0136901691095553,0.0261549724438405,3.81455125782682e-10
NMR metabolomics,X23424.Total Lipids in VLDL,GBA,Lysosomal acid glucosylceramidase,37572,0.031238176452104,0.00498691533109406,0.0214638224031597,0.0410125305010484,3.8687622057735e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CA6,Carbonic anhydrase 6,40295,-0.0374571166144204,0.00599575496250535,-0.0492087963409309,-0.0257054368879099,4.28346568710488e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CILP,Cartilage intermediate layer protein 1,37998,0.0316429274302409,0.00507794107043793,0.0216901629321826,0.0415956919282993,4.75831680294236e-10
NMR metabolomics,X23424.Total Lipids in VLDL,NPTX2,Neuronal pentraxin-2,37998,-0.0191931029826527,0.00308187001663173,-0.0252335682152509,-0.0131526377500545,4.87177772985904e-10
NMR metabolomics,X23424.Total Lipids in VLDL,LTB,Lymphotoxin-beta,37900,0.0207633448765449,0.00334418820532525,0.0142087359941074,0.0273179537589823,5.49664091766425e-10
NMR metabolomics,X23424.Total Lipids in VLDL,ASPN,Asporin,37990,0.0159411926821816,0.0025730893280413,0.0108979375992206,0.0209844477651425,5.98396194593966e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CRH,Corticoliberin,39947,0.0503242118253495,0.00817552606962896,0.0343001807288767,0.0663482429218222,7.6698587629882e-10
NMR metabolomics,X23424.Total Lipids in VLDL,PPM1A,Protein phosphatase 1A,39980,0.0179490930668137,0.00292133979769265,0.0122232670633361,0.0236749190702913,8.23645649968896e-10
NMR metabolomics,X23424.Total Lipids in VLDL,PI3,Elafin,40074,0.0307788959977301,0.00503502761249121,0.0209102418772473,0.0406475501182129,1.00127924117901e-09
NMR metabolomics,X23424.Total Lipids in VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37562,0.0487965839245582,0.00798592679078966,0.0331441674146104,0.0644490004345059,1.02247417851024e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ALPP,"Alkaline phosphatase, placental type",40305,0.0590999489659647,0.00968993830057231,0.040107669896843,0.0780922280350864,1.09140034652925e-09
NMR metabolomics,X23424.Total Lipids in VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40305,0.0213229799246288,0.0034977917843362,0.0144673080273298,0.0281786518219277,1.11187271251621e-09
NMR metabolomics,X23424.Total Lipids in VLDL,NFYA,Nuclear transcription factor Y subunit alpha,37562,0.0221035652407459,0.00363106457149764,0.0149866786806105,0.0292204518008813,1.17998317783161e-09
NMR metabolomics,X23424.Total Lipids in VLDL,PGA4,Pepsin A-4,37987,0.0389620146594711,0.00641317833119693,0.0263921851303251,0.0515318441886171,1.2707086006485e-09
NMR metabolomics,X23424.Total Lipids in VLDL,MTPN,Myotrophin,40042,0.0189168795371535,0.00311740482272462,0.0128067660846132,0.0250269929896937,1.32386157573248e-09
NMR metabolomics,X23424.Total Lipids in VLDL,DSG3,Desmoglein-3,40419,0.0190615689372125,0.0031493372997236,0.0128888678297542,0.0252342700446707,1.45744908018937e-09
NMR metabolomics,X23424.Total Lipids in VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,40516,0.0207413547084958,0.00343167978495781,0.0140152623299785,0.0274674470870132,1.53583834368847e-09
NMR metabolomics,X23424.Total Lipids in VLDL,AGR2,Anterior gradient protein 2 homolog,39839,0.0576235876903122,0.00953459283157752,0.0389357857404203,0.0763113896402042,1.54158429047509e-09
NMR metabolomics,X23424.Total Lipids in VLDL,DDC,Aromatic-L-amino-acid decarboxylase,40330,-0.0275936364674758,0.00457083759303488,-0.0365524781498241,-0.0186347947851274,1.60611285968175e-09
NMR metabolomics,X23424.Total Lipids in VLDL,SBSN,Suprabasin,37977,-0.0191182524315579,0.00316974008465537,-0.0253309429974824,-0.0129055618656334,1.66692797411482e-09
NMR metabolomics,X23424.Total Lipids in VLDL,FSTL3,Follistatin-related protein 3,40293,0.017702147042658,0.00293604879296758,0.0119474914084415,0.0234568026768745,1.68387906485306e-09
NMR metabolomics,X23424.Total Lipids in VLDL,SEL1L,Protein sel-1 homolog 1,37628,0.018453533540742,0.00306277509751579,0.0124504943496111,0.024456572731873,1.73509565077753e-09
NMR metabolomics,X23424.Total Lipids in VLDL,REG3G,Regenerating islet-derived protein 3-gamma,37900,0.022921530419959,0.0038074025207364,0.0154590214793157,0.0303840393606024,1.78678193196791e-09
NMR metabolomics,X23424.Total Lipids in VLDL,HEPACAM2,HEPACAM family member 2,37942,-0.0230548754344454,0.00383955351430479,-0.0305804003224828,-0.015529350546408,1.96766015780897e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,37562,0.0574026135255983,0.00956967240830461,0.0386460556053213,0.0761591714458754,2.04533983462844e-09
NMR metabolomics,X23424.Total Lipids in VLDL,APOB,Apolipoprotein B-100,37987,0.0126205045359502,0.00210600680065135,0.00849273120667356,0.0167482778652268,2.11729120754001e-09
NMR metabolomics,X23424.Total Lipids in VLDL,NRP2,Neuropilin-2,40332,-0.0163717358466689,0.0027328910872116,-0.0217282023776036,-0.0110152693157341,2.13544540089134e-09
NMR metabolomics,X23424.Total Lipids in VLDL,PFDN2,Prefoldin subunit 2,39961,0.0316509569374492,0.0052871120659244,0.0212882172882374,0.042013696586661,2.19219002714177e-09
NMR metabolomics,X23424.Total Lipids in VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,40305,0.0200057270436843,0.0033443974435686,0.0134507080542899,0.0265607460330788,2.25343638850909e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ICOSLG,ICOS ligand,40305,0.0107552253554329,0.00179807722918802,0.00723099398622441,0.0142794567246414,2.25824926007428e-09
NMR metabolomics,X23424.Total Lipids in VLDL,GNLY,Granulysin,40332,0.0285470554669354,0.00477555935425284,0.0191869591325999,0.037907151801271,2.31097309329199e-09
NMR metabolomics,X23424.Total Lipids in VLDL,KIF1C,Kinesin-like protein KIF1C,37562,0.0212038200982662,0.00355215554787333,0.0142415952244345,0.0281660449720979,2.4445623347386e-09
NMR metabolomics,X23424.Total Lipids in VLDL,RCOR1,REST corepressor 1,40042,0.0251240380138873,0.00421375800248556,0.0168650723290156,0.033383003698759,2.53953259873003e-09
NMR metabolomics,X23424.Total Lipids in VLDL,IL31RA,Interleukin-31 receptor subunit alpha,37544,0.0228027753869083,0.00382525381651153,0.0153052779065457,0.0303002728672709,2.56970637400717e-09
NMR metabolomics,X23424.Total Lipids in VLDL,DGCR6,Protein DGCR6,37541,0.0255115042750489,0.00428966314687333,0.0171037645071772,0.0339192440429206,2.79717027091621e-09
NMR metabolomics,X23424.Total Lipids in VLDL,IL7R,Interleukin-7 receptor subunit alpha,40332,-0.0294641064984387,0.00495738404336816,-0.0391805792234403,-0.0197476337734371,2.8487628109235e-09
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,37901,0.0268898078428781,0.00452539217559251,0.0180200391787167,0.0357595765070394,2.88556381150428e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,37598,0.0216224102389635,0.00363998201449154,0.0144880454905601,0.0287567749873669,2.91777475358532e-09
NMR metabolomics,X23424.Total Lipids in VLDL,PRTG,Protogenin,40489,0.0140611406991054,0.00236829208464484,0.00941928821320156,0.0187029931850093,2.9582547508789e-09
NMR metabolomics,X23424.Total Lipids in VLDL,GGT5,Glutathione hydrolase 5 proenzyme,40228,0.0126425578813937,0.00213265112756226,0.00846256167137171,0.0168225540914158,3.12861368676565e-09
NMR metabolomics,X23424.Total Lipids in VLDL,IL1R1,Interleukin-1 receptor type 1,40303,-0.0124133495725343,0.00210047412273751,-0.0165302788530998,-0.00829642029196882,3.4957961365271e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40042,-0.0168464745632534,0.00285337124416355,-0.022439082201814,-0.0112538669246928,3.62030617601587e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CHAD,Chondroadherin,37671,0.029932854556765,0.00507211584624375,0.0199915074981272,0.0398742016154027,3.69139166756529e-09
NMR metabolomics,X23424.Total Lipids in VLDL,KIT,Mast/stem cell growth factor receptor Kit,40372,-0.0164232407344319,0.00278588952768954,-0.0218835842087034,-0.0109628972601604,3.81906096690115e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL9,C-X-C motif chemokine 9,40422,0.0374627605908878,0.00636567142836085,0.0249860445913006,0.0499394765904751,4.05720499527089e-09
NMR metabolomics,X23424.Total Lipids in VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37628,0.0202908686020222,0.00344934285533434,0.0135301566055669,0.0270515805984775,4.13842517359025e-09
NMR metabolomics,X23424.Total Lipids in VLDL,TEK,Angiopoietin-1 receptor,40411,0.0118932722508334,0.00202406774081017,0.00792609947884544,0.0158604450228213,4.28858330397372e-09
NMR metabolomics,X23424.Total Lipids in VLDL,IDS,Iduronate 2-sulfatase,40516,0.00477181054997013,0.000813176365534389,0.00317798487352273,0.00636563622641753,4.49456654253749e-09
NMR metabolomics,X23424.Total Lipids in VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,40044,0.0240956473249543,0.00410985912374603,0.0160403234424121,0.0321509712074965,4.64074166972354e-09
NMR metabolomics,X23424.Total Lipids in VLDL,VIT,Vitrin,37990,0.0203817696972468,0.00347749032424038,0.0135658886617356,0.0271976507327579,4.70633758763212e-09
NMR metabolomics,X23424.Total Lipids in VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40044,0.0199213478880398,0.00340134569602968,0.0132547103238216,0.026587985452258,4.81072396480488e-09
NMR metabolomics,X23424.Total Lipids in VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37901,-0.018143314206263,0.00310502563504056,-0.0242291644509425,-0.0120574639615835,5.23900415999365e-09
NMR metabolomics,X23424.Total Lipids in VLDL,EGFLAM,Pikachurin,37901,0.0169007677156076,0.00290281663936457,0.0112112471024531,0.0225902883287622,5.94049594485031e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CA7,Carbonic anhydrase 7,37714,-0.0193267232771851,0.00332065282716528,-0.025835202818429,-0.0128182437359411,6.0151230180955e-09
NMR metabolomics,X23424.Total Lipids in VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40305,0.0189623536192492,0.00325871652548317,0.0125752692293022,0.0253494380091962,6.03559279358676e-09
NMR metabolomics,X23424.Total Lipids in VLDL,FABP3,"Fatty acid-binding protein, heart",37990,0.0259836886623364,0.0044831979431091,0.0171966206938425,0.0347707566308302,6.95133917405433e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ECM1,Extracellular matrix protein 1,37655,0.0201726629603513,0.00349304369364075,0.0133262973208155,0.0270190285998872,7.86414028882126e-09
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40332,0.0156661195429724,0.00272033127472691,0.0103342702445077,0.0209979688414372,8.62286770755017e-09
NMR metabolomics,X23424.Total Lipids in VLDL,MRC1,Macrophage mannose receptor 1,37987,0.0153376906129444,0.00266503141293262,0.0101142290435965,0.0205611521822924,8.84337850323142e-09
NMR metabolomics,X23424.Total Lipids in VLDL,SCGB1A1,Uteroglobin,40384,0.030506438060737,0.00533352312306505,0.0200527327395295,0.0409601433819445,1.08592906136565e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CA12,Carbonic anhydrase 12,40305,-0.017340613440982,0.00303820654901731,-0.0232954982770559,-0.0113857286049081,1.16686747377403e-08
NMR metabolomics,X23424.Total Lipids in VLDL,TMPRSS11D,Transmembrane protease serine 11D,37921,0.0207589099724838,0.00364165491604511,0.0136212663370354,0.0278965536079322,1.2202961185318e-08
NMR metabolomics,X23424.Total Lipids in VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,37959,0.0201478724505505,0.00353474989192728,0.013219762662373,0.0270759822387279,1.22353351525467e-08
NMR metabolomics,X23424.Total Lipids in VLDL,VEGFB,Vascular endothelial growth factor B,37598,0.0152642101353654,0.00269464750881304,0.00998270101809181,0.0205457192526389,1.50422417461758e-08
NMR metabolomics,X23424.Total Lipids in VLDL,PREB,Prolactin regulatory element-binding protein,40044,0.0157612129285995,0.00279119010254338,0.0102904803276145,0.0212319455295846,1.6633985904997e-08
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37959,0.0386647953557787,0.0068519619065867,0.0252349500188688,0.0520946406926886,1.7059053873901e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ATXN2,Ataxin-2,37541,0.0613392916806917,0.0108745743719495,0.0400251259116706,0.0826534574497128,1.72953280061351e-08
NMR metabolomics,X23424.Total Lipids in VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39961,0.0160701490433265,0.00285293117184385,0.0104784039465126,0.0216618941401405,1.8032776743736e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CTSB,Cathepsin B,40353,-0.0284931059005035,0.00507587313990053,-0.0384418172547086,-0.0185443945462985,2.01657666537398e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CLPS,Colipase,40311,0.0362071449206312,0.00645211454223677,0.0235610004178472,0.0488532894234153,2.03734318960497e-08
NMR metabolomics,X23424.Total Lipids in VLDL,JAM2,Junctional adhesion molecule B,40471,0.0137731797605099,0.0024555967818029,0.0089602100681762,0.0185861494528436,2.06990581018415e-08
NMR metabolomics,X23424.Total Lipids in VLDL,DUSP3,Dual specificity protein phosphatase 3,39961,0.0446811653429469,0.00798644957259514,0.0290277241806604,0.0603346065052334,2.24841424045963e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CAT,Catalase,37786,0.0287073051309224,0.00513656720500427,0.018639633409114,0.0387749768527308,2.33112128250111e-08
NMR metabolomics,X23424.Total Lipids in VLDL,QPCT,Glutaminyl-peptide cyclotransferase,40373,0.0141289427995953,0.00252842091240235,0.00917323781128669,0.0190846477879039,2.33397376693383e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,37987,0.0207396399955934,0.00371535406358497,0.0134575460309668,0.0280217339602199,2.4213925137511e-08
NMR metabolomics,X23424.Total Lipids in VLDL,OMD,Osteomodulin,40422,-0.0232223731582671,0.00416665637737567,-0.0313890196579234,-0.0150557266586107,2.53879817421045e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,39980,0.0217624300427776,0.00390936076017535,0.0141000829528339,0.0294247771327212,2.6383373367247e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CCL28,C-C motif chemokine 28,40278,0.0311855661980089,0.00560943847951958,0.0201910667781506,0.0421800656178673,2.74951584920792e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM5,Intercellular adhesion molecule 5,40359,0.023003358082768,0.0041495072373768,0.0148703238975095,0.0311363922680265,3.00965235101265e-08
NMR metabolomics,X23424.Total Lipids in VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37572,0.0543330642809273,0.00980492080310072,0.0351154195068499,0.0735507090550047,3.05833573968151e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,37598,0.016392934861398,0.00296487119271247,0.0105817873236815,0.0222040823991144,3.2810114702247e-08
NMR metabolomics,X23424.Total Lipids in VLDL,SCARF2,Scavenger receptor class F member 2,40471,-0.0154399481296493,0.00279617075751746,-0.0209204428143835,-0.00995945344491505,3.40725159816027e-08
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40228,0.0211547726525116,0.00384895727099951,0.0136108164013526,0.0286987289036707,3.94002002462354e-08
NMR metabolomics,X23424.Total Lipids in VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,37714,0.0223161925092431,0.00406166350994909,0.0143553320297428,0.0302770529887433,3.99389161895958e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ATXN10,Ataxin-10,39961,0.0373470399729279,0.00681866719198764,0.0239824522766321,0.0507116276692236,4.38892775090517e-08
NMR metabolomics,X23424.Total Lipids in VLDL,LUZP2,Leucine zipper protein 2,37900,0.0230209820334192,0.00421675493750505,0.0147561423559093,0.0312858217109291,4.86200976131588e-08
NMR metabolomics,X23424.Total Lipids in VLDL,BCAM,Basal cell adhesion molecule,40332,-0.0121514301978251,0.0022288793097476,-0.0165200336449304,-0.00778282675071979,5.06033045338832e-08
NMR metabolomics,X23424.Total Lipids in VLDL,LMOD1,Leiomodin-1,37959,-0.0186275953966752,0.00341992238452868,-0.0253306432703514,-0.011924547522999,5.21848337484928e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40042,0.0249492656012631,0.00459502723381078,0.0159430122229939,0.0339555189795322,5.73181934509645e-08
NMR metabolomics,X23424.Total Lipids in VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40403,-0.0226079405312565,0.00416431610943145,-0.0307700001057421,-0.0144458809567709,5.75091017375361e-08
NMR metabolomics,X23424.Total Lipids in VLDL,LY9,T-lymphocyte surface antigen Ly-9,40182,0.0146361036771582,0.00270232557825352,0.00933954554378125,0.0199326618105351,6.18026784262112e-08
NMR metabolomics,X23424.Total Lipids in VLDL,APOE,Apolipoprotein E,38013,0.0382846414101303,0.00706873231273708,0.0244299260771656,0.052139356743095,6.19672493772676e-08
NMR metabolomics,X23424.Total Lipids in VLDL,FCRLB,Fc receptor-like B,39980,0.0310876792630692,0.00574489747898669,0.0198276802042553,0.0423476783218831,6.34770372704951e-08
NMR metabolomics,X23424.Total Lipids in VLDL,SLC16A1,Monocarboxylate transporter 1,39961,0.0306049045781138,0.00565679725318664,0.0195175819618679,0.0416922271943596,6.38566829236016e-08
NMR metabolomics,X23424.Total Lipids in VLDL,PRKD2,Serine/threonine-protein kinase D2,37562,0.024253118529799,0.0044843330103578,0.0154638258294978,0.0330424112301003,6.47016872893502e-08
NMR metabolomics,X23424.Total Lipids in VLDL,EPHB4,Ephrin type-B receptor 4,40536,-0.0125086748170389,0.00231545432653542,-0.0170469652970483,-0.00797038433702945,6.67438942804861e-08
NMR metabolomics,X23424.Total Lipids in VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37942,0.0316901151768387,0.00587743201004197,0.0201703484371564,0.043209881916521,7.09183370470581e-08
NMR metabolomics,X23424.Total Lipids in VLDL,MUC16,Mucin-16,40305,0.0949930301595918,0.0176283032797605,0.0604415557312612,0.129544504587922,7.19967233090759e-08
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40489,0.0128289458164876,0.00238159139448227,0.00816102668330235,0.0174968649496729,7.2770240715268e-08
NMR metabolomics,X23424.Total Lipids in VLDL,SCN4B,Sodium channel subunit beta-4,37628,0.0213062169640085,0.00395698067966133,0.0135505348318723,0.0290618990961447,7.39076594655219e-08
NMR metabolomics,X23424.Total Lipids in VLDL,MEPE,Matrix extracellular phosphoglycoprotein,40357,0.0134374609036482,0.00250068094594071,0.0085361262496044,0.018338795557692,7.83012631827062e-08
NMR metabolomics,X23424.Total Lipids in VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40434,0.017075498672454,0.00317844000340995,0.0108457562657705,0.0233052410791375,7.88318374233352e-08
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40502,0.0191635419292149,0.0035688892342761,0.0121685190300338,0.0261585648283961,8.00052351157559e-08
NMR metabolomics,X23424.Total Lipids in VLDL,MILR1,Allergin-1,40044,-0.0252341130629322,0.00470138983716788,-0.0344488371437813,-0.0160193889820832,8.10343642390919e-08
NMR metabolomics,X23424.Total Lipids in VLDL,RALY,RNA-binding protein Raly,37900,0.0244386932111332,0.00455434859277914,0.0155121699692861,0.0333652164529803,8.18309839637377e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CLSTN2,Calsyntenin-2,40516,-0.0196955442599003,0.00367173639762576,-0.0268921475992468,-0.0124989409205538,8.24824350858383e-08
NMR metabolomics,X23424.Total Lipids in VLDL,FGF16,Fibroblast growth factor 16,37598,0.0248670238707798,0.00464589850556755,0.0157610627998674,0.0339729849416922,8.82201014057247e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM4,Intercellular adhesion molecule 4,40341,-0.0265667962072457,0.00496427880676216,-0.0362967826684995,-0.0168368097459919,8.83931990033705e-08
NMR metabolomics,X23424.Total Lipids in VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,39980,0.0295352490460215,0.00552373585197767,0.0187087267761453,0.0403617713158977,9.07044911429385e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CCL21,C-C motif chemokine 21,40422,0.0213399572676262,0.0039961359370244,0.0135075308310584,0.029172383704194,9.41419685069903e-08
NMR metabolomics,X23424.Total Lipids in VLDL,GPC1,Glypican-1,40489,0.0147328722255595,0.00276232839347286,0.00931870857435267,0.0201470358767663,9.76455648759501e-08
NMR metabolomics,X23424.Total Lipids in VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",40422,0.0136506923458932,0.00257653342964732,0.00860068682378447,0.018700697868002,1.18576936158716e-07
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37901,0.0107002057066775,0.00202659474313505,0.00672808001013282,0.0146723314032222,1.31270717363576e-07
NMR metabolomics,X23424.Total Lipids in VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40228,0.0344963117053256,0.00655891662406261,0.0216408351221629,0.0473517882884884,1.46371725089651e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CRISP3,Cysteine-rich secretory protein 3,37875,-0.0133869198035706,0.00254890950459682,-0.0183827824325804,-0.00839105717456083,1.52739968189455e-07
NMR metabolomics,X23424.Total Lipids in VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,39980,0.0254862146362695,0.00485379750700835,0.0159727715225332,0.0349996577500059,1.53454775541367e-07
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA1,Annexin A1,37608,0.0205393252765269,0.00391261494580781,0.0128705999827436,0.0282080505703102,1.54874609924789e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CSF1,Macrophage colony-stimulating factor 1,40422,0.0133503654587825,0.00254471580074851,0.00836272248931542,0.0183380084282496,1.57158966837647e-07
NMR metabolomics,X23424.Total Lipids in VLDL,RAB37,Ras-related protein Rab-37,40044,0.0411309013018739,0.00784686591997,0.0257510440987327,0.0565107585050151,1.61180683278787e-07
NMR metabolomics,X23424.Total Lipids in VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,40319,0.0120942251831114,0.00230794256921422,0.00757065774745153,0.0166177926187713,1.62400862531176e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN1,Contactin-1,40536,-0.0135909509442562,0.0025958957346703,-0.01867890658421,-0.0085029953043024,1.66561047121227e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TPM3,Tropomyosin alpha-3 chain,37562,-0.0210145132910128,0.00401508940407051,-0.028884088522991,-0.0131449380590346,1.68546664623314e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CENPF,Centromere protein F,37714,0.0269523565750231,0.00515371061054322,0.0168510837783584,0.0370536293716878,1.72368679649588e-07
NMR metabolomics,X23424.Total Lipids in VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,39980,0.019989851152238,0.00382392624816055,0.0124949557058433,0.0274847465986327,1.73975945391525e-07
NMR metabolomics,X23424.Total Lipids in VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,37900,0.022348600752527,0.00427525004729288,0.0139691106598329,0.030728090845221,1.74449569149726e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CREBZF,CREB/ATF bZIP transcription factor,37482,-0.0130299337300764,0.00249658788893115,-0.0179232459923814,-0.00813662146777133,1.82559883995216e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CHL1,Neural cell adhesion molecule L1-like protein,40379,-0.0155066916465985,0.00297751804043826,-0.0213426270058575,-0.00967075628733952,1.93341095809422e-07
NMR metabolomics,X23424.Total Lipids in VLDL,RPS10,40S ribosomal protein S10,37562,-0.0207777850087206,0.00399981188468489,-0.028617416302703,-0.0129381537147382,2.08134839879805e-07
NMR metabolomics,X23424.Total Lipids in VLDL,GBP2,Guanylate-binding protein 2,40044,0.029071531078875,0.00560310530004652,0.0180894446907838,0.0400536174669662,2.14689184083923e-07
NMR metabolomics,X23424.Total Lipids in VLDL,LIF,Leukemia inhibitory factor,39961,0.0256550399374293,0.00495805347746156,0.0159372551216046,0.0353728247532539,2.31473660426801e-07
NMR metabolomics,X23424.Total Lipids in VLDL,BRD1,Bromodomain-containing protein 1,37714,-0.0151565986434446,0.00292927048601175,-0.0208979687960277,-0.00941522849086161,2.32243517480029e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40422,0.0128263769983829,0.00248324740798885,0.00795921207872473,0.017693541918041,2.43118360217127e-07
NMR metabolomics,X23424.Total Lipids in VLDL,NPTX1,Neuronal pentraxin-1,40332,0.0191284225508939,0.00371233059305974,0.0118522545884968,0.026404590513291,2.59876974384945e-07
NMR metabolomics,X23424.Total Lipids in VLDL,S100A14,Protein S100-A14,37959,0.0261138924464746,0.00507490115721527,0.0161670861783326,0.0360606987146165,2.70269784540151e-07
NMR metabolomics,X23424.Total Lipids in VLDL,ITM2A,Integral membrane protein 2A,40341,-0.0285065125436519,0.00556394478383872,-0.0394118443199758,-0.017601180767328,3.03531707275877e-07
NMR metabolomics,X23424.Total Lipids in VLDL,PRUNE2,Protein prune homolog 2,37714,0.0142836487627777,0.00279130269459653,0.00881269548136845,0.0197546020441869,3.14442467312133e-07
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40044,0.0202331537156744,0.00395824949399712,0.01247498470744,0.0279913227239087,3.23148667739318e-07
NMR metabolomics,X23424.Total Lipids in VLDL,FSTL1,Follistatin-related protein 1,37628,-0.0108261849775502,0.00212328268287964,-0.0149878190359942,-0.00666455091910606,3.4656325823036e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CCN3,CCN family member 3,40522,0.0161583912549585,0.00317453587074257,0.00993630094830307,0.0223804815616139,3.62103097892694e-07
NMR metabolomics,X23424.Total Lipids in VLDL,AZU1,Azurocidin,39809,0.0371850055729133,0.0073242696744535,0.0228294370109845,0.0515405741348422,3.8801298159679e-07
NMR metabolomics,X23424.Total Lipids in VLDL,KLK8,Kallikrein-8,39801,0.016914995125565,0.00334397457092449,0.010360804966553,0.023469185284577,4.2777824711589e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TNC,Tenascin,40403,-0.0223534767734834,0.00444361930071428,-0.0310629706028834,-0.0136439829440834,4.94604867539826e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CSF3,Granulocyte colony-stimulating factor,40044,0.0231275838398765,0.00459813566104461,0.0141152379442291,0.0321399297355239,4.96513919340631e-07
NMR metabolomics,X23424.Total Lipids in VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40159,0.0279657205744774,0.00557305854999545,0.0170425258164863,0.0388889153324685,5.27772670218956e-07
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40516,0.0164324259613871,0.00328125721598494,0.0100011618180566,0.0228636901047176,5.55913654366616e-07
NMR metabolomics,X23424.Total Lipids in VLDL,KLK11,Kallikrein-11,40260,0.0139563598715865,0.00279606299970832,0.00847607639215824,0.0194366433510149,6.05706825217513e-07
NMR metabolomics,X23424.Total Lipids in VLDL,OLFM4,Olfactomedin-4,37177,0.0577203066171373,0.0116308971695594,0.034923748164801,0.0805168650694737,7.04300412975951e-07
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37990,0.012398011635475,0.00249956579016668,0.00749886268674831,0.0172971605842017,7.13240207135246e-07
NMR metabolomics,X23424.Total Lipids in VLDL,COMP,Cartilage oligomeric matrix protein,40198,0.0157653718614476,0.00318269952954338,0.00952728078354261,0.0220034629393527,7.36616498057569e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40357,0.0137939724387158,0.00278730959177065,0.00833084563884536,0.0192570992385863,7.54174392062938e-07
NMR metabolomics,X23424.Total Lipids in VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40411,0.0123337486591788,0.00249380305089607,0.00744589467942255,0.0172216026389351,7.66190451122247e-07
NMR metabolomics,X23424.Total Lipids in VLDL,IL6ST,Interleukin-6 receptor subunit beta,40359,0.00810426761160214,0.00164389328612654,0.00488223677079411,0.0113262984524102,8.30908373856289e-07
NMR metabolomics,X23424.Total Lipids in VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,40311,0.0406752679331181,0.00825133981028983,0.0245026419049501,0.0568478939612862,8.32583889173064e-07
NMR metabolomics,X23424.Total Lipids in VLDL,LHB,Lutropin subunit beta,39980,0.0393379689698122,0.00799268417997084,0.0236723079770693,0.055003629962555,8.66548684333856e-07
NMR metabolomics,X23424.Total Lipids in VLDL,PROCR,Endothelial protein C receptor,37562,-0.0171747279466051,0.00349558725607631,-0.0240260789685147,-0.0103233769246955,9.06562898012312e-07
NMR metabolomics,X23424.Total Lipids in VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,39980,0.0248772488431923,0.00506482050570862,0.0149502006520034,0.0348042970343812,9.11750068006559e-07
NMR metabolomics,X23424.Total Lipids in VLDL,VEGFD,Vascular endothelial growth factor D,40483,-0.0153640236551685,0.00313195597975674,-0.0215026573754918,-0.00922538993484534,9.40709624386662e-07
NMR metabolomics,X23424.Total Lipids in VLDL,DLL4,Delta-like protein 4,37628,0.0390544417017362,0.00796429397904165,0.0234444255028146,0.0546644579006578,9.51737470018241e-07
NMR metabolomics,X23424.Total Lipids in VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,37482,0.0275401620386086,0.00562326436117628,0.016518563890703,0.0385617601865141,9.82085747519638e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TPSAB1,Tryptase alpha/beta-1,40498,0.024281780576608,0.00495897802090172,0.0145621836556406,0.0340013774975754,9.84932050595195e-07
NMR metabolomics,X23424.Total Lipids in VLDL,KIAA1549L,UPF0606 protein KIAA1549L,37714,-0.013440971685027,0.00274555397125417,-0.0188222574686852,-0.00805968590136883,9.91897932754746e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CASP1,Caspase-1,39961,0.0309977292055582,0.00633367478951288,0.0185837266181129,0.0434117317930034,9.97416358356713e-07
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,40536,-0.0111249602058592,0.00227646571413275,-0.0155868330055594,-0.00666308740615903,1.03399809559709e-06
NMR metabolomics,X23424.Total Lipids in VLDL,GLYR1,Putative oxidoreductase GLYR1,37900,0.0278109763448571,0.00572204821660194,0.0165957618403173,0.0390261908493968,1.18520098030869e-06
NMR metabolomics,X23424.Total Lipids in VLDL,LXN,Latexin,40183,-0.03033159855429,0.00624488680961365,-0.0425715767011328,-0.0180916204074473,1.20306126557888e-06
NMR metabolomics,X23424.Total Lipids in VLDL,GZMH,Granzyme H,40042,0.0340997352774785,0.00702137786568476,0.0203378346607364,0.0478616358942206,1.20602168701248e-06
NMR metabolomics,X23424.Total Lipids in VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,40325,0.0101592586071803,0.0021029855447333,0.00603740693950307,0.0142811102748576,1.37203935608408e-06
NMR metabolomics,X23424.Total Lipids in VLDL,FOSB,Protein fosB,39961,0.017770900996325,0.00368347580440638,0.0105512884196885,0.0249905135729615,1.41694687670333e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CHRM1,Muscarinic acetylcholine receptor M1,37572,-0.0171325500049811,0.00355749409967843,-0.0241052384403508,-0.0101598615696113,1.48171580876516e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CRLF1,Cytokine receptor-like factor 1,40422,0.0118976884768947,0.00247181572510014,0.00705292965569844,0.016742447298091,1.49786799937532e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37901,0.0178932011535088,0.00371881952970306,0.0106043148752908,0.0251820874317268,1.514074194993e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA3,Alpha-1-antichymotrypsin,37958,0.00666638807037539,0.00139030944886239,0.00394138155060511,0.00939139459014567,1.64495986053016e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CDH1,Cadherin-1,39806,0.0181017712120077,0.00377672595630303,0.0106993883376537,0.0255041540863616,1.65860799638306e-06
NMR metabolomics,X23424.Total Lipids in VLDL,B2M,Beta-2-microglobulin,38013,0.0143245929842305,0.00299198274601997,0.00846030680203141,0.0201888791664297,1.70520160200173e-06
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",39961,0.0124173566015762,0.00259996197165507,0.00732143113713225,0.0175132820660201,1.80472667417652e-06
NMR metabolomics,X23424.Total Lipids in VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37562,0.0220568499892759,0.00462039731039455,0.0130008712609026,0.0311128287176492,1.82735700132502e-06
NMR metabolomics,X23424.Total Lipids in VLDL,PCDHB15,Protocadherin beta-15,37900,-0.0181565882933371,0.00380538039271223,-0.025615133863053,-0.0106980427236211,1.8497010949665e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37598,0.0163081636249218,0.00342067623196084,0.0096036382102786,0.0230126890395651,1.8850106310431e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CNPY2,Protein canopy homolog 2,40042,0.0273971969067017,0.00575357328251804,0.0161201932729663,0.038674200540437,1.93627135022339e-06
NMR metabolomics,X23424.Total Lipids in VLDL,NEFL,Neurofilament light polypeptide,39903,0.0191117877216345,0.00402207528497591,0.0112285201630817,0.0269950552801872,2.03505589616378e-06
NMR metabolomics,X23424.Total Lipids in VLDL,PRELP,Prolargin,40357,0.0102987381082269,0.00218214052583355,0.00602174267759312,0.0145757335388606,2.38370716471819e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SEPTIN8,Septin-8,37921,0.0141799741112493,0.00300535827228553,0.00828947189756968,0.020070476324929,2.40295575667182e-06
NMR metabolomics,X23424.Total Lipids in VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37998,-0.0115296383365568,0.00244464258153295,-0.0163211377963614,-0.00673813887675226,2.42582927915701e-06
NMR metabolomics,X23424.Total Lipids in VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,40305,0.0137434360662308,0.00291463124082699,0.00803075883420986,0.0194561132982517,2.43378862253226e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,37562,0.0159012471718247,0.00337422532998126,0.00928776552506142,0.0225147288185879,2.47135773956932e-06
NMR metabolomics,X23424.Total Lipids in VLDL,MYL3,Myosin light chain 3,37628,-0.0304046071642204,0.00645555312927471,-0.0430574912975988,-0.017751723030842,2.50444124453522e-06
NMR metabolomics,X23424.Total Lipids in VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,39961,0.0631524440725142,0.0134097444119338,0.036869345025124,0.0894355431199044,2.50544637611372e-06
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40517,0.0120446712275261,0.00255772616628751,0.00703152794160263,0.0170578145134497,2.50852880010707e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CA14,Carbonic anhydrase 14,40489,-0.0152912185146235,0.00324801007295487,-0.021657318257615,-0.00892511877163194,2.52408985431438e-06
NMR metabolomics,X23424.Total Lipids in VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,37900,0.0158128043968881,0.00336540509851967,0.00921661040378953,0.0224089983899866,2.64502782389916e-06
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH1,Protocadherin-1,40475,0.0096255848513916,0.00204929016950624,0.00560897611915936,0.0136421935836238,2.66157455402602e-06
NMR metabolomics,X23424.Total Lipids in VLDL,EBI3_IL27,Interleukin-27,40453,-0.0137612458191943,0.00293505710824365,-0.0195139577513518,-0.00800853388703673,2.77379562301786e-06
NMR metabolomics,X23424.Total Lipids in VLDL,NXPH1,Neurexophilin-1,39961,0.0166421053496978,0.00355162324982968,0.00968092378003165,0.023603286919364,2.81272684888903e-06
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX1,Peroxiredoxin-1,39953,-0.039328740306816,0.00839847310030661,-0.055789747583417,-0.0228677330302151,2.85320624449778e-06
NMR metabolomics,X23424.Total Lipids in VLDL,EPHX2,Bifunctional epoxide hydrolase 2,40042,0.0275540321084644,0.0058994641433414,0.0159910823875152,0.0391169818294135,3.02829013382743e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CLASP1,CLIP-associating protein 1,37482,0.0315436584708153,0.00675337144519054,0.0183070504382418,0.0447802665033887,3.03024960740052e-06
NMR metabolomics,X23424.Total Lipids in VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40228,0.0112057688770036,0.00240183718571194,0.00649816799300817,0.015913369760999,3.10397502309468e-06
NMR metabolomics,X23424.Total Lipids in VLDL,LYAR,Cell growth-regulating nucleolar protein,39980,0.0230532454665474,0.00494972368336411,0.0133517870471537,0.0327547038859411,3.22754893111822e-06
NMR metabolomics,X23424.Total Lipids in VLDL,C1QL2,Complement C1q-like protein 2,37598,0.0189077300238591,0.00406148267295241,0.0109472239848724,0.0268682360628459,3.26552286684561e-06
NMR metabolomics,X23424.Total Lipids in VLDL,IFNG,Interferon gamma,40044,0.0495430797950523,0.0107014680571202,0.0285682024030966,0.0705179571870079,3.69400806781121e-06
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37990,0.0144131553671214,0.00311500000680364,0.00830775535378624,0.0205185553804565,3.74412277713095e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SHISA5,Protein shisa-5,37998,0.0108215611149658,0.00234763441355933,0.00622019766438948,0.015422924565542,4.07208904792264e-06
NMR metabolomics,X23424.Total Lipids in VLDL,UROS,Uroporphyrinogen-III synthase,37572,0.0305020838751369,0.00662991867232643,0.0175074432773771,0.0434967244728967,4.25072485782017e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CD7,T-cell antigen CD7,37567,0.0186044719955003,0.00405587138824772,0.0106549640745348,0.0265539799164659,4.53723091953106e-06
NMR metabolomics,X23424.Total Lipids in VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,40042,0.0238891175555227,0.00521897877139801,0.0136599191635826,0.0341183159474628,4.74529124058375e-06
NMR metabolomics,X23424.Total Lipids in VLDL,TBC1D17,TBC1 domain family member 17,39961,0.0198010949512081,0.00433198172606461,0.0113104107681215,0.0282917791342948,4.89362453911605e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,37714,0.0296054606197372,0.00647960888990547,0.0169054271955225,0.0423054940439519,4.94430650572107e-06
NMR metabolomics,X23424.Total Lipids in VLDL,VWF,von Willebrand factor,40536,-0.0306447215610873,0.00672342437700306,-0.0438226333400133,-0.0174668097821613,5.2047145554123e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB1,Integrin beta-1,40333,0.00937997097945003,0.00205923816265279,0.00534386418065057,0.0134160777782495,5.27581340153775e-06
NMR metabolomics,X23424.Total Lipids in VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,40284,0.0149420793937671,0.00328075477993182,0.00851180002510072,0.0213723587624334,5.29110985713192e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ODAM,Odontogenic ameloblast-associated protein,39934,0.0229772632017414,0.00504787954591614,0.0130834192917457,0.032871107111737,5.35773512494238e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37541,0.0265874598222366,0.00584929918127857,0.0151228334269306,0.0380520862175426,5.53197947812258e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CD86,T-lymphocyte activation antigen CD86,37901,0.0125265119097701,0.0027591692874982,0.00711854010627359,0.0179344837132665,5.67538197034806e-06
NMR metabolomics,X23424.Total Lipids in VLDL,EPHB6,Ephrin type-B receptor 6,40192,0.0133409599953709,0.00293980622684442,0.00757893979075588,0.019102980199986,5.71994920982088e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SLAMF7,SLAM family member 7,40341,-0.0245684341193819,0.00543077693136315,-0.0352127569048537,-0.0139241113339101,6.11425735568393e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CALCB,Calcitonin gene-related peptide 2,37942,0.0170370263307036,0.00376699130553152,0.00965372337186184,0.0244203292895454,6.15721197025077e-06
NMR metabolomics,X23424.Total Lipids in VLDL,LAG3,Lymphocyte activation gene 3 protein,40305,-0.0174818332874988,0.00387031067306793,-0.0250676422067119,-0.00989602436828566,6.3202284176019e-06
NMR metabolomics,X23424.Total Lipids in VLDL,OBP2B,Odorant-binding protein 2b,40184,-0.0281506692642649,0.00623658266691422,-0.0403743712914168,-0.0159269672371131,6.41389620966904e-06
NMR metabolomics,X23424.Total Lipids in VLDL,EIF5,Eukaryotic translation initiation factor 5,37562,0.0193930956149298,0.00429771901688796,0.0109695663418294,0.0278166248880302,6.46508441682474e-06
NMR metabolomics,X23424.Total Lipids in VLDL,FUCA1,Tissue alpha-L-fucosidase,40437,0.0344323297717017,0.00763316369461757,0.0194713289302512,0.0493933306131521,6.50171300678887e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6V1D,V-type proton ATPase subunit D,40305,0.0111467569683234,0.00247569134728521,0.0062944019276444,0.0159991120090024,6.76430627404548e-06
NMR metabolomics,X23424.Total Lipids in VLDL,PADI4,Protein-arginine deiminase type-4,39934,0.0294166787591753,0.00654203990351749,0.016594280548281,0.0422390769700696,6.95630988641104e-06
NMR metabolomics,X23424.Total Lipids in VLDL,REN,Renin,40359,-0.0301309835965384,0.00670952400539638,-0.0432816506471153,-0.0169803165459615,7.1462572642149e-06
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS53,Serine protease 53,37942,0.0155314593213414,0.00346658637320348,0.00873695002986256,0.0223259686128202,7.51397777349452e-06
NMR metabolomics,X23424.Total Lipids in VLDL,EP300,Histone acetyltransferase p300,37598,0.0126375706689797,0.00282102232983297,0.00710836690250705,0.0181667744354523,7.53489316387573e-06
NMR metabolomics,X23424.Total Lipids in VLDL,GZMB,Granzyme B,40341,0.0264509646421541,0.00592189443786644,0.0148440515439359,0.0380578777403723,8.00061043244758e-06
NMR metabolomics,X23424.Total Lipids in VLDL,GFAP,Glial fibrillary acidic protein,39959,0.0196480117478248,0.0044115914181544,0.0110012925682422,0.0282947309274075,8.49833648170311e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ITGAM,Integrin alpha-M,40332,-0.0132151830037269,0.00298145766481535,-0.019058840026765,-0.00737152598068878,9.37895860681609e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40306,-0.0288766292829648,0.00651933511704971,-0.0416545261123822,-0.0160987324535474,9.51358945435558e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SAA4,Serum amyloid A-4 protein,38013,0.0136397505227075,0.00308073769915208,0.00760150463236942,0.0196779964130456,9.61078962916157e-06
NMR metabolomics,X23424.Total Lipids in VLDL,FABP9,Fatty acid-binding protein 9,40341,0.023252469774966,0.00525894299823694,0.0129449414984216,0.0335599980515104,9.86637062505819e-06
NMR metabolomics,X23424.Total Lipids in VLDL,BCL2L15,Bcl-2-like protein 15,37598,0.0234697119006519,0.00533753510771004,0.0130081430895402,0.0339312807117635,1.10565018397326e-05
NMR metabolomics,X23424.Total Lipids in VLDL,IL34,Interleukin-34,39934,0.0148646694378216,0.00338087580316341,0.00823815286362127,0.0214911860120218,1.10645603305213e-05
NMR metabolomics,X23424.Total Lipids in VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,40305,-0.0135139190751603,0.00308711244158707,-0.019564659460671,-0.00746317868964962,1.20801478506225e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CTRC,Chymotrypsin-C,40360,0.0257810159336704,0.00589888245017169,0.0142192063313339,0.0373428255360069,1.24752886549314e-05
NMR metabolomics,X23424.Total Lipids in VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,40471,0.0094578848838837,0.00216766286753351,0.00520926566351802,0.0137065041042494,1.28992064702472e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ITGBL1,Integrin beta-like protein 1,37998,0.0143670900633681,0.00329625632194537,0.00790642767235513,0.020827752454381,1.31856753671242e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CALB1,Calbindin,40305,0.0173880591600363,0.00399100122375783,0.00956569676147091,0.0252104215586016,1.32797292759311e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ENO1,Alpha-enolase,40299,0.0324464743833922,0.00745843823453378,0.017827935443706,0.0470650133230784,1.36798686797419e-05
NMR metabolomics,X23424.Total Lipids in VLDL,MET,Hepatocyte growth factor receptor,40375,-0.00820779011664441,0.00188935373667737,-0.0119109234405321,-0.00450465679275677,1.40628891994807e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SLAMF8,SLAM family member 8,39980,0.0218704352666013,0.00503972597154287,0.0119925723623772,0.0317482981708253,1.4363918224245e-05
NMR metabolomics,X23424.Total Lipids in VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,37541,-0.0136145119667522,0.00314357762388855,-0.0197759241095738,-0.00745309982393068,1.49608291185591e-05
NMR metabolomics,X23424.Total Lipids in VLDL,VCAN,Versican core protein,40471,-0.0122476147721469,0.00282924929713479,-0.0177929433945311,-0.00670228614976271,1.50746589548023e-05
NMR metabolomics,X23424.Total Lipids in VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,40009,0.0209934937491295,0.00486605238921384,0.0114560310662703,0.0305309564319886,1.61114440163372e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40536,0.0118786677530926,0.00276104286612209,0.00646702373549329,0.0172903117706919,1.70078401910586e-05
NMR metabolomics,X23424.Total Lipids in VLDL,HYAL1,Hyaluronidase-1,40214,0.00929832937750078,0.00216198741188789,0.00506083405020052,0.013535824704801,1.71187142328302e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PEPD,Xaa-Pro dipeptidase,37987,0.0104749887512404,0.00243591798531379,0.00570058950002539,0.0152493880024554,1.71822062493012e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CRTAP,Cartilage-associated protein,37572,0.0196832216179142,0.00457722715982796,0.0107118563846514,0.028654586851177,1.71838400620672e-05
NMR metabolomics,X23424.Total Lipids in VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40357,0.0155073451579954,0.00360995196136749,0.0084318393137151,0.0225828510022756,1.75160143611188e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CDH17,Cadherin-17,40359,-0.0273263392476061,0.00637183200550011,-0.0398151299783863,-0.0148375485168259,1.80850224508672e-05
NMR metabolomics,X23424.Total Lipids in VLDL,MYOM2,Myomesin-2,37562,-0.0190365742777686,0.00444496411222267,-0.0277487039377251,-0.0103244446178122,1.85929972376955e-05
NMR metabolomics,X23424.Total Lipids in VLDL,NEDD9,Enhancer of filamentation 1,37598,0.0133740183421066,0.00312450191308557,0.00724999459245894,0.0194980420917544,1.87906571630067e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40286,0.0723476981914976,0.0169098882479595,0.039204317225497,0.105491079157498,1.89324806834183e-05
NMR metabolomics,X23424.Total Lipids in VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,39961,0.015962006643012,0.00373259893274189,0.00864611273483789,0.0232779005511861,1.91094407566905e-05
NMR metabolomics,X23424.Total Lipids in VLDL,OSM,Oncostatin-M,40268,0.0291130949793316,0.00682423332581154,0.015737597660741,0.0424885922979222,2.00045289808508e-05
NMR metabolomics,X23424.Total Lipids in VLDL,GFRA2,GDNF family receptor alpha-2,40305,0.00852043547605823,0.00199840481790678,0.00460356203296093,0.0124373089191555,2.02306708492842e-05
NMR metabolomics,X23424.Total Lipids in VLDL,FLT1,Vascular endothelial growth factor receptor 1,40272,0.00929163683225999,0.00217937780832439,0.00502005632794419,0.0135632173365758,2.02474610556588e-05
NMR metabolomics,X23424.Total Lipids in VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,37959,0.0107770050808632,0.00253826056819538,0.00580201436720021,0.0157519957945261,2.19248676882208e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CR2,Complement receptor type 2,40403,0.0185183906624573,0.00437195842681649,0.009949352145897,0.0270874291790176,2.29098443100764e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CST1,Cystatin-SN,36179,0.0417543164983686,0.00985961654578467,0.0224294680686307,0.0610791649281066,2.30415699235595e-05
NMR metabolomics,X23424.Total Lipids in VLDL,RPA2,Replication protein A 32 kDa subunit,37598,0.0130613045374806,0.00308596557669383,0.00701281200716074,0.0191097970678006,2.32691695585566e-05
NMR metabolomics,X23424.Total Lipids in VLDL,GIMAP7,GTPase IMAP family member 7,37671,-0.0129524599555735,0.00306161527383435,-0.0189532258922888,-0.00695169401885813,2.34642724636926e-05
NMR metabolomics,X23424.Total Lipids in VLDL,FAM171B,Protein FAM171B,37900,0.0110430736939549,0.00261612485650644,0.00591546897520228,0.0161706784127075,2.44647893098733e-05
NMR metabolomics,X23424.Total Lipids in VLDL,TGFB2,Transforming growth factor beta-2 proprotein,37900,0.0211019245378966,0.00500095170077211,0.0113000592043832,0.0309037898714099,2.46361161957166e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CA1,Carbonic anhydrase 1,40003,0.0248217755940383,0.00588479052894319,0.0132875861573096,0.036355965030767,2.47924797306511e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SNX18,Sorting nexin-18,37901,0.0180830554367323,0.00429262608905478,0.00966950830218491,0.0264966025712796,2.54109020652599e-05
NMR metabolomics,X23424.Total Lipids in VLDL,EXTL1,Exostosin-like 1,37562,0.0189997059701779,0.00451664327550349,0.0101470851501911,0.0278523267901647,2.60966602104337e-05
NMR metabolomics,X23424.Total Lipids in VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40305,0.0177904700329417,0.00423250220759212,0.00949476570606117,0.0260861743598223,2.64494902722713e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CST7,Cystatin-F,40376,0.0363680725657266,0.00865744796172084,0.0193994745607537,0.0533366705706994,2.67439595831227e-05
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE1,Ribonuclease pancreatic,37987,0.00954645634769638,0.00227929402269694,0.00507904006321037,0.0140138726321824,2.82783280558363e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA6,Corticosteroid-binding globulin,38013,0.00705093877935559,0.00168587024611588,0.00374663309696847,0.0103552444617427,2.90295598043643e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,39961,0.0161361715069331,0.00385898777255183,0.00857255547273151,0.0236997875411347,2.91244296459261e-05
NMR metabolomics,X23424.Total Lipids in VLDL,AHNAK2,Protein AHNAK2,37628,0.0112904608680449,0.00270363574289974,0.00599133481196145,0.0165895869241284,2.98550939595924e-05
NMR metabolomics,X23424.Total Lipids in VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40042,0.013709716752124,0.00329534875793855,0.00725083318656443,0.0201686003176836,3.19500161084623e-05
NMR metabolomics,X23424.Total Lipids in VLDL,MBL2,Mannose-binding protein C,37810,-0.0418362151293807,0.010060163009121,-0.0615541346272579,-0.0221182956315035,3.2220115028953e-05
NMR metabolomics,X23424.Total Lipids in VLDL,NXPH3,Neurexophilin-3,37598,0.0119081244014252,0.00286648403466654,0.00628981569347876,0.0175264331093716,3.28402859501145e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SPARCL1,SPARC-like protein 1,40346,-0.0107709024671691,0.00259572906656832,-0.015858531437643,-0.00568327349669519,3.34978712569519e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CD48,CD48 antigen,40396,0.0114433710953885,0.00275909094982302,0.00603555283373533,0.0168511893570416,3.37843915867519e-05
NMR metabolomics,X23424.Total Lipids in VLDL,MYOM1,Myomesin-1,37541,0.0183604382280817,0.0044273686914187,0.00968279559290109,0.0270380808632624,3.38937968729254e-05
NMR metabolomics,X23424.Total Lipids in VLDL,GPNMB,Transmembrane glycoprotein NMB,39957,0.0109951669376893,0.00266009477207825,0.00578138118441594,0.0162089526909627,3.59355153461908e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,37998,0.0229927671152654,0.00556299172171698,0.0120893033407001,0.0338962308898307,3.59953363424481e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ELAVL4,ELAV-like protein 4,37541,0.034030567037865,0.0082371968299322,0.0178856612511979,0.0501754728245321,3.62914899306447e-05
NMR metabolomics,X23424.Total Lipids in VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40341,-0.0150436644196836,0.00364462415227871,-0.0221871277581499,-0.00790020108121734,3.68389323532132e-05
NMR metabolomics,X23424.Total Lipids in VLDL,RAB44,Ras-related protein Rab-44,37900,0.015417002663811,0.00376298969113266,0.008041542869191,0.022792462458431,4.20975923821064e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SLC13A1,Solute carrier family 13 member 1,37900,0.0240217976543966,0.00586685744330921,0.0125227570655105,0.0355208382432826,4.25570341281994e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CA9,Carbonic anhydrase 9,40489,-0.0173470284299214,0.00423708546064112,-0.0256517159327779,-0.00904234092706476,4.25898327687236e-05
NMR metabolomics,X23424.Total Lipids in VLDL,DNPEP,Aspartyl aminopeptidase,37942,0.0229309011911302,0.00561009680581804,0.0119351114517268,0.0339266909305335,4.38696646200134e-05
NMR metabolomics,X23424.Total Lipids in VLDL,RAB39B,Ras-related protein Rab-39B,37562,0.0343556922424162,0.00842937734476484,0.0178341126466771,0.0508772718381553,4.61447261184137e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ROBO4,Roundabout homolog 4,37628,-0.0068755657374721,0.00168860122499486,-0.010185224138462,-0.00356590733648217,4.69334948493156e-05
NMR metabolomics,X23424.Total Lipids in VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,40359,0.0107875504576506,0.00265710619271649,0.00557962231992627,0.0159954785953749,4.93314625286883e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SPON1,Spondin-1,40379,0.0125613727511521,0.00309438465466051,0.00649637882801748,0.0186263666742867,4.94321249057313e-05
NMR metabolomics,X23424.Total Lipids in VLDL,GIPC2,PDZ domain-containing protein GIPC2,37942,0.0111481444615213,0.00275083432254407,0.00575650918933489,0.0165397797337076,5.09265782460824e-05
NMR metabolomics,X23424.Total Lipids in VLDL,FOLR1,Folate receptor alpha,40299,0.0108209941835212,0.0026706207067881,0.0055865775982165,0.0160554107688259,5.10532718047445e-05
NMR metabolomics,X23424.Total Lipids in VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,39980,0.0114720196104738,0.00284508900086842,0.00589564516877168,0.0170483940521759,5.55167948395866e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SSH3,Protein phosphatase Slingshot homolog 3,37482,0.0111127546868491,0.00276219111563945,0.00569886010019576,0.0165266492735024,5.77450927526364e-05
NMR metabolomics,X23424.Total Lipids in VLDL,IL10RA,Interleukin-10 receptor subunit alpha,40044,0.0228259843872489,0.00567408013572239,0.0117047873212331,0.0339471814532648,5.77687722992895e-05
NMR metabolomics,X23424.Total Lipids in VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40471,0.0272554790404886,0.00679501410749881,0.0139372513897909,0.0405737066911862,6.0710900845262e-05
NMR metabolomics,X23424.Total Lipids in VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37901,-0.0261746634666176,0.00652528392868498,-0.0389642199668402,-0.013385106966395,6.07201335265105e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CST6,Cystatin-M,39992,0.0180378609162438,0.00450075461142729,0.00921638187784626,0.0268593399546412,6.1588101702941e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CTRL,Chymotrypsin-like protease CTRL-1,37942,-0.0248217088387606,0.00619565370937704,-0.0369651901091396,-0.0126782275683816,6.2005735572464e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ITGAV,Integrin alpha-V,40489,0.00615782340739511,0.00154104385611899,0.00313737744940189,0.00917826936538832,6.47429408464137e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37959,-0.0142555826921566,0.00357183869386208,-0.0212563865321262,-0.00725477885218689,6.61136822920759e-05
NMR metabolomics,X23424.Total Lipids in VLDL,TDO2,"Tryptophan 2,3-dioxygenase",37572,0.0146082500680004,0.00366875033003648,0.00741749942112889,0.0217990007148719,6.87625230600517e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ACRV1,Acrosomal protein SP-10,37598,0.0132279485956784,0.00333477152995018,0.00669179639697601,0.0197641007943807,7.32694171641889e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SYT1,Synaptotagmin-1,37942,0.014615937390655,0.00369480760415568,0.00737411448650987,0.0218577602948002,7.66676169283205e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CDH15,Cadherin-15,40435,0.0164811412734249,0.0041698697546588,0.00830819655429368,0.0246540859925562,7.76925965656314e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,40332,0.016109217726048,0.00408012486831917,0.00811217298414242,0.0241062624679536,7.90750282641553e-05
NMR metabolomics,X23424.Total Lipids in VLDL,STX5,Syntaxin-5,37598,0.0156369954111134,0.00396195812002118,0.00787155749587191,0.0234024333263549,7.96199444744218e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PSPN,Persephin,40341,0.0368236881967457,0.00935499317791348,0.0184879015680352,0.0551594748254561,8.31138485017782e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40305,-0.0155274053992421,0.00394506156030864,-0.0232597260574471,-0.00779508474103719,8.32360356409369e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC1,Sialoadhesin,40422,0.0160250942578618,0.00407383587650481,0.00804037593991234,0.0240098125758112,8.40151145814674e-05
NMR metabolomics,X23424.Total Lipids in VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,39980,0.0210882800314632,0.00536292181459219,0.0105769532748625,0.0315996067880639,8.45245337412608e-05
NMR metabolomics,X23424.Total Lipids in VLDL,MFAP4,Microfibril-associated glycoprotein 4,37671,-0.0116371878809423,0.00296051796342856,-0.0174398030892623,-0.00583457267262233,8.50970763661583e-05
NMR metabolomics,X23424.Total Lipids in VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37598,0.0130636952566312,0.00332475098653716,0.0065471833230184,0.019580207190244,8.56560735339529e-05
NMR metabolomics,X23424.Total Lipids in VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38013,-0.00722585225730164,0.00184676344580121,-0.010845508611072,-0.00360619590353126,9.17111289325804e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37628,0.0136039836785486,0.00348350517224426,0.00677631354094986,0.0204316538161474,9.45947476393595e-05
NMR metabolomics,X23424.Total Lipids in VLDL,NECTIN1,Nectin-1,37598,0.0117935833034901,0.00302031592510164,0.00587376409029086,0.0177134025166893,9.47935907995773e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",40332,0.0135658870310778,0.0034896072282363,0.00672625686373467,0.020405517198421,0.000101689236114543
NMR metabolomics,X23424.Total Lipids in VLDL,CD109,CD109 antigen,40332,-0.0121890581882017,0.003145861479514,-0.0183549466880491,-0.00602316968835425,0.000107214472892873
NMR metabolomics,X23424.Total Lipids in VLDL,EDN1,Endothelin-1,37628,0.0106397824349189,0.00274793837332929,0.00525382322319347,0.0160257416466443,0.000108505306898818
NMR metabolomics,X23424.Total Lipids in VLDL,ERC2,ERC protein 2,37572,0.0281245334623462,0.00727288312789613,0.0138696825316698,0.0423793843930227,0.000110695887158227
NMR metabolomics,X23424.Total Lipids in VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,37714,0.0216137744445739,0.00559087732200112,0.0106556548934517,0.0325718939956961,0.00011120805052924
NMR metabolomics,X23424.Total Lipids in VLDL,PMS1,PMS1 protein homolog 1,37572,0.0188811523736718,0.00491577355441818,0.00924623620701218,0.0285160685403314,0.000123144686326611
NMR metabolomics,X23424.Total Lipids in VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37942,0.0196463566934827,0.00511759613120415,0.00961586827632259,0.0296768451106428,0.000124109966926355
NMR metabolomics,X23424.Total Lipids in VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37900,0.0159438170914397,0.00416050427324091,0.00778922871588752,0.0240984054669919,0.000127588757207739
NMR metabolomics,X23424.Total Lipids in VLDL,CDH3,Cadherin-3,40471,0.0127261703760382,0.00333591545227097,0.0061877760895871,0.0192645646624893,0.000136751855881779
NMR metabolomics,X23424.Total Lipids in VLDL,NPR1,Atrial natriuretic peptide receptor 1,37562,-0.0145310373977438,0.00381393396042823,-0.0220063479601832,-0.00705572683530451,0.000139608979679012
NMR metabolomics,X23424.Total Lipids in VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37714,0.0258188216897777,0.00677959209630916,0.0125308211810118,0.0391068221985437,0.000140547613367246
NMR metabolomics,X23424.Total Lipids in VLDL,NINJ1,Ninjurin-1,39980,0.0202003011155816,0.00530718511005462,0.00979821829987459,0.0306023839312887,0.000141650183205029
NMR metabolomics,X23424.Total Lipids in VLDL,NUP50,Nuclear pore complex protein Nup50,37562,-0.0128007125128403,0.00336372175657819,-0.0193936071557335,-0.00620781786994702,0.000142149605069654
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40341,0.0120276596854524,0.00316121592802436,0.00583167646652469,0.0182236429043802,0.000142475188137565
NMR metabolomics,X23424.Total Lipids in VLDL,ARTN,Artemin,40044,0.0159284725752507,0.00419646484236971,0.00770340148420606,0.0241535436662953,0.000147791645222642
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA7A,Semaphorin-7A,40490,0.00959068901441306,0.0025308470866373,0.00463022872460395,0.0145511493042222,0.000151492238803514
NMR metabolomics,X23424.Total Lipids in VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39961,0.0176543617677484,0.00466546540903338,0.008510049566043,0.0267986739694538,0.000154876185164221
NMR metabolomics,X23424.Total Lipids in VLDL,COL9A2,Collagen alpha-2(IX) chain,37714,0.0165683971299003,0.00438430096079526,0.0079751672467416,0.025161627013059,0.000158130793736521
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40167,0.0114783352737891,0.00303799964438308,0.0055238559707983,0.01743281457678,0.000158514416916239
NMR metabolomics,X23424.Total Lipids in VLDL,EPHA2,Ephrin type-A receptor 2,39759,0.0109545541829429,0.00290253762898842,0.00526558043012565,0.0166435279357602,0.000161172962426525
NMR metabolomics,X23424.Total Lipids in VLDL,FABP1,"Fatty acid-binding protein, liver",40357,0.0327892480628258,0.00873953297029317,0.0156597634410512,0.0499187326846005,0.000176171432566415
NMR metabolomics,X23424.Total Lipids in VLDL,ITGA11,Integrin alpha-11,40341,-0.0119823902038419,0.00320538522628387,-0.0182649452473583,-0.00569983516032554,0.000185987980424218
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP5,Rho GTPase-activating protein 5,37482,0.0273039534205746,0.00731673351245912,0.0129631557361547,0.0416447511049944,0.000190989825166471
NMR metabolomics,X23424.Total Lipids in VLDL,CYB5A,Cytochrome b5,37482,0.0259033242991116,0.00694758285477462,0.0122860619037533,0.0395205866944698,0.000193520243111731
NMR metabolomics,X23424.Total Lipids in VLDL,PLIN3,Perilipin-3,40359,0.0148657849792407,0.00399202946636873,0.00704140722515798,0.0226901627333234,0.000196871990415034
NMR metabolomics,X23424.Total Lipids in VLDL,GLP1R,Glucagon-like peptide 1 receptor,37541,-0.0134603207231465,0.00363264163226457,-0.0205802983223851,-0.00634034312390799,0.000211942709170814
NMR metabolomics,X23424.Total Lipids in VLDL,TCN1,Transcobalamin-1,37766,0.011559335453106,0.00312105452802126,0.00544206857818435,0.0176766023280277,0.000213367152563949
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39757,0.0227095615977457,0.0061365667999257,0.0106818906698913,0.0347372325256001,0.000215763462156928
NMR metabolomics,X23424.Total Lipids in VLDL,SIRPB1,Signal-regulatory protein beta-1,40335,0.0156287455038205,0.00422434472077125,0.00734902985110883,0.0239084611565321,0.000216595399903974
NMR metabolomics,X23424.Total Lipids in VLDL,ACTN2,Alpha-actinin-2,37562,-0.0191335853604384,0.00517277610362059,-0.0292722265235348,-0.00899494419734208,0.000217419849998655
NMR metabolomics,X23424.Total Lipids in VLDL,PTK7,Inactive tyrosine-protein kinase 7,39961,0.0134369606035236,0.00363455926069143,0.00631322445256841,0.0205606967544788,0.000218915290551922
NMR metabolomics,X23424.Total Lipids in VLDL,NME1,Nucleoside diphosphate kinase A,37598,-0.0076786825532887,0.00207806553035939,-0.0117516909927931,-0.00360567411378429,0.000220682836271184
NMR metabolomics,X23424.Total Lipids in VLDL,LRRC38,Leucine-rich repeat-containing protein 38,37572,0.0172323407060235,0.00467534688433812,0.00806866081272074,0.0263960205993262,0.000228913822423979
NMR metabolomics,X23424.Total Lipids in VLDL,IGSF21,Immunoglobulin superfamily member 21,37628,0.0135979627325228,0.0036937933875547,0.00635812769291557,0.02083779777213,0.000232973947055896
NMR metabolomics,X23424.Total Lipids in VLDL,SATB1,DNA-binding protein SATB1,37959,0.0104540766792028,0.00284457519060443,0.00487870930561817,0.0160294440527875,0.000238683470789664
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC14A,C-type lectin domain family 14 member A,40332,-0.0108782133590017,0.00296112084016801,-0.016682010205731,-0.00507441651227243,0.000239866866379227
NMR metabolomics,X23424.Total Lipids in VLDL,DSC2,Desmocollin-2,40177,-0.0116568658767245,0.00317350784462354,-0.0178769412521866,-0.00543679050126232,0.000240345100930586
NMR metabolomics,X23424.Total Lipids in VLDL,IL1RAP,Interleukin-1 receptor accessory protein,40332,-0.0148904544341531,0.00405550720479208,-0.0228392485555455,-0.00694166031276058,0.000241767895221438
NMR metabolomics,X23424.Total Lipids in VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37901,0.0176431210204902,0.00481549640242973,0.00820474807172797,0.0270814939692525,0.000249434297947692
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37628,-0.00923104954815317,0.00252003520062693,-0.014170318541382,-0.00429178055492439,0.000250193109822899
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN2,Contactin-2,40489,0.0154355349769619,0.00422158424315154,0.00716122986038484,0.0237098400935389,0.000256662763442011
NMR metabolomics,X23424.Total Lipids in VLDL,ANPEP,Aminopeptidase N,40370,0.00971810851817131,0.00266040609443375,0.00450371257308116,0.0149325044632615,0.000260161231003563
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40330,0.0108308706442824,0.00296550304806408,0.00501848467007679,0.016643256618488,0.000260750064114126
NMR metabolomics,X23424.Total Lipids in VLDL,DDX25,ATP-dependent RNA helicase DDX25,37572,-0.0135322375589875,0.00370910378733099,-0.0208020809821562,-0.00626239413581876,0.000264917282099631
NMR metabolomics,X23424.Total Lipids in VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,37919,0.0131643324542395,0.00360911062266058,0.00609047563382478,0.0202381892746543,0.000265774412983911
NMR metabolomics,X23424.Total Lipids in VLDL,CPE,Carboxypeptidase E,40360,-0.0130285069317825,0.00360049134174225,-0.0200854699615973,-0.00597154390196766,0.000297192781907135
NMR metabolomics,X23424.Total Lipids in VLDL,SNU13,NHP2-like protein 1,37562,0.0213044447045986,0.00590110513129765,0.00973827864725519,0.032870610761942,0.000307046944073555
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL5,Fc receptor-like protein 5,40332,-0.0189989305475113,0.00526885308568936,-0.0293258825954624,-0.00867197849956014,0.000312032313460422
NMR metabolomics,X23424.Total Lipids in VLDL,NMRK2,Nicotinamide riboside kinase 2,37482,-0.0148452150147395,0.00412865916012493,-0.0229373869685843,-0.00675304306089462,0.000324778052886605
NMR metabolomics,X23424.Total Lipids in VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37900,0.017562625625374,0.00488628623467292,0.00798550460541508,0.0271397466453329,0.000326467226898066
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37562,-0.0177067450523062,0.00493030548823135,-0.0273701438092396,-0.00804334629537276,0.000330097453917947
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37714,0.0148916952855523,0.00416266872143723,0.0067328645915353,0.0230505259795692,0.000348212790375524
NMR metabolomics,X23424.Total Lipids in VLDL,CAPS,Calcyphosin,37942,0.032050952391331,0.00896276514771427,0.0144839327018111,0.049617972080851,0.000350096274571972
NMR metabolomics,X23424.Total Lipids in VLDL,RBM19,Probable RNA-binding protein 19,37562,-0.0161706250004255,0.00453195798444061,-0.025053262649929,-0.00728798735092187,0.000360818425403834
NMR metabolomics,X23424.Total Lipids in VLDL,CDKL5,Cyclin-dependent kinase-like 5,37541,-0.0181939933930083,0.00513439975078752,-0.0282574169045518,-0.00813056988146472,0.000396156309656424
NMR metabolomics,X23424.Total Lipids in VLDL,FCAR,Immunoglobulin alpha Fc receptor,40341,0.0156490736197309,0.00442815878612582,0.00696988239892432,0.0243282648405376,0.000410497570424474
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFRB,Platelet-derived growth factor receptor beta,40536,0.0115412899334332,0.00327565971806435,0.00512099688602709,0.0179615829808394,0.000427313327974402
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN4,Contactin-4,40332,-0.00803984803761676,0.00228844390968016,-0.0125251981005899,-0.00355449797464365,0.000443911517493562
NMR metabolomics,X23424.Total Lipids in VLDL,SCG3,Secretogranin-3,40379,-0.0110228945974229,0.00313844944780848,-0.0171742555151275,-0.00487153367971826,0.000445626623689019
NMR metabolomics,X23424.Total Lipids in VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40379,-0.0113261059127212,0.00322759364972322,-0.0176521894661787,-0.00500002235926363,0.000450784262486002
NMR metabolomics,X23424.Total Lipids in VLDL,KIAA1549,UPF0606 protein KIAA1549,37714,0.0232976154430929,0.00670093011319496,0.0101637924212308,0.036431438464955,0.000509111710463472
NMR metabolomics,X23424.Total Lipids in VLDL,SCGB2A2,Mammaglobin-A,37562,-0.0105377709642306,0.00303450766637713,-0.0164854059903297,-0.00459013593813139,0.000517016701013665
NMR metabolomics,X23424.Total Lipids in VLDL,RGMA,Repulsive guidance molecule A,40471,-0.0100890434675135,0.00291215809184327,-0.0157968733275263,-0.00438121360750068,0.000532694952827476
NMR metabolomics,X23424.Total Lipids in VLDL,SDC1,Syndecan-1,40359,0.0130154481969553,0.00376558302111186,0.00563490547557605,0.0203959909183345,0.00054882493023082
NMR metabolomics,X23424.Total Lipids in VLDL,EFHD1,EF-hand domain-containing protein D1,37959,0.0113241344311017,0.00327743830758221,0.00490035534824061,0.0177479135139629,0.000551617952960672
NMR metabolomics,X23424.Total Lipids in VLDL,MELTF,Melanotransferrin,37990,0.00951761484925329,0.00275771010711635,0.00411250303930524,0.0149227266592013,0.0005596484614732
NMR metabolomics,X23424.Total Lipids in VLDL,PDRG1,p53 and DNA damage-regulated protein 1,37572,0.0175549905697593,0.00509024747572144,0.00757810551734528,0.0275318756221733,0.000564956901568811
NMR metabolomics,X23424.Total Lipids in VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39823,-0.0280995168093025,0.00815327647792311,-0.0440799387060318,-0.0121190949125732,0.000569610988953456
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37998,-0.0125969019282747,0.00365946434759618,-0.0197694520495632,-0.00542435180698614,0.000578574730536673
NMR metabolomics,X23424.Total Lipids in VLDL,SIL1,Nucleotide exchange factor SIL1,37628,0.0104052205971605,0.00302350290143187,0.00447915491035402,0.0163312862839669,0.000580410270913451
NMR metabolomics,X23424.Total Lipids in VLDL,SDK2,Protein sidekick-2,37671,0.0123758608001114,0.00360334318145778,0.00531330816445415,0.0194384134357686,0.000595361489751346
NMR metabolomics,X23424.Total Lipids in VLDL,SLC4A1,Band 3 anion transport protein,37998,-0.0149662617224138,0.00436431951042416,-0.0235203279628452,-0.00641219548198245,0.000607095864268825
NMR metabolomics,X23424.Total Lipids in VLDL,RCC1,Regulator of chromosome condensation,37900,0.0165463168869234,0.00482736291855585,0.00708468556655396,0.0260079482072929,0.000610743364188697
NMR metabolomics,X23424.Total Lipids in VLDL,AMPD3,AMP deaminase 3,37942,0.0234635478328762,0.00684597763254407,0.0100454316730898,0.0368816639926626,0.000611326513219093
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS4,Galectin-4,40357,0.0170013475216001,0.00496620875009923,0.00726757837140557,0.0267351166717945,0.000619975509969499
NMR metabolomics,X23424.Total Lipids in VLDL,PRKCQ,Protein kinase C theta type,40044,0.0143003450722797,0.00418196285561542,0.0061036978752735,0.0224969922692859,0.000628901358294247
NMR metabolomics,X23424.Total Lipids in VLDL,MAPK13,Mitogen-activated protein kinase 13,37482,0.0133439652483133,0.00390660956032633,0.00568701051007372,0.021000919986553,0.000638028740531728
NMR metabolomics,X23424.Total Lipids in VLDL,NME3,Nucleoside diphosphate kinase 3,40379,0.00769564825011343,0.00225385645944848,0.0032780895895944,0.0121132069106324,0.000640735397256371
NMR metabolomics,X23424.Total Lipids in VLDL,APOA4,Apolipoprotein A-IV,38013,0.0117751982511842,0.00347329871636519,0.00496753276710845,0.01858286373526,0.000700392263367114
NMR metabolomics,X23424.Total Lipids in VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40228,0.0192970430814435,0.00571432252487283,0.00809697093269279,0.0304971152301943,0.000734684970535253
NMR metabolomics,X23424.Total Lipids in VLDL,CD34,Hematopoietic progenitor cell antigen CD34,40408,0.00769363024906618,0.0022837273136769,0.00321752471425946,0.0121697357838729,0.000756496561281843
NMR metabolomics,X23424.Total Lipids in VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37598,0.0139339523264604,0.00413606078984082,0.00582727317837243,0.0220406314745485,0.000756871388579841
NMR metabolomics,X23424.Total Lipids in VLDL,SEZ6L2,Seizure 6-like protein 2,40305,-0.00751480278971371,0.00223552787430193,-0.0118964374233455,-0.00313316815608193,0.000776939716845346
NMR metabolomics,X23424.Total Lipids in VLDL,TFF3,Trefoil factor 3,40309,0.016819655581076,0.00502526664984641,0.00697013294737698,0.0266691782147749,0.000818759224259166
NMR metabolomics,X23424.Total Lipids in VLDL,DCN,Decorin,40042,-0.00714736743717147,0.00214688246050373,-0.0113552570597588,-0.00293947781458416,0.000873026327579766
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37998,0.0112318865897394,0.00337537960198043,0.00461614256985778,0.0178476306096211,0.000878333194880253
NMR metabolomics,X23424.Total Lipids in VLDL,F3,Tissue factor,40393,-0.00878878337716788,0.00264422662213686,-0.0139714675565561,-0.00360609919777964,0.000890116547198614
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37598,0.00987320906099394,0.00297075813611685,0.00405052311420491,0.015695895007783,0.000891496240410223
NMR metabolomics,X23424.Total Lipids in VLDL,IL11,Interleukin-11,40044,0.0199809977090378,0.00601936714469135,0.00818303810544277,0.0317789573126329,0.000904012296589475
NMR metabolomics,X23424.Total Lipids in VLDL,CPA4,Carboxypeptidase A4,37410,0.0137474998453087,0.00415018362966444,0.00561313993116638,0.021881859759451,0.000927179452220247
NMR metabolomics,X23424.Total Lipids in VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37562,-0.00997561625506099,0.00301200142899226,-0.0158791390558858,-0.00407209345423616,0.000928966492072185
NMR metabolomics,X23424.Total Lipids in VLDL,GSAP,Gamma-secretase-activating protein,39980,0.0278009529211676,0.00842175784512227,0.0112943075447279,0.0443075982976072,0.000965283152178987
NMR metabolomics,X23424.Total Lipids in VLDL,SEZ6,Seizure protein 6 homolog,37572,-0.0097419381521112,0.0029564015741485,-0.0155364852374423,-0.00394739106678015,0.000986120351492481
NMR metabolomics,X23424.Total Lipids in VLDL,PGLYRP1,Peptidoglycan recognition protein 1,40451,0.0132580346246856,0.00402539163197941,0.0053682670260059,0.0211478022233652,0.000991274221238582
NMR metabolomics,X23424.Total Lipids in VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37628,-0.00636876626898043,0.00193579012453853,-0.0101629149130759,-0.00257461762488492,0.00100447307528318
NMR metabolomics,X23424.Total Lipids in VLDL,CRTAC1,Cartilage acidic protein 1,40536,0.00905523617186133,0.00275472382282599,0.00365597747912239,0.0144544948646003,0.00101417855400892
NMR metabolomics,X23424.Total Lipids in VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40228,0.0322614691878971,0.0098427201161961,0.0129697377601527,0.0515532006156414,0.00104883385405522
NMR metabolomics,X23424.Total Lipids in VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37572,0.0113056109156742,0.00345500280574007,0.00453380541642366,0.0180774164149247,0.0010697331195498
NMR metabolomics,X23424.Total Lipids in VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40379,0.0102634521310669,0.00314217441020894,0.00410479028705737,0.0164221139750764,0.00109172525951017
NMR metabolomics,X23424.Total Lipids in VLDL,NMI,N-myc-interactor,37857,0.0220740788129144,0.0067603598165119,0.00882377357255105,0.0353243840532777,0.00109652575581596
NMR metabolomics,X23424.Total Lipids in VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37598,0.0270968069258204,0.00830526599691449,0.010818485571868,0.0433751282797728,0.00110674672170264
NMR metabolomics,X23424.Total Lipids in VLDL,NTF3,Neurotrophin-3,40341,0.0107309999137483,0.00328980383498901,0.00428298439716987,0.0171790154303268,0.00110902871954892
NMR metabolomics,X23424.Total Lipids in VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39961,0.0169911828610389,0.00520967570688738,0.00678021847553965,0.0272021472465382,0.00111076856217827
NMR metabolomics,X23424.Total Lipids in VLDL,NCR1,Natural cytotoxicity triggering receptor 1,40306,0.0110311634660743,0.00339091089097511,0.00438497811976311,0.0176773488123855,0.00114369475263868
NMR metabolomics,X23424.Total Lipids in VLDL,KIRREL2,Kin of IRRE-like protein 2,39961,0.012291703026819,0.00378329326525234,0.00487644822692445,0.0197069578267136,0.00116081401407035
NMR metabolomics,X23424.Total Lipids in VLDL,CDH6,Cadherin-6,40359,-0.0115553846104305,0.00356870543292719,-0.0185500472589678,-0.0045607219618932,0.00120627442787778
NMR metabolomics,X23424.Total Lipids in VLDL,JUN,Transcription factor AP-1,40044,0.0157737980485011,0.00488549075177399,0.00619823617502408,0.0253493599219781,0.00124610326295308
NMR metabolomics,X23424.Total Lipids in VLDL,CHGA,Chromogranin-A,37998,-0.0275357697372708,0.00852825364021285,-0.044251146872088,-0.0108203926024536,0.00124619977203827
NMR metabolomics,X23424.Total Lipids in VLDL,FAM3D,Protein FAM3D,37901,0.0250617590831819,0.00776836989109593,0.00983575409663388,0.0402877640697299,0.00125777178005884
NMR metabolomics,X23424.Total Lipids in VLDL,NELL2,Protein kinase C-binding protein NELL2,40422,0.00856976558653356,0.00265800871455159,0.00336006850601244,0.0137794626670547,0.00126609959239711
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM26,Tripartite motif-containing protein 26,37482,0.0167655975851245,0.00520686378940075,0.00656014455789905,0.02697105061235,0.00128548233172278
NMR metabolomics,X23424.Total Lipids in VLDL,RBPMS,RNA-binding protein with multiple splicing,37598,0.0196816439633515,0.00611582892735833,0.00769461926572914,0.0316686686609738,0.00129333995835378
NMR metabolomics,X23424.Total Lipids in VLDL,CD209,CD209 antigen,40382,-0.0117508477670078,0.00365418217373853,-0.0189130448275354,-0.00458865070648032,0.00130374729316888
NMR metabolomics,X23424.Total Lipids in VLDL,LTA4H,Leukotriene A-4 hydrolase,40489,0.0175005067867658,0.00545497967278847,0.00680874662810036,0.0281922669454312,0.00133844591903158
NMR metabolomics,X23424.Total Lipids in VLDL,LPA,Apolipoprotein(a),37735,-0.0530243277683934,0.0165810429421506,-0.0855231719350086,-0.0205254836017781,0.00138762347563746
NMR metabolomics,X23424.Total Lipids in VLDL,IFNGR1,Interferon gamma receptor 1,40422,0.00615904059462963,0.0019270938343436,0.00238193667931617,0.00993614450994309,0.00139606016839343
NMR metabolomics,X23424.Total Lipids in VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37562,-0.0123523737306659,0.00386662120822488,-0.0199309512987867,-0.00477379616254519,0.00140347903040139
NMR metabolomics,X23424.Total Lipids in VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37714,0.0200934671468203,0.00628984058854805,0.00776537959326615,0.0324215547003745,0.0014035679731503
NMR metabolomics,X23424.Total Lipids in VLDL,BOC,Brother of CDO,40042,-0.00709961076609009,0.00222280571929353,-0.0114563099759054,-0.00274291155627476,0.00140601864073843
NMR metabolomics,X23424.Total Lipids in VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40332,0.0126387345907223,0.00396273449163857,0.00487177498711071,0.0204056941943339,0.00142846649259402
NMR metabolomics,X23424.Total Lipids in VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37959,0.0145647740695705,0.00458522417984335,0.00557773467707749,0.0235518134620634,0.00149420482239117
NMR metabolomics,X23424.Total Lipids in VLDL,MANSC4,MANSC domain-containing protein 4,37562,0.0196956563418748,0.00622165385187704,0.00750121479219579,0.0318900978915538,0.00155084314770897
NMR metabolomics,X23424.Total Lipids in VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,37541,-0.0102332475459877,0.00323991158729511,-0.0165834742570861,-0.00388302083488932,0.00158946022612952
NMR metabolomics,X23424.Total Lipids in VLDL,IL15RA,Interleukin-15 receptor subunit alpha,40044,0.0105983419870387,0.00335658952282737,0.00401942652229702,0.0171772574517803,0.00159446074624353
NMR metabolomics,X23424.Total Lipids in VLDL,FOLH1,Glutamate carboxypeptidase 2,37598,0.032157629617643,0.010189744597523,0.0121857302064979,0.0521295290287882,0.00160374748253058
NMR metabolomics,X23424.Total Lipids in VLDL,TSC1,Hamartin,37598,0.0226803576874035,0.00721783907621209,0.00853339309802782,0.0368273222767792,0.00168018973284983
NMR metabolomics,X23424.Total Lipids in VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37628,0.018380145786988,0.00585368510841614,0.00690692297449239,0.0298533685994836,0.00169363174521841
NMR metabolomics,X23424.Total Lipids in VLDL,STX3,Syntaxin-3,37942,0.0114330862080508,0.00365497296186658,0.00426933920279232,0.0185968332133093,0.00176320494137945
NMR metabolomics,X23424.Total Lipids in VLDL,TIMP2,Metalloproteinase inhibitor 2,37990,-0.00737404732648523,0.00235790740745988,-0.0119955458451066,-0.00275254880786386,0.00176751970138168
NMR metabolomics,X23424.Total Lipids in VLDL,GFRAL,GDNF family receptor alpha-like,37477,-0.0182667643821574,0.00585456203523838,-0.0297417059712246,-0.00679182279309015,0.00181190214203418
NMR metabolomics,X23424.Total Lipids in VLDL,TERF1,Telomeric repeat-binding factor 1,37598,-0.00877407334002498,0.00281260722625914,-0.0142867835034929,-0.00326136317655706,0.00181518206347792
NMR metabolomics,X23424.Total Lipids in VLDL,TYMP,Thymidine phosphorylase,40257,0.0195534623407022,0.00627166694335789,0.00726099513172074,0.0318459295496837,0.00182567049047798
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",37460,0.00744980780981043,0.0023929702928912,0.00275958603574367,0.0121400295838772,0.00185468650260021
NMR metabolomics,X23424.Total Lipids in VLDL,NTF4,Neurotrophin-4,39980,0.0119457906959423,0.00384667046850241,0.00440631657767759,0.019485264814207,0.00190307052007853
NMR metabolomics,X23424.Total Lipids in VLDL,KLK4,Kallikrein-4,40489,-0.0177842749270135,0.00572784505101569,-0.0290108512270042,-0.00655769862702273,0.00190687447912144
NMR metabolomics,X23424.Total Lipids in VLDL,MATN3,Matrilin-3,40203,-0.00912068417560283,0.00294510292784233,-0.0148930859141738,-0.00334828243703187,0.00195900548372139
NMR metabolomics,X23424.Total Lipids in VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,37598,-0.0182773534034392,0.00591734208302861,-0.0298753438861752,-0.00667936292070309,0.00201400928204481
NMR metabolomics,X23424.Total Lipids in VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37635,-0.0141180643865776,0.00458796267975626,-0.0231104712388999,-0.00512565753425532,0.0020938577538466
NMR metabolomics,X23424.Total Lipids in VLDL,SCN2B,Sodium channel subunit beta-2,37572,-0.00863216072934808,0.00280581901308945,-0.0141315659950034,-0.00313275546369275,0.00209862863813657
NMR metabolomics,X23424.Total Lipids in VLDL,NEO1,Neogenin,37959,0.00619786750384038,0.00201471163844584,0.00224903269248653,0.0101467023151942,0.00210002384842547
NMR metabolomics,X23424.Total Lipids in VLDL,FMR1,Synaptic functional regulator FMR1,39980,0.0101790123403385,0.00330965708260706,0.00369208445842863,0.0166659402222483,0.00210480521569576
NMR metabolomics,X23424.Total Lipids in VLDL,BRD3,Bromodomain-containing protein 3,37562,0.0140457285177966,0.00458298478587153,0.00506307833748841,0.0230283786981048,0.00218290529146972
NMR metabolomics,X23424.Total Lipids in VLDL,TEF,Thyrotroph embryonic factor,37562,0.0124945130532064,0.00407781609357716,0.0045019935097952,0.0204870325966177,0.00218827102971027
NMR metabolomics,X23424.Total Lipids in VLDL,NRCAM,Neuronal cell adhesion molecule,40359,0.00806716840334554,0.00263313932458382,0.00290621532716126,0.0132281214795298,0.00218978206723278
NMR metabolomics,X23424.Total Lipids in VLDL,CLC,Galectin-10,40333,-0.0189542825799112,0.0061909141230744,-0.031088474261137,-0.00682009089868533,0.00220503890308331
NMR metabolomics,X23424.Total Lipids in VLDL,INHBB,Inhibin beta B chain,37671,0.0148819519696058,0.00486562191162101,0.00534533302282861,0.024418570916383,0.00222824645001183
NMR metabolomics,X23424.Total Lipids in VLDL,PADI2,Protein-arginine deiminase type-2,40044,0.0161553794853803,0.00528544930592782,0.00579589884576175,0.0265148601249988,0.00224259151614979
NMR metabolomics,X23424.Total Lipids in VLDL,DIPK2B,Divergent protein kinase domain 2B,37671,0.00770983082847056,0.00252266420528313,0.00276540898611563,0.0126542526708255,0.00224589638919696
NMR metabolomics,X23424.Total Lipids in VLDL,DRAXIN,Draxin,40228,0.0124655367908172,0.00408074228966808,0.0044672819030678,0.0204637916785667,0.00225644354972662
NMR metabolomics,X23424.Total Lipids in VLDL,TNXB,Tenascin-X,40332,-0.00727012721138343,0.00239876832769255,-0.0119717131336608,-0.00256854128910604,0.00244319663512771
NMR metabolomics,X23424.Total Lipids in VLDL,COL1A1,Collagen alpha-1(I) chain,40536,-0.00738138422300448,0.00244396673103346,-0.0121715590158301,-0.00259120943017889,0.00252964708082464
NMR metabolomics,X23424.Total Lipids in VLDL,DDA1,DET1- and DDB1-associated protein 1,37562,0.011644430258058,0.00385896481773782,0.00408085921529191,0.0192080013008242,0.00255357407056843
NMR metabolomics,X23424.Total Lipids in VLDL,TFF2,Trefoil factor 2,40396,0.0161701566771515,0.00536242554148821,0.00565980261583464,0.0266805107384684,0.00256997363626949
NMR metabolomics,X23424.Total Lipids in VLDL,QSOX1,Sulfhydryl oxidase 1,37761,0.012653048377203,0.00423682906893921,0.00434886340208217,0.0209572333523239,0.00282757353466759
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC6A,C-type lectin domain family 6 member A,39980,0.0131595913752036,0.00441022725987325,0.00451554594585203,0.0218036368045552,0.00285060579138132
NMR metabolomics,X23424.Total Lipids in VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37942,-0.00734437507485407,0.00246311804385352,-0.012172086440807,-0.00251666370890116,0.00287128132968261
NMR metabolomics,X23424.Total Lipids in VLDL,NDRG1,Protein NDRG1,39961,0.0192302758181309,0.00648318475776431,0.00652323369291282,0.0319373179433489,0.00301986074939189
NMR metabolomics,X23424.Total Lipids in VLDL,HMBS,Porphobilinogen deaminase,40489,0.0126249290678791,0.00427991363377594,0.00423629834567829,0.02101355979008,0.00318429387584326
NMR metabolomics,X23424.Total Lipids in VLDL,PTTG1,Securin,37714,0.0114678890708211,0.00390961716093019,0.00380503943539793,0.0191307387062443,0.00336006452168644
NMR metabolomics,X23424.Total Lipids in VLDL,BLVRB,Flavin reductase,40332,0.0183043579178402,0.00624564852514669,0.0060628868085527,0.0305458290271277,0.00338639870414937
NMR metabolomics,X23424.Total Lipids in VLDL,SPINT1,Kunitz-type protease inhibitor 1,40278,0.00705480886176913,0.00241045680411722,0.00233031352569938,0.0117793041978389,0.00343009293780841
NMR metabolomics,X23424.Total Lipids in VLDL,SCP2,Non-specific lipid-transfer protein,39980,0.0215084607071913,0.00735246740654653,0.00709762459036015,0.0359192968240225,0.0034457896483648
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPT2,Angiopoietin-2,40489,-0.0106374680972479,0.00364639196833887,-0.0177843963551921,-0.00349053983930372,0.00353612805608512
NMR metabolomics,X23424.Total Lipids in VLDL,SH3GL3,Endophilin-A3,37643,0.0227882663166484,0.00783914342904737,0.00742354519571556,0.0381529874375813,0.00365539270232472
NMR metabolomics,X23424.Total Lipids in VLDL,MYO6,Unconventional myosin-VI,37959,0.0102818583294253,0.00353851796507368,0.0033463631178809,0.0172173535409697,0.00367031936653666
NMR metabolomics,X23424.Total Lipids in VLDL,SAT1,Diamine acetyltransferase 1,37562,-0.014371591887863,0.0049471691234604,-0.0240680433698454,-0.00467514040588062,0.00367851325216711
NMR metabolomics,X23424.Total Lipids in VLDL,SEPTIN7,Septin-7,37714,0.0144133370429282,0.00496460168516501,0.00468271774000479,0.0241439563458516,0.00369954478934246
NMR metabolomics,X23424.Total Lipids in VLDL,FDX2,"Ferredoxin-2, mitochondrial",37562,0.0157971456244868,0.00544914157315581,0.00511682814110147,0.0264774631078722,0.00374957410394303
NMR metabolomics,X23424.Total Lipids in VLDL,DCTPP1,dCTP pyrophosphatase 1,40359,0.00862882985711511,0.00298538522474167,0.00277747481662143,0.0144801848976088,0.00385324609538948
NMR metabolomics,X23424.Total Lipids in VLDL,CD5L,CD5 antigen-like,37934,0.0126945031528312,0.0044000773702009,0.00407035150723739,0.0213186547984249,0.0039195485481382
NMR metabolomics,X23424.Total Lipids in VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37959,0.0119045828365455,0.00412761303986641,0.0038144612784073,0.0199947043946836,0.00393113840659056
NMR metabolomics,X23424.Total Lipids in VLDL,NPTXR,Neuronal pentraxin receptor,40359,0.00916408182113441,0.00319574109106693,0.00290042928264322,0.0154277343596256,0.00414151945833218
NMR metabolomics,X23424.Total Lipids in VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,37900,0.00770164967553557,0.00268639222117755,0.00243632092202756,0.0129669784290436,0.00415142214787434
NMR metabolomics,X23424.Total Lipids in VLDL,CENPJ,Centromere protein J,37714,0.0197713630969705,0.00693238080389098,0.00618389672134419,0.0333588294725968,0.00435080376795556
NMR metabolomics,X23424.Total Lipids in VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37900,0.013535257596051,0.00475807255919686,0.00420943538002516,0.0228610798120768,0.00445213137173828
NMR metabolomics,X23424.Total Lipids in VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40042,0.00725439702994726,0.00255209466708258,0.0022522914824654,0.0122565025774291,0.00448156257791907
NMR metabolomics,X23424.Total Lipids in VLDL,CLIC5,Chloride intracellular channel protein 5,37572,-0.0086752831706867,0.00305199713589525,-0.0146571975570414,-0.00269336878433202,0.00448311761338937
NMR metabolomics,X23424.Total Lipids in VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40536,0.0187518908694134,0.00660124230262821,0.00581345595626209,0.0316903257825647,0.004507669910168
NMR metabolomics,X23424.Total Lipids in VLDL,NRXN3,Neurexin-3,37572,0.00933471215875529,0.0032966948796709,0.00287319019460032,0.0157962341229102,0.0046395438956603
NMR metabolomics,X23424.Total Lipids in VLDL,ART3,Ecto-ADP-ribosyltransferase 3,40403,-0.00884890473497684,0.00312661931126497,-0.0149770785850562,-0.0027207308848975,0.00465795239472288
NMR metabolomics,X23424.Total Lipids in VLDL,HBQ1,Hemoglobin subunit theta-1,40489,-0.0157414136296081,0.00556406078219055,-0.0266469727627015,-0.00483585449651458,0.00467336570268644
NMR metabolomics,X23424.Total Lipids in VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37714,0.0141708246722547,0.00501716323055343,0.00433718474037002,0.0240044646041395,0.00474296163814172
NMR metabolomics,X23424.Total Lipids in VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37562,-0.0109797131556223,0.00389828213178994,-0.0186203461339306,-0.00333908017731398,0.00486147613584781
NMR metabolomics,X23424.Total Lipids in VLDL,ARG1,Arginase-1,40227,0.0139966629618276,0.0049800923817361,0.00423568189362481,0.0237576440300303,0.00495220330652674
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC7A,C-type lectin domain family 7 member A,40516,0.0154822960890869,0.00551389160256264,0.00467506854806412,0.0262895236301097,0.00499303407614494
NMR metabolomics,X23424.Total Lipids in VLDL,IL1RL1,Interleukin-1 receptor-like 1,40490,-0.011951895884255,0.00426431564712695,-0.0203099545526238,-0.00359383721588616,0.00507265830999262
NMR metabolomics,X23424.Total Lipids in VLDL,CDH23,Cadherin-23,37942,-0.0069893665180326,0.00249715465753079,-0.011883789646793,-0.00209494338927225,0.00513446888511717
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA3G,Semaphorin-3G,37671,0.0114267410218084,0.00408311663370946,0.00342383241973787,0.0194296496238789,0.00514094821167287
NMR metabolomics,X23424.Total Lipids in VLDL,SAFB2,Scaffold attachment factor B2,37959,0.00729362236628011,0.0026154061544949,0.0021674263034701,0.0124198184290901,0.00529916516809585
NMR metabolomics,X23424.Total Lipids in VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40042,-0.00547085342691501,0.00196787429365945,-0.00932788704248753,-0.00161381981134249,0.00544101876192528
NMR metabolomics,X23424.Total Lipids in VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40400,0.0167271890802269,0.00602026286386034,0.00492747386706062,0.0285269042933932,0.00546774834116386
NMR metabolomics,X23424.Total Lipids in VLDL,SAG,S-arrestin,37541,-0.0140231664692848,0.00505306910814298,-0.023927181921245,-0.00411915101732454,0.00552497695922535
NMR metabolomics,X23424.Total Lipids in VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37541,-0.0161183478460515,0.00581225887887686,-0.0275103752486501,-0.00472632044345287,0.00555926690236026
NMR metabolomics,X23424.Total Lipids in VLDL,CD55,Complement decay-accelerating factor,39802,0.00685649912564932,0.00247496303908205,0.0020055715690485,0.0117074266822501,0.00560644257397147
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC10A,C-type lectin domain family 10 member A,40228,-0.00941185059307794,0.00339777330252288,-0.0160714862660228,-0.0027522149201331,0.00561208913264311
NMR metabolomics,X23424.Total Lipids in VLDL,CHRDL2,Chordin-like protein 2,40359,0.0148187771671287,0.00535873197431016,0.00431566249748081,0.0253218918367766,0.00569270338206283
NMR metabolomics,X23424.Total Lipids in VLDL,NGF,Beta-nerve growth factor,40228,0.00317730622980314,0.00114912076157961,0.00092502953710711,0.00542958292249917,0.00569908421045708
NMR metabolomics,X23424.Total Lipids in VLDL,TMOD4,Tropomodulin-4,37482,-0.010949678544128,0.00396543492384588,-0.0187219309948659,-0.00317742609339007,0.0057655770368088
NMR metabolomics,X23424.Total Lipids in VLDL,TK1,"Thymidine kinase, cytosolic",37714,0.0116702839752017,0.00422724970084307,0.00338487456154928,0.0199556933888541,0.00577520485275575
NMR metabolomics,X23424.Total Lipids in VLDL,TSPAN8,Tetraspanin-8,37901,0.0270779874591427,0.00981173234648435,0.00784699206003342,0.0463089828582521,0.005792282541762
NMR metabolomics,X23424.Total Lipids in VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,37482,0.0232186326960194,0.00842315957215304,0.00670923993459947,0.0397280254574394,0.00585007731596092
NMR metabolomics,X23424.Total Lipids in VLDL,AMBN,Ameloblastin,40044,-0.00770758491898092,0.00279824174026603,-0.0131921387299023,-0.00222303110805949,0.00588610825149405
NMR metabolomics,X23424.Total Lipids in VLDL,CPTP,Ceramide-1-phosphate transfer protein,37562,-0.0104834921784702,0.00381765847602624,-0.0179661027914816,-0.00300088156545875,0.00603992885879853
NMR metabolomics,X23424.Total Lipids in VLDL,NCAM1,Neural cell adhesion molecule 1,40403,-0.00713308070152484,0.00259919574227967,-0.012227504356393,-0.00203865704665669,0.00607002305424279
NMR metabolomics,X23424.Total Lipids in VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39980,-0.0083784853233658,0.00305692589053201,-0.0143700600688085,-0.00238691057792305,0.00613560429223219
NMR metabolomics,X23424.Total Lipids in VLDL,IL20RA,Interleukin-20 receptor subunit alpha,40044,0.0119447775988985,0.00436022690627053,0.00339873286260822,0.0204908223351887,0.00616054119507698
NMR metabolomics,X23424.Total Lipids in VLDL,CD2,T-cell surface antigen CD2,37562,0.00990370003913781,0.00361648402473471,0.00281539135065778,0.0169920087276178,0.00618056519459985
NMR metabolomics,X23424.Total Lipids in VLDL,SOD3,Extracellular superoxide dismutase,37987,-0.0151987598433481,0.00558318609917603,-0.0261418045977331,-0.00425571508896309,0.00649244860246514
NMR metabolomics,X23424.Total Lipids in VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40332,0.00677559466251135,0.00249166063790433,0.00189193981221885,0.0116592495128038,0.00654896067561461
NMR metabolomics,X23424.Total Lipids in VLDL,ACE,Angiotensin-converting enzyme,37987,-0.00655655329167089,0.00241208791261711,-0.0112842456004004,-0.00182886098294136,0.00657204180390612
NMR metabolomics,X23424.Total Lipids in VLDL,LMNB1,Lamin-B1,37874,0.0145916472245178,0.00537878689449348,0.00404922491131053,0.025134069537725,0.00667996435709213
NMR metabolomics,X23424.Total Lipids in VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40228,-0.0072321870961058,0.00266833196662818,-0.012462117750697,-0.00200225644151457,0.00672793183175925
NMR metabolomics,X23424.Total Lipids in VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37562,-0.0153786588542601,0.00567446584435533,-0.0265006119091965,-0.00425670579932365,0.00673400749478944
NMR metabolomics,X23424.Total Lipids in VLDL,CFD,Complement factor D,38013,0.00486862635637145,0.00179719150372498,0.00134613100907048,0.00839112170367241,0.00675671553536809
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC12A,C-type lectin domain family 12 member A,37598,0.00524258200909307,0.00193648300383824,0.00144707532157013,0.00903808869661601,0.00679267570864281
NMR metabolomics,X23424.Total Lipids in VLDL,PRR4,Proline-rich protein 4,37577,-0.0175270911646233,0.00651189421700983,-0.0302904038299626,-0.00476377849928405,0.00712109098268567
NMR metabolomics,X23424.Total Lipids in VLDL,CD160,CD160 antigen,40516,0.01156967032913,0.00429997546579848,0.00314171841616493,0.019997622242095,0.00713896470379621
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL14,C-X-C motif chemokine 14,40044,0.0155229320514725,0.0057919077989454,0.00417079276553953,0.0268750713374055,0.00736759879079257
NMR metabolomics,X23424.Total Lipids in VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,40357,0.0736774638863921,0.0275336143070267,0.0197115798446197,0.127643347928165,0.00746030755726526
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37562,0.0131812240843692,0.00492938647961323,0.00351962658432725,0.0228428215844111,0.00750433372084521
NMR metabolomics,X23424.Total Lipids in VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37562,-0.0122278294340267,0.00459161680248257,-0.0212273983668925,-0.00322826050116081,0.00775242632879943
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH12,Protocadherin-12,37959,0.00644151310533973,0.00241909722778577,0.00170008253887962,0.0111829436717998,0.00775909242991734
NMR metabolomics,X23424.Total Lipids in VLDL,LEO1,RNA polymerase-associated protein LEO1,37959,0.00778198678278486,0.00292603404403652,0.00204696005647328,0.0135170135090964,0.00783332435477321
NMR metabolomics,X23424.Total Lipids in VLDL,PI16,Peptidase inhibitor 16,37987,-0.00617118272877871,0.00232590827855163,-0.0107299629547399,-0.00161240250281751,0.00798172841000058
NMR metabolomics,X23424.Total Lipids in VLDL,DPP10,Inactive dipeptidyl peptidase 10,40341,0.00850068344952251,0.00320558756206437,0.00221773182787635,0.0147836350711687,0.00801355603577645
NMR metabolomics,X23424.Total Lipids in VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37714,0.00899981078530476,0.00340189443793224,0.00233209768695757,0.0156675238836519,0.00816594606921277
NMR metabolomics,X23424.Total Lipids in VLDL,CLMP,CXADR-like membrane protein,40489,0.00506702383769274,0.00192017714804892,0.00130347662751686,0.00883057104786862,0.00832727352418499
NMR metabolomics,X23424.Total Lipids in VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,40305,-0.00655377589279385,0.00248636892469887,-0.0114270589852036,-0.00168049280038407,0.00840005484461271
NMR metabolomics,X23424.Total Lipids in VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37900,0.0169455768744329,0.00646390092497338,0.00427633106148504,0.0296148226873807,0.00876240077958282
NMR metabolomics,X23424.Total Lipids in VLDL,AIF1L,Allograft inflammatory factor 1-like,37628,0.014364968597509,0.00547973269364105,0.00362469251797252,0.0251052446770454,0.00876514191081955
NMR metabolomics,X23424.Total Lipids in VLDL,PDCD6,Programmed cell death protein 6,40359,-0.0172081401227723,0.00656963828719745,-0.0300846311656793,-0.0043316490798653,0.00881827560288903
NMR metabolomics,X23424.Total Lipids in VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40341,0.0369876347280968,0.014163306085432,0.00922755480065012,0.0647477146555435,0.00902277207979629
NMR metabolomics,X23424.Total Lipids in VLDL,BMP4,Bone morphogenetic protein 4,40203,-0.0111494082608699,0.00427874682959031,-0.0195357520468669,-0.00276306447487289,0.00917555990072968
NMR metabolomics,X23424.Total Lipids in VLDL,PLAUR,Urokinase plasminogen activator surface receptor,40264,0.00653852090725101,0.00251303564981994,0.00161297103360393,0.0114640707808981,0.00928110751101604
NMR metabolomics,X23424.Total Lipids in VLDL,PON1,Serum paraoxonase/arylesterase 1,37987,-0.0063386801385297,0.00244415306881498,-0.0111292201534071,-0.00154814012365235,0.00951329310796529
NMR metabolomics,X23424.Total Lipids in VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37541,-0.0160019025078643,0.00617160293834566,-0.0280982442670217,-0.00390556074870677,0.00952963456601153
NMR metabolomics,X23424.Total Lipids in VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,37628,0.0103546614082327,0.00399676140223728,0.00252100905984762,0.0181883137566177,0.00958689362539913
NMR metabolomics,X23424.Total Lipids in VLDL,MKI67,Proliferation marker protein Ki-67,37598,0.00923613462451876,0.00357286782718729,0.00223331368323167,0.0162389555658059,0.00974642272921793
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB7,Integrin beta-7,40489,0.0110716024568558,0.00428667155917807,0.00266972620086682,0.0194734787128449,0.00980907114620944
NMR metabolomics,X23424.Total Lipids in VLDL,SSB,Lupus La protein,39961,0.0146620338363295,0.00569598171630634,0.00349790967236908,0.0258261580002899,0.0100592783965444
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,40341,0.0157989963924551,0.00614970510726677,0.0037455743822122,0.0278524184026979,0.0102063544973459
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA1,Alpha-1-antitrypsin,37779,-0.00196601210893703,0.000766898625652189,-0.00346913341521532,-0.000462890802658739,0.0103705132445795
NMR metabolomics,X23424.Total Lipids in VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37598,0.00738339870500954,0.00288059792459333,0.00173742677280661,0.0130293706372125,0.0103838096892093
NMR metabolomics,X23424.Total Lipids in VLDL,CDK1,Cyclin-dependent kinase 1,37482,0.00887589420419479,0.00346489129371668,0.00208470726851009,0.0156670811398795,0.0104282939943959
NMR metabolomics,X23424.Total Lipids in VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39961,0.0119811245249333,0.00469037313687797,0.00278799317665246,0.0211742558732141,0.0106463360370033
NMR metabolomics,X23424.Total Lipids in VLDL,DDI2,Protein DDI1 homolog 2,37671,0.0188389353690183,0.00738475019819987,0.00436482498054655,0.03331304575749,0.0107507708135573
NMR metabolomics,X23424.Total Lipids in VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37562,0.0119461395757545,0.00469203335089867,0.00274975420799312,0.0211425249435159,0.010906378445187
NMR metabolomics,X23424.Total Lipids in VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40044,0.0286461321354218,0.0113234154145575,0.00645223792288915,0.0508400263479544,0.0114220727022712
NMR metabolomics,X23424.Total Lipids in VLDL,MUC2,Mucin-2,37998,0.0215509670899628,0.00856840677762005,0.00475688980582752,0.0383450443740981,0.0119091072270899
NMR metabolomics,X23424.Total Lipids in VLDL,DPEP1,Dipeptidase 1,40192,-0.0120303446657212,0.00478784635881357,-0.0214145235289957,-0.00264616580244656,0.011991576139733
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G1B,Phospholipase A2,40514,-0.00990667499975042,0.00394417384853592,-0.0176372557428808,-0.00217609425662001,0.012024038989914
NMR metabolomics,X23424.Total Lipids in VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,39961,0.011499404455106,0.00458325669042971,0.00251622134186378,0.0204825875683482,0.0121173623832432
NMR metabolomics,X23424.Total Lipids in VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37598,0.0146626154206723,0.00585183032597339,0.00319302798176443,0.0261322028595801,0.0122347811460324
NMR metabolomics,X23424.Total Lipids in VLDL,TNN,Tenascin-N,37998,0.010353410485978,0.00413564662405211,0.00224754310283587,0.0184592778691201,0.0123103593879016
NMR metabolomics,X23424.Total Lipids in VLDL,FGFR4,Fibroblast growth factor receptor 4,37671,0.0125676816141756,0.0050533581549636,0.0026630996304469,0.0224722635979042,0.0128949240768953
NMR metabolomics,X23424.Total Lipids in VLDL,STX1B,Syntaxin-1B,37572,0.0101020716049728,0.00406472362817189,0.00213521329375585,0.0180689299161897,0.012956466370725
NMR metabolomics,X23424.Total Lipids in VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37562,-0.00895057378915181,0.00361729928567274,-0.0160404803890704,-0.00186066718923325,0.0133593160344681
NMR metabolomics,X23424.Total Lipids in VLDL,CA11,Carbonic anhydrase-related protein 11,39980,0.0077100699421813,0.00311924083846384,0.00159635789879216,0.0138237819855704,0.013454949945514
NMR metabolomics,X23424.Total Lipids in VLDL,IL19,Interleukin-19,39924,0.0157551138526351,0.006392109199522,0.00322657982157197,0.0282836478836982,0.0137206962435502
NMR metabolomics,X23424.Total Lipids in VLDL,MYH4,Myosin-4,37562,-0.0111058940782591,0.00450677081625623,-0.0199391648781213,-0.00227262327839684,0.0137420500473187
NMR metabolomics,X23424.Total Lipids in VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,40536,0.00961968119429852,0.00390741859443496,0.001961140749206,0.017278221639391,0.0138306594657468
NMR metabolomics,X23424.Total Lipids in VLDL,CRNN,Cornulin,39857,0.015378514354588,0.00625909186373862,0.0031106943016603,0.0276463344075157,0.0140216762032667
NMR metabolomics,X23424.Total Lipids in VLDL,LIFR,Leukemia inhibitory factor receptor,40341,-0.00563607006272723,0.00230542298810344,-0.01015469911941,-0.00111744100604449,0.0145080116308164
NMR metabolomics,X23424.Total Lipids in VLDL,COMMD9,COMM domain-containing protein 9,37900,0.00906866040820046,0.00370950006938591,0.00179804027220406,0.0163392805441968,0.0145095191594628
NMR metabolomics,X23424.Total Lipids in VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",37598,0.00668707566806744,0.00274785836362525,0.00130127327536195,0.0120728780607729,0.0149644280556055
NMR metabolomics,X23424.Total Lipids in VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37184,0.01118216677677,0.00461432439834438,0.002138090956015,0.020226242597525,0.0153915484140211
NMR metabolomics,X23424.Total Lipids in VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,37901,0.00624641673309999,0.00257799603005146,0.00119354451419913,0.0112992889520008,0.0154071540344236
NMR metabolomics,X23424.Total Lipids in VLDL,NOP56,Nucleolar protein 56,37562,0.0253907873524167,0.0104794428703396,0.00485107932655115,0.0459304953782822,0.0154100328127309
NMR metabolomics,X23424.Total Lipids in VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,40359,0.0130657111228272,0.00540860932093042,0.00246483685380353,0.0236665853918508,0.0157151232510243
NMR metabolomics,X23424.Total Lipids in VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37900,0.0216652610806239,0.00896836046952433,0.0040872745603562,0.0392432476008916,0.0157163468447835
NMR metabolomics,X23424.Total Lipids in VLDL,CTSV,Cathepsin L2,40444,0.00964834721508733,0.00399751312761167,0.00181322148496845,0.0174834729452062,0.015807504785203
NMR metabolomics,X23424.Total Lipids in VLDL,MYH7B,Myosin-7B,37482,-0.0104215655625601,0.00432795022365629,-0.0189043480009264,-0.00193878312419373,0.0160553905897815
NMR metabolomics,X23424.Total Lipids in VLDL,IL17RA,Interleukin-17 receptor A,40332,0.0099383011688756,0.00413138812277079,0.00184078044824485,0.0180358218895063,0.0161590693796918
NMR metabolomics,X23424.Total Lipids in VLDL,CD33,Myeloid cell surface antigen CD33,40411,0.0179137371179778,0.00747298548231772,0.00326668557263507,0.0325607886633205,0.0165353688735814
NMR metabolomics,X23424.Total Lipids in VLDL,TXNL1,Thioredoxin-like protein 1,37525,0.0215652355778796,0.00902438020368366,0.00387745037865959,0.0392530207770996,0.0168778787612188
NMR metabolomics,X23424.Total Lipids in VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40044,0.0129159823413434,0.00540648383093366,0.0023192740327134,0.0235126906499733,0.0169070331543285
NMR metabolomics,X23424.Total Lipids in VLDL,SUSD5,Sushi domain-containing protein 5,37604,-0.00771922890757134,0.00323355183763133,-0.0140569905093287,-0.00138146730581394,0.0169899501444888
NMR metabolomics,X23424.Total Lipids in VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,37572,0.0136495007821942,0.0057181434765412,0.00244193956817349,0.024857061996215,0.016998206407693
NMR metabolomics,X23424.Total Lipids in VLDL,CLSPN,Claspin,39925,0.00767860848244361,0.0032185737996717,0.00137020383508708,0.0139870131298001,0.0170577861246448
NMR metabolomics,X23424.Total Lipids in VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37572,-0.0072395557893702,0.00303891743869187,-0.0131958339692063,-0.00128327760953413,0.0172199159203013
NMR metabolomics,X23424.Total Lipids in VLDL,NAPRT,Nicotinate phosphoribosyltransferase,37942,0.00744279699298138,0.00312644328386259,0.00131496815661071,0.013570625829352,0.0172984791227459
NMR metabolomics,X23424.Total Lipids in VLDL,TLR4,Toll-like receptor 4,37598,0.00635123402233726,0.00269108959273227,0.00107669842058201,0.0116257696240925,0.0182846539146339
NMR metabolomics,X23424.Total Lipids in VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37714,0.0124889147908851,0.00531448853736643,0.00207251725764684,0.0229053123241233,0.0187892514608765
NMR metabolomics,X23424.Total Lipids in VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",39961,0.00954549393466207,0.00406413764207647,0.00157978415619218,0.017511203713132,0.0188508907965774
NMR metabolomics,X23424.Total Lipids in VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,37598,0.0081768390365125,0.00349565323243674,0.00132535870093649,0.0150283193720885,0.0193428373079997
NMR metabolomics,X23424.Total Lipids in VLDL,CEP290,Centrosomal protein of 290 kDa,37714,0.0117565515717829,0.00504128811479101,0.0018756268667925,0.0216374762767733,0.019712787952748
NMR metabolomics,X23424.Total Lipids in VLDL,GPR101,Probable G-protein coupled receptor 101,37541,-0.014180848074476,0.00611216806261728,-0.0261606974772059,-0.00220099867174618,0.0203507061484576
NMR metabolomics,X23424.Total Lipids in VLDL,SOX9,Transcription factor SOX-9,37572,0.00595732584836211,0.00256794404284376,0.000924155524388347,0.0109904961723359,0.0203625563065463
NMR metabolomics,X23424.Total Lipids in VLDL,INSL4,Early placenta insulin-like peptide,37900,-0.0118485988309799,0.00511738462194664,-0.0218786726899953,-0.00181852497196447,0.0206080921144106
NMR metabolomics,X23424.Total Lipids in VLDL,SULT1A1,Sulfotransferase 1A1,40471,-0.0279499964654997,0.0121061803085872,-0.0516781098703306,-0.00422188306066889,0.0209707993872959
NMR metabolomics,X23424.Total Lipids in VLDL,RETN,Resistin,40283,0.00898078002383707,0.00390142923230545,0.00133397872851839,0.0166275813191558,0.0213525707266267
NMR metabolomics,X23424.Total Lipids in VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37457,0.0194031609075841,0.00844093624450655,0.00285892586835129,0.035947395946817,0.0215378908174294
NMR metabolomics,X23424.Total Lipids in VLDL,VIM,Vimentin,40042,0.0255749931075469,0.0111544087334722,0.00371235198994144,0.0474376342251523,0.0218719227638504
NMR metabolomics,X23424.Total Lipids in VLDL,SUMF1,Formylglycine-generating enzyme,37598,0.0144857991898018,0.00635363741956243,0.00203266984745949,0.0269389285321442,0.0226282442212198
NMR metabolomics,X23424.Total Lipids in VLDL,CDHR1,Cadherin-related family member 1,39961,0.00943718527632497,0.00414440047628379,0.00131416034280874,0.0175602102098412,0.0227942289203951
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,37901,0.0118197786008385,0.00522068648739858,0.00158723308553732,0.0220523241161397,0.0235882707056622
NMR metabolomics,X23424.Total Lipids in VLDL,GBP6,Guanylate-binding protein 6,37562,-0.0101794052176295,0.00449660719767328,-0.0189927553250692,-0.0013660551101899,0.0236028833618957
NMR metabolomics,X23424.Total Lipids in VLDL,RLN1,Prorelaxin H1,37959,-0.0176322802269533,0.00779864927000059,-0.0329176327961545,-0.00234692765775218,0.0237787973331915
NMR metabolomics,X23424.Total Lipids in VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37987,0.0100905243458509,0.00447215427859693,0.00132510195980089,0.0188559467319009,0.0240677002839459
NMR metabolomics,X23424.Total Lipids in VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,40405,-0.0108171759074349,0.00479981676476505,-0.0202248167663744,-0.00140953504849541,0.0242308096890635
NMR metabolomics,X23424.Total Lipids in VLDL,TMEM132A,Transmembrane protein 132A,37628,0.0133812480011021,0.00594173356674272,0.00173545021028633,0.0250270457919178,0.0243337321099042
NMR metabolomics,X23424.Total Lipids in VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",37482,0.0193059874149235,0.0085821771726182,0.00248492015659182,0.0361270546732552,0.0244945132444117
NMR metabolomics,X23424.Total Lipids in VLDL,FDX1,"Adrenodoxin, mitochondrial",37562,0.0133757346109834,0.00595248461311114,0.00170886476928562,0.0250426044526813,0.0246512061550679
NMR metabolomics,X23424.Total Lipids in VLDL,IL17C,Interleukin-17C,40044,-0.0148186935887941,0.00661465610056515,-0.0277834195459018,-0.00185396763168642,0.0250866629245138
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,37562,0.00827675007750491,0.00369877904442435,0.00102714315043317,0.0155263570045766,0.0252574920010645
NMR metabolomics,X23424.Total Lipids in VLDL,CEP164,Centrosomal protein of 164 kDa,40044,0.0134164711007698,0.00603049740272274,0.00159669619143324,0.0252362460101064,0.0261109225635443
NMR metabolomics,X23424.Total Lipids in VLDL,FBLN2,Fibulin-2,37998,-0.00647125342344769,0.00291437419227625,-0.0121834268403091,-0.000759080006586229,0.0264039908284168
NMR metabolomics,X23424.Total Lipids in VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40355,-0.0103583357085803,0.00469244702298009,-0.0195555318736213,-0.00116113954353934,0.0272969576009671
NMR metabolomics,X23424.Total Lipids in VLDL,GSTP1,Glutathione S-transferase P,39871,-0.0145104507693572,0.00658266285201986,-0.0274124699593161,-0.00160843157939823,0.0275149054612372
NMR metabolomics,X23424.Total Lipids in VLDL,TMEM25,Transmembrane protein 25,37959,-0.00909209776538349,0.00413957021356121,-0.0172056553839635,-0.000978540146803515,0.0280811965451744
NMR metabolomics,X23424.Total Lipids in VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,39980,0.0106200794204063,0.00484738467270497,0.00111920546190451,0.020120953378908,0.0284746702056105
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",37562,0.00826545230378781,0.0037934463996154,0.000830297360541622,0.015700607247034,0.0293585692001211
NMR metabolomics,X23424.Total Lipids in VLDL,AKAP12,A-kinase anchor protein 12,37671,-0.00447935967944001,0.00205986275058454,-0.0085166906705857,-0.000442028688294319,0.0296784272498106
NMR metabolomics,X23424.Total Lipids in VLDL,RAD51,DNA repair protein RAD51 homolog 1,37714,0.0111669654743826,0.00513870250647987,0.00109510856168205,0.0212388223870831,0.0297896843654376
NMR metabolomics,X23424.Total Lipids in VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37541,0.0117195579123386,0.00541585571248202,0.00110448071587384,0.0223346351088034,0.0304873934623342
NMR metabolomics,X23424.Total Lipids in VLDL,ADRA2A,Alpha-2A adrenergic receptor,37562,-0.0147147418480576,0.00681525106351507,-0.0280726339325471,-0.00135684976356805,0.0308612513813625
NMR metabolomics,X23424.Total Lipids in VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40411,-0.00705703046263768,0.00326908487420625,-0.0134644368160819,-0.000649624109193437,0.0308869558012273
NMR metabolomics,X23424.Total Lipids in VLDL,MAMDC2,MAM domain-containing protein 2,37990,-0.00692108132928362,0.00320885556657277,-0.0132104382397662,-0.000631724418800993,0.0310334142113836
NMR metabolomics,X23424.Total Lipids in VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37562,0.0114387436679159,0.00531104559437485,0.0010290943029412,0.0218483930328906,0.031276784401303
NMR metabolomics,X23424.Total Lipids in VLDL,WNT9A,Protein Wnt-9a,40044,0.00578130070514851,0.00270278342461327,0.000483845192906507,0.0110787562173905,0.0324497479142498
NMR metabolomics,X23424.Total Lipids in VLDL,RLN2,Prorelaxin H2,37643,0.0284879918148626,0.013320212387899,0.00238037553458061,0.0545956080951445,0.0324779575195938
NMR metabolomics,X23424.Total Lipids in VLDL,UNG,Uracil-DNA glycosylase,37900,0.00683208202636674,0.00320360165030748,0.000553022791764084,0.0131111412609694,0.032973533082975
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL6,Fc receptor-like protein 6,40341,0.0134782539596746,0.00635820886962941,0.00101616457520091,0.0259403433441482,0.034036745007666
NMR metabolomics,X23424.Total Lipids in VLDL,IFNW1,Interferon omega-1,37562,-0.00736560059777254,0.00348618313329135,-0.0141985195390236,-0.000532681656521502,0.0346369158857273
NMR metabolomics,X23424.Total Lipids in VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,37572,0.00587896466183703,0.00279036359793747,0.000409852009879592,0.0113480773137945,0.035146809934107
NMR metabolomics,X23424.Total Lipids in VLDL,TGFBR3,Transforming growth factor beta receptor type 3,40536,-0.00653174903440391,0.00310896334510829,-0.0126253171908161,-0.000438180877991667,0.035661654645542
NMR metabolomics,X23424.Total Lipids in VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,40516,0.00869733650144348,0.00415547823852169,0.000552599153940977,0.016842073848946,0.0363665076373234
NMR metabolomics,X23424.Total Lipids in VLDL,CADPS,Calcium-dependent secretion activator 1,37572,-0.00891532912913989,0.00426229089096383,-0.017269419275429,-0.000561238982850784,0.0364867381730267
NMR metabolomics,X23424.Total Lipids in VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,37541,-0.00982911500841933,0.00474739181572327,-0.0191340029672369,-0.000524227049601722,0.0384321968846657
NMR metabolomics,X23424.Total Lipids in VLDL,IL33,Interleukin-33,40044,0.0075377442958889,0.00364672865394808,0.000390156134150659,0.0146853324576271,0.0387517528980402
NMR metabolomics,X23424.Total Lipids in VLDL,IL2RG,Cytokine receptor common subunit gamma,37900,0.00753837831678479,0.00365127478068381,0.000381879746644535,0.0146948768869251,0.0389811221874932
NMR metabolomics,X23424.Total Lipids in VLDL,ID4,DNA-binding protein inhibitor ID-4,37714,-0.00886831424993886,0.00430827631542214,-0.0173125358281662,-0.000424092671711472,0.0395677191879343
NMR metabolomics,X23424.Total Lipids in VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,37942,0.00600590645150575,0.00293049837714373,0.000262129632304038,0.0117496832707075,0.0404375436723681
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB2,Integrin beta-2,40221,0.0055260261849764,0.00270116429988807,0.000231744157195785,0.010820308212757,0.0407931796688192
NMR metabolomics,X23424.Total Lipids in VLDL,GUK1,Guanylate kinase,37562,-0.00774166707103074,0.00380383043970185,-0.0151971747328464,-0.000286159409215108,0.0418478808954383
NMR metabolomics,X23424.Total Lipids in VLDL,ATP1B4,Protein ATP1B4,37482,-0.00811096742041583,0.00400522281478954,-0.0159612041374033,-0.00026073070342832,0.0428776837920049
NMR metabolomics,X23424.Total Lipids in VLDL,GLI2,Zinc finger protein GLI2,37598,-0.00642160267892972,0.00318780191993165,-0.0126696944419958,-0.000173510915863674,0.0439847712904136
NMR metabolomics,X23424.Total Lipids in VLDL,SLC12A2,Solute carrier family 12 member 2,37562,-0.00545509098705891,0.00270826950723056,-0.0107632992212308,-0.000146882752887007,0.0440052611797205
NMR metabolomics,X23424.Total Lipids in VLDL,CEP152,Centrosomal protein of 152 kDa,37482,0.00792165800424138,0.00393389532400557,0.000211223169190474,0.0156320928392923,0.0440622795689835
NMR metabolomics,X23424.Total Lipids in VLDL,CLSTN1,Calsyntenin-1,39961,0.00997557349812055,0.00495646101425156,0.000260909910187502,0.0196902370860536,0.0441697289143775
NMR metabolomics,X23424.Total Lipids in VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37959,0.013131867615068,0.00652688755759185,0.000339168002187938,0.025924567227948,0.0442434724378353
NMR metabolomics,X23424.Total Lipids in VLDL,PLAU,Urokinase-type plasminogen activator,40332,0.0055524535448487,0.00276553946290708,0.000131996197550831,0.0109729108921466,0.044689013981284
NMR metabolomics,X23424.Total Lipids in VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37541,-0.0104413251452361,0.00521235427309966,-0.0206575395205115,-0.000225110769960801,0.0451777003435411
NMR metabolomics,X23424.Total Lipids in VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37959,-0.00445675799787932,0.00223309465633987,-0.00883362352430547,-7.98924714531793e-05,0.0459782939009652
NMR metabolomics,X23424.Total Lipids in VLDL,DOCK9,Dedicator of cytokinesis protein 9,37541,0.0225201525313573,0.0113099744936564,0.000352602523790751,0.0446877025389239,0.0464822664655536
NMR metabolomics,X23424.Total Lipids in VLDL,EPHA4,Ephrin type-A receptor 4,37671,0.00529614536445155,0.00266242227641821,7.77977026718687e-05,0.0105144930262312,0.0466974291894546
NMR metabolomics,X23424.Total Lipids in VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,37598,0.0127371293596433,0.00646512513389653,6.54840972061244e-05,0.0254087746220805,0.0488445642563591
NMR metabolomics,X23424.Total Lipids in VLDL,TCN2,Transcobalamin-2,40497,0.00553445317674585,0.00280967384016539,2.74924500216784e-05,0.01104141390347,0.0488801981437381
NMR metabolomics,X23424.Total Lipids in VLDL,EPN1,Epsin-1,37714,0.00823973068443244,0.00418405558577568,3.89817363121055e-05,0.0164404796325528,0.0489375141133825
NMR metabolomics,X23424.Total Lipids in VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37562,-0.00623209863933188,0.00317526406662572,-0.0124556162099183,-8.58106874548036e-06,0.0497018703762663
NMR metabolomics,X23424.Total Lipids in VLDL,PEAR1,Platelet endothelial aggregation receptor 1,40536,0.00415293083288992,0.00212440787427312,-1.09086006853882e-05,0.00831677026646523,0.0506162904887451
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40471,0.00502972530835312,0.00257369694285343,-1.47206996395973e-05,0.0100741713163458,0.0506854473397449
NMR metabolomics,X23424.Total Lipids in VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37482,0.00488845114601403,0.00250923479339413,-2.96490490384639e-05,0.00980655134106653,0.0514143879966218
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP30,Rho GTPase-activating protein 30,37714,0.0069346309391428,0.00356524622654506,-5.32516648855293e-05,0.0139225135431711,0.0517884211548838
NMR metabolomics,X23424.Total Lipids in VLDL,DCC,Netrin receptor DCC,37572,0.00429190857451935,0.00220972423847887,-3.9150932899237e-05,0.00862296808193794,0.0521242896408809
NMR metabolomics,X23424.Total Lipids in VLDL,LTO1,Protein LTO1 homolog,40044,0.00751180431476079,0.00388085190124335,-9.46654116761782e-05,0.0151182740411978,0.0529339020091401
NMR metabolomics,X23424.Total Lipids in VLDL,CDH22,Cadherin-22,37714,-0.00538881228623813,0.0027892557800645,-0.0108557536151646,7.81290426882892e-05,0.0533821029028632
NMR metabolomics,X23424.Total Lipids in VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37677,-0.0120357915644729,0.00623017615803797,-0.0242469368342273,0.000175353705281555,0.0533988482946413
NMR metabolomics,X23424.Total Lipids in VLDL,KIAA2013,Uncharacterized protein KIAA2013,37900,0.010404003164373,0.00543785598086175,-0.000254194558116046,0.021062200886862,0.0557366732844686
NMR metabolomics,X23424.Total Lipids in VLDL,GAD1,Glutamate decarboxylase 1,37482,-0.00468455021772618,0.00244906271185883,-0.00948471313296949,0.000115612697517125,0.0557964442408676
NMR metabolomics,X23424.Total Lipids in VLDL,CCND2,G1/S-specific cyclin-D2,37714,0.00663872781607636,0.00347071173744444,-0.000163867189314748,0.0134413228214675,0.055797005620162
NMR metabolomics,X23424.Total Lipids in VLDL,AIDA,"Axin interactor, dorsalization-associated protein",37572,0.0151107212043223,0.00791290483553294,-0.000398572273322252,0.0306200146819669,0.0562026436565533
NMR metabolomics,X23424.Total Lipids in VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37572,-0.00882883876533222,0.00463835809431822,-0.0179200206301959,0.000262343099531484,0.0570049490419093
NMR metabolomics,X23424.Total Lipids in VLDL,RSPO1,R-spondin-1,40228,0.00634919196736122,0.00333672932980972,-0.000190797519065828,0.0128891814537883,0.0570823543849749
NMR metabolomics,X23424.Total Lipids in VLDL,CALY,Neuron-specific vesicular protein calcyon,37562,-0.00689125337461059,0.00362434302496968,-0.0139949657035512,0.000212458954329984,0.0572741593165029
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA6C,Semaphorin-6C,37598,0.00479098433121601,0.00252025552583853,-0.00014871649942751,0.00973068516185954,0.0573249740154515
NMR metabolomics,X23424.Total Lipids in VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,37628,0.00587872609006303,0.0030958922915651,-0.000189222801404564,0.0119466749815306,0.0576021582554661
NMR metabolomics,X23424.Total Lipids in VLDL,GDF15,Growth/differentiation factor 15,40536,0.00762403377416965,0.00404682731174522,-0.000307747756850984,0.0155558153051903,0.0595893104966218
NMR metabolomics,X23424.Total Lipids in VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37572,-0.011732643586398,0.00623572049663183,-0.0239546557597964,0.000489368587000369,0.0599231037058612
NMR metabolomics,X23424.Total Lipids in VLDL,NPTN,Neuroplastin,39980,0.0149684014250619,0.0079651070732891,-0.000643208438584742,0.0305800112887085,0.0602295241288994
NMR metabolomics,X23424.Total Lipids in VLDL,MSLNL,Mesothelin-like protein,37572,-0.00666725010859181,0.00355826535299899,-0.0136414502004698,0.000306949983286202,0.0609890227000401
NMR metabolomics,X23424.Total Lipids in VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37562,0.015739439031505,0.00840070999256702,-0.000725952553926389,0.0322048306169363,0.0610099609073724
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB116,Beta-defensin 116,37541,-0.0139836357728588,0.00748853754379334,-0.0286611693586938,0.000693897812976123,0.0618766421237944
NMR metabolomics,X23424.Total Lipids in VLDL,TTN,Titin,37562,-0.0116055031595393,0.00621762128792749,-0.0237920408838772,0.000581034564798584,0.0619867146034854
NMR metabolomics,X23424.Total Lipids in VLDL,ENG,Endoglin,40536,-0.00299218521043785,0.00160402541227738,-0.00613607501850151,0.000151704597625805,0.0621403886067797
NMR metabolomics,X23424.Total Lipids in VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,40225,0.0102443513459639,0.00549432667303444,-0.000524528933183591,0.0210132316251114,0.0622655037632039
NMR metabolomics,X23424.Total Lipids in VLDL,PGLYRP4,Peptidoglycan recognition protein 4,37562,0.0111037247505089,0.00596190511947193,-0.000581609283656121,0.0227890587846738,0.0625626405944502
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL12,Stromal cell-derived factor 1,40044,0.00712366343261206,0.00382797318647789,-0.000379164012884608,0.0146264908781087,0.0627701667554999
NMR metabolomics,X23424.Total Lipids in VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40536,0.00480408613669715,0.0025824816733783,-0.000257577943124324,0.00986575021651862,0.0628670557654376
NMR metabolomics,X23424.Total Lipids in VLDL,RALB,Ras-related protein Ral-B,37598,0.00520891454006999,0.00280342286201296,-0.000285794269475407,0.0107036233496154,0.0631835094471422
NMR metabolomics,X23424.Total Lipids in VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,39865,0.00658833806896277,0.00355987471339352,-0.000389016369288529,0.0135656925072141,0.0642286934095238
NMR metabolomics,X23424.Total Lipids in VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37900,0.00790234710442744,0.00427706757795019,-0.000480705348354923,0.0162853995572098,0.0646809224821596
NMR metabolomics,X23424.Total Lipids in VLDL,PPM1B,Protein phosphatase 1B,37598,0.011072357103086,0.00600620266905628,-0.000699800128264275,0.0228445143344364,0.0652804184450213
NMR metabolomics,X23424.Total Lipids in VLDL,MMP8,Neutrophil collagenase,40442,0.0125734545979607,0.00689387143082318,-0.000938533406452753,0.0260854426023741,0.0681919349939247
NMR metabolomics,X23424.Total Lipids in VLDL,KRT8,"Keratin, type II cytoskeletal 8",37541,0.010594672212372,0.00582291491990901,-0.000818241030649666,0.0220075854553937,0.0688611971551937
NMR metabolomics,X23424.Total Lipids in VLDL,GHRHR,Growth hormone-releasing hormone receptor,39961,0.00958787568968177,0.0052754490469862,-0.000752004442411169,0.0199277558217747,0.0691672116465403
NMR metabolomics,X23424.Total Lipids in VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37959,-0.00504184317195115,0.00278271400534389,-0.0104959626224252,0.000412276278522872,0.070032530731955
NMR metabolomics,X23424.Total Lipids in VLDL,BABAM1,BRISC and BRCA1-A complex member 1,37598,0.00503415875211357,0.00278643873837059,-0.000427261175092782,0.0104955786793199,0.0708375297100373
NMR metabolomics,X23424.Total Lipids in VLDL,SPP1,Osteopontin,40497,-0.0080618756337317,0.00448113092776204,-0.0168448922521453,0.000721140984681895,0.0720261305327129
NMR metabolomics,X23424.Total Lipids in VLDL,NRTN,Neurturin,40044,0.00836470022930564,0.0046673916575827,-0.000783387419556461,0.0175127878781677,0.0731271471090177
NMR metabolomics,X23424.Total Lipids in VLDL,CD200,OX-2 membrane glycoprotein,40341,-0.00438585618373829,0.0024487734005173,-0.00918545204875219,0.000413739681275613,0.0733055712776374
NMR metabolomics,X23424.Total Lipids in VLDL,PDCL2,Phosducin-like protein 2,37482,0.00913703072043474,0.00510911906528645,-0.000876842647526698,0.0191509040883962,0.0737384398857221
NMR metabolomics,X23424.Total Lipids in VLDL,TNR,Tenascin-R,40228,-0.00712797600283768,0.00399874957117741,-0.0149655251623454,0.000709573156670036,0.0746786080003398
NMR metabolomics,X23424.Total Lipids in VLDL,NLGN2,Neuroligin-2,37541,-0.00814413310214155,0.00457239729645643,-0.0171060318031962,0.000817765598913047,0.0749108590219526
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4M,C-type lectin domain family 4 member M,37969,-0.00812834206102516,0.00457932601364728,-0.0171038210477738,0.000847136925723514,0.0759190020542379
NMR metabolomics,X23424.Total Lipids in VLDL,KRT19,"Keratin, type I cytoskeletal 19",40310,0.0113287509784707,0.00640122792161831,-0.00121765574790117,0.0238751577048426,0.0767833787947157
NMR metabolomics,X23424.Total Lipids in VLDL,AOC3,Membrane primary amine oxidase,40403,-0.00505110966932999,0.00286030682067322,-0.0106573110378495,0.000555091699189528,0.0774262477344606
NMR metabolomics,X23424.Total Lipids in VLDL,CD99,CD99 antigen,40332,-0.00322302681522593,0.00182890995275246,-0.00680769032262075,0.000361636692168894,0.0780435099959859
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,40451,0.00494907671206094,0.00280904298368425,-0.000556647535960198,0.0104548009600821,0.078115885683874
NMR metabolomics,X23424.Total Lipids in VLDL,ZP4,Zona pellucida sperm-binding protein 4,37482,-0.00539471768504556,0.00308284558081439,-0.0114370950234418,0.000647659653350631,0.0801565219869554
NMR metabolomics,X23424.Total Lipids in VLDL,CTNNA1,Catenin alpha-1,37541,-0.00599994812166566,0.00343429672970661,-0.0127311697118906,0.000731273468559302,0.0806490868640577
NMR metabolomics,X23424.Total Lipids in VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",37959,0.00697752296991293,0.00399630816256805,-0.000855241028720452,0.0148102869685463,0.0808350378700469
NMR metabolomics,X23424.Total Lipids in VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,37541,-0.00681654441040381,0.00390727072733415,-0.0144747950359787,0.000841706215171117,0.081081562702844
NMR metabolomics,X23424.Total Lipids in VLDL,PSMC3,26S proteasome regulatory subunit 6A,37482,-0.00498158811081323,0.00285974938802181,-0.010586696911336,0.000623520689709525,0.0815378730237235
NMR metabolomics,X23424.Total Lipids in VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,37572,0.00579875591454817,0.0033462287033268,-0.000759852343972359,0.0123573641730687,0.0831328936613167
NMR metabolomics,X23424.Total Lipids in VLDL,GUCA2A,Guanylin,40276,-0.0054265297914462,0.00315376268055567,-0.0116079046453353,0.000754845062442911,0.0853334410291764
NMR metabolomics,X23424.Total Lipids in VLDL,CD58,Lymphocyte function-associated antigen 3,40335,-0.00286236770622064,0.00166425092783952,-0.00612429952478611,0.000399564112344819,0.0854676391269658
NMR metabolomics,X23424.Total Lipids in VLDL,ZPR1,Zinc finger protein ZPR1,37541,0.0158079509772709,0.00920210992842905,-0.00222818448245006,0.0338440864369918,0.0858455201898834
NMR metabolomics,X23424.Total Lipids in VLDL,LYPLA2,Acyl-protein thioesterase 2,37541,0.0175811841045297,0.0102401986227456,-0.00248960519605161,0.0376519734051111,0.0860249023686958
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,40305,0.00881605587622017,0.00514900940236271,-0.00127600255241073,0.0189081143048511,0.0868821659861388
NMR metabolomics,X23424.Total Lipids in VLDL,RGS8,Regulator of G-protein signaling 8,40044,0.0107300269008345,0.00626834190276642,-0.00155592322858764,0.0230159770302567,0.086956970296302
NMR metabolomics,X23424.Total Lipids in VLDL,MN1,Transcriptional activator MN1,37572,-0.00964938269701323,0.00564671630978601,-0.0207169466641938,0.00141818127016736,0.0875026670250687
NMR metabolomics,X23424.Total Lipids in VLDL,CPVL,Probable serine carboxypeptidase CPVL,40465,0.00651112671321535,0.0038181566847155,-0.000972460388827036,0.0139947138152577,0.0881567051853091
NMR metabolomics,X23424.Total Lipids in VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37900,0.00766744701981551,0.00452309168626858,-0.0011978126852709,0.0165327067249019,0.0900647462213071
NMR metabolomics,X23424.Total Lipids in VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37900,-0.0136548662858844,0.00806019817857041,-0.0294528547158824,0.00214312214411365,0.0902674451597289
NMR metabolomics,X23424.Total Lipids in VLDL,HTR1B,5-hydroxytryptamine receptor 1B,37541,-0.00680639794974798,0.00402751071552368,-0.0147003189521744,0.00108752305267844,0.091056288020463
NMR metabolomics,X23424.Total Lipids in VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,37714,0.0145928359951804,0.00866918802261909,-0.00239877252915298,0.0315844445195138,0.0923407498963171
NMR metabolomics,X23424.Total Lipids in VLDL,SPRING1,SREBP regulating gene protein,37482,0.00918408986761392,0.00545640903501234,-0.00151047184101027,0.0198786515762381,0.0923652250259366
NMR metabolomics,X23424.Total Lipids in VLDL,PFDN4,Prefoldin subunit 4,37482,0.00866628956394228,0.00514879267923191,-0.00142534408735226,0.0187579232152368,0.0923662859009324
NMR metabolomics,X23424.Total Lipids in VLDL,COL5A1,Collagen alpha-1(V) chain,37671,0.00630958676784681,0.00375493403343755,-0.0010500839376908,0.0136692574733844,0.092913727114017
NMR metabolomics,X23424.Total Lipids in VLDL,KIF20B,Kinesin-like protein KIF20B,37541,0.0124005735240918,0.00739590514050405,-0.00209540055129613,0.0268965475994797,0.093628760605686
NMR metabolomics,X23424.Total Lipids in VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40451,0.00545009770472306,0.00325836047238264,-0.000936288821146907,0.011836484230593,0.0944157056043327
NMR metabolomics,X23424.Total Lipids in VLDL,FGF12,Fibroblast growth factor 12,37598,0.00763416795925492,0.00456574228684977,-0.00131468692297064,0.0165830228414805,0.0945374590948041
NMR metabolomics,X23424.Total Lipids in VLDL,IL25,Interleukin-25,37429,0.00551599346368778,0.00330755777280824,-0.000966819771016361,0.0119988066983919,0.0954006623415305
NMR metabolomics,X23424.Total Lipids in VLDL,ENDOU,Poly(U)-specific endoribonuclease,36973,0.00790750232615533,0.00475256306243542,-0.00140752127621809,0.0172225259285288,0.0961695247365041
NMR metabolomics,X23424.Total Lipids in VLDL,OSTN,Osteocrin,37572,-0.00676920293392532,0.00407294950917225,-0.0147521839719029,0.00121377810405229,0.0965385914039665
NMR metabolomics,X23424.Total Lipids in VLDL,PAPPA,Pappalysin-1,40044,0.00734943845496022,0.00443325789587056,-0.00133974702094608,0.0160386239308665,0.0973787088252834
NMR metabolomics,X23424.Total Lipids in VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37562,-0.00692209976220268,0.00418080451730315,-0.0151164766161169,0.0012722770917115,0.0978093452971711
NMR metabolomics,X23424.Total Lipids in VLDL,MYL4,Myosin light chain 4,37628,-0.00822439478629308,0.00497279830205141,-0.0179710794583138,0.00152228988572769,0.098176407390422
NMR metabolomics,X23424.Total Lipids in VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,37942,0.00876119883391216,0.00533486470677974,-0.00169513599137612,0.0192175336592004,0.100560842127532
NMR metabolomics,X23424.Total Lipids in VLDL,LEG1,Protein LEG1 homolog,37231,-0.0107988225576919,0.00658442395615942,-0.0237042935117643,0.00210664839638057,0.101018182643001
NMR metabolomics,X23424.Total Lipids in VLDL,MSMB,Beta-microseminoprotein,40236,0.0106714489551574,0.00651722238794222,-0.00210230692520939,0.0234452048355241,0.101562078099633
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37998,-0.0212981910635566,0.0130191211205781,-0.0468156684598896,0.00421928633277636,0.101880360830543
NMR metabolomics,X23424.Total Lipids in VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,40228,0.00777769793587839,0.00475545980299524,-0.00154300327799227,0.0170983991497491,0.101957906847249
NMR metabolomics,X23424.Total Lipids in VLDL,TUBB3,Tubulin beta-3 chain,37541,-0.00428386329309936,0.00263213459645034,-0.00944284710214203,0.000875120515943303,0.10364983901985
NMR metabolomics,X23424.Total Lipids in VLDL,CSH1,Chorionic somatomammotropin hormone 1,37987,0.00537050890710525,0.00330171098557182,-0.00110084462461552,0.011841862438826,0.103848845810444
NMR metabolomics,X23424.Total Lipids in VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37959,0.0174381731044192,0.0107623236082467,-0.00365598116774441,0.0385323273765828,0.105191588580486
NMR metabolomics,X23424.Total Lipids in VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,37482,-0.00391473089919651,0.00241956677228926,-0.00865708177288347,0.00082761997449044,0.105698215890979
NMR metabolomics,X23424.Total Lipids in VLDL,BSND,Barttin,37482,-0.00525107938790248,0.00324887120458491,-0.0116188669488889,0.00111670817308395,0.106058407638956
NMR metabolomics,X23424.Total Lipids in VLDL,ZNF75D,Zinc finger protein 75D,37714,0.00909466737210271,0.00562895239351386,-0.00193807931918445,0.0201274140633899,0.106184169353396
NMR metabolomics,X23424.Total Lipids in VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39961,0.0102129085745742,0.00638400600978542,-0.00229974320460522,0.0227255603537536,0.10967112296251
NMR metabolomics,X23424.Total Lipids in VLDL,SOX2,Transcription factor SOX-2,37937,0.00352542177399397,0.00220446751324009,-0.000795334551956615,0.00784617809994456,0.109795836656768
NMR metabolomics,X23424.Total Lipids in VLDL,KRT17,"Keratin, type I cytoskeletal 17",37562,0.00579945009918422,0.00363083621382798,-0.00131698887991862,0.0129158890782871,0.110228142275894
NMR metabolomics,X23424.Total Lipids in VLDL,SLK,STE20-like serine/threonine-protein kinase,37714,0.0117142200107247,0.00735202273415022,-0.00269574454820974,0.0261241845696591,0.111109351549
NMR metabolomics,X23424.Total Lipids in VLDL,CRHR1,Corticotropin-releasing factor receptor 1,40042,0.00953480065502025,0.00598501979558277,-0.00219583814432198,0.0212654394543625,0.11115557301701
NMR metabolomics,X23424.Total Lipids in VLDL,COL9A1,Collagen alpha-1(IX) chain,40341,0.00707181253213219,0.00444047029643303,-0.00163150924887654,0.0157751343131409,0.111273913172415
NMR metabolomics,X23424.Total Lipids in VLDL,SCARB1,Scavenger receptor class B member 1,39961,0.00889474620897036,0.00559099854059948,-0.00206361093060463,0.0198531033485453,0.111651391988477
NMR metabolomics,X23424.Total Lipids in VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,39961,0.0103963606749316,0.00653537905001585,-0.00241298226309943,0.0232057036129627,0.111679119249481
NMR metabolomics,X23424.Total Lipids in VLDL,MB,Myoglobin,40536,-0.0073487304646071,0.00462302460644819,-0.0164098586932456,0.00171239776403134,0.11194608835111
NMR metabolomics,X23424.Total Lipids in VLDL,CORO6,Coronin-6,37541,-0.00548110123682686,0.00344921372524035,-0.0122415601382979,0.00127935766464422,0.112064869021433
NMR metabolomics,X23424.Total Lipids in VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,37959,0.00709465263551303,0.00446540248330157,-0.00165753623175805,0.0158468415027841,0.112127887958355
NMR metabolomics,X23424.Total Lipids in VLDL,COPE,Coatomer subunit epsilon,39961,0.00723737509988521,0.00455808820002237,-0.00169647777215863,0.016171227971929,0.112349839901964
NMR metabolomics,X23424.Total Lipids in VLDL,REXO2,"Oligoribonuclease, mitochondrial",37562,-0.00736898023371698,0.00464260712857062,-0.0164684902057154,0.00173052973828144,0.112480049903911
NMR metabolomics,X23424.Total Lipids in VLDL,TJP3,Tight junction protein ZO-3,37541,-0.00657674329023491,0.00416033925929262,-0.0147310082384484,0.00157752165797862,0.113943594752075
NMR metabolomics,X23424.Total Lipids in VLDL,GPR158,Probable G-protein coupled receptor 158,37959,0.00549522673749243,0.00348594961763222,-0.00133723451306671,0.0123276879880516,0.114958669066358
NMR metabolomics,X23424.Total Lipids in VLDL,TSLP,Thymic stromal lymphopoietin,40042,0.00894637930953619,0.00574092876122704,-0.00230584106246881,0.0201985996815412,0.119170477931074
NMR metabolomics,X23424.Total Lipids in VLDL,PRND,Prion-like protein doppel,37942,-0.00790103225526029,0.00507312583970718,-0.0178443589010864,0.00204229439056578,0.119392172689933
NMR metabolomics,X23424.Total Lipids in VLDL,FGF9,Fibroblast growth factor 9,37457,0.00591217673132748,0.00384600243992448,-0.00162598805092449,0.0134503415135795,0.12426218975347
NMR metabolomics,X23424.Total Lipids in VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,37482,-0.00837713088990683,0.00545240078547756,-0.0190638364294428,0.00230957464962919,0.124461785727198
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37901,-0.0043687960573582,0.00284641784428205,-0.00994777503215102,0.00121018291743462,0.124846649662303
NMR metabolomics,X23424.Total Lipids in VLDL,DUSP29,Dual specificity phosphatase 29,37572,-0.00962089325067212,0.00630824658428706,-0.0219850565558748,0.00274327005453052,0.127250892652871
NMR metabolomics,X23424.Total Lipids in VLDL,IL15,Interleukin-15,40341,0.00470538081125348,0.00308691994344726,-0.00134498227790315,0.0107557439004101,0.12745460015784
NMR metabolomics,X23424.Total Lipids in VLDL,CHP1,Calcineurin B homologous protein 1,37541,0.0105239505575849,0.00691131989004171,-0.00302223642689689,0.0240701375420666,0.127854902374795
NMR metabolomics,X23424.Total Lipids in VLDL,ACTN4,Alpha-actinin-4,40044,0.0046541030059791,0.00306327762603237,-0.00134992114104435,0.0106581271530025,0.128701911863638
NMR metabolomics,X23424.Total Lipids in VLDL,BTLA,B- and T-lymphocyte attenuator,37482,0.0127458244252884,0.00841705902400855,-0.00375161126176838,0.0292432601123451,0.129977880686763
NMR metabolomics,X23424.Total Lipids in VLDL,JCHAIN,Immunoglobulin J chain,40044,-0.0088011691662097,0.00582242329294956,-0.0202131188203908,0.00261078048797143,0.130656174969113
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37990,0.0104600479140181,0.0069286630771092,-0.00312013171711591,0.0240402275451522,0.131149030000087
NMR metabolomics,X23424.Total Lipids in VLDL,BEX3,Protein BEX3,37482,-0.00682367082643726,0.00452527391219879,-0.0156932076943469,0.00204586604147236,0.131603784552843
NMR metabolomics,X23424.Total Lipids in VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37541,0.00781084087702051,0.00519256709310719,-0.00236659062546959,0.0179882723795106,0.132545010748276
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA11,Serpin A11,40536,0.00567015878232482,0.00377980673768881,-0.00173826242354525,0.0130785799881949,0.133603285039945
NMR metabolomics,X23424.Total Lipids in VLDL,SHPK,Sedoheptulokinase,37714,-0.00607728547749694,0.00405536162766088,-0.0140257942677123,0.00187122331271839,0.134006320175665
NMR metabolomics,X23424.Total Lipids in VLDL,SEZ6L,Seizure 6-like protein,40411,0.003863354509928,0.00258477964734226,-0.00120281359886282,0.00892952261871882,0.135024206515963
NMR metabolomics,X23424.Total Lipids in VLDL,GSN,Gelsolin,37928,-0.00268224186052274,0.00179592669801364,-0.00620225818862948,0.000837774467583995,0.13532607604232
NMR metabolomics,X23424.Total Lipids in VLDL,RTKN2,Rhotekin-2,37562,-0.00744742257239569,0.00499083407923304,-0.0172294573676925,0.00233461222290108,0.13566553582501
NMR metabolomics,X23424.Total Lipids in VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,37998,-0.00298384598225715,0.00200110274038551,-0.00690600735341275,0.000938315388898455,0.135958306364018
NMR metabolomics,X23424.Total Lipids in VLDL,TAP1,Antigen peptide transporter 1,37714,-0.00865250445448984,0.00583426631916359,-0.0200876664400505,0.0027826575310708,0.138085081104031
NMR metabolomics,X23424.Total Lipids in VLDL,PSMG4,Proteasome assembly chaperone 4,37598,0.00789085655848415,0.00533793640887866,-0.00257149880291802,0.0183532119198863,0.139362223848783
NMR metabolomics,X23424.Total Lipids in VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40276,0.0083677744923103,0.0056654036447606,-0.00273641665142048,0.0194719656360411,0.139696800527688
NMR metabolomics,X23424.Total Lipids in VLDL,THY1,Thy-1 membrane glycoprotein,40471,-0.00388073069715429,0.00263742828133626,-0.00905009012857337,0.00128862873426479,0.141200698127516
NMR metabolomics,X23424.Total Lipids in VLDL,ACTA2,"Actin, aortic smooth muscle",40042,-0.00604787733913522,0.00411373098491642,-0.0141107900695714,0.00201503539130096,0.141536328801811
NMR metabolomics,X23424.Total Lipids in VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37900,0.00901685055874916,0.00614334762301023,-0.00302411078235088,0.0210578118998492,0.142197649792173
NMR metabolomics,X23424.Total Lipids in VLDL,HIP1,Huntingtin-interacting protein 1,37562,0.00473154976007881,0.00322447394133442,-0.00158841916493666,0.0110515186850943,0.142294914003547
NMR metabolomics,X23424.Total Lipids in VLDL,DCLRE1C,Protein artemis,37482,-0.00441134771618148,0.00300846327538281,-0.0103079357359318,0.00148524030356883,0.142587266537943
NMR metabolomics,X23424.Total Lipids in VLDL,CHIT1,Chitotriosidase-1,40398,0.0205916505161631,0.0140550658324865,-0.0069562785155104,0.0481395795478366,0.142921628908194
NMR metabolomics,X23424.Total Lipids in VLDL,PALM3,Paralemmin-3,37562,0.0100460968692034,0.0068676169535246,-0.00341443235970477,0.0235066260981116,0.143540235063535
NMR metabolomics,X23424.Total Lipids in VLDL,SCGN,Secretagogin,40044,-0.00603199807207818,0.00413650344766496,-0.0141395448295015,0.00207554868534515,0.144795657157731
NMR metabolomics,X23424.Total Lipids in VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,40309,-0.00534991512023585,0.00367269341961061,-0.0125483942226726,0.00184856398220094,0.145226332691279
NMR metabolomics,X23424.Total Lipids in VLDL,KLK15,Kallikrein-15,37880,0.00703044648832049,0.00484245624020926,-0.00246076774248967,0.0165216607191306,0.146570907952016
NMR metabolomics,X23424.Total Lipids in VLDL,DENND2B,DENN domain-containing protein 2B,37562,-0.00720530467913345,0.00497190448953274,-0.0169502374786176,0.00253962812035072,0.147304494269148
NMR metabolomics,X23424.Total Lipids in VLDL,FBN2,Fibrillin-2,37572,0.00831716922112231,0.00576645352787738,-0.00298507969351735,0.019619418135762,0.149231200714781
NMR metabolomics,X23424.Total Lipids in VLDL,METAP1,Methionine aminopeptidase 1,39961,0.00417681034280404,0.00289696343586953,-0.00150123799150023,0.00985485867710832,0.149382066673787
NMR metabolomics,X23424.Total Lipids in VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,37562,-0.00696707496637201,0.00483349514157272,-0.0164407254438545,0.00250657551111052,0.149491209860332
NMR metabolomics,X23424.Total Lipids in VLDL,RYR1,Ryanodine receptor 1,37562,-0.0047176051607225,0.0032736284847406,-0.0111339169908141,0.00169870666936907,0.149582115799555
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM3,Intercellular adhesion molecule 3,40536,-0.003421908029756,0.00237516420022966,-0.00807722986220614,0.00123341380269413,0.149687853710209
NMR metabolomics,X23424.Total Lipids in VLDL,REG1B,Lithostathine-1-beta,40536,0.00756372330538181,0.00525878244253043,-0.00274349028197783,0.0178709368927414,0.150367517830678
NMR metabolomics,X23424.Total Lipids in VLDL,UNC5D,Netrin receptor UNC5D,37598,0.00362977262770107,0.00253172028636039,-0.00133239913356529,0.00859194438896742,0.151676572716441
NMR metabolomics,X23424.Total Lipids in VLDL,KEL,Kell blood group glycoprotein,39961,0.00479423429893085,0.00335790592613783,-0.0017872613162993,0.011375729914161,0.15338532614119
NMR metabolomics,X23424.Total Lipids in VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37714,-0.00993334357875418,0.00697876690601746,-0.0236117267145484,0.00374503955704004,0.154653439496537
NMR metabolomics,X23424.Total Lipids in VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37572,-0.00702504133640312,0.00493981475249738,-0.016707078251298,0.00265699557849173,0.155013310633151
NMR metabolomics,X23424.Total Lipids in VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,37482,-0.0127683009108901,0.00903946332925108,-0.0304856490362222,0.00494904721444198,0.157824754854655
NMR metabolomics,X23424.Total Lipids in VLDL,REG3A,Regenerating islet-derived protein 3-alpha,40536,-0.0080975923712555,0.00573525322643405,-0.0193386886950662,0.00314350395255523,0.157999352018293
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB104A_DEFB104B,Beta-defensin 104,37541,0.00757166314159325,0.0053677726707023,-0.00294917129298326,0.0180924975761697,0.158392786286215
NMR metabolomics,X23424.Total Lipids in VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37562,0.00608268143394408,0.00432705896900654,-0.00239835414530875,0.0145637170131969,0.159827681748364
NMR metabolomics,X23424.Total Lipids in VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,40044,0.00386690392498849,0.00275561771227023,-0.00153410679106116,0.00926791464103815,0.160553197436274
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G2A,"Phospholipase A2, membrane associated",40293,-0.00761389719541979,0.00544276594265255,-0.0182817184430188,0.00305392405217921,0.161861894269836
NMR metabolomics,X23424.Total Lipids in VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37562,-0.00698127696539446,0.00500045840968521,-0.0167821754483775,0.00281962151758855,0.162699775491465
NMR metabolomics,X23424.Total Lipids in VLDL,YY1,Transcriptional repressor protein YY1,37598,0.00371095990493597,0.00265953604306873,-0.00150173073947873,0.00892365054935068,0.162936578331842
NMR metabolomics,X23424.Total Lipids in VLDL,GKN1,Gastrokine-1,39602,0.00366208297967659,0.00263536330179467,-0.00150322909184096,0.00882739505119413,0.16467285532288
NMR metabolomics,X23424.Total Lipids in VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40422,0.00542119159110731,0.00390487916861939,-0.0022323715793867,0.0130747547616013,0.165061347649279
NMR metabolomics,X23424.Total Lipids in VLDL,ERVV_1,,37562,-0.00635647186359951,0.00457955456634636,-0.0153323988136384,0.00261945508643936,0.165157299095388
NMR metabolomics,X23424.Total Lipids in VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37598,0.00475210273228844,0.00343686617446224,-0.00198415496965755,0.0114883604342344,0.166785011046443
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC11A,C-type lectin domain family 11 member A,40296,0.00624001848845636,0.00451536913528571,-0.00261010501670364,0.0150901419936164,0.167006257432748
NMR metabolomics,X23424.Total Lipids in VLDL,GH2,Growth hormone variant,39980,0.0219828922469008,0.0159131097150868,-0.00920680279466928,0.053172587288471,0.167165792799136
NMR metabolomics,X23424.Total Lipids in VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37562,-0.00806575007195833,0.00593182891233609,-0.0196921347401371,0.0035606345962204,0.173935331094521
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTSL5,ADAMTS-like protein 5,37990,-0.00498024252720198,0.00366319738877511,-0.0121601094092012,0.00219962435479723,0.1739999817966
NMR metabolomics,X23424.Total Lipids in VLDL,SHH,Sonic hedgehog protein,37598,-0.0055895751832741,0.0041155814851283,-0.0136561148941256,0.00247696452757737,0.174439539634926
NMR metabolomics,X23424.Total Lipids in VLDL,LAMA1,Laminin subunit alpha-1,37562,-0.00719566490733653,0.00531787125961686,-0.0176186925761856,0.00322736276151252,0.176043815755321
NMR metabolomics,X23424.Total Lipids in VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38013,0.00241797188553932,0.00179422876420424,-0.00109871649230098,0.00593466026337963,0.17779717220097
NMR metabolomics,X23424.Total Lipids in VLDL,AREG,Amphiregulin,40305,-0.00625842682971846,0.00466144812880157,-0.0153948651621695,0.00287801150273261,0.179423077527171
NMR metabolomics,X23424.Total Lipids in VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37901,-0.0219741407859242,0.016388714740637,-0.0540960216775728,0.0101477401057244,0.180005028366759
NMR metabolomics,X23424.Total Lipids in VLDL,RASA1,Ras GTPase-activating protein 1,39961,0.00408895492509292,0.00307222626837403,-0.00193260856092017,0.010110518411106,0.183227666877669
NMR metabolomics,X23424.Total Lipids in VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,37598,0.0028185833543221,0.00211869342542398,-0.00133405575950889,0.00697122246815309,0.183429235287086
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB5,Integrin beta-5,40411,0.00463729545917304,0.00348808626958676,-0.00219935362921701,0.0114739445475631,0.183712961481372
NMR metabolomics,X23424.Total Lipids in VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,37482,0.0103159096577219,0.00777821820154605,-0.00492939801730833,0.0255612173327522,0.184778114952044
NMR metabolomics,X23424.Total Lipids in VLDL,LY6D,Lymphocyte antigen 6D,40268,0.00465819580496113,0.00351914532986699,-0.00223932904157817,0.0115557206515004,0.185630975875942
NMR metabolomics,X23424.Total Lipids in VLDL,GAMT,Guanidinoacetate N-methyltransferase,37562,-0.0048756139936762,0.00368879242089706,-0.0121056471386344,0.00235441915128204,0.186278755322102
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB118,Beta-defensin 118,37541,0.00727597563965765,0.00551655931795051,-0.00353648062352535,0.0180884319028406,0.187214374096851
NMR metabolomics,X23424.Total Lipids in VLDL,LCN15,Lipocalin-15,37959,-0.00794779010711506,0.00602951161806209,-0.0197656328785168,0.00387005266428663,0.187476382715943
NMR metabolomics,X23424.Total Lipids in VLDL,MORF4L2,Mortality factor 4-like protein 2,37482,-0.00454539715552816,0.00344933155247607,-0.0113060869983813,0.00221529268732494,0.187606586436683
NMR metabolomics,X23424.Total Lipids in VLDL,DCUN1D1,DCN1-like protein 1,37541,-0.00932249703129595,0.00707922252531526,-0.0231977731809139,0.00455277911832195,0.187901410568299
NMR metabolomics,X23424.Total Lipids in VLDL,RELB,Transcription factor RelB,37598,0.0064007386646247,0.00488306086980637,-0.00317006064019578,0.0159715379694452,0.189946684881313
NMR metabolomics,X23424.Total Lipids in VLDL,MYOC,Myocilin,40332,-0.00564212956913993,0.0043177599041981,-0.0141049389813682,0.00282067984308834,0.19132467368898
NMR metabolomics,X23424.Total Lipids in VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,37541,-0.00869305297384743,0.00671811729210787,-0.0218605628663789,0.00447445691868398,0.195698062250595
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,40332,-0.00395908466758832,0.00306023934121896,-0.00995715377637748,0.00203898444120084,0.195781893622029
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA10,Annexin A10,39961,0.010032917647548,0.0077833333361496,-0.00522241569130521,0.0252882509864012,0.197408335520373
NMR metabolomics,X23424.Total Lipids in VLDL,FAM171A2,Protein FAM171A2,37959,0.019521945525573,0.0152019558958419,-0.0102738880302771,0.0493177790814231,0.199103359172971
NMR metabolomics,X23424.Total Lipids in VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37942,0.0045207668060418,0.00354559636283432,-0.00242860206511346,0.0114701356771971,0.202318079495628
NMR metabolomics,X23424.Total Lipids in VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,39980,-0.00371815286193678,0.00291671814840748,-0.00943492043281544,0.00199861470894189,0.202408757220565
NMR metabolomics,X23424.Total Lipids in VLDL,TFRC,Transferrin receptor protein 1,40391,-0.00471982240794515,0.0037215828229514,-0.0120141247409299,0.00257447992503959,0.204734405333131
NMR metabolomics,X23424.Total Lipids in VLDL,SCN3B,Sodium channel subunit beta-3,37541,0.00549166880244025,0.00434606617872552,-0.00302662090786178,0.0140099585127423,0.206397825846799
NMR metabolomics,X23424.Total Lipids in VLDL,RRP15,RRP15-like protein,37541,-0.0107792519001537,0.00863039814970336,-0.0276948322735723,0.0061363284732649,0.211692300509557
NMR metabolomics,X23424.Total Lipids in VLDL,TGFBR1,TGF-beta receptor type-1,37598,0.00254342843626395,0.00203954112749984,-0.00145407217363573,0.00654092904616362,0.212398024788082
NMR metabolomics,X23424.Total Lipids in VLDL,CDAN1,Codanin-1,37942,0.00273557364146515,0.00219436193640954,-0.00156537575389754,0.00703652303682784,0.212552130296272
NMR metabolomics,X23424.Total Lipids in VLDL,PXDNL,Peroxidasin-like protein,37900,0.00688246329117678,0.00553967783972275,-0.00397530527467982,0.0177402318570334,0.214112840161251
NMR metabolomics,X23424.Total Lipids in VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,40042,0.00933617755499302,0.007550066008808,-0.00546195182227066,0.0241343069322567,0.216265763787842
NMR metabolomics,X23424.Total Lipids in VLDL,SELL,L-selectin,38013,0.00270168730875356,0.0021872690497375,-0.00158536002873194,0.00698873464623906,0.216782143006002
NMR metabolomics,X23424.Total Lipids in VLDL,CA8,Carbonic anhydrase-related protein,37598,-0.00325278198718435,0.00263459385135366,-0.00841658593583751,0.00191102196146882,0.216985588924019
NMR metabolomics,X23424.Total Lipids in VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37482,0.00588985337891754,0.00479242733693327,-0.00350330420147167,0.0152830109593068,0.219097115324324
NMR metabolomics,X23424.Total Lipids in VLDL,NCAN,Neurocan core protein,40471,0.00430101769766633,0.00350975652563605,-0.00257810509258033,0.011180140487913,0.220425176319555
NMR metabolomics,X23424.Total Lipids in VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37598,-0.00340754097428631,0.00278456572820253,-0.00886528980156327,0.00205020785299064,0.221078151220482
NMR metabolomics,X23424.Total Lipids in VLDL,CNTNAP4,Contactin-associated protein-like 4,37572,0.0117399227394196,0.00960936690710301,-0.00709443639850233,0.0305742818773415,0.221836780047647
NMR metabolomics,X23424.Total Lipids in VLDL,MMP13,Collagenase 3,39961,-0.00379479204203542,0.00310856176268009,-0.0098875730968884,0.00229798901281755,0.222197388832169
NMR metabolomics,X23424.Total Lipids in VLDL,AGBL2,Cytosolic carboxypeptidase 2,37541,0.0105224390268416,0.0086204206989522,-0.00637358554310475,0.0274184635967879,0.222243960792078
NMR metabolomics,X23424.Total Lipids in VLDL,HLA_DRA,,40288,-0.00413367232001193,0.00339574484088895,-0.0107893322081543,0.00252198756813041,0.223504635659012
NMR metabolomics,X23424.Total Lipids in VLDL,SMPD1,Sphingomyelin phosphodiesterase,40380,0.00541614978542754,0.00447548723680129,-0.00335580519870299,0.0141881047695581,0.226227391698139
NMR metabolomics,X23424.Total Lipids in VLDL,DUOX2,Dual oxidase 2,40042,0.00823114474330823,0.00683314224037317,-0.00516181404782318,0.0216241035344396,0.228379344017177
NMR metabolomics,X23424.Total Lipids in VLDL,WIF1,Wnt inhibitory factor 1,40489,0.00385749961160615,0.00322385196626981,-0.00246125024228267,0.010176249465495,0.231499743274268
NMR metabolomics,X23424.Total Lipids in VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37541,-0.00651932602286073,0.00545413678778651,-0.0172094341269223,0.00417078208120084,0.231991759135551
NMR metabolomics,X23424.Total Lipids in VLDL,FRMD7,FERM domain-containing protein 7,37572,0.00375547891664014,0.00314983571010754,-0.00241819907517063,0.00992915690845091,0.233173934114551
NMR metabolomics,X23424.Total Lipids in VLDL,GPA33,Cell surface A33 antigen,40305,-0.0152795264844915,0.0128281896483154,-0.0404227781951898,0.00986372522620674,0.233636146902632
NMR metabolomics,X23424.Total Lipids in VLDL,TAGLN3,Transgelin-3,37482,-0.00688091959286734,0.00577963740390567,-0.0182090089045225,0.00444716971878778,0.233853862835709
NMR metabolomics,X23424.Total Lipids in VLDL,GPHA2,Glycoprotein hormone alpha-2,37901,0.00547200644815498,0.00462973505821185,-0.00360227426594025,0.0145462871622502,0.237255772193827
NMR metabolomics,X23424.Total Lipids in VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37482,-0.00499819068667046,0.00422922304199213,-0.013287467848975,0.00329108647563412,0.237297730329755
NMR metabolomics,X23424.Total Lipids in VLDL,IL36A,Interleukin-36 alpha,37598,-0.00661198521229356,0.0055998405258003,-0.0175876726428621,0.00436370221827502,0.237725294240847
NMR metabolomics,X23424.Total Lipids in VLDL,GID8,Glucose-induced degradation protein 8 homolog,37959,0.00377109231841265,0.0031973255541258,-0.00249566576767392,0.0100378504044992,0.238238975991496
NMR metabolomics,X23424.Total Lipids in VLDL,COL3A1,Collagen alpha-1(III) chain,37998,-0.00256171941756815,0.00218409606255769,-0.00684254770018122,0.00171910886504493,0.240857792669043
NMR metabolomics,X23424.Total Lipids in VLDL,SLC44A4,Choline transporter-like protein 4,37572,-0.00777453683581291,0.00663162225900127,-0.0207725164634554,0.00522344279182958,0.241080605910217
NMR metabolomics,X23424.Total Lipids in VLDL,DKKL1,Dickkopf-like protein 1,40305,-0.00970623935154295,0.00828195629269053,-0.0259388736852164,0.00652639498213049,0.241225014769885
NMR metabolomics,X23424.Total Lipids in VLDL,KDM3A,Lysine-specific demethylase 3A,37598,-0.0102750759856862,0.00877280964363812,-0.027469782887217,0.00691963091584447,0.241523072451665
NMR metabolomics,X23424.Total Lipids in VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37541,0.00633910621425321,0.00548286246551168,-0.00440730421814967,0.0170855166466561,0.247633840412147
NMR metabolomics,X23424.Total Lipids in VLDL,IL24,Interleukin-24,40044,0.00537316708007868,0.00465156098698041,-0.00374389245440291,0.0144902266145603,0.248054065848499
NMR metabolomics,X23424.Total Lipids in VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,37942,0.00434591600302369,0.00376904381780186,-0.00304140987986795,0.0117332418859153,0.24890811171534
NMR metabolomics,X23424.Total Lipids in VLDL,LPO,Lactoperoxidase,39831,-0.00643461798262554,0.00558332055475585,-0.017377926269947,0.00450869030469592,0.249145275713922
NMR metabolomics,X23424.Total Lipids in VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,37572,0.0039166674452813,0.0034123148808107,-0.00277146972110767,0.0106048046116703,0.251070562142631
NMR metabolomics,X23424.Total Lipids in VLDL,NRN1,Neuritin,37959,-0.00396438456690228,0.00346219264034738,-0.0107502821419831,0.00282151300817858,0.252208628715533
NMR metabolomics,X23424.Total Lipids in VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,37714,0.00697159706728673,0.00610139718043011,-0.00498714140635628,0.0189303355409297,0.253215757635356
NMR metabolomics,X23424.Total Lipids in VLDL,IL20,Interleukin-20,40044,0.00546958437759198,0.00481062651380894,-0.00395924358947354,0.0148984123446575,0.255564272037473
NMR metabolomics,X23424.Total Lipids in VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40434,-0.00785427094129823,0.00692616582897053,-0.0214295559660805,0.005721014083484,0.256811624234779
NMR metabolomics,X23424.Total Lipids in VLDL,SLC51B,Organic solute transporter subunit beta,37562,-0.0085424797105138,0.0075386794881717,-0.0233182915073303,0.00623333208630272,0.257170594271361
NMR metabolomics,X23424.Total Lipids in VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37482,0.00618956985079313,0.00548762888408282,-0.0045661827620092,0.0169453224635955,0.259377285380591
NMR metabolomics,X23424.Total Lipids in VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,37541,0.00531973736369302,0.00471670323969795,-0.00392500098611496,0.014564475713501,0.259403622743764
NMR metabolomics,X23424.Total Lipids in VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37572,-0.00542506133452697,0.00481431792366649,-0.0148611244649133,0.00401100179585934,0.259822371262559
NMR metabolomics,X23424.Total Lipids in VLDL,RBP7,Retinoid-binding protein 7,37901,0.00617110611716199,0.00551817676114759,-0.00464452033468729,0.0169867325690113,0.263448877410751
NMR metabolomics,X23424.Total Lipids in VLDL,TLR2,Toll-like receptor 2,37714,0.00242601024240492,0.00217475654023886,-0.00183651257646325,0.00668853306127308,0.264642779553679
NMR metabolomics,X23424.Total Lipids in VLDL,MMP9,Matrix metalloproteinase-9,40312,0.00641349999581451,0.00575719951315464,-0.00487061104996859,0.0176976110415976,0.265297578175516
NMR metabolomics,X23424.Total Lipids in VLDL,IL36G,Interleukin-36 gamma,37551,0.00726241529766772,0.00653216247622098,-0.0055406231557254,0.0200654537510608,0.266247383974229
NMR metabolomics,X23424.Total Lipids in VLDL,TMPRSS5,Transmembrane protease serine 5,40159,-0.00395763968898857,0.00355981391726587,-0.0109348749668297,0.00301959558885253,0.266260670123669
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4C,C-type lectin domain family 4 member C,40341,0.00476410067214941,0.00429892998118626,-0.00366180209097565,0.0131900034352745,0.267789567159214
NMR metabolomics,X23424.Total Lipids in VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37541,0.00341327979627043,0.00308020299874073,-0.00262391808126139,0.00945047767380226,0.26782401290668
NMR metabolomics,X23424.Total Lipids in VLDL,KLHL41,Kelch-like protein 41,37959,0.00494322701383829,0.00448821912010022,-0.00385368246155814,0.0137401364892347,0.270751684382638
NMR metabolomics,X23424.Total Lipids in VLDL,TP53BP1,TP53-binding protein 1,37598,0.00926981791549207,0.00841955557470605,-0.00723251101093179,0.0257721468419159,0.270922645177001
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40365,-0.00512676943360327,0.00465772874806646,-0.0142559177798135,0.00400237891260698,0.271043204062427
NMR metabolomics,X23424.Total Lipids in VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37562,-0.00209382133113956,0.00191306505989753,-0.00584342884853871,0.00165578618625959,0.273762357307729
NMR metabolomics,X23424.Total Lipids in VLDL,THBS2,Thrombospondin-2,40332,-0.00368959338254598,0.00337146276947535,-0.0102976604107177,0.00291847364562571,0.273813798483867
NMR metabolomics,X23424.Total Lipids in VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,37572,0.00896614169395473,0.00820055094532766,-0.00710693815888749,0.0250392215467969,0.274256521814916
NMR metabolomics,X23424.Total Lipids in VLDL,GSTM4,Glutathione S-transferase Mu 4,37562,-0.00739595228775302,0.00678664059117159,-0.0206977678464493,0.0059058632709433,0.275829635270585
NMR metabolomics,X23424.Total Lipids in VLDL,TXNDC15,Thioredoxin domain-containing protein 15,40411,0.00277813366360218,0.00255891574215881,-0.00223734119102909,0.00779360851823344,0.27764217598852
NMR metabolomics,X23424.Total Lipids in VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,40489,-0.00362384436158631,0.00334059421256622,-0.0101714090182161,0.00292372029504348,0.278030828029124
NMR metabolomics,X23424.Total Lipids in VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,37562,0.0122458370688552,0.0113199568384063,-0.00994127833442107,0.0344329524721315,0.279364925904899
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37714,0.00705405167610447,0.00657174657670298,-0.00582657161423337,0.0199346749664423,0.283115384406069
NMR metabolomics,X23424.Total Lipids in VLDL,IL17A,Interleukin-17A,40028,0.00430401344914298,0.00402227369461702,-0.00357964299230637,0.0121876698905923,0.284615680356884
NMR metabolomics,X23424.Total Lipids in VLDL,CCNE1,G1/S-specific cyclin-E1,37598,0.00940076804805003,0.00887148479873552,-0.00798734215747159,0.0267888782535717,0.289318238477694
NMR metabolomics,X23424.Total Lipids in VLDL,KLK1,Kallikrein-1,40209,-0.0127293419490894,0.0120158902622817,-0.0362804868631616,0.0108218029649827,0.289444958525541
NMR metabolomics,X23424.Total Lipids in VLDL,HDAC8,Histone deacetylase 8,37598,0.00627584242998416,0.00592468502895463,-0.00533654022676692,0.0178882250867352,0.289496194218768
NMR metabolomics,X23424.Total Lipids in VLDL,S100G,Protein S100-G,37959,-0.0044482644829459,0.00420284087122388,-0.0126858325905447,0.0037893036246529,0.289894464220263
NMR metabolomics,X23424.Total Lipids in VLDL,PNMA2,Paraneoplastic antigen Ma2,37541,0.00431738629736902,0.0041128193039518,-0.0037437395383765,0.0123785121331145,0.293857567799806
NMR metabolomics,X23424.Total Lipids in VLDL,CLNS1A,Methylosome subunit pICln,37572,0.00333499854020158,0.00317996585757027,-0.00289773454063615,0.00956773162103932,0.294311160407121
NMR metabolomics,X23424.Total Lipids in VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,37482,-0.0063714164015465,0.00607948804094503,-0.0182872129617988,0.00554438015870576,0.294649487132041
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE10,Inactive ribonuclease-like protein 10,37628,-0.00482625322472531,0.00461886766860269,-0.0138792338551866,0.00422672740573596,0.296088519216145
NMR metabolomics,X23424.Total Lipids in VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,37541,-0.00282059515655876,0.00270071726120174,-0.00811400098851417,0.00247281067539665,0.296325464893389
NMR metabolomics,X23424.Total Lipids in VLDL,ENOPH1,Enolase-phosphatase E1,37900,0.00565637732485591,0.00542043338990843,-0.00496767211936461,0.0162804267690764,0.296722294912911
NMR metabolomics,X23424.Total Lipids in VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,37562,-0.00357109292520449,0.00342828038267316,-0.0102905224752439,0.00314833662483491,0.297589850041824
NMR metabolomics,X23424.Total Lipids in VLDL,ESPL1,Separin,37482,-0.00565233252011602,0.005430960836482,-0.0162970157596207,0.0049923507193887,0.298005770407804
NMR metabolomics,X23424.Total Lipids in VLDL,EVI2B,Protein EVI2B,37482,0.00412727503126651,0.00399224483595722,-0.00369752484720965,0.0119520749097427,0.301238045750029
NMR metabolomics,X23424.Total Lipids in VLDL,TFF1,Trefoil factor 1,40261,0.00756615104936569,0.00732131062793804,-0.00678361778139288,0.0219159198801243,0.301412834975637
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37671,0.00393449792251681,0.00381459341955318,-0.00354210517980742,0.011411101024841,0.302356635037839
NMR metabolomics,X23424.Total Lipids in VLDL,MYBPC1,"Myosin-binding protein C, slow-type",37990,-0.00614333432247969,0.00598218180146049,-0.0178684106533422,0.00558174200838286,0.304467652496922
NMR metabolomics,X23424.Total Lipids in VLDL,DCUN1D2,DCN1-like protein 2,37482,0.00786505635482445,0.00766357930781084,-0.0071555590884848,0.0228856717981337,0.304773865840869
NMR metabolomics,X23424.Total Lipids in VLDL,REST,RE1-silencing transcription factor,37482,-0.00346862033833036,0.00339671028343613,-0.0101261724938652,0.00318893181720446,0.307192625021137
NMR metabolomics,X23424.Total Lipids in VLDL,FZD10,Frizzled-10,37572,0.00587895726113562,0.00576546526730535,-0.00542135466278287,0.0171792691850541,0.307896777697448
NMR metabolomics,X23424.Total Lipids in VLDL,REG1A,Lithostathine-1-alpha,40274,-0.00466953004145627,0.00459198613783493,-0.0136698228716127,0.0043307627887002,0.309222837523374
NMR metabolomics,X23424.Total Lipids in VLDL,EPO,Erythropoietin,40341,0.00748395683273529,0.00737119276455832,-0.00696358098579901,0.0219314946512696,0.309979285582415
NMR metabolomics,X23424.Total Lipids in VLDL,UBQLN3,Ubiquilin-3,37562,-0.00432422668261168,0.00427521078433737,-0.0127036398199129,0.00405518645468957,0.31181252369088
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH17,Protocadherin-17,40359,-0.00328217898927957,0.00328092538276826,-0.00971279273950537,0.00314843476094623,0.317140851494545
NMR metabolomics,X23424.Total Lipids in VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37572,-0.00399543930587093,0.00400000833187339,-0.0118354556363428,0.00384457702460091,0.317882029148807
NMR metabolomics,X23424.Total Lipids in VLDL,ALPI,Intestinal-type alkaline phosphatase,37598,0.0114596610518296,0.0114864318540126,-0.011053745382035,0.0339730674856943,0.31845808136426
NMR metabolomics,X23424.Total Lipids in VLDL,CA3,Carbonic anhydrase 3,40500,0.0056954347166282,0.00574432897227595,-0.00556345006903265,0.0169543195022891,0.321462172757381
NMR metabolomics,X23424.Total Lipids in VLDL,MTR,Methionine synthase,37562,0.00613077188385843,0.00619970729499205,-0.00602065441432598,0.0182821981820429,0.322739686172455
NMR metabolomics,X23424.Total Lipids in VLDL,CBX2,Chromobox protein homolog 2,37562,-0.00384980235616811,0.00389607085264038,-0.0114861012273432,0.00378649651500703,0.323110003275982
NMR metabolomics,X23424.Total Lipids in VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37598,-0.0042928202493056,0.00434628127244563,-0.012811531543299,0.00422589104468784,0.323317971580098
NMR metabolomics,X23424.Total Lipids in VLDL,DNLZ,DNL-type zinc finger protein,37541,-0.00888194973035694,0.00900679736228329,-0.0265352725604322,0.0087713730997183,0.324083376651149
NMR metabolomics,X23424.Total Lipids in VLDL,TG,Thyroglobulin,37900,-0.0109230232474194,0.0111022095036022,-0.0326833538744798,0.010837307379641,0.325201902597765
NMR metabolomics,X23424.Total Lipids in VLDL,FZD8,Frizzled-8,37541,0.004127345707228,0.00425018886763476,-0.00420302447333614,0.0124577158877921,0.331517916409364
NMR metabolomics,X23424.Total Lipids in VLDL,CRISP2,Cysteine-rich secretory protein 2,40489,0.00556798441741385,0.00577131604290776,-0.00574379502668536,0.0168797638615131,0.334675281226826
NMR metabolomics,X23424.Total Lipids in VLDL,PITHD1,PITH domain-containing protein 1,37457,-0.00748233262440498,0.00777761490246172,-0.02272645783323,0.00776179258442,0.336050240679857
NMR metabolomics,X23424.Total Lipids in VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37457,-0.00463520898363592,0.00486815046810391,-0.0141767839011196,0.00490636593384773,0.341038660313392
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,40359,-0.00240766351129826,0.00252948180539534,-0.00736544784987313,0.00255012082727661,0.341192284013811
NMR metabolomics,X23424.Total Lipids in VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,37562,-0.00467502625075497,0.00494535362984724,-0.0143679193652556,0.00501786686374562,0.344504226442948
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA4C,Semaphorin-4C,40305,0.00251158254932733,0.00266734051258123,-0.00271640485533188,0.00773956995398654,0.346408990672805
NMR metabolomics,X23424.Total Lipids in VLDL,HDDC2,5'-deoxynucleotidase HDDC2,37901,0.00386477083191349,0.00410839099384531,-0.00418767551602332,0.0119172171798503,0.34687458813741
NMR metabolomics,X23424.Total Lipids in VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,37987,0.00227308507503631,0.00242067983836041,-0.0024714474081501,0.00701761755822272,0.347733352617323
NMR metabolomics,X23424.Total Lipids in VLDL,CNTNAP2,Contactin-associated protein-like 2,40341,0.00354685240544753,0.00378018626781961,-0.0038623126794789,0.010956017490374,0.348117619430036
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,40203,-0.00295869889120424,0.00316485617321111,-0.00916181699069802,0.00324441920828954,0.349874549115867
NMR metabolomics,X23424.Total Lipids in VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37998,-0.00219919528532199,0.00236114972479611,-0.00682704874592236,0.00242865817527839,0.351658815616749
NMR metabolomics,X23424.Total Lipids in VLDL,NENF,Neudesin,37900,0.00952728447661609,0.010235649812028,-0.0105345891549587,0.0295891581081909,0.351976688492447
NMR metabolomics,X23424.Total Lipids in VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37541,-0.00402533251380405,0.00434599569464987,-0.0125434840753178,0.0044928190477097,0.354350605020421
NMR metabolomics,X23424.Total Lipids in VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,37598,0.00513528061090491,0.00554765966292828,-0.00573813232843453,0.0160086935502443,0.354636510677576
NMR metabolomics,X23424.Total Lipids in VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37714,0.00315788290658684,0.00341489266267593,-0.00353530671225798,0.00985107252543166,0.355118744612527
NMR metabolomics,X23424.Total Lipids in VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37562,-0.00326991944483685,0.00358457437725929,-0.0102956852242651,0.00375584633459135,0.361669837305317
NMR metabolomics,X23424.Total Lipids in VLDL,CEP350,Centrosome-associated protein 350,37482,0.00322899383878523,0.00355100850378739,-0.00373098282863805,0.0101889705062085,0.363199424639795
NMR metabolomics,X23424.Total Lipids in VLDL,PSMA1,Proteasome subunit alpha type-1,39980,-0.00399148945768318,0.00438979088748141,-0.0125954795971467,0.00461250068178039,0.363223622348428
NMR metabolomics,X23424.Total Lipids in VLDL,ERCC1,DNA excision repair protein ERCC-1,37482,0.00289299807936339,0.00318251175895836,-0.003344724968195,0.00913072112692178,0.363351200541921
NMR metabolomics,X23424.Total Lipids in VLDL,PSCA,Prostate stem cell antigen,37901,0.0221753669516397,0.0245696944938678,-0.0259812342563411,0.0703319681596206,0.366781170985364
NMR metabolomics,X23424.Total Lipids in VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37541,-0.00270273396179754,0.00299578957580908,-0.00857448153038334,0.00316901360678827,0.366979184050682
NMR metabolomics,X23424.Total Lipids in VLDL,PYDC1,Pyrin domain-containing protein 1,37628,-0.00363125150901154,0.00403692760791623,-0.0115436296205273,0.00428112660250426,0.368398201822465
NMR metabolomics,X23424.Total Lipids in VLDL,CD27,CD27 antigen,40411,0.00343120160541722,0.00383052591137606,-0.00407662918087986,0.0109390323917143,0.370398691426369
NMR metabolomics,X23424.Total Lipids in VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,37572,0.00361948491240107,0.00405950243876345,-0.00433713986757529,0.0115761096923774,0.372619423464626
NMR metabolomics,X23424.Total Lipids in VLDL,PCNA,Proliferating cell nuclear antigen,37482,0.00527874374497133,0.00592406291300038,-0.00633241956450941,0.0168899070544521,0.372909066705501
NMR metabolomics,X23424.Total Lipids in VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,40332,0.002880864395184,0.0032409504026539,-0.00347139839401765,0.00923312718438565,0.374073012488885
NMR metabolomics,X23424.Total Lipids in VLDL,AMY2A,Pancreatic alpha-amylase,39695,0.0039519952379253,0.00444599548869583,-0.00476215591991853,0.0126661463957691,0.374076915260882
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJA1,DnaJ homolog subfamily A member 1,37482,-0.00395231069943691,0.00445116670196926,-0.0126765974352967,0.00477197603642285,0.374596457703122
NMR metabolomics,X23424.Total Lipids in VLDL,PSAPL1,Proactivator polypeptide-like 1,37901,-0.00424258623448391,0.00477984913107483,-0.0136110905313906,0.00512591806242276,0.374772710558651
NMR metabolomics,X23424.Total Lipids in VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39980,-0.00640951562863707,0.00723610063628022,-0.0205922728757463,0.00777324161847216,0.375755585159264
NMR metabolomics,X23424.Total Lipids in VLDL,PROK1,Prokineticin-1,40341,-0.00572704676528674,0.00648574052479305,-0.0184390981938811,0.00698500466330764,0.377238144690781
NMR metabolomics,X23424.Total Lipids in VLDL,AMIGO1,Amphoterin-induced protein 1,37572,0.00417363093972683,0.00472765331547974,-0.00509256955861346,0.0134398314380671,0.377353817760695
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB5,Serpin B5,40042,-0.00405858165271748,0.00459952542546679,-0.0130736514866324,0.00495648818119743,0.377578792851618
NMR metabolomics,X23424.Total Lipids in VLDL,IL1A,Interleukin-1 alpha,40044,0.00445099461708233,0.00507964888507262,-0.00550511719766001,0.0144071064318247,0.380912745060205
NMR metabolomics,X23424.Total Lipids in VLDL,CDH4,Cadherin-4,37541,0.00409774660067269,0.00468891158736144,-0.00509252011055574,0.0132880133119011,0.382176347314996
NMR metabolomics,X23424.Total Lipids in VLDL,OFD1,Oral-facial-digital syndrome 1 protein,37714,0.00561547844515927,0.00643155807861163,-0.00699037538891952,0.0182213322792381,0.382617171883794
NMR metabolomics,X23424.Total Lipids in VLDL,SEPTIN3,Neuronal-specific septin-3,37959,-0.00607841204485697,0.00696718190208489,-0.0197340885729433,0.0075772644832294,0.382986723446204
NMR metabolomics,X23424.Total Lipids in VLDL,CAPN3,Calpain-3,37900,0.00305519026143175,0.00351068190790604,-0.0038257462780641,0.00993612680092759,0.384176321640022
NMR metabolomics,X23424.Total Lipids in VLDL,ITGAX,Integrin alpha-X,37714,0.00454199408895357,0.0052270048337563,-0.00570293538520878,0.0147869235631159,0.384891435352164
NMR metabolomics,X23424.Total Lipids in VLDL,CHEK2,Serine/threonine-protein kinase Chk2,40042,-0.00275126565120823,0.00317944552658351,-0.00898297888331192,0.00348044758089546,0.386871685676865
NMR metabolomics,X23424.Total Lipids in VLDL,HMCN2,Hemicentin-2,37648,-0.00465711138115674,0.00540154878513437,-0.0152441470000201,0.00592992423770662,0.388603728576369
NMR metabolomics,X23424.Total Lipids in VLDL,MMP15,Matrix metalloproteinase-15,37990,0.0040617257614657,0.00471467681866663,-0.00517904080312088,0.0133024923260523,0.38897428006868
NMR metabolomics,X23424.Total Lipids in VLDL,DOC2B,Double C2-like domain-containing protein beta,37572,0.0029209031643335,0.00340921407973139,-0.00376115643194003,0.00960296276060703,0.39158914565741
NMR metabolomics,X23424.Total Lipids in VLDL,GJA8,Gap junction alpha-8 protein,37482,0.00505523151760214,0.00590107974568519,-0.00651088478394084,0.0166213478191451,0.391647394925313
NMR metabolomics,X23424.Total Lipids in VLDL,DLGAP5,Disks large-associated protein 5,37959,-0.00427909391585562,0.00508029314956384,-0.0142364684890008,0.00567828065728951,0.399639040606373
NMR metabolomics,X23424.Total Lipids in VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39980,0.00960929838632376,0.011421268105609,-0.0127763871006699,0.0319949838733174,0.400164134371016
NMR metabolomics,X23424.Total Lipids in VLDL,TNNI3,"Troponin I, cardiac muscle",40042,0.00670617429602331,0.00798088499342541,-0.0089363602910905,0.0223487088831371,0.400764561849256
NMR metabolomics,X23424.Total Lipids in VLDL,LAYN,Layilin,40192,-0.00271656029203386,0.00323821993488508,-0.00906347136440861,0.00363035078034089,0.401535119636251
NMR metabolomics,X23424.Total Lipids in VLDL,TBR1,T-box brain protein 1,37572,0.0038538977275431,0.00461749404682163,-0.0051963906042273,0.0129041860593135,0.403941424241127
NMR metabolomics,X23424.Total Lipids in VLDL,EDNRB,Endothelin receptor type B,37598,0.00374197254567276,0.00448865870314219,-0.00505579851248593,0.0125397436038314,0.404493109372828
NMR metabolomics,X23424.Total Lipids in VLDL,TEX101,Testis-expressed protein 101,37572,0.00309680378797823,0.00371811298379168,-0.00419069766025346,0.0103843052362099,0.404918189496573
NMR metabolomics,X23424.Total Lipids in VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37671,0.00302170139774195,0.00363029381606955,-0.00409367448175437,0.0101370772772383,0.405222358176421
NMR metabolomics,X23424.Total Lipids in VLDL,OTOA,Otoancorin,37541,-0.00431773583503603,0.00518872658209534,-0.0144876399359429,0.00585216826587084,0.405346315265299
NMR metabolomics,X23424.Total Lipids in VLDL,TOP1,DNA topoisomerase 1,37901,0.00839468658105179,0.0100893158305406,-0.0113803724468078,0.0281697456089114,0.405402693116352
NMR metabolomics,X23424.Total Lipids in VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,37714,0.00353624898645521,0.0042545082521142,-0.00480258718768862,0.011875085160599,0.405888665529827
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN5,Contactin-5,40367,-0.00288943638986796,0.00349044724749961,-0.00973071299496719,0.00395184021523127,0.407789021486979
NMR metabolomics,X23424.Total Lipids in VLDL,HLA_A,,37959,0.00255587615077369,0.00309008233505758,-0.00350068522593916,0.00861243752748654,0.408182331447529
NMR metabolomics,X23424.Total Lipids in VLDL,PRRT3,Proline-rich transmembrane protein 3,37628,0.00293877545999906,0.00355431233185503,-0.00402767671043681,0.00990522763043492,0.408354234411266
NMR metabolomics,X23424.Total Lipids in VLDL,S100A3,Protein S100-A3,37900,0.0035764030310835,0.0043427208765432,-0.00493532988694117,0.0120881359491082,0.410215756967254
NMR metabolomics,X23424.Total Lipids in VLDL,IL21R,Interleukin-21 receptor,37598,0.00435433252865811,0.00530519219666185,-0.00604384417679912,0.0147525092341153,0.41179325399778
NMR metabolomics,X23424.Total Lipids in VLDL,RAP1A,Ras-related protein Rap-1A,37598,0.00541175304076761,0.00660288621798775,-0.00752990394648839,0.0183534100280236,0.41245665780083
NMR metabolomics,X23424.Total Lipids in VLDL,SPESP1,Sperm equatorial segment protein 1,37990,0.00213640793356489,0.00260766856000695,-0.00297462244404873,0.00724743831117851,0.412641707512661
NMR metabolomics,X23424.Total Lipids in VLDL,IGLC2,Immunoglobulin lambda constant 2,37978,-0.00187423957628963,0.002293820557332,-0.00637012786866034,0.00262164871608108,0.413895938018196
NMR metabolomics,X23424.Total Lipids in VLDL,SCIN,Adseverin,37541,0.00563524921396268,0.00695168429501478,-0.00799005200426628,0.0192605504321916,0.41759247771456
NMR metabolomics,X23424.Total Lipids in VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,37541,0.00438392849624336,0.00541018345178283,-0.00622003106925097,0.0149878880617377,0.417776469866915
NMR metabolomics,X23424.Total Lipids in VLDL,SMC3,Structural maintenance of chromosomes protein 3,37482,0.00427942392329432,0.00528826111316587,-0.00608556785851078,0.0146444157050994,0.418397161361804
NMR metabolomics,X23424.Total Lipids in VLDL,OPTC,Opticin,40305,-0.00341928200756871,0.00424395705149702,-0.0117374378285029,0.00489887381336545,0.420438015956387
NMR metabolomics,X23424.Total Lipids in VLDL,MYBPC2,"Myosin-binding protein C, fast-type",37628,-0.00629071497422367,0.00780938298677904,-0.0215971056283106,0.00901567567986325,0.420526761704714
NMR metabolomics,X23424.Total Lipids in VLDL,ISM2,Isthmin-2,37998,-0.00339308005037244,0.0042149086952945,-0.0116543010931497,0.00486814099240477,0.420823054664987
NMR metabolomics,X23424.Total Lipids in VLDL,APOH,Beta-2-glycoprotein 1,40332,0.00266920009044962,0.0033413209020343,-0.0038797888775376,0.00921818905843684,0.42439179072589
NMR metabolomics,X23424.Total Lipids in VLDL,NEB,Nebulin,37562,0.00275001036868617,0.00344994853037457,-0.00401188875084799,0.00951190948822033,0.425397899281917
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA5,Annexin A5,39896,0.00228695121337426,0.00288305986987563,-0.00336384613158199,0.0079377485583305,0.42765164707142
NMR metabolomics,X23424.Total Lipids in VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,37572,0.00545514780268867,0.00688297227360768,-0.00803547785358238,0.0189457734589597,0.42805030496265
NMR metabolomics,X23424.Total Lipids in VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40333,-0.00552857734368568,0.00699136679950366,-0.0192316562707129,0.0081745015833415,0.429088840863326
NMR metabolomics,X23424.Total Lipids in VLDL,KLK14,Kallikrein-14,40489,-0.00339519713236062,0.00432772373779891,-0.0118775356584465,0.00508714139372524,0.43274510695411
NMR metabolomics,X23424.Total Lipids in VLDL,CD164L2,CD164 sialomucin-like 2 protein,37572,0.00273469107994804,0.00348707782965438,-0.00409998146617454,0.00956936362607062,0.432915952929177
NMR metabolomics,X23424.Total Lipids in VLDL,TSPAN15,Tetraspanin-15,37562,-0.00377004785095572,0.00483665367119733,-0.0132498890465025,0.00570979334459104,0.43571436642561
NMR metabolomics,X23424.Total Lipids in VLDL,H2AP,Huntingtin-interacting protein M,37482,-0.00382925622027256,0.00493722612500337,-0.0135062194252792,0.00584770698473404,0.438006018759126
NMR metabolomics,X23424.Total Lipids in VLDL,SLAMF1,Signaling lymphocytic activation molecule,40044,-0.00433521015059018,0.00560952415803128,-0.0153298775003315,0.00665945719915112,0.43963454290146
NMR metabolomics,X23424.Total Lipids in VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",37482,-0.00362180381355832,0.00469169597898213,-0.0128175279323633,0.00557392030524666,0.440151843118719
NMR metabolomics,X23424.Total Lipids in VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37562,-0.00441219101442782,0.00576015296286069,-0.0157020908216348,0.00687770879277913,0.443698992655292
NMR metabolomics,X23424.Total Lipids in VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39980,0.00913656743388789,0.0119311380673671,-0.0142484631781517,0.0325215980459275,0.443821822614081
NMR metabolomics,X23424.Total Lipids in VLDL,NLGN1,Neuroligin-1,37572,-0.00500610429267187,0.00659735445391488,-0.017936919022345,0.0079247104370013,0.447982959189144
NMR metabolomics,X23424.Total Lipids in VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,37883,0.00301571377217632,0.00397987843147745,-0.00478484795351947,0.0108162754978721,0.448619838144774
NMR metabolomics,X23424.Total Lipids in VLDL,NPHS2,Podocin,37598,-0.00752756655597623,0.00993647612277756,-0.0270030597566203,0.0119479266446678,0.448722606350091
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM2,Intercellular adhesion molecule 2,40536,0.0022183625522675,0.0029327058030662,-0.00352974082174226,0.00796646592627725,0.449407430869999
NMR metabolomics,X23424.Total Lipids in VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37714,0.00448326898820052,0.00597053659684581,-0.00721898274161726,0.0161855207180183,0.45272686319878
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40411,0.00316121194119597,0.00422169582801073,-0.00511331188170506,0.011435735764097,0.453987923707861
NMR metabolomics,X23424.Total Lipids in VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37482,0.0039933865569826,0.00534872028580135,-0.00649010520318804,0.0144768783171532,0.455314907455133
NMR metabolomics,X23424.Total Lipids in VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,37562,-0.00406622927295848,0.00549422154688252,-0.0148349035048482,0.00670244495893127,0.459257441070602
NMR metabolomics,X23424.Total Lipids in VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37572,0.00547219330445522,0.00742271396080384,-0.0090763260587203,0.0200207126676307,0.461000108215916
NMR metabolomics,X23424.Total Lipids in VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,37562,0.00226748204706395,0.00307743072045998,-0.00376428216503761,0.00829924625916551,0.461251023075775
NMR metabolomics,X23424.Total Lipids in VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,37562,0.00228414194034365,0.00310751254701695,-0.00380658265180958,0.00837486653249687,0.462329081719894
NMR metabolomics,X23424.Total Lipids in VLDL,CSRP3,Cysteine and glycine-rich protein 3,37562,-0.00671873567568012,0.00915558827095373,-0.0246636886867494,0.0112262173353892,0.463059463057158
NMR metabolomics,X23424.Total Lipids in VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37541,0.00503591610564506,0.00691400250251662,-0.00851552879928751,0.0185873610105776,0.466403330190836
NMR metabolomics,X23424.Total Lipids in VLDL,ALMS1,Alstrom syndrome protein 1,37714,0.00308675018426995,0.00426450720946714,-0.00527168394628564,0.0114451843148256,0.469186917557266
NMR metabolomics,X23424.Total Lipids in VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37564,0.00261610902028439,0.00361486704915529,-0.00446903039605999,0.00970124843662876,0.46925779249875
NMR metabolomics,X23424.Total Lipids in VLDL,TEX33,Testis-expressed protein 33,37714,-0.00269687445057801,0.0037363849525773,-0.0100201889576295,0.0046264400564735,0.470438108506931
NMR metabolomics,X23424.Total Lipids in VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37562,-0.00479898933710906,0.00668611148868586,-0.0179037678549333,0.00830578918071521,0.472921210095693
NMR metabolomics,X23424.Total Lipids in VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,40289,0.00184009742571359,0.00258492680920011,-0.00322635912031862,0.00690655397174581,0.476564013371361
NMR metabolomics,X23424.Total Lipids in VLDL,GFRA3,GDNF family receptor alpha-3,40194,-0.00191034896360576,0.00269048535184412,-0.00718370025322024,0.00336300232600872,0.477690599592502
NMR metabolomics,X23424.Total Lipids in VLDL,GAGE2A,G antigen 2A,37482,0.00415217743499062,0.00590080317238395,-0.00741339678288193,0.0157177516528632,0.481655180645954
NMR metabolomics,X23424.Total Lipids in VLDL,CGN,Cingulin,37572,0.0027609529603239,0.00397277679302447,-0.00502568955400406,0.0105475954746519,0.487087628746229
NMR metabolomics,X23424.Total Lipids in VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,37998,-0.00179774955865686,0.00262438463775153,-0.00694154344864986,0.00334604433133614,0.493344561732994
NMR metabolomics,X23424.Total Lipids in VLDL,ADA2,Adenosine deaminase 2,40258,0.00270164247775625,0.00394476079421428,-0.00503008867890375,0.0104333736344162,0.493436936366656
NMR metabolomics,X23424.Total Lipids in VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40374,0.00365934802075654,0.00537228255566225,-0.00687032578834147,0.0141890218298545,0.495784396818384
NMR metabolomics,X23424.Total Lipids in VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37900,-0.00497088307867916,0.0073554857358584,-0.0193876351209616,0.0094458689636033,0.499175300137787
NMR metabolomics,X23424.Total Lipids in VLDL,ANKRA2,Ankyrin repeat family A protein 2,37482,0.00358321656314343,0.00534855292915567,-0.00689994717800167,0.0140663803042885,0.502907075351654
NMR metabolomics,X23424.Total Lipids in VLDL,ANK2,Ankyrin-2,37562,0.00471130138886926,0.00703419927804272,-0.00907572919609446,0.018498331973833,0.503015696403357
NMR metabolomics,X23424.Total Lipids in VLDL,PGM2,Phosphoglucomutase-2,37572,0.00376546272794611,0.00567787959015808,-0.00736318126876372,0.014894106724656,0.507226192515704
NMR metabolomics,X23424.Total Lipids in VLDL,TP73,Tumor protein p73,37572,0.00218593071392251,0.00330971347222793,-0.00430110769164425,0.00867296911948926,0.50897078763375
NMR metabolomics,X23424.Total Lipids in VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37562,0.00294874190872793,0.00449585727000094,-0.00586313834047391,0.0117606221579298,0.511912984526027
NMR metabolomics,X23424.Total Lipids in VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,37714,-0.00507557311270547,0.00780233612020721,-0.0203681519083116,0.0102170056829007,0.515367869861654
NMR metabolomics,X23424.Total Lipids in VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,37482,-0.00310087570994845,0.00477764109410701,-0.0124650522543982,0.00626330083450129,0.516324565374896
NMR metabolomics,X23424.Total Lipids in VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,37541,0.00462588001119653,0.00715445903293505,-0.00939685969335618,0.0186486197157492,0.517919676821987
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40332,0.00217559502573053,0.00341824088077122,-0.00452415710058106,0.00887534715204212,0.524481732100086
NMR metabolomics,X23424.Total Lipids in VLDL,UPK3A,Uroplakin-3a,37541,0.00300322005429689,0.00474012315403492,-0.00628742132761155,0.0122938614362053,0.526369769208888
NMR metabolomics,X23424.Total Lipids in VLDL,BTNL10,Butyrophilin-like protein 10,37482,0.00249226714750734,0.00396565255350413,-0.00528041185736075,0.0102649461523754,0.529711487322949
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,40422,0.00164553485167701,0.00261927393731582,-0.003488242065462,0.00677931176881602,0.529855165844131
NMR metabolomics,X23424.Total Lipids in VLDL,RAB6B,Ras-related protein Rab-6B,39961,0.00287866501532836,0.00460056243924469,-0.00613843736559124,0.011895767396248,0.531507665363576
NMR metabolomics,X23424.Total Lipids in VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37541,0.00292515020846406,0.00468274975438647,-0.00625303931013341,0.0121033397270615,0.532201790609178
NMR metabolomics,X23424.Total Lipids in VLDL,DDX1,ATP-dependent RNA helicase DDX1,37901,0.00305500547716418,0.0048908188966907,-0.00653099956034959,0.0126410105146779,0.532217371562425
NMR metabolomics,X23424.Total Lipids in VLDL,MUCL3,Mucin-like protein 3,37482,-0.00266601422182658,0.00427047491596296,-0.011036145057114,0.00570411661346082,0.532448166633779
NMR metabolomics,X23424.Total Lipids in VLDL,MORF4L1,Mortality factor 4-like protein 1,37714,-0.00241384307718376,0.00386759800210642,-0.00999433516131233,0.00516664900694482,0.532559886993475
NMR metabolomics,X23424.Total Lipids in VLDL,MAPT,Microtubule-associated protein tau,39961,0.00312314625141313,0.00501100666018764,-0.00669842680255465,0.0129447193053809,0.53312464813752
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC2L,C-type lectin domain family 2 member L,37572,0.00290805968690519,0.00469741151789849,-0.00629886688817585,0.0121149862619862,0.535876347279385
NMR metabolomics,X23424.Total Lipids in VLDL,HK2,Hexokinase-2,40042,-0.00160648477990367,0.00260752915323702,-0.00671724192024822,0.00350427236044088,0.53784104301667
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,40536,0.00169815324255808,0.00277591590749793,-0.00374264193613786,0.00713894842125402,0.540714995725272
NMR metabolomics,X23424.Total Lipids in VLDL,CASQ2,Calsequestrin-2,37562,-0.00288650630218907,0.00475091624234306,-0.0121983021371815,0.00642528953280333,0.543484326601356
NMR metabolomics,X23424.Total Lipids in VLDL,CRYBB2,Beta-crystallin B2,37942,-0.00394504896028546,0.00649692942162925,-0.0166790306266788,0.00878893270610787,0.543716828784671
NMR metabolomics,X23424.Total Lipids in VLDL,KIRREL1,Kin of IRRE-like protein 1,37541,0.00353956106604881,0.00584493126355724,-0.00791650421052337,0.014995626342621,0.544805596494222
NMR metabolomics,X23424.Total Lipids in VLDL,CEP112,Centrosomal protein of 112 kDa,37562,0.00268732893125948,0.0044713407167547,-0.00607649887357972,0.0114511567360987,0.547842458260637
NMR metabolomics,X23424.Total Lipids in VLDL,HMMR,Hyaluronan mediated motility receptor,37460,-0.00276370117179804,0.00461548620509348,-0.0118100541337813,0.00628265179018519,0.549324198491927
NMR metabolomics,X23424.Total Lipids in VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37959,0.00183966617578045,0.00310412156538082,-0.00424441209236597,0.00792374444392686,0.553423491855154
NMR metabolomics,X23424.Total Lipids in VLDL,PRR5,Proline-rich protein 5,37598,0.00270351645990795,0.00456936032195468,-0.00625242977112321,0.0116594626909391,0.554087181152009
NMR metabolomics,X23424.Total Lipids in VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39708,0.00207786135715878,0.00352014065984048,-0.00482161433612855,0.00897733705044611,0.555013073254524
NMR metabolomics,X23424.Total Lipids in VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37482,-0.0047808325439113,0.00815511342016629,-0.0207648548474372,0.0112031897596146,0.55772614209517
NMR metabolomics,X23424.Total Lipids in VLDL,ART5,Ecto-ADP-ribosyltransferase 5,37541,0.00353239352628128,0.00602651947235021,-0.00827958463952514,0.0153443716920877,0.557790496648631
NMR metabolomics,X23424.Total Lipids in VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,37990,-0.00162709463961475,0.00278944494164255,-0.00709440672523415,0.00384021744600464,0.559698327223457
NMR metabolomics,X23424.Total Lipids in VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,37572,-0.00213158056868042,0.00367203530285924,-0.00932876976228453,0.00506560862492368,0.561594052092666
NMR metabolomics,X23424.Total Lipids in VLDL,IL10,Interleukin-10,40044,0.00468445531136147,0.0081102420464254,-0.0112116190996323,0.0205805297223552,0.563544253816168
NMR metabolomics,X23424.Total Lipids in VLDL,IFNL2,Interferon lambda-2,37541,0.00350971367517002,0.00613089399539479,-0.00850683855580377,0.0155262659061438,0.5670177684746
NMR metabolomics,X23424.Total Lipids in VLDL,EVPL,Envoplakin,37714,-0.00185172335631255,0.00326531920854007,-0.00825174900505109,0.00454830229242599,0.570663989805146
NMR metabolomics,X23424.Total Lipids in VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40042,0.00175711981226856,0.00310134144684992,-0.00432150942355728,0.0078357490480944,0.571016098154761
NMR metabolomics,X23424.Total Lipids in VLDL,IL20RB,Interleukin-20 receptor subunit beta,37598,0.00228818023038538,0.00404199756253967,-0.00563413499219237,0.0102104954529631,0.571334556511766
NMR metabolomics,X23424.Total Lipids in VLDL,PCARE,Photoreceptor cilium actin regulator,37541,0.00460914098365105,0.00815593589669133,-0.0113764933738639,0.020594775341166,0.571996954035982
NMR metabolomics,X23424.Total Lipids in VLDL,GIPR,Gastric inhibitory polypeptide receptor,37598,0.00261384537811632,0.00463444994260091,-0.00646967650938146,0.0116973672656141,0.572761461135439
NMR metabolomics,X23424.Total Lipids in VLDL,IL5,Interleukin-5,40044,0.00773851507118166,0.0137558006545973,-0.019222854211829,0.0346998843541923,0.573740056557956
NMR metabolomics,X23424.Total Lipids in VLDL,DLL1,Delta-like protein 1,40411,-0.00152869788467129,0.00275685758629693,-0.00693213875381327,0.00387474298447068,0.579239424944744
NMR metabolomics,X23424.Total Lipids in VLDL,IL3RA,Interleukin-3 receptor subunit alpha,40044,0.00166490336534723,0.00300350320614103,-0.00422196291868918,0.00755176964938364,0.57936748088876
NMR metabolomics,X23424.Total Lipids in VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37714,-0.00334060213239073,0.00603755323901798,-0.015174206480866,0.0084930022160845,0.580064615017926
NMR metabolomics,X23424.Total Lipids in VLDL,PLB1,"Phospholipase B1, membrane-associated",37942,0.00316072314702729,0.00573254484029279,-0.00807506473994657,0.0143965110340012,0.58139279254478
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40042,0.00166030253898464,0.00302173893568948,-0.00426230577496674,0.00758291085293602,0.5827027042016
NMR metabolomics,X23424.Total Lipids in VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37628,-0.00211198657948494,0.00384671140413243,-0.00965154093158451,0.00542756777261463,0.582989417336578
NMR metabolomics,X23424.Total Lipids in VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40359,0.00162904639910801,0.00296751295794958,-0.00418727899847316,0.00744537179668918,0.583040493622083
NMR metabolomics,X23424.Total Lipids in VLDL,OMG,Oligodendrocyte-myelin glycoprotein,40305,-0.00323493690604852,0.00592593935842607,-0.0148497780485636,0.00837990423646658,0.58514623305385
NMR metabolomics,X23424.Total Lipids in VLDL,MFAP3L,Microfibrillar-associated protein 3-like,37572,0.00344804530274563,0.0063558119131249,-0.00900934604697918,0.0159054366524704,0.587481443055753
NMR metabolomics,X23424.Total Lipids in VLDL,NXPE4,NXPE family member 4,37562,-0.00186255846134257,0.00344566828560945,-0.00861606830113709,0.00489095137845195,0.588826477900941
NMR metabolomics,X23424.Total Lipids in VLDL,UGDH,UDP-glucose 6-dehydrogenase,37562,0.00493472481097842,0.00920764254908282,-0.0131122545852239,0.0229817042071808,0.592010547114246
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39961,0.00406562507969965,0.00764311987478316,-0.0109148898748753,0.0190461400342746,0.594780255861667
NMR metabolomics,X23424.Total Lipids in VLDL,TLR1,Toll-like receptor 1,37598,0.00131764520070339,0.00247871611595015,-0.00354063838655892,0.00617592878796569,0.595023306094701
NMR metabolomics,X23424.Total Lipids in VLDL,ZNF830,Zinc finger protein 830,37900,-0.0040469382691763,0.00763904137586285,-0.0190194593658675,0.0109255828275149,0.596279852025308
NMR metabolomics,X23424.Total Lipids in VLDL,TCP11,T-complex protein 11 homolog,37714,-0.00304438620365793,0.0057517354791224,-0.0143177877427378,0.00822901533542197,0.59660710540173
NMR metabolomics,X23424.Total Lipids in VLDL,HRAS,GTPase Hras,37697,-0.00491185358762056,0.00931490026719667,-0.023169058111326,0.0133453509360849,0.597986154727557
NMR metabolomics,X23424.Total Lipids in VLDL,DHODH,Dihydroorotate dehydrogenase,37562,0.00239524465666805,0.00457991525168943,-0.00658138923664322,0.0113718785499793,0.600990843946986
NMR metabolomics,X23424.Total Lipids in VLDL,MLLT1,Protein ENL,37482,0.00352760003365834,0.00678803312897248,-0.00977694489912773,0.0168321449664444,0.603295972385927
NMR metabolomics,X23424.Total Lipids in VLDL,MERTK,Tyrosine-protein kinase Mer,40516,0.00125842888279532,0.00246272058966085,-0.00356850347293995,0.00608536123853059,0.609364146441162
NMR metabolomics,X23424.Total Lipids in VLDL,SPRR1B,Cornifin-B,37714,0.00409047417993767,0.00806478013297747,-0.0117164948806982,0.0198974432405735,0.61202138905218
NMR metabolomics,X23424.Total Lipids in VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37482,-0.00269755015513702,0.00531954357215028,-0.0131238555565516,0.00772875524627753,0.612091969258626
NMR metabolomics,X23424.Total Lipids in VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",37562,-0.00197748829480636,0.00390086123087006,-0.00962317630731168,0.00566819971769897,0.612208016346572
NMR metabolomics,X23424.Total Lipids in VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,40044,0.00178156319336602,0.00353842834570766,-0.00515375636422098,0.00871688275095303,0.614626940888997
NMR metabolomics,X23424.Total Lipids in VLDL,HEBP1,Heme-binding protein 1,40042,0.00257339015122885,0.00513527779929959,-0.00749175433539835,0.012638534637856,0.616293782856469
NMR metabolomics,X23424.Total Lipids in VLDL,PKLR,Pyruvate kinase PKLR,40374,-0.0031301564702697,0.00626079682337378,-0.0154013182440823,0.00914100530354291,0.617109197328826
NMR metabolomics,X23424.Total Lipids in VLDL,IL13,Interleukin-13,40044,0.00225761898737391,0.00452359869288364,-0.00660863445067802,0.0111238724254258,0.617732971798746
NMR metabolomics,X23424.Total Lipids in VLDL,MAG,Myelin-associated glycoprotein,37572,0.00219936701436057,0.00441207036903682,-0.0064482909089516,0.0108470249376727,0.61814802158806
NMR metabolomics,X23424.Total Lipids in VLDL,TPT1,Translationally-controlled tumor protein,40044,0.00310766644292983,0.00627207008762803,-0.0091855909288211,0.0154009238146808,0.620270439392614
NMR metabolomics,X23424.Total Lipids in VLDL,OGN,Mimecan,40332,0.00189816359109622,0.00383521557054032,-0.00561885892716282,0.00941518610935525,0.620656316570088
NMR metabolomics,X23424.Total Lipids in VLDL,RBP1,Retinol-binding protein 1,37572,0.00318872920615103,0.00652132623116448,-0.00959307020693135,0.0159705286192334,0.624871509283003
NMR metabolomics,X23424.Total Lipids in VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37562,0.00276952419749919,0.00568208591259763,-0.00836736419119217,0.0139064125861905,0.625973626093734
NMR metabolomics,X23424.Total Lipids in VLDL,S100A16,Protein S100-A16,39934,0.00285537508548063,0.00586235251765878,-0.00863483584913058,0.0143455860200918,0.626215736578095
NMR metabolomics,X23424.Total Lipids in VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,37572,-0.00364964065558215,0.00750998416862788,-0.0183692096260928,0.0110699283149285,0.626995263787301
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40471,-0.00206851179009867,0.00434423329530039,-0.0105832090488874,0.0064461854686901,0.633973174256822
NMR metabolomics,X23424.Total Lipids in VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37959,0.00190778793067109,0.00402841574104858,-0.00598790692178413,0.00980348278312631,0.635805181466724
NMR metabolomics,X23424.Total Lipids in VLDL,RUVBL1,RuvB-like 1,39980,0.00477122164626738,0.0101291353429579,-0.0150818836259301,0.0246243269184648,0.637619229379954
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX2,Peroxiredoxin-2,37763,0.0027847806645794,0.00592746100577238,-0.00883304290673447,0.0144026042358933,0.638498440163972
NMR metabolomics,X23424.Total Lipids in VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39980,0.00156918225005211,0.00336099733407433,-0.00501837252473357,0.0081567370248378,0.640592325037964
NMR metabolomics,X23424.Total Lipids in VLDL,MFAP3,Microfibril-associated glycoprotein 3,40042,0.00218928806531127,0.00469293839883095,-0.00700887119639739,0.0113874473270199,0.640859240308499
NMR metabolomics,X23424.Total Lipids in VLDL,POF1B,Protein POF1B,37598,-0.0020259963922333,0.00439226955857285,-0.0106348447270361,0.00658285194256949,0.644616748703373
NMR metabolomics,X23424.Total Lipids in VLDL,ZNF174,Zinc finger protein 174,37598,-0.00169339081489022,0.00367721800771813,-0.00890073811001776,0.00551395648023732,0.64515875902515
NMR metabolomics,X23424.Total Lipids in VLDL,CDC123,Cell division cycle protein 123 homolog,37482,0.00275802142827903,0.00607412111799133,-0.00914725596298397,0.014663298819542,0.649792494954629
NMR metabolomics,X23424.Total Lipids in VLDL,CNTF,Ciliary neurotrophic factor,37541,-0.00145555059781827,0.00320663787615398,-0.00774056083508006,0.00482945963944352,0.649895385601084
NMR metabolomics,X23424.Total Lipids in VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,37500,0.0014618436425426,0.00326804561044575,-0.00494352575393107,0.00786721303901627,0.654655544825474
NMR metabolomics,X23424.Total Lipids in VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,37572,-0.00296471825825363,0.00663491799092268,-0.0159691575204621,0.0100397210039548,0.655001064799621
NMR metabolomics,X23424.Total Lipids in VLDL,KLK12,Kallikrein-12,39980,-0.00600527915985174,0.0134998192026619,-0.0324649247970691,0.0204543664773656,0.65644053702992
NMR metabolomics,X23424.Total Lipids in VLDL,DAND5,DAN domain family member 5,37598,-0.00225581534953058,0.00515717756567092,-0.0123638833782456,0.00785225267918442,0.661819206663135
NMR metabolomics,X23424.Total Lipids in VLDL,IL17F,Interleukin-17F,40044,0.00325459629009634,0.00750156983773359,-0.0114484805918615,0.0179576731720542,0.66439947972327
NMR metabolomics,X23424.Total Lipids in VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40471,0.00193234013748984,0.00446611799689664,-0.00682125113642757,0.0106859314114072,0.665262814513048
NMR metabolomics,X23424.Total Lipids in VLDL,IGFL4,Insulin growth factor-like family member 4,37598,-0.00321824263080765,0.00745585284423262,-0.0178317142055036,0.0113952289438883,0.666010325076758
NMR metabolomics,X23424.Total Lipids in VLDL,TSPAN7,Tetraspanin-7,37541,0.00372592142591769,0.00867358114614194,-0.0132742976205205,0.0207261404723559,0.667514597569165
NMR metabolomics,X23424.Total Lipids in VLDL,HDAC9,Histone deacetylase 9,37541,-0.00257232237515713,0.00600432960011371,-0.01434080839138,0.00919616364106574,0.668358781877575
NMR metabolomics,X23424.Total Lipids in VLDL,IL22,Interleukin-22,37900,-0.00261289465074608,0.00616732100477328,-0.0147008438201017,0.00947505451860955,0.671814956779536
NMR metabolomics,X23424.Total Lipids in VLDL,AXL,Tyrosine-protein kinase receptor UFO,40403,0.00108664432475468,0.00258917397870514,-0.00398813667350739,0.00616142532301675,0.674719305571794
NMR metabolomics,X23424.Total Lipids in VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37482,0.00250706255036127,0.00603444071085897,-0.00932044124292232,0.0143345663436449,0.677812783025778
NMR metabolomics,X23424.Total Lipids in VLDL,EXOSC10,Exosome component 10,37562,0.00245722351892767,0.00595191834852711,-0.00920853644418547,0.0141229834820408,0.679726464532029
NMR metabolomics,X23424.Total Lipids in VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37598,0.00109579434613132,0.00266856559373331,-0.00413459421758598,0.00632618290984861,0.681350209616057
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40332,0.00458723080251856,0.0112204948738433,-0.0174049391502143,0.0265794007552514,0.682672821000568
NMR metabolomics,X23424.Total Lipids in VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,37598,0.00162009272470376,0.00398489161036815,-0.00619029483161782,0.00943048028102533,0.684338685490699
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40341,0.00324693596144356,0.00802351123040737,-0.0124791460501549,0.018973017973042,0.685719893526582
NMR metabolomics,X23424.Total Lipids in VLDL,IL4R,Interleukin-4 receptor subunit alpha,40341,-0.00138102979609184,0.00341760327411904,-0.00807953221336516,0.00531747262118148,0.686149720092992
NMR metabolomics,X23424.Total Lipids in VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,37598,0.00356412394750677,0.00888376182681502,-0.0138480492330507,0.0209762971280642,0.688282823836983
NMR metabolomics,X23424.Total Lipids in VLDL,NCLN,Nicalin,40044,-0.00200087843457232,0.00503680592492845,-0.0118730180474321,0.00787126117828745,0.691187486177278
NMR metabolomics,X23424.Total Lipids in VLDL,VASN,Vasorin,40116,0.00102313048552069,0.0025850631060042,-0.00404359320224755,0.00608985417328892,0.692268667322372
NMR metabolomics,X23424.Total Lipids in VLDL,FGF6,Fibroblast growth factor 6,37598,-0.00160194596648673,0.00407468684566741,-0.00958833218399486,0.0063844402510214,0.69421818322041
NMR metabolomics,X23424.Total Lipids in VLDL,HSP90B1,Endoplasmin,39878,-0.00254342968122785,0.00661956899729023,-0.0155177849159167,0.010430925553461,0.700814099960132
NMR metabolomics,X23424.Total Lipids in VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37598,0.0017535376030997,0.00459665008934853,-0.00725589657202342,0.0107629717782228,0.702852059483198
NMR metabolomics,X23424.Total Lipids in VLDL,MYL6B,Myosin light chain 6B,37572,-0.00333009040072679,0.00875741051726975,-0.0204946150145755,0.0138344342131219,0.703758794146676
NMR metabolomics,X23424.Total Lipids in VLDL,IL9,Interleukin-9,37714,0.00205338914823197,0.00544041857771335,-0.0086098312640862,0.0127166095605501,0.705858481419441
NMR metabolomics,X23424.Total Lipids in VLDL,IL2RA,Interleukin-2 receptor subunit alpha,40208,-0.00141338462526091,0.00379515954338982,-0.00885189733030495,0.00602512807978314,0.709586879241602
NMR metabolomics,X23424.Total Lipids in VLDL,EPHA10,Ephrin type-A receptor 10,39961,0.00228414435093891,0.00616388259949918,-0.00979706554407949,0.0143653542459573,0.710963570683718
NMR metabolomics,X23424.Total Lipids in VLDL,SHD,SH2 domain-containing adapter protein D,37531,0.00306742278808751,0.00831897252248483,-0.0132377633559828,0.0193726089321578,0.712337816439283
NMR metabolomics,X23424.Total Lipids in VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37562,0.000891140441702981,0.00243067292859007,-0.00387297849833355,0.00565525938173951,0.713906215168136
NMR metabolomics,X23424.Total Lipids in VLDL,FGF5,Fibroblast growth factor 5,40044,-0.00111359114276345,0.00304057898442262,-0.00707312595223179,0.00484594366670489,0.71418863586102
NMR metabolomics,X23424.Total Lipids in VLDL,AMY2B,Alpha-amylase 2B,39311,0.00166617832579717,0.00454966920509212,-0.00725117331618338,0.0105835299677777,0.714206384349405
NMR metabolomics,X23424.Total Lipids in VLDL,TPBGL,Trophoblast glycoprotein-like,37572,0.00143121989847908,0.00395275131451725,-0.00631617267797473,0.00917861247493289,0.717296624167139
NMR metabolomics,X23424.Total Lipids in VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,37714,-0.00185266560580598,0.00514724034479424,-0.0119412566816027,0.00823592546999074,0.718902396200802
NMR metabolomics,X23424.Total Lipids in VLDL,PRTN3,Myeloblastin,39897,-0.00157800352271407,0.00443130114470154,-0.0102633537663291,0.00710734672090094,0.721767636881949
NMR metabolomics,X23424.Total Lipids in VLDL,SLC39A14,Zinc transporter ZIP14,39961,0.00111612857545595,0.0031498985067429,-0.00505767249776013,0.00728992964867203,0.723090448677297
NMR metabolomics,X23424.Total Lipids in VLDL,ARG2,"Arginase-2, mitochondrial",37900,0.00148229498186514,0.00420371573969396,-0.00675698786793502,0.0097215778316653,0.724382303494898
NMR metabolomics,X23424.Total Lipids in VLDL,TXK,Tyrosine-protein kinase TXK,37714,0.00251949455962895,0.00718045921071132,-0.0115542054933652,0.0165931946126231,0.725682379202933
NMR metabolomics,X23424.Total Lipids in VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37541,0.00200406798696198,0.00571232331731093,-0.00919208571496744,0.0132002216888914,0.72571974946006
NMR metabolomics,X23424.Total Lipids in VLDL,GUCY2C,Heat-stable enterotoxin receptor,37714,-0.00281255051510639,0.00803334448251925,-0.0185579057008441,0.0129328046706313,0.726262053959
NMR metabolomics,X23424.Total Lipids in VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,37541,0.00216918671744215,0.00630807221943371,-0.0101946348326479,0.0145330082675322,0.730946010209304
NMR metabolomics,X23424.Total Lipids in VLDL,SAP18,Histone deacetylase complex subunit SAP18,37714,0.00242283248390778,0.00706788904870662,-0.0114302300515572,0.0162758950193728,0.731758604204247
NMR metabolomics,X23424.Total Lipids in VLDL,LMOD2,Leiomodin-2,37541,0.00209348995558405,0.00615534808136745,-0.00997099228389615,0.0141579721950643,0.733779819429668
NMR metabolomics,X23424.Total Lipids in VLDL,CD177,CD177 antigen,40316,-0.004091431931703,0.012035102753776,-0.027680233329104,0.019497369465698,0.733892503542613
NMR metabolomics,X23424.Total Lipids in VLDL,IFNL1,Interferon lambda-1,39961,0.00145240244322529,0.00427431784489335,-0.00692526053276567,0.00983006541921625,0.73401364533984
NMR metabolomics,X23424.Total Lipids in VLDL,SPINT3,Kunitz-type protease inhibitor 3,37901,0.00412528368770315,0.0121684433390179,-0.0197248652567719,0.0279754326321782,0.734603793173972
NMR metabolomics,X23424.Total Lipids in VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,37598,0.00155083546138173,0.00478174507018771,-0.00782138487618618,0.0109230557989496,0.745697789133269
NMR metabolomics,X23424.Total Lipids in VLDL,CSF2RB,Cytokine receptor common subunit beta,37598,-0.00135268295832528,0.00419385669437915,-0.00957264207930841,0.00686727616265785,0.747049415676321
NMR metabolomics,X23424.Total Lipids in VLDL,PLXDC1,Plexin domain-containing protein 1,39980,0.00101821025245856,0.00319991509875373,-0.00525362334109875,0.00729004384601587,0.750338159511271
NMR metabolomics,X23424.Total Lipids in VLDL,IKZF2,Zinc finger protein Helios,39980,0.00269977978227008,0.0088329086206408,-0.0146127211141859,0.020012280678726,0.759875134970603
NMR metabolomics,X23424.Total Lipids in VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37482,-0.000986028754417039,0.00327099107879873,-0.00739717126886255,0.00542511376002847,0.763078864310915
NMR metabolomics,X23424.Total Lipids in VLDL,STC2,Stanniocalcin-2,40309,-0.000765398121351799,0.00255730488921623,-0.00577771570421561,0.00424691946151202,0.764716041345926
NMR metabolomics,X23424.Total Lipids in VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37482,-0.00171508885525655,0.00574431819842183,-0.0129739525241633,0.00954377481365024,0.765271887203944
NMR metabolomics,X23424.Total Lipids in VLDL,CD70,CD70 antigen,40341,0.00116438663951312,0.00391535459335639,-0.00650970836346539,0.00883848164249164,0.766172794460687
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,37541,-0.00198969984370688,0.00672331878198433,-0.0151674046563962,0.0111880049689824,0.767280497380446
NMR metabolomics,X23424.Total Lipids in VLDL,ESR1,Estrogen receptor,37598,0.0016244315187256,0.00551424230851073,-0.00918348340595543,0.0124323464434066,0.768313017712331
NMR metabolomics,X23424.Total Lipids in VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37562,0.00186750205755875,0.00636601313918601,-0.0106098836952458,0.0143448878103633,0.769255428430532
NMR metabolomics,X23424.Total Lipids in VLDL,CYTH3,Cytohesin-3,37482,0.00203783647793895,0.00698965922272187,-0.0116618955985959,0.0157375685544738,0.770635204758783
NMR metabolomics,X23424.Total Lipids in VLDL,NECTIN4,Nectin-4,40411,-0.000835623672147246,0.0028780888463905,-0.00647667781107262,0.00480543046677813,0.771560083984744
NMR metabolomics,X23424.Total Lipids in VLDL,IL18RAP,Interleukin-18 receptor accessory protein,40128,0.00476033602451674,0.016486009116358,-0.0275522418435449,0.0370729138925784,0.772776473727006
NMR metabolomics,X23424.Total Lipids in VLDL,UPK3BL1,Uroplakin-3b-like protein 1,37692,0.00151770447353186,0.00527400711588711,-0.00881934947360688,0.0118547584206706,0.773526806842128
NMR metabolomics,X23424.Total Lipids in VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37572,-0.00155043261805981,0.0053993322496196,-0.0121331238273142,0.0090322585911946,0.773999967089616
NMR metabolomics,X23424.Total Lipids in VLDL,L1CAM,Neural cell adhesion molecule L1,40411,0.000762290351714277,0.00266491143920887,-0.0044609360691351,0.00598551677256366,0.774845713370892
NMR metabolomics,X23424.Total Lipids in VLDL,PDIA2,Protein disulfide-isomerase A2,37482,-0.00112408197950836,0.00394020796810727,-0.00884688959699862,0.00659872563798189,0.775430386962848
NMR metabolomics,X23424.Total Lipids in VLDL,RANGAP1,Ran GTPase-activating protein 1,39980,-0.00132907831835659,0.00469599027865741,-0.0105332192645251,0.00787506262781194,0.777162152531297
NMR metabolomics,X23424.Total Lipids in VLDL,CRX,Cone-rod homeobox protein,40042,0.00275910452800987,0.0101289571848868,-0.0170936515543683,0.0226118606103881,0.785319857042312
NMR metabolomics,X23424.Total Lipids in VLDL,ENPEP,Glutamyl aminopeptidase,37562,0.00119143455321968,0.00439399658009669,-0.00742079874376982,0.00980366785020919,0.786279519383327
NMR metabolomics,X23424.Total Lipids in VLDL,STEAP4,Metalloreductase STEAP4,37541,-0.00193051251447695,0.00713222207333844,-0.0159096677782203,0.0120486427492664,0.786645457096189
NMR metabolomics,X23424.Total Lipids in VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,39961,-0.00162455262630918,0.00618755964535614,-0.0137521695312072,0.0105030642785888,0.792899828278707
NMR metabolomics,X23424.Total Lipids in VLDL,PMCH,Pro-MCH,37562,-0.00208565232370161,0.00804999885686043,-0.0178636500831481,0.0136923454357448,0.795571965161436
NMR metabolomics,X23424.Total Lipids in VLDL,ABO,Histo-blood group ABO system transferase,37987,0.00352892657175328,0.013625720041746,-0.0231774847100688,0.0302353378535754,0.795646818897235
NMR metabolomics,X23424.Total Lipids in VLDL,EDDM3B,Epididymal secretory protein E3-beta,37900,-0.00100940276055214,0.00403651850797232,-0.00892097903617789,0.0069021735150736,0.802538840584255
NMR metabolomics,X23424.Total Lipids in VLDL,IL2RB,Interleukin-2 receptor subunit beta,40044,0.000914029692636023,0.00366136400585322,-0.00626224375883628,0.00809030314410833,0.802867618193777
NMR metabolomics,X23424.Total Lipids in VLDL,IL31,Interleukin-31,37598,-0.00136694673442208,0.00551322633441104,-0.0121728703498677,0.00943897688102356,0.804185068206025
NMR metabolomics,X23424.Total Lipids in VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37562,-0.00115000344603641,0.00466131770358936,-0.0102861861450715,0.00798617925299874,0.805134909925423
NMR metabolomics,X23424.Total Lipids in VLDL,DBH,Dopamine beta-hydroxylase,37967,-0.00245545712229157,0.00997066439289693,-0.0219979593323696,0.0170870450877864,0.805478399685636
NMR metabolomics,X23424.Total Lipids in VLDL,MORC3,MORC family CW-type zinc finger protein 3,37942,0.000655989012506342,0.00267081903363782,-0.00457881629342379,0.00589079431843647,0.805985231698399
NMR metabolomics,X23424.Total Lipids in VLDL,FGF7,Fibroblast growth factor 7,37482,0.00186781813749955,0.00767822601378714,-0.0131815048495232,0.0169171411245223,0.807806519345128
NMR metabolomics,X23424.Total Lipids in VLDL,CPLX2,Complexin-2,37482,-0.000693929228562691,0.00293615272595919,-0.0064487885714427,0.00506093011431732,0.813172857743833
NMR metabolomics,X23424.Total Lipids in VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,37482,0.00107160007318141,0.00467316549077832,-0.00808780428874409,0.0102310044351069,0.818632163734722
NMR metabolomics,X23424.Total Lipids in VLDL,IL2,Interleukin-2,40044,-0.000675626072611595,0.00295444128973023,-0.00646633100048284,0.00511507885525965,0.819119471947626
NMR metabolomics,X23424.Total Lipids in VLDL,ACHE,Acetylcholinesterase,37671,-0.000686907571264583,0.00301742491925731,-0.00660106041300891,0.00522724527047975,0.81992424014892
NMR metabolomics,X23424.Total Lipids in VLDL,PPT1,Palmitoyl-protein thioesterase 1,37572,0.00167152163654986,0.00739015188119155,-0.0128131760505856,0.0161562193236853,0.821063150734058
NMR metabolomics,X23424.Total Lipids in VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37562,-0.00140508142159565,0.0062501792072913,-0.0136554326678866,0.0108452698246953,0.822133249440035
NMR metabolomics,X23424.Total Lipids in VLDL,CDC25A,M-phase inducer phosphatase 1,37482,-0.000864539822741367,0.00388106074972921,-0.00847141889221063,0.00674233924672789,0.82372684958483
NMR metabolomics,X23424.Total Lipids in VLDL,SELENOP,Selenoprotein P,38013,0.000472950725615324,0.00213355246348063,-0.00370881210280672,0.00465471355403737,0.82457187896399
NMR metabolomics,X23424.Total Lipids in VLDL,FGF3,Fibroblast growth factor 3,37598,0.00063772670262961,0.00288630484997436,-0.00501943080332014,0.00629488420857936,0.825135431441622
NMR metabolomics,X23424.Total Lipids in VLDL,SLC1A4,Neutral amino acid transporter A,37572,-0.0010983708738445,0.00497249171444738,-0.0108444546341614,0.00864771288647237,0.825181962950149
NMR metabolomics,X23424.Total Lipids in VLDL,KRT14,"Keratin, type I cytoskeletal 14",39530,0.000582162980743021,0.0026948320659467,-0.00469970786851251,0.00586403382999855,0.828967745347948
NMR metabolomics,X23424.Total Lipids in VLDL,WFDC12,WAP four-disulfide core domain protein 12,40465,-0.0012852860471633,0.00601622219521705,-0.0130770815497887,0.0105065094554621,0.830833072730568
NMR metabolomics,X23424.Total Lipids in VLDL,TPSD1,Tryptase delta,37959,-0.000753870026820746,0.00361106312457772,-0.00783155375099307,0.00632381369735158,0.834633452380426
NMR metabolomics,X23424.Total Lipids in VLDL,OMP,Olfactory marker protein,37541,0.00100063919741388,0.00479552009459403,-0.00839858018799042,0.0103998585828182,0.834715942358683
NMR metabolomics,X23424.Total Lipids in VLDL,FGF20,Fibroblast growth factor 20,37598,0.000882303384769504,0.00423482372054958,-0.00741795110750766,0.00918255787704667,0.834963002846462
NMR metabolomics,X23424.Total Lipids in VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39961,0.000904182340489015,0.00437585672382905,-0.00767249683821592,0.00948086151919395,0.836301708519117
NMR metabolomics,X23424.Total Lipids in VLDL,BRD2,Bromodomain-containing protein 2,37541,0.00066471612016916,0.0032703895781587,-0.0057452474530219,0.00707467969336022,0.838940537830999
NMR metabolomics,X23424.Total Lipids in VLDL,DIPK1C,Divergent protein kinase domain 1C,37572,-0.000821181857235305,0.00406257617702077,-0.00878383116419601,0.0071414674497254,0.839815663344007
NMR metabolomics,X23424.Total Lipids in VLDL,SLITRK1,SLIT and NTRK-like protein 1,37598,0.000613224086163819,0.00305020076810447,-0.00536516941932094,0.00659161759164858,0.840667401970361
NMR metabolomics,X23424.Total Lipids in VLDL,HBZ,Hemoglobin subunit zeta,37990,0.00178007461612539,0.0099215766732963,-0.0176662156635354,0.0212263648957861,0.85761493985331
NMR metabolomics,X23424.Total Lipids in VLDL,NOS2,"Nitric oxide synthase, inducible",37562,-0.000663639342027339,0.00372192139301645,-0.00795860527233958,0.0066313265882849,0.85848575411442
NMR metabolomics,X23424.Total Lipids in VLDL,COL4A4,Collagen alpha-4(IV) chain,37688,-0.000883615810948119,0.0049668306864108,-0.0106186039563133,0.00885137233441705,0.858801603479901
NMR metabolomics,X23424.Total Lipids in VLDL,CD82,CD82 antigen,37714,-0.000698996893510475,0.0039626232251272,-0.00846573841475978,0.00706774462773883,0.859984349518763
NMR metabolomics,X23424.Total Lipids in VLDL,LRP2BP,LRP2-binding protein,37572,0.00144160321622376,0.00822270058300804,-0.014674889926472,0.0175580963589195,0.860830965027335
NMR metabolomics,X23424.Total Lipids in VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,37482,0.00231598837712961,0.013408776034962,-0.0239652126513958,0.0285971894056551,0.862872764012299
NMR metabolomics,X23424.Total Lipids in VLDL,NOS1,"Nitric oxide synthase, brain",39961,0.000804133500096315,0.00470267091261997,-0.00841310148863883,0.0100213684888315,0.864229879774872
NMR metabolomics,X23424.Total Lipids in VLDL,PALLD,Palladin,37598,0.000668903881447655,0.00393253416256661,-0.00703886307718289,0.0083766708400782,0.864938146462253
NMR metabolomics,X23424.Total Lipids in VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,40424,0.000333322279340422,0.00197615342057942,-0.00353993842499525,0.00420658298367609,0.866056568970961
NMR metabolomics,X23424.Total Lipids in VLDL,PFDN6,Prefoldin subunit 6,37572,0.00104676098191548,0.00625975338914719,-0.011222355660813,0.013315877624644,0.867198894394312
NMR metabolomics,X23424.Total Lipids in VLDL,PRC1,Protein regulator of cytokinesis 1,37900,-0.000730562116117268,0.00441188786999999,-0.00937786234131724,0.0079167381090827,0.868482534064168
NMR metabolomics,X23424.Total Lipids in VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37959,-0.00041450505657928,0.00251872656799486,-0.00535120912984921,0.00452219901669065,0.869285462954634
NMR metabolomics,X23424.Total Lipids in VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,37714,-0.00103546841169704,0.00636009080783503,-0.0135012463950537,0.0114303095716596,0.870672740031347
NMR metabolomics,X23424.Total Lipids in VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37714,0.000770494974322721,0.00478459074382782,-0.00860730288357982,0.0101482928322253,0.87206690386701
NMR metabolomics,X23424.Total Lipids in VLDL,VNN2,Vascular non-inflammatory molecule 2,40305,-0.000679235851148972,0.00422874888354776,-0.00896758366290258,0.00760911196060464,0.872392102359089
NMR metabolomics,X23424.Total Lipids in VLDL,CHGB,Secretogranin-1,40406,-0.000604733131976201,0.0037977788858351,-0.00804837974821299,0.00683891348426059,0.873487029120807
NMR metabolomics,X23424.Total Lipids in VLDL,SHC1,SHC-transforming protein 1,37482,0.00166242422535335,0.0110657558464676,-0.0200264572337231,0.0233513056844297,0.880584362148006
NMR metabolomics,X23424.Total Lipids in VLDL,FH,"Fumarate hydratase, mitochondrial",37541,0.00120039016802857,0.00810157462754622,-0.014678696101962,0.0170794764380192,0.882212851633769
NMR metabolomics,X23424.Total Lipids in VLDL,HCG22,Protein PBMUCL2,37562,0.000746464441775859,0.00506054225959257,-0.00917219838702557,0.0106651272705773,0.882734273861676
NMR metabolomics,X23424.Total Lipids in VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,37598,-0.000562244508948174,0.00388673148773815,-0.00818023822491494,0.0070557492070186,0.884983585102893
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,37541,0.00101016290673962,0.00698969751856613,-0.01268964422965,0.0147099700431292,0.885090754183553
NMR metabolomics,X23424.Total Lipids in VLDL,NELL1,Protein kinase C-binding protein NELL1,40411,-0.000566222513105755,0.00399963789713553,-0.00840551279149139,0.00727306776527988,0.887422680900026
NMR metabolomics,X23424.Total Lipids in VLDL,PGR,Progesterone receptor,37598,-0.0013758249095489,0.00980815801457367,-0.0205998146181133,0.0178481647990155,0.888446029636648
NMR metabolomics,X23424.Total Lipids in VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,37998,0.000384545998832836,0.00279203798954034,-0.00508784846066623,0.00585694045833191,0.890456250303262
NMR metabolomics,X23424.Total Lipids in VLDL,FOLR3,Folate receptor gamma,40355,-0.00238210102772729,0.0173554522705459,-0.0363987874779973,0.0316345854225427,0.890831958572951
NMR metabolomics,X23424.Total Lipids in VLDL,TFAP2A,Transcription factor AP-2-alpha,37541,-0.000764084551579602,0.00574222439165219,-0.0120188443592179,0.0104906752560587,0.894144645316821
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,40536,0.000360739722537961,0.00272553744551894,-0.00498131367067916,0.00570279311575508,0.894704809615574
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC1A,C-type lectin domain family 1 member A,40042,0.000401652972394701,0.00311353345753024,-0.00570087260436457,0.00650417854915397,0.897357494218957
NMR metabolomics,X23424.Total Lipids in VLDL,C9orf40,Uncharacterized protein C9orf40,37901,0.000979015168532395,0.00778436822194218,-0.0142783465464743,0.0162363768835391,0.899918393835894
NMR metabolomics,X23424.Total Lipids in VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,37562,-0.000574526608433052,0.00460771412738894,-0.00960564629811536,0.00845659308124926,0.900772478286841
NMR metabolomics,X23424.Total Lipids in VLDL,BMP10,Bone morphogenetic protein 10,37671,-0.000297326190744827,0.00271135845925184,-0.00561158877087844,0.00501693638938878,0.912681092035199
NMR metabolomics,X23424.Total Lipids in VLDL,ZP3,Zona pellucida sperm-binding protein 3,37628,-0.00270925037592736,0.0248377389826127,-0.0513912187818482,0.0459727180299935,0.913142301767252
NMR metabolomics,X23424.Total Lipids in VLDL,IGLON5,IgLON family member 5,37482,-0.000947757464333552,0.00892542356750456,-0.0184415876566425,0.0165460727279754,0.915436196495186
NMR metabolomics,X23424.Total Lipids in VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,37714,0.000412363076179953,0.00389732306394646,-0.00722639012915512,0.00805111628151502,0.915737283589823
NMR metabolomics,X23424.Total Lipids in VLDL,SKIV2L,Helicase SKI2W,37562,0.000395569331220884,0.00384512432092968,-0.00714087433780128,0.00793201300024305,0.918063305759316
NMR metabolomics,X23424.Total Lipids in VLDL,CLINT1,Clathrin interactor 1,37482,0.000444738565562963,0.0043514769827894,-0.00808415632070426,0.00897363345183018,0.918596286865091
NMR metabolomics,X23424.Total Lipids in VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37541,-0.000326657203503921,0.00320761833902595,-0.00661358914799478,0.00596027474098694,0.918886880369535
NMR metabolomics,X23424.Total Lipids in VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,37541,0.000525032518386979,0.00546597506519943,-0.0101882786094039,0.0112383436461779,0.923478610715704
NMR metabolomics,X23424.Total Lipids in VLDL,CASP4,Caspase-4,37714,-0.00153910432090854,0.0161651825949081,-0.0332228622069285,0.0301446535651114,0.924148616355158
NMR metabolomics,X23424.Total Lipids in VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37562,0.000483006215269185,0.00512316489478943,-0.0095583969785181,0.0105244094090565,0.924889072413215
NMR metabolomics,X23424.Total Lipids in VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,37541,0.000262390221798248,0.00283891300864537,-0.00530187927514668,0.00582665971874318,0.92636075999511
NMR metabolomics,X23424.Total Lipids in VLDL,TPSG1,Tryptase gamma,37598,0.000235969686186603,0.00258535810782154,-0.00483133220514361,0.00530327157751682,0.92727820041353
NMR metabolomics,X23424.Total Lipids in VLDL,IL3,Interleukin-3,37482,-0.000518858086101132,0.0057043189605741,-0.0116993232488264,0.0106616070766241,0.927526715345065
NMR metabolomics,X23424.Total Lipids in VLDL,DCDC2C,Doublecortin domain-containing protein 2C,37482,0.000544007188609613,0.00601606172089787,-0.0112474737843502,0.0123354881615694,0.927950245850049
NMR metabolomics,X23424.Total Lipids in VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,37598,-0.00042622728419578,0.00520122792944685,-0.0106206340259116,0.00976817945752004,0.934689761685389
NMR metabolomics,X23424.Total Lipids in VLDL,KCNIP4,Kv channel-interacting protein 4,39961,0.000389183520786373,0.00484155608068412,-0.00910026639735451,0.00987863343892726,0.935932909296274
NMR metabolomics,X23424.Total Lipids in VLDL,CBLN1,Cerebellin-1,37541,0.000704788015774353,0.00929255294546253,-0.0175086157573322,0.0189181917888809,0.939544058310601
NMR metabolomics,X23424.Total Lipids in VLDL,KLK3,Prostate-specific antigen,37998,-0.000371918820050183,0.00540770016818224,-0.0109710111496874,0.010227173509587,0.9451691089378
NMR metabolomics,X23424.Total Lipids in VLDL,EPB41L5,Band 4.1-like protein 5,37572,0.000411251027191913,0.00602880264679423,-0.0114052021605248,0.0122277042149086,0.945616020539649
NMR metabolomics,X23424.Total Lipids in VLDL,FOS,Proto-oncogene c-Fos,37457,0.000226895572965526,0.00332688116132309,-0.00629379150322773,0.00674758264915878,0.945626930445711
NMR metabolomics,X23424.Total Lipids in VLDL,PRG3,Proteoglycan 3,37998,0.000314469851758001,0.00473437572554868,-0.00896490657031741,0.00959384627383341,0.947042306408246
NMR metabolomics,X23424.Total Lipids in VLDL,LY96,Lymphocyte antigen 96,40228,-0.00021604618247341,0.00327019440598959,-0.006625627218213,0.00619353485326618,0.947326720944884
NMR metabolomics,X23424.Total Lipids in VLDL,PLXDC2,Plexin domain-containing protein 2,37942,0.000166290252661811,0.00252443408362445,-0.00478160055124211,0.00511418105656573,0.947480478589099
NMR metabolomics,X23424.Total Lipids in VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,37541,-0.000241613143207164,0.00380427014109793,-0.00769798261975911,0.00721475633334478,0.949360540235404
NMR metabolomics,X23424.Total Lipids in VLDL,DPEP2,Dipeptidase 2,40305,-0.000159046995193276,0.00270109999641027,-0.00545320298815741,0.00513510899777086,0.953046593919927
NMR metabolomics,X23424.Total Lipids in VLDL,TNPO1,Transportin-1,37714,0.000194071518795521,0.0033574696623407,-0.00638656901939224,0.00677471205698329,0.953906490562372
NMR metabolomics,X23424.Total Lipids in VLDL,PODXL2,Podocalyxin-like protein 2,40411,-0.000147472356109354,0.00256982267906807,-0.00518432480708277,0.00488938009486406,0.954238274788209
NMR metabolomics,X23424.Total Lipids in VLDL,TMPRSS11B,Transmembrane protease serine 11B,37541,0.000392904718822043,0.00743927607787682,-0.0141880763938165,0.0149738858314606,0.957880185221227
NMR metabolomics,X23424.Total Lipids in VLDL,KHDC3L,KH domain-containing protein 3,37482,-0.000335613151748845,0.00646350571180126,-0.0130040843468793,0.0123328580433816,0.958589790220665
NMR metabolomics,X23424.Total Lipids in VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,37687,0.000213806636875614,0.00478664106301614,-0.00916800984663601,0.00959562312038724,0.964373121648751
NMR metabolomics,X23424.Total Lipids in VLDL,INSL3,Insulin-like 3,37942,-0.000244150584969863,0.00564017758922865,-0.011298898659858,0.0108105974899183,0.965472798587337
NMR metabolomics,X23424.Total Lipids in VLDL,CDSN,Corneodesmosin,40456,-0.000175068424136609,0.00406483060856286,-0.00814213641691982,0.0077919995686466,0.965647022056361
NMR metabolomics,X23424.Total Lipids in VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37572,-0.000160134488624156,0.00391093532386797,-0.00782556772340539,0.00750529874615707,0.967340112596616
NMR metabolomics,X23424.Total Lipids in VLDL,GAL,Galanin peptides,40422,-0.000225600216449314,0.00587589235270341,-0.011742349227748,0.0112911487948494,0.969373861101839
NMR metabolomics,X23424.Total Lipids in VLDL,CCDC50,Coiled-coil domain-containing protein 50,37959,-0.000279780288334101,0.00741312267298678,-0.0148095007273882,0.01424994015072,0.969894568914949
NMR metabolomics,X23424.Total Lipids in VLDL,SUSD4,Sushi domain-containing protein 4,37900,0.000143069624238085,0.00421736674961223,-0.00812296920500189,0.00840910845347806,0.972938319960814
NMR metabolomics,X23424.Total Lipids in VLDL,EFNB2,Ephrin-B2,37572,0.000181994080633396,0.00548081602170782,-0.0105604053219139,0.0109243934831807,0.973511094462904
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",37959,-0.000114137868838983,0.00348856575250896,-0.00695172674375655,0.00672345100607859,0.973900187489348
NMR metabolomics,X23424.Total Lipids in VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,37541,-0.000144152625320733,0.00478065686426449,-0.00951424007927914,0.00922593482863767,0.975945245052459
NMR metabolomics,X23424.Total Lipids in VLDL,MORN4,MORN repeat-containing protein 4,37482,-0.000187393258904564,0.00747529130493817,-0.0148389642165834,0.0144641776987742,0.980000824883534
NMR metabolomics,X23424.Total Lipids in VLDL,MAGEA3,Melanoma-associated antigen 3,37714,0.00016595700880871,0.00800052260597941,-0.0155150672989109,0.0158469813165283,0.983450763204029
NMR metabolomics,X23424.Total Lipids in VLDL,IL4,Interleukin-4,40044,0.000148274283296569,0.00847223604058517,-0.0164573083562504,0.0167538569228435,0.986037000787832
NMR metabolomics,X23424.Total Lipids in VLDL,BCAN,Brevican core protein,40228,3.55526448586677e-05,0.00315875072151575,-0.0061555987693122,0.00622670405902954,0.99101991247094
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJA4,DnaJ homolog subfamily A member 4,37942,6.87339410302485e-05,0.00673196027784026,-0.0131259082035367,0.0132633760855972,0.991853816885497
NMR metabolomics,X23424.Total Lipids in VLDL,RBM25,RNA-binding protein 25,37482,-3.91491709968337e-05,0.0043898884245019,-0.00864333048302056,0.00856503214102689,0.992884669789565
NMR metabolomics,X23424.Total Lipids in VLDL,HTR1A,5-hydroxytryptamine receptor 1A,37541,6.42912069014731e-05,0.00766024796335342,-0.0149497948012712,0.0150783772150742,0.993303692045929
NMR metabolomics,X23424.Total Lipids in VLDL,EPGN,Epigen,37900,-1.90163972938005e-05,0.00467880233612076,-0.00918946897609049,0.00915143618150289,0.996757168849313
NMR metabolomics,X23424.Total Lipids in VLDL,GAD2,Glutamate decarboxylase 2,37598,-1.25688585511824e-05,0.00448748271926449,-0.00880803498830958,0.00878289727120721,0.997765273988241
NMR metabolomics,X23424.Total Lipids in VLDL,TET2,Methylcytosine dioxygenase TET2,37697,2.64092788411338e-05,0.00953062446163592,-0.0186536146659653,0.0187064332236475,0.997789113269147
